<SEC-DOCUMENT>0001171520-23-000181.txt : 20230525
<SEC-HEADER>0001171520-23-000181.hdr.sgml : 20230525
<ACCEPTANCE-DATETIME>20230525085301
ACCESSION NUMBER:		0001171520-23-000181
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		69
CONFORMED PERIOD OF REPORT:	20230228
FILED AS OF DATE:		20230525
DATE AS OF CHANGE:		20230525

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SONO TEK CORP
		CENTRAL INDEX KEY:			0000806172
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIAL INDUSTRY MACHINERY, NEC [3559]
		IRS NUMBER:				141568099
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			0228

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40763
		FILM NUMBER:		23956410

	BUSINESS ADDRESS:	
		STREET 1:		2012 RT 9W BLDG 3
		CITY:			MILTON
		STATE:			NY
		ZIP:			12547
		BUSINESS PHONE:		8457952020

	MAIL ADDRESS:	
		STREET 1:		2012 RT. 9W, BLDG. 3,
		CITY:			MILTON
		STATE:			NY
		ZIP:			12547
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>eps10796_sotk.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:sotk="http://sono-tek.com/20230228">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_sotk_sono%2Dtek.com_20230228 -->
<!-- Field: Set; Name: xdx; ID: xdx_041_20220301_20230228 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0000806172 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DDocumentFiscalYearFocus_2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentAnnualReport_true -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DDocumentTransitionReport_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_07A_SO_eps10796__sotk.xdxs -->
<body style="font: 11pt Cambria,Times New Roman, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityCentralIndexKey">0000806172</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:DocumentAnnualReport">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:DocumentTransitionReport">false</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2021-03-012022-02-28" id="xdx2ixbrl0192" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="sotk:GainFromForgivenessOfPaycheckProtectionProgramLoan" contextRef="From2022-03-01to2023-02-28" id="xdx2ixbrl0194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-03-012022-02-28" id="xdx2ixbrl0233" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-03-01to2023-02-28" id="xdx2ixbrl0264" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="sotk:AccountsReceivableReserve" contextRef="From2021-03-012022-02-28" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="sotk:PaycheckProtectionProgramLoanForgiveness" contextRef="From2022-03-01to2023-02-28" id="xdx2ixbrl0301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-03-01to2023-02-28" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-03-01to2023-02-28" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-03-01to2023-02-28" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-03-012022-02-28" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-02-28_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2022-02-28_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2022-03-01to2023-02-28" id="xdx2ixbrl0811" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" id="xdx2ixbrl0835" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="sotk:CapitalizedRdExpensesIrcSection174" contextRef="AsOf2022-02-28" id="xdx2ixbrl0855" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sotk-20230228.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-03-01to2023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:EquipmentAndFurnishingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:EquipmentAndFurnishingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_FluxingSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:FluxingSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_FluxingSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:FluxingSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_IntegratedCoatingSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:IntegratedCoatingSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_IntegratedCoatingSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:IntegratedCoatingSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_MultiAxisCoatingSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:MultiAxisCoatingSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_MultiAxisCoatingSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:MultiAxisCoatingSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_OemSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OemSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_OemSystemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OemSystemsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_OtherProductLineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OtherProductLineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_OtherProductLineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OtherProductLineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_ProductLineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:ProductLineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_ProductLineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:ProductLineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sotk:TwoThousandThirteenStockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sotk:TwoThousandThirteenStockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_NonEmployeeDirectorsStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:NonEmployeeDirectorsStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_NonEmployeeDirectorsStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:NonEmployeeDirectorsStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-012021-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-01</xbrli:startDate>
        <xbrli:endDate>2021-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_LaboratoryEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:LaboratoryEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_custom_LaboratoryEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:LaboratoryEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_TradeshowAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:TradeshowAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_custom_TradeshowAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:TradeshowAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_LetterOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_LetterOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_UnsecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-30_us-gaap_UnsecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_srt_AsiaPacificMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_srt_AsiaPacificMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_MiddleEastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_srt_LatinAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_srt_LatinAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sotk:ForeignCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sotk:ForeignCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_TwoCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:TwoCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_custom_ThreeCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:ThreeCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_ThreeCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:ThreeCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012022-02-28_custom_TwoCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000806172</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:TwoCustomersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2022-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
Washington, D.C. 20549</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 13pt Cambria,serif; margin: 0; text-align: center"><b>FORM <span id="xdx_90F_edei--DocumentType_c20220301__20230228_z2mNoidopq9"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)<br />
OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">For the Fiscal Year ended: <b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20220301__20230228_zvvNimIf7MGa"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_905_edei--CurrentFiscalYearEndDate_c20220301__20230228_zWgvnM1nGYX3"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">February 28</ix:nonNumeric></span>, 2023</ix:nonNumeric></span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">Commission File Number: <b><span id="xdx_909_edei--EntityFileNumber_c20220301__20230228_zNsUlDlr8DCl"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityFileNumber">000-16035</ix:nonNumeric></span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 9pt Sans-Serif; margin: 0; text-align: center; color: Red"><img src="sotk-logo.jpg" alt="" style="height: 0.56in; width: 6.5in" /></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">(Name of registrant as specified in its charter)</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;<span id="xdx_90F_edei--EntityRegistrantName_c20220301__20230228_z3Ez43gNyR85" style="display: none"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityRegistrantName">Sono Tek Corp</ix:nonNumeric></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 52%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt; text-transform: uppercase"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20220301__20230228_z9LgdAO52ve9"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">new york</ix:nonNumeric></span></b></span></td>
    <td style="width: 48%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20220301__20230228_zvKFfTlm1SOa"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityTaxIdentificationNumber">14-1568099</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt">(State or other Jurisdiction of<br />
Incorporation or Organization)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt">(IRS Employer Identification Number)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20220301__20230228_zNxQHgtxPi76"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityAddressAddressLine1">2012 Route 9W</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressCityOrTown_c20220301__20230228_zoHj7iE5pbD2"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityAddressCityOrTown">Milton</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20220301__20230228_zTS7sNpLypf2"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20220301__20230228_zKNKhj9u8oL1"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityAddressPostalZipCode">12547</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; text-align: center; margin-top: 0; margin-bottom: 0">Registrant's Telephone Number, Including Area Code: <b><span id="xdx_90D_edei--CityAreaCode_c20220301__20230228_zBwCWGocEnU6"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:CityAreaCode">(845)</ix:nonNumeric></span> <span id="xdx_901_edei--LocalPhoneNumber_c20220301__20230228_zYfcUcDvknHe"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:LocalPhoneNumber">795-2020</ix:nonNumeric></span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">Securities Registered Pursuant to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr>
    <td style="vertical-align: bottom; width: 33%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Title of each class</span></b></span></td>
    <td style="vertical-align: bottom; width: 34%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Trading Symbol(s)</span></b></span></td>
    <td style="vertical-align: top; width: 33%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Name of each exchange <br />
<span style="text-decoration: underline">on which registered</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90A_edei--Security12bTitle_c20220301__20230228_zds8WO0TWSBk"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:Security12bTitle">Common Stock $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_901_edei--TradingSymbol_c20220301__20230228_zwfKwdEgUAUa"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:TradingSymbol">SOTK</ix:nonNumeric></span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_904_edei--SecurityExchangeName_c20220301__20230228_z4QliqdmXZCi"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span><br />
(Capital Market)</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">Securities Registered Pursuant to Section 12(g) of the Act: None</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">Indicate by check mark if the registrant
is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160;&#9744;&#160;&#160;<span id="xdx_900_edei--EntityWellKnownSeasonedIssuer_c20220301__20230228_z6YqjmyCRICg"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>&#160;&#9745;</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">Indicate by check mark if the registrant
is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes&#160;&#9744;&#160;&#160;<span id="xdx_90B_edei--EntityVoluntaryFilers_c20220301__20230228_zkXldYigRmje"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>&#160;&#9745;</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. <span id="xdx_900_edei--EntityCurrentReportingStatus_c20220301__20230228_z41mjDHc7nb8"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;&#9745;&#160;&#160;No&#160;&#9744;</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <span id="xdx_90D_edei--EntityInteractiveDataCurrent_c20220301__20230228_zHRMfTa2g6M7"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;&#9745;&#160;&#160;No&#160;&#9744;</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated
filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#34;emerging growth company&#34; in Rule
12b-2 of the Exchange Act.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 30%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Large Accelerated Filer &#9744;</span></td>
    <td style="width: 37%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Accelerated Filer &#9744;</span></td>
    <td style="width: 33%; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_905_edei--EntityFilerCategory_c20220301__20230228_z13dO7CWpHT1"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span> &#9745;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Smaller reporting company <span id="xdx_90D_edei--EntitySmallBusiness_c20220301__20230228_zwumG0LEvmOf"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9745;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Emerging growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20220301__20230228_zJhqpV8M67rh"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. <span id="xdx_903_edei--IcfrAuditorAttestationFlag_c20220301__20230228_z4zkHpfg0Yr"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt:booleanfalse" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">If securities are registered pursuant
to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect
the correction of an error to previously issued financial statements. <span id="xdx_909_edei--DocumentFinStmtErrorCorrectionFlag_c20220301__20230228_zO23YyM21aXg"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt:booleanfalse" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 11pt Segoe UI Symbol,sans-serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">Indicate by check mark whether any of
those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). &#9744;</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman,serif; margin: 0"><span style="font-family: Cambria,serif">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;&#9744;&#160;&#160;<span id="xdx_90C_edei--EntityShellCompany_c20220301__20230228_z4kRM4TDLG72"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span>&#160;&#9745;</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">As of August 31, 2022 the last business day of the Registrant&#8217;s most recently completed
second fiscal quarter, the aggregate market value of the Registrant's Common Stock held by non-affiliates of the Registrant was approximately
$<span id="xdx_909_edei--EntityPublicFloat_iI_c20230831_z9uE787k2Cpk"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2023-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,462,747</ix:nonFraction></span> computed by reference to the average of the bid and asked prices of the Common Stock on said date, which average was $5.52.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">The Registrant had <span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_c20230523_zNmekD38C7P2"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-05-23" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,742,073</ix:nonFraction></span> shares of Common Stock outstanding as of May 23, 2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">DOCUMENTS INCORPORATED BY REFERENCE: <span id="xdx_901_edei--DocumentsIncorporatedByReferenceTextBlock_c20220301__20230228_z1F2kvHHgfIb"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="dei:DocumentsIncorporatedByReferenceTextBlock">None.</ix:nonNumeric></span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0 0 8pt; text-align: center"><b>TABLE OF CONTENTS </b></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Cambria,Times New Roman,serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 10%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 84%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3"><span style="font-family: Cambria,serif; font-size: 11pt">PART I</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 1.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item1">Business</a>.</span></td>
    <td>1</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 1A.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item1a">Risk Factors</a>.</span></td>
    <td>5&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 1B.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item1b">Unresolved Staff Comments</a>.</span></td>
    <td>20&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 2.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item2">Properties</a>.</span></td>
    <td>20&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 3.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item3">Legal Proceedings</a>.</span></td>
    <td>20&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 4.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item4">Mine Safety Disclosures</a>.</span></td>
    <td>20&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3"><span style="font-family: Cambria,serif; font-size: 11pt">PART II</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 5.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item5">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a>.</span></td>
    <td>21&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 6.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">[Reserved].</span></td>
    <td>21&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 7.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item7">Management's Discussion and Analysis of Financial Condition and Results of Operations</a>.</span></td>
    <td>21&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 7A.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item7a">Quantitative and Qualitative Disclosures about Market Risk</a></span></td>
    <td>28&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 8.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item8">Financial Statements and Supplementary Data</a></span></td>
    <td>28&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 9.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item9">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>
    <td>28&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 9A.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item9a">Controls and Procedures</a>.</span></td>
    <td>29&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 9B.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item9b">Other Information</a>.</span></td>
    <td>29&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 9C.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item9c">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a>.</span></td>
    <td>29</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3"><span style="font-family: Cambria,serif; font-size: 11pt">PART III</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 10.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item10">Directors, Executive Officers and Corporate Governance</a>.</span></td>
    <td>30&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 11.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item11">Executive Compensation</a>.</span></td>
    <td>34&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 12.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item12">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a>.</span></td>
    <td>37&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 13.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item13">Certain Relationships and Related Transactions</a>.</span></td>
    <td>38&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 14.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item14">Principal Accountant Fees and Services</a>.</span></td>
    <td>39&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Item 15.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item15">Exhibits, Financial Statement Schedules</a></span></td>
    <td>40&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; font-family: Times New Roman,serif">&#160;</td>
    <td style="vertical-align: top; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Item 16.</span></td>
    <td style="vertical-align: top; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><a href="#item16">Form 10-K Summary</a>.</span></td>
    <td>41&#160;</td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>PART I</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item1"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 1</span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>BUSINESS</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 11pt 0; text-align: justify">Sono-Tek Corporation (the &#8220;Company&#8221;, &#8220;Sono-Tek&#8221;,
&#8220;We&#8221; or &#8220;Our&#8221;) is the world leader in the design and manufacture of ultrasonic coating systems for applying precise,
thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics,
alternative energy, medical, industrial and emerging research &amp; development/other markets. We design and manufacture custom-engineered
ultrasonic coating systems incorporating our patented technology, in combination with strong applications engineering knowledge, to assist
our customers in achieving their desired coating solutions.</p>

<p style="font: 11pt Cambria,serif; margin: 0 0 6pt; text-align: justify">Our ultrasonic nozzle systems use high frequency ultrasonic
vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing microscopic layers of protective
and other useful materials over a wide variety of surfaces, including glass and metals. Our equipment solutions are environmentally-friendly,
efficient and highly reliable. They enable dramatic reductions in overspray, savings in raw materials, water and energy usage and provide
improved process repeatability, transfer efficiency, high uniformity and reduced emissions. We serve a variety of industries and applications
and have a broad base of customers.</p>

<p style="font: 11pt Cambria,serif; margin: 0 0 6pt; text-align: justify">The applications that are employing our unique coating technology
and expertise have been expanding as the advantages of ultrasonic coatings are more broadly recognized. The original application of our
technology was to coat the inner surface of blood collection tubes used for medical diagnostic testing. Our products enable the application
of a thin and uniform coating of material that prevents coagulation of blood. Following that initial breakthrough, our technology was
then used for applying uniform flux coatings to printed circuit boards, a critical part of the fabrication process for all electronic
devices. A later application for much larger surfaces was to address the many challenges that glass manufacturers faced. They needed a
solution for specialized glass applications in the construction and automotive industries. Among other things, our ultrasonic nozzles
are used to provide coatings that improve durability, create filters, increase clarity, reduce reflection, enable conductivity, and enhance
safety. We have invested significant resources to enhance our market diversity by leveraging our core ultrasonic coating technology. As
a result, we have increased our portfolio of products, the industries we serve, and the countries in which we sell our products.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We were founded by the inventor of the ultrasonic nozzle, Dr. Harvey
Berger, and incorporated in New York on March 21, 1975. We became a public company in 1987 and our stock is traded on the Nasdaq Capital
Market. Our corporate offices are located in Milton, New York where our production facilities are co-located. We also have a sales and
service office in Singapore and an application process development laboratory in Guangzhou, China. We are ISO 9001 qualified since registering
in September 1998 and have been recertified annually since then.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our fiscal year ends on February 28. We refer to the fiscal year ended
February 28, 2023 as &#8220;fiscal 2023&#8221; and use similar protocol for previous fiscal years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Our Products, Markets and Customers</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our products are used in a wide range of applications. We provide
our customers a broad offering of ultrasonic spray coating equipment solutions custom suited for their requirements and we continually
expand our offerings to address new applications. Our products include fully integrated Multi-Axis Coating Systems, Integrated Coating
Systems, Fluxing Systems, OEM Systems and other related systems. We invest heavily in research and development to continually bring to
market new solutions for our customers, to increase our market share and to solve high value problems in manufacturing.</p>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our Multi-Axis Coating Systems, Integrated Coating Systems and Fluxing
Systems provide complete fully integrated solutions for our customers, while we created the Universal Align to offer our customers subsystems
that integrate our nozzles and generators that they can then incorporate into their original equipment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We have built our brand and reputation on providing high quality,
highly reliable products that provide consistent performance for critical applications in demanding operating environments. Our surface
coating solutions are used in 24/7 work schedules, under harsh and challenging manufacturing environments, where they provide value in
a continuous and dependable fashion.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We target the following markets where our product quality and consistency
and application knowledge are valued by our customers:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>Micro-Electronics/Electronics:</b></span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Printed circuit boards: Ultrasonic flux application removes oxidation and is more efficient than standard, historic processes</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Semiconductors: Applications of micron-thin photo-resist layers onto complex wafers</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Sensors: Application of chemical, biological or other detection coatings as well as physical photoelectric elements for conversion of input and output signals</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Display/panel glass on personal electronic devices: for sensitivity to temperature, imprint, pressure and for physical protection</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>Medical: </b>Our systems are used in this industry to apply micron layers of polymers and drugs, biomedical materials and anti-coagulants.</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Implanted medical devices such as:</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 188px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Tahoma,sans-serif; font-size: 11pt">&#9642;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Stents and balloons</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 188px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Tahoma,sans-serif; font-size: 11pt">&#9642;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Artificial joints</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Blood collection tubes</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Diagnostic devices</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Bandages/protective wraps</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Lenses</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>Industrial</b></span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Flat (&#8220;float&#8221;) glass used for windows in buildings and vehicles</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Textiles: high performance value adding coatings such as anti-microbial, anti-stain, flame retardant and moisture barriers</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Food packaging and food safety: anti-microbial coatings</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Food: coatings of flavors, ingredients and other additives</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>Alternative Energy</b>: Our systems provide coatings of chemicals and other materials that act as catalysts, barriers, facilitators of symbiosis or other interactions between surfaces.</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Fuel cells</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Solar cells</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>Emerging Research and Development / Other Markets</b></span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Research and development efforts at universities, research institutions and government agencies that are not part of our already established markets</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 113px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">o</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">A variety of other small industries using our coating technology, that have not yet matured into a developed marketplace for our ultrasonic coating machines</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our principal customers include original equipment manufacturers,
distributors and end users of our products in the industries that we serve.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our products are sold primarily through our direct sales personnel,
select independent distributors and through sales representatives around the world that are trained on our technologies and products.
Our distributors are typically experts in their industries and recognize the significant value that our technology provides their customers.
We provide extensive training and on-site support with our direct sales force and application engineers, who also respond to leads generated
by our web site and the trade shows in which we participate. To grow sales, we continue to strengthen our laboratory and applications
engineering personnel and support our worldwide process development labs with additional ultrasonic coating equipment, in conjunction
with sponsoring various technical training seminars for our distribution network.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We also provide application consulting services enabling our customers
to rely on our surface coating expertise and specific customer process optimization. We offer these services both in our application process
development laboratory and at our customers&#8217; sites where we can assist in the design and development of customized coating systems.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We are a global business and our geographical sales mix can vary from
year to year depending on the timing of orders from customers. In fiscal 2023, 55% of our sales were from outside the U.S. and Canada.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Our Strengths</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">From our core strengths and capabilities we:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Have built a strong reputation in the industry based on our ability to solve our customers&#8217; complex problems and provide custom engineered, value-added solutions.</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Are renowned for our product quality, customer service and responsiveness and critical thinking that enables a strong problem-solving culture throughout our organization.</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Have expanded our ability to provide coating services for low to mid-volume demand to support our customers&#8217; product development and testing.</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Are continually developing new technologies and solutions to address an ever-changing marketplace.</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Have built a strong balance sheet with no debt, which we believe, provides us with the financial flexibility to pursue our strategic plans for growth, including aggressive pursuit of organic and other development opportunities.</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Our Strategy</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our strategy is to further advance the use of ultrasonic coating technologies
for the microscopic coating of surfaces in a broader array of applications which enable better outcomes for our customers&#8217; products
and processes. We believe product superiority is imperative and that it is attained through the extensive experience that we have in the
coatings industry, our proprietary manufacturing know-how and skills, and our unique work force that we have built over the years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We intend to leverage our innovative technologies, proprietary know-how,
unique talent and experience, and global reach to:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Grow the business globally by reaching new markets and further penetrating the markets and customers we currently serve;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Increase our earnings power through lean manufacturing processes, automation and continuous improvement;</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Develop new and unique technologies that solve our customers&#8217; most challenging problems;</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Meet or exceed our customers&#8217; expectations; and</span></td></tr>
  </table>
<p style="font: 3pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="width: 38px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Provide an acceptable return to our shareholders.</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">To accomplish these objectives, we believe that we must judiciously
deploy our monetary and human capital in order to expand our presence in our targeted markets and create broader offerings for our customers.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Availability of Raw Materials</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Historically, we have not been adversely impacted by the availability
of raw materials or components used in the manufacture of our products. However, since the onset of the COVID-19 pandemic, we have encountered
challenges in procuring supplies of various materials and components, and electronic components in particular, due to well-documented
shortages and constraints in the global supply chain. Lead times for ordered components may vary significantly, and some components used
to manufacture our products are provided by a limited number of sources. We have experienced lengthened lead times throughout our supply
chain as a result of supply chain constraints and material shortages that have occurred through fiscal year 2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Generally, except in instances of pandemic related supply chain issues,
all raw materials used in our products are available from many different domestic suppliers. We purchase circuit board assemblies and
sheet metal components from a wide range of suppliers throughout the world.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">When materials are plentiful, we carefully manage our inventory using
lean manufacturing processes. We provide a limited warranty on all of our products that covers parts and labor for a period of one year
from the date of sale<span style="color: #222222; background-color: white">. </span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Research and Development</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We believe that our long-term growth is dependent upon the development
and commercialization of ultrasonic coating technologies to solve customers&#8217; high value problems across a wide spectrum of applications
in various industries, while also advancing the utility of our core technology. During fiscal 2023 and fiscal 2022, we spent $2,149,000
and $1,730,000, respectively, on research and development activities related to new products and services and the ongoing improvement
of existing products and services. As a percentage of sales, research and development expenses were 14.3% and 10.1% in fiscal 2023 and
2022, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Intellectual Property</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our business is based in part on the technology covered by our U.S.
patents. We also rely on unpatented know-how in the design and production of our nozzle systems, subsystems and complete solutions. We
have executed non-disclosure and non-compete agreements with all of our employees to safeguard our intellectual property. We execute reciprocal
non-disclosure agreements with our key customers to safeguard any jointly developed intellectual property.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Competition</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We operate in competitive markets in many of our industry segments.
We compete against alternative coating technologies, as well as global and regional manufacturers of nozzles and other products based
on price, quality, product features, application engineering and follow-up service. We maintain our competitive position by providing
highly effective solutions that meet our customers&#8217; requirements and needs. In several emerging markets, we encounter less competition
compared to more established markets based on the uniqueness of our ultrasonic technology in these applications.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><b><i>Information Regarding Sales Outside
the United States and Canada and Significant Customers</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023 and fiscal 2022, net sales to customers outside
the U.S. and Canada accounted for approximately $8,254,000, or 55% of total net sales, and $11,653,000, or 68% of total net sales, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our two largest customers accounted for 14% of net sales in fiscal
2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Employees</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">As of February 28, 2023, we employed 73 full-time and 11 part-time
employees. We believe that relations with our employees are generally good.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Available Information</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We are subject to the informational requirements of the Securities
Exchange Act of 1934, as amended. Therefore, we file &#8220;reports, proxy statements and other information with the Securities and Exchange
Commission (&#8220;SEC&#8221;). The SEC maintains a website at www.sec.gov that contains the reports, proxy statements and other information
for registrants that file electronically, as we do. Additionally, these reports may be read and copied at the Public Reference Room of
the SEC at 100 F Street, N.E., Washington, DC 20549. Information regarding the SEC&#8217;s Public Reference Room may be obtained by calling
1-800-SEC-0330.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We maintain a website at http://www.sono-tek.com. On our site, we
provide copies of our Forms 8-K, 10-K, 10-Q, Proxy and Annual Report as soon as reasonably practicable after filing electronically
such material with the SEC. Copies are also available, without charge, from Sono-Tek Corporation, 2012 Route 9W, Milton, NY 12547.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item1a"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 98px; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 1A </span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>RISKS RELATED TO OUR BUSINESS AND OPERATIONS</b>&#160;</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0"><b><i>&#160;</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Ongoing impacts from COVID-19 or another
pandemic, epidemic or outbreak of an infectious disease may materially and adversely impact our business, prospects, financial condition
and operating results.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">The COVID-19 pandemic has adversely impacted our
business, and it, as well as other possible health pandemics, epidemics or outbreaks, may materially and adversely impact our business,
prospects, financial condition and operating results in the future. Our engineering and product development operations, among others,
cannot all be conducted in a remote working structure and often require on-site access to materials and equipment. We have customers with
international operations in varying industries. We also depend on suppliers and manufacturers worldwide. We are currently experiencing
disruptions and delays in our supply chain. Depending upon the duration of the ongoing effects of the COVID-19 pandemic, which may linger
for some time even if significant health risks abate, our customers, suppliers, manufacturers and partners may suspend or delay their
engagement with us or take other actions or experience their own negative impacts, any of which could result in a material adverse effect
on our financial condition and ability to meet current timelines. The COVID-19 pandemic has adversely affected and may continue to adversely
affect our ability to recruit skilled employees to join our team and to meet our product development timelines. Our response to the ongoing
COVID-19 pandemic and its ongoing impacts on our supply chain and business activities may prove to be inadequate, and we may be unable
to operate in the manner necessary to avoid interruptions, reputational harm and delays in our product development and shipments, any
of which could have a material adverse effect on our business, prospects, financial condition and operating results. In addition, pre-COVID-19
supply chain, economic and business conditions may not ever return.</p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">To the extent COVID-19 continues to impact our
business, financial position and results of operations, it may also have the effect of heightening certain of the other risks described
in this Annual Report on Form 10-K, such as those relating to our international operations and global strategies and our dependence on
third-party suppliers.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We do not have long-term commitments for significant revenues
with most of our customers and may be unable to retain existing customers, attract new customers or replace departing customers with new
customers that can provide comparable revenues and profit margins.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Because we generally do not obtain firm, long-term
volume purchase commitments from our customers, most of our sales are derived from individual purchase orders. We remain dependent upon
securing new purchase orders in the future in order to sustain and grow our revenues. Accordingly, there is no assurance that our revenues
and business will grow in the future. Our failure to maintain and expand our customer relationships could materially and adversely affect
our business and results of operations.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>In recent years, a few major customers and distributors have
accounted for a significant portion of our revenue. Our revenue could decline if we are unable to maintain or develop relationships with
additional customers or distributors and our results of operations could be adversely affected if any one of these customers is unable
to meet their financial obligations to us.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">For the year ended February 28, 2023, our two
largest customers accounted for approximately 14% of our net sales. For the year ended February 28, 2022, our two largest customers accounted
for approximately 24% of our net sales. If we are unable to diversify our customer base, our future results could be heavily dependent
on these customers and distributors. Our dependence on a limited number of customers and distributors means that the loss of a major customer
or distributor or any reduction in orders by a major customer or distributor would materially reduce our net sales and adversely affect
our results of operations. We expect that sales to relatively few customers will continue to account for a significant percentage of our
net sales for the foreseeable future; however, these customers or our other customers, may not use our products at current levels in the
future, if at all. Customer purchase orders may be delayed or cancelled, and order volume levels can be changed with loss of deposit as
the only penalty. We may not be able to replace cancelled, delayed, or reduced purchase orders with new orders. If any one of these customers
reduces its demand for our products, it will likely have a material adverse effect on our operations.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Furthermore, a significant portion of our accounts
receivables is concentrated with a few&#160;major customers, who may not be able to meet their financial obligations to us. The failure
of any such customers to pay amounts owed to us in a timely fashion or at all could have an adverse effect on our results of operations.&#160;The
Company is also exposed to credit risk on its accounts receivable, and this risk is heightened during periods when economic conditions
worsen. The Company's outstanding receivables are not covered by collateral or credit insurance. The Company's exposure to credit and
collectability risk on its receivables may also be higher in certain international markets, and its ability to mitigate such risks may
be limited. While the Company has procedures to monitor and limit exposure to credit risk on its receivables, there can be no assurance
such procedures will effectively limit our credit risk and avoid losses.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We will need to raise additional funds to develop our business,
which may adversely affect our future growth.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;We may finance a portion of our anticipated
future growth and possibly future strategic acquisitions through public or private equity offerings or debt financings. Additional funds
may not be available when we need them on terms that are acceptable to us, or at all. If adequate funds are not available, we may be required
to delay or reduce the scope of, our plans to grow our revenues or to consummate one or more strategic acquisitions<i>&#160;</i>or otherwise
to scale back our business plans. In addition, we could be forced to reduce or forego attractive business opportunities. To the extent
that we raise additional funds by issuing equity securities, our stockholders may experience significant dilution. In addition, debt financing,
if available, may involve restrictive covenants. We may seek to access the public or private capital markets whenever conditions are favorable,
even if we do not have an immediate need for additional capital at that time. Our access to the financial markets and the pricing and
terms we receive in the financial markets could be adversely impacted by various factors, including changes in financial markets and interest
rates.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We may be adversely affected by global and regional economic
conditions and military, legislative, regulatory and political developments.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We sell our products around the world, and we
expect to continue to derive a substantial portion of sales from outside the U.S. The uncertain macroeconomic environment caused by the
outbreak of COVID-19 may adversely affect our results and could have a negative impact on demand for our products. In addition, we are
currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical
instability due to the ongoing military conflict between Russia and Ukraine. Our business, financial condition and results of operations
could be materially adversely affected by any negative impact on the global economy and capital markets resulting from the conflict in
Ukraine or any other geopolitical tensions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Customers or suppliers may experience cash flow
problems and as a result, may modify, delay or cancel plans to purchase our products, and suppliers may significantly and quickly increase
their prices or reduce their output. Additionally, if customers are not successful in generating sufficient revenue or are precluded from
securing financing, they may not be able to pay, or may delay payment of, amounts owed to us. Any inability of current and/or potential
customers to purchase our products and/or to pay us for our products may adversely affect our sales, earnings and cash flow. Sales and
earnings could also be affected by our ability to manage the risks and uncertainties associated with the application of local legal requirements
or the enforceability of laws and contractual obligations, trade protection measures, changes in tax laws, regional political instability,
war, terrorist activities, severe or prolonged adverse weather conditions and natural disasters as well as health epidemics or pandemics.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Our success will depend, to a large degree, on the expertise
and experience of the members of our management team, the loss of whom could have a material adverse effect on our business.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our success is, to a large degree, dependent upon
the expertise and experience of the management team and its ability to attract and retain qualified personnel who are technically proficient.
The loss of the services of one or more of such personnel could have a material adverse effect on our business. Our business may be adversely
affected if we are unable to continue to attract and retain such personnel.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We will need to add qualified additional personnel as we expand
our business, and we may not be able to employ such persons, which could affect our ability to expand and have a material adverse effect
on our business.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;In order to expand our product offerings
and customer base, we will need to hire additional qualified personnel. We may not be able to identify such persons, and even if we identify
them, we may not have the funds or ability to employ them, which could have a material adverse effect on our business.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Although we have not experienced any material
disruptions due to labor shortages to date, we have observed an overall tightening and increasingly competitive labor market. A sustained
labor shortage or increased turnover rates within our employee base, whether caused by COVID-19 or as a result of general macroeconomic
factors, could lead to increased costs, such as increased overtime to meet demand and increased wage rates to attract and retain employees,
and could negatively affect our ability to complete our projects according to the required schedule or otherwise efficiently operate our
business. If we are unable to hire and retain employees capable of performing at a high level, or if mitigation measures we may take to
respond to a decrease in labor availability, such as overtime and third-party outsourcing, have unintended negative effects, our business
could be adversely affected. An overall labor shortage, lack of skilled labor, increased turnover or labor inflation, caused by COVID-19
or as a result of general macroeconomic factors, could have a material adverse impact on our operations, results of operations, liquidity
or cash flows.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>If we are unable to manage our expected growth, our business
may be materially and adversely affected.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;We expect to expand our operations, including
by expanding our internal resources, making acquisitions and entering into new markets, and we intend to continue to focus on rapid growth,
including organic growth and possibly acquisitions. The growth of our business could place significant strain on our management, operational
and financial resources. To manage our future growth, we could be required to improve existing or implement new operational or financial
systems, procedures and controls or expand, train and manage a growing employee base. Our failure to accomplish any of these tasks could
materially and adversely affect our business. Even if we are successful in integrating future acquisitions into our existing operations,
we may not derive the benefits, such as operational or administrative synergies, that we expected from such acquisitions, which may result
in the investment of our capital resources without realizing the expected returns on such investment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Our inability to protect our intellectual property rights could
negatively affect our business and results of operations.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our ability to compete effectively depends in
part upon developing, maintaining and/or protecting intellectual property rights relevant to our ultrasonic nozzles and coating processes.
We rely principally on a combination of patent protection, trade secret laws, confidentiality and non-disclosure agreements, and trusted
business relationships to establish, maintain and protect the intellectual property rights relevant to our business. These measures, however,
may not be adequate in every given case to permit us to gain or retain any competitive advantage, particularly in those countries where
the laws do not protect our proprietary rights as fully as in the United States.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Where we consider it appropriate, we may seek
patent protection in the United States on technologies used in, or relating to, our ultrasonic nozzles, applications and manufacturing
processes. The issuance of a patent is not conclusive as to its scope, validity and enforceability. Thus, any patent or patent application
which may issue into a patent held by us could be challenged, invalidated or held unenforceable in litigation or proceedings before the
U.S. Patent and Trademark Office and/or other patent tribunals or circumvented by others. No consistent policy regarding the breadth of
patent claims has emerged to date in the United States, and the landscape could become more uncertain in view of future rule changes by
the United States Patent and Trademark Office, the introduction of patent reform legislation and decisions in patent law cases by United
States federal courts. The patent landscape outside the United States is even less predictable. As a result, the validity and enforceability
of patents cannot be predicted with certainty. In addition, we may fail to apply for patents on important technologies or product candidates
in a timely fashion, if at all, and our existing and future patents may not be sufficiently broad to prevent others from utilizing our
technologies or from developing competing products or technologies.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our patent strategy involves complex legal and
factual questions. Our ability to maintain and solidify our proprietary technology may depend in part upon our success in obtaining patent
rights and enforcing those rights once granted or licensed. Our issued patents and those that may be issued in the future may be challenged,
invalidated, rendered unenforceable or circumvented, which could limit our ability to prevent competitors from marketing similar or related
products, or shorten the term of patent protection that we may have for our products, processes and enabling technologies. In addition,
the rights granted under any issued patents may not provide us with competitive advantages against competitors with similar technology.
Furthermore, our competitors may independently develop similar technologies, duplicate technology developed by us or otherwise possess
intellectual property rights that could limit our ability to manufacture our products and operate our business.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We also rely on trade secret protection for our
confidential and proprietary information. Trade secrets, however, can be difficult to protect. We may not be able to maintain our technology
or know-how as trade secrets, and competitors may develop or acquire equally valuable or more valuable technology or know-how related
to the manufacture of comparable ultrasonic nozzles. We also seek to protect our confidential and proprietary information, in part, by
requiring all employees, consultants and business partners to execute confidentiality and/or nondisclosure agreements upon the commencement
of any employment, consulting arrangement or engagement with us. These agreements generally require that all confidential and proprietary
information developed by the employee, consultant, or business partner, or made known to the employee, consultant or business partner
by us, during the course of the relationship with us, be kept confidential and not disclosed to third parties. These agreements may be
breached and may not provide adequate remedies in the event of breach. To the extent that our employees, consultants, or business partners
use intellectual property owned by others in their work for and/or with us, disputes could arise as to the rights in related or resulting
technologies, know-how or inventions. Moreover, while we also require customers and vendors to execute agreements containing confidentiality
and/or nondisclosure provisions, we may not have obtained such agreements from all of our customers and vendors. In addition, our trade
secrets may otherwise become known or be independently discovered by competitors, customers, or vendors. Such customers or vendors may
also be subject to laws and regulations that require them to disclose information that we would otherwise seek to keep confidential.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Moreover, others may independently develop and
obtain patents covering technologies that are similar or superior to the product forms, applications, or manufacturing processes that
we employ. If that happens, we may need to obtain licenses for these technologies and may not be able to obtain licenses on reasonable
terms, if at all, which could limit our ability to manufacture our future products and operate our business. In addition, third parties
could utilize our intellectual property rights in territories where we do not have intellectual property protection. Such third parties
may then try to import products made using our intellectual property rights into the United States or other countries, which could have
a material adverse effect on our business.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We could become subject to intellectual property litigation
that could be costly, limit or cancel our intellectual property rights, divert time and efforts away from business operations, require
us to pay damages and/or otherwise have an adverse material impact on our business.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">The success of our business is highly dependent
on protecting our intellectual property rights. Unauthorized parties may attempt to copy or otherwise obtain and use our products and/or
enabling technologies. Policing the unauthorized use of our intellectual property rights is difficult and expensive, as is enforcing these
rights against unauthorized use by others. Identifying unauthorized use of our intellectual property rights is difficult because we may
be unable to monitor the processes and/or materials being employed by other parties. The steps we have taken may not prevent unauthorized
use of our intellectual property rights, particularly in foreign countries where enforcement of intellectual property rights may be more
difficult than in the United States.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our continued commercial success will also depend
in part upon not infringing the patents or violating the intellectual property rights of third parties. We are aware of patents and patent
applications generally relating to aspects of our technologies filed by, and issued to, third parties. Nevertheless, we cannot determine
with certainty whether such patents or patent applications of other parties may materially affect our ability to conduct our business.
There may be existing patents of which we are unaware that we may inadvertently infringe, resulting in claims against us or our customers.
In the event that the manufacture, use and/or sale of our products or processes is challenged, or if our product forms or processes conflict
with the patent rights of others, third parties could bring legal actions against us or our customers in the United States, Asia, Europe
or other countries, claiming damages and seeking to enjoin the manufacturing and/or marketing of our products. Additionally, it is not
possible to predict with certainty what patent claims may issue from any relevant third-party pending patent applications. Third parties
may be able to obtain patents with claims relating to our product forms, applications and/or manufacturing processes which they could
attempt to assert against us or our customers.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">In either case, litigation may be necessary to
enforce, protect or defend our intellectual property rights or to determine the validity and scope of the intellectual property rights
of others. Any litigation could be unsuccessful, cause us to incur substantial costs, divert resources and the efforts of our personnel
away from daily operations, harm our reputation and/or result in the impairment of our intellectual property rights. In some cases, litigation
may be threatened or brought by a patent holding company or other adverse patent owner who has no relevant product revenues and against
which our patents may provide little or no deterrence. If we are found to infringe any patents, we could be required to (1) pay substantial
monetary damages, including lost profits, reasonable royalties and/or treble damages if an infringement is found to be willful and/or
(2) totally discontinue or substantially modify any products or processes that are found to be in violation of another party&#8217;s intellectual
property rights. If our competitors are able to use our technology without payment to us, our ability to compete effectively could be
harmed.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>The markets within which we compete are highly competitive.
Many of our competitors have greater financial and other resources than we do and one or more of these competitors could use their greater
financial and other resources to gain market share at our expense.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">If our business continues to develop as expected,
we anticipate that our revenues will continue to grow. If, due to capital constraints or otherwise, we are unable to fulfill our existing
backlog in a timely manner and/or procure and timely fulfill our anticipated future backlog, our customers and potential customers may
decide to use competing systems or products. If we are unable to fulfill the demand for products and systems in a timely manner, our customers
and potential customers may choose to purchase products from our competitors. In addition, we could face new competition from large international
or domestic companies with established industrial brands and distribution networks that enter our end markets. Demand for our products
may also be affected by our ability to respond to changes in design and functionality, to respond to downward pricing pressure, and to
provide shorter lead times for our products than our competitors. If we are unable to respond successfully to these competitive pressures,
we could lose market share, which could have an adverse impact on our results. We cannot assure that we will be able to compete successfully
in our markets or compete effectively against current and new competitors as our industry continues to evolve.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Rapid technological changes may prevent us from remaining current
with our technological resources and maintaining competitive product and service offerings.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">The markets in which we and our customers operate
are characterized by rapid technological change. Significant technological changes could render our existing and potential new products,
systems and technology obsolete. Our future success will depend, in large part, upon our ability to:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="width: 90%; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">effectively identify and develop leading technologies;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">continue to develop our technical expertise;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">enhance our current products and systems with new, improved and competitive technology; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-bottom: 8pt; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="padding-bottom: 8pt; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">respond to technological changes in a cost-effective and timely manner.</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">If we are unable to successfully respond to technological
change or if we do not respond to it in a cost-effective and timely manner, then our business will be materially and adversely affected.
We cannot assure you that we will be successful in responding to changing technology. In addition, technologies developed by others may
render our products, systems and technology uncompetitive or obsolete. Even if we do successfully respond to technological advances, the
integration of new technology may require substantial time and expense, and we cannot assure you that we will succeed in adapting our
products, systems and technology in a timely and cost-effective manner.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>If we are unable to continue to develop new and enhanced products
and systems that achieve market acceptance in a timely manner, our competitive position and operating results could be harmed.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our future success will depend on our ability
to continue to develop new and enhanced ultrasonic nozzles and coating systems and related products that achieve market acceptance in
a timely and cost-effective manner. The markets in which we and our customers operate are characterized by frequent introductions of new
and enhanced products and services, evolving industry standards and regulatory requirements, government incentives and changes in customer
needs. The successful development and market acceptance of our products and systems, depends on a number of factors, including:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify; width: 90%"><span style="font-family: Cambria,serif; font-size: 11pt">the impact of the COVID-19 pandemic on the global markets;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the changing requirements and preferences of the potential customers in our markets;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the accurate prediction of market requirements, including regulatory issues;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the timely completion and introduction of new products and systems to avoid obsolescence;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the quality, price and performance of new products and systems;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the availability, quality, price and performance of competing products and systems;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">our customer service and support capabilities and responsiveness;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the successful development of our relationships with existing and potential customers; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-bottom: 8pt; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="padding-bottom: 8pt; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">changes in industry standards.</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We may experience financial or technical difficulties
or limitations that could prevent us from introducing new or enhanced products or systems. Furthermore, any of these new or enhanced products
and systems could contain problems that are discovered after they are introduced. We may need to significantly modify the design of these
products and systems to correct problems. Rapidly changing industry standards and customer preferences and requirements may impede market
acceptance of our products and systems.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Development and enhancement of our products and
systems will require significant additional investment and could strain our management, financial and operational resources. The lack
of market acceptance of our products or systems or our inability to generate sufficient revenues from this development or enhancement
to offset their development costs could have a material adverse effect on our business. In addition, we may experience delays or other
problems in releasing new products and systems and enhancements, and any such delays or problems may cause customers to forego purchases
of our products and systems and to purchase those of our competitors.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We cannot provide assurance that products and
systems that we have recently developed or that we develop in the future will achieve market acceptance. If our new products and systems
fail to achieve market acceptance, or if we fail to develop new or enhanced products and systems that achieve market acceptance, our growth
prospects, operating results and competitive position could be adversely affected.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We manufacture and assemble all our products at one facility.
Any prolonged disruption in the operations of this facility would result in a decline in our sales and profitability.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We manufacture and assemble our products and systems
at our production facility located in Milton, New York. Any prolonged disruption in the operations of our manufacturing and assembly facility,
whether due to the COVID-19 pandemic, equipment or information technology infrastructure failure, labor difficulties, destruction of or
damage to this facility as a result of a hurricane, earthquake, fire, flood, other catastrophes, and other operational problems would
result in a decline in our sales and profitability. In the event of a business interruption at our facility, we may be unable to shift
manufacturing and assembly capabilities to alternate locations, accept materials from suppliers or meet customer shipment needs, among
other severe consequences. Such an event could have a material and adverse impact on our financial condition and results of our operations.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Failure to obtain adequate supplies of components and raw materials
or failure to obtain components or raw materials at affordable prices could negatively affect our ability to supply products to our customers
and negatively affect our profit margins.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We use a variety of components and raw materials
in the manufacture of our products. As other industries develop products utilizing similar components and raw materials that we use, we
may not be able to obtain adequate supplies of components and raw materials required for the manufacture of our existing and future products
that would prevent us from supplying products to our customers and materially affect our business. Furthermore, any increased demand for,
the raising of tariff rates on, or an increase of non-tariff trade barriers that apply to the components and raw materials that we use
could increase the price we must pay to obtain them and could adversely affect our profitability, which would have an adverse effect on
our financial results.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Recently, we have encountered challenges in our
supply of various materials and components, and electronic components in particular, due to well-documented shortages and constraints
in the global supply chain. Lead times for ordered components may vary significantly, and some components used to manufacture our products
are provided by a limited number of sources. We have experienced lengthened lead times throughout our supply chain as a result of supply
chain constraints and material shortages that have occurred in the recent months, and may continue through fiscal year 2024.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We may rely on sub-contractors to meet current demand for our
products, and we may need to obtain additional manufacturing capacity in order to increase production of our existing products or to produce
our proposed new products, the failure of which could have a material adverse effect on our operations.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We may not have sufficient internal manufacturing
capacity to meet the current demand for our products, and we may need to rely on&#160;subcontractors to enable us to meet this demand.
Since we may rely on our subcontractors for a significant amount of our production capacity, the loss of the services of our subcontractors
would have a material adverse effect on our business. Our plans for the growth of our business rely upon increasing sales of our existing
products and systems and developing and marketing new products. We may not have adequate internal manufacturing facilities to substantially
increase production of our products and obtaining additional manufacturing capacity in-house could require substantial capital expenditures.
We may not have the capital resources to obtain or construct new facilities to expand manufacturing capacity and meet increasing demand
for our products, which could have a material adverse effect on our operations. Conversely, any significant decrease in demand for our
products could create idle plant capacity and an inability to cover fixed costs, which could adversely impact our results of operations
and financial condition.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We are exposed to risks related to our international sales,
and the failure to manage these risks could harm our business.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition to our net sales to customers within the U.S. and Canada, we may become increasingly
dependent on net sales to customers outside the U.S. and Canada as we pursue expanding our business with customers worldwide. In the fiscal
years ended February 28, 2023 and 2022, our net sales outside of the U.S. and Canada accounted for approximately 55% and 68%, respectively,
of our total net sales. We continue to expect that a significant portion of our future revenues will be from international sales. As a
result, the occurrence of any international, political, economic, or geographic event could result in a significant decline in revenue.
There are significant risks associated with conducting operations internationally, requiring significant financial commitments to support
such operations. These numerous and sometimes conflicting laws and regulations include internal control and disclosure rules, data privacy
and filtering requirements, anti-corruption laws, such as the Foreign Corrupt Practices Act, and other local laws prohibiting corrupt
payments to governmental officials, and anti-competition regulations, among others.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Violations of these laws and regulations could
result in fines and penalties, criminal sanctions against us, our officers, or our employees, prohibitions on the conduct of our business
and on our ability to offer our products and services in one or more countries, and could also materially affect our brand, our international
expansion efforts, our ability to attract and retain employees, our business, and our operating results. Although we have implemented
policies and procedures designed to ensure compliance with these laws and regulations, there can be no assurance that our employees, contractors,
or agents will not violate our policies.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 0 0 1in; text-align: justify; text-indent: -31.5pt">Some of the risks and challenges of
conducting business internationally include:</p>

<p style="font: 11pt Cambria,serif; margin: 0 0 0 1in; text-align: justify; text-indent: -31.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="width: 90%; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the impact of COVID-19 on the global markets;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">requirements or preferences for domestic products or solutions, which could reduce demand for our products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">unexpected changes in regulatory requirements;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">restrictions on the import or export of critical technology;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">management communication and integration problems resulting from cultural and geographic dispersion;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">the burden of complying with a variety of laws and regulations in various countries;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">difficulties in enforcing contracts;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the uncertainty of protection for intellectual property rights in some countries;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">application of the income tax laws and regulations of multiple jurisdictions, including relatively low-rate and relatively high-rate jurisdictions, to our sales and other transactions, which results in additional complexity and uncertainty;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">tariffs and trade barriers, export regulations and other regulatory and contractual limitations on our ability to sell products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">failure to comply with both U.S. and foreign laws, including export and antitrust regulations, the Foreign Corrupt Practices Act and any trade regulations ensuring fair trade practices;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">heightened risk of unfair or corrupt business practices in certain geographies and of improper or fraudulent sales arrangements that may impact financial results and result in restatements of, or irregularities in, financial statements;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">potentially adverse tax consequences, including multiple and possibly overlapping tax structures;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">general economic and geopolitical conditions, including war and acts of terrorism;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">lack of the availability of qualified third-party financing; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">currency exchange controls.&#160;</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">While these factors and the impacts of these factors
are difficult to predict, any one or more of them could adversely affect our business, financial condition and results of operations in
the future.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Any liability damages resulting from technical faults or failures
of our products could be substantial and could materially adversely affect our business and results of operations.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our products are used by customers and integrated
into customers&#8217; machines and systems, and therefore a malfunction or the inadequate design of our products could result in product
liability claims. Any liability for damages resulting from technical faults or failures could be substantial and could materially adversely
affect our business and results of operations. In addition, a well-publicized actual or perceived problem could adversely affect the market&#8217;s
perception of our products, which would materially impact our financial condition and operating results.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Inflationary Pressures and Rising Prices for Goods and Services.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Inflation rose sharply beginning in late 2021
and continued rising through 2022 at levels not seen for over 40 years. Although the Federal Reserve has significantly increased interest
rates in response to rising inflation, inflationary pressures are currently expected to remain elevated throughout 2023. Small to medium-sized
businesses may be impacted more during periods of high inflation as they are not as able to leverage economics of scale to mitigate cost
pressures compared to larger businesses. Inflation has the potential to adversely affect our liquidity, business, financial condition
and results of operations by increasing our overall cost structure, particularly if we are unable to achieve commensurate increases in
the prices we charge our customers. The existence of inflation in the economy has resulted in, and may continue to result in, higher interest
rates and capital costs, shipping costs, supply shortages, increased costs of labor, weakening exchange rates and other similar effects.
As a result of inflation, we have experienced and may continue to experience, cost increases. Although we may take measures to mitigate
the impact of this inflation, if these measures are not effective our business, financial condition, results of operations and liquidity
could be materially adversely affected. Even if such measures are effective, there could be a difference between the timing of when these
beneficial actions impact our results of operations and when the cost inflation is incurred.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We could become liable for damages resulting from our manufacturing
activities, which could have a material adverse effect on our business or cause us to cease operations.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">The nature of our manufacturing operations exposes
us to potential claims and liability for environmental damage, personal injury, loss of life and damage to, or destruction of, property.
Our manufacturing operations are subject to numerous laws and regulations that govern environmental protection and human health and safety.
These laws and regulations have changed frequently in the past and it is reasonable to expect additional and more stringent changes in
the future. Our manufacturing operations may not comply with future laws and regulations, and we may be required to make significant unanticipated
capital and operating expenditures to bring our operations within compliance with such evolving regulations. If we fail to comply with
applicable environmental laws and regulations, manufacturing guidelines, and workplace safety requirements, governmental authorities may
seek to impose fines and penalties on us or to revoke or deny the issuance or renewal of operating permits, and private parties may seek
damages from us. Under such circumstances, we could be required to curtail or cease operations, conduct site remediation or other corrective
action, or pay substantial damage claims for which may not have sufficient or any insurance coverage for claims.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>If we fail to maintain an effective system of internal control
over financial reporting, we may not be able to accurately report our financial results, and current and potential stockholders may lose
confidence in our financial reporting.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Section 404 of the Sarbanes-Oxley Act of 2002
requires our management to assess the effectiveness of our internal control over financial reporting and to disclose in our filing if
such controls were unable to provide assurance that a material error would be prevented or detected in a timely manner. We have an ongoing
program to review the design of our internal controls framework in keeping with changes in business needs, implement necessary changes
to our controls design and test the system and process controls necessary to comply with these requirements. If in the future, our internal
controls over financial reporting are determined to be not effective resulting in a material weakness or significant deficiency, investor
perceptions regarding the reliability of our financial statements may be adversely affected which could cause a decline in the market
price of our stock and otherwise negatively affect our liquidity and financial condition.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We may have risks associated with security of our information
technology systems.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We make significant efforts to maintain the security
and integrity of our information technology systems and data. Despite significant efforts to create security barriers to such systems,
it is virtually impossible for us to entirely mitigate this risk. There is a risk of industrial espionage, cyber-attacks, misuse or theft
of information or assets, or damage to assets by people who may gain unauthorized access to our facilities, systems, or information. Such
cybersecurity breaches, misuse, or other disruptions could lead to the disclosure of confidential information; improper usage and distribution
of our intellectual property; theft, manipulation, and destruction of private and proprietary data; and production downtimes. Although
we actively employ measures to prevent unauthorized access to our information systems, preventing unauthorized use or infringement of
our rights is inherently difficult. These events could adversely affect our financial results and any legal action in connection with
any such cybersecurity breach could be costly and time-consuming and may divert management&#8217;s attention and adversely affect the
market&#8217;s perception of us and our products. In addition, we must frequently expand our internal information system to meet increasing
demand in storage, computing and communication, which may result in increased costs. Our internal information system is expensive to expand
and must be highly secure due to the sensitive nature of our customers&#8217; information that we transmit. Building and managing the
support necessary for our growth places significant demands on our management and resources. These demands may divert such resources from
the continued growth of our business and implementation of our business strategy.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">RISKS RELATED TO OUR COMMON STOCK</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Future equity financings and issuances of shares under equity
compensation plans would dilute your ownership and could adversely affect your common stock ownership rights in comparison with those
of other security holders.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our board of directors has the power to issue
additional shares of common without stockholder approval. Additional shares are subject to issuance through various equity compensation
plans or through the exercise of currently outstanding equity awards. Our stockholders do not have preemptive rights to any common stock
issued by us in the future; therefore, stockholders may experience additional dilution of their equity investment if we issue additional
shares of common stock in the future, including shares issuable under equity incentive plans, or if we issue securities that are convertible
into shares of our common stock.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">If additional funds are raised through the issuance
of equity securities, the percentage of ownership of our existing stockholders will be reduced, and such newly issued securities may have
rights, preferences or privileges senior to those of existing stockholders. If we issue additional common stock or securities convertible
into common stock, such issuance will reduce the proportionate ownership and voting power of each other stockholder. In addition, such
stock issuances might result in a reduction of the market value of our common stock, which could make our stock unattractive to existing
stockholders.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Provisions in our articles of incorporation and bylaws could
discourage changes in the composition of our board of directors which could hinder an acquisition of us by a third party, even if the
acquisition would be favorable to you, thereby adversely affecting existing stockholders.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our articles of incorporation and bylaws contain
provisions that may have the effect of making more difficult or delaying attempts by others to obtain control of our board of directors
and our Company, even when these attempts may be in the best interests of stockholders. For example, our articles of incorporation and
bylaws provide for a classified board of directors which could delay or prevent changes in our control or management, including transactions
in which stockholders might otherwise receive a premium for their shares over then-current market prices. These provisions may also limit
the ability of stockholders to approve transactions that they may deem to be in their best interests.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>There is limited trading volume of our common stock, which could
make it difficult for you to liquidate an investment in our common stock in a timely manner.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Since August 27, 2021, our common stock has been&#160;traded
on the Nasdaq Capital Market under the symbol SOTK. Because there is limited volume in our common stock, investors may not be able to
liquidate their investments when they desire to do so.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, if we fail to meet the criteria set
forth in SEC and Nasdaq Capital Market rules and regulations, various requirements would be imposed by law on broker-dealers who sell
our securities to persons other than established customers and accredited investors. Consequently, such regulations may deter broker-dealers
from recommending or selling our common stock, which may further affect its liquidity.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>If securities analysts do not publish research or reports about
our business or if they downgrade us or our sector, the price of our common stock could decline.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">The trading market for our common stock will depend
in part on research and reports that industry or financial analysts publish about us or our business. Furthermore, if one or more of the
analysts who cover us downgrades us, the industry in which we operate, or the stock of any of our competitors, the price of our common
stock may decline. If one or more of these analysts ceases coverage altogether, we could lose visibility, which could also lead to a decline
in the price of our common stock.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Our operating results can fluctuate significantly from period
to period, which makes our operating results difficult to predict and can cause our operating results, in any particular period, to be
less than comparable periods and expectations from time to time.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our operating results have fluctuated significantly
from quarter-to-quarter, period-to-period and year-to-year during our operating history and are likely to continue to fluctuate in the
future due to a variety of factors, many of which are outside of our control. Certain factors that may affect our operating results include,
without limitation, those set forth under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
&#8212; Critical Accounting Policies&#8221; in this Annual Report on Form 10-K.</p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Because we have little or no control over many
of these factors, our operating results are difficult to predict. Any adverse change in any of these factors could negatively affect our
business and results of operations.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Our revenues, net income and other operating results
are heavily dependent upon the size and timing of customer orders and projects, and the timing of the completion of those projects. The
timing of our receipt of large individual orders, and of project completion, is difficult for us to predict. Because our operating expenses
are based on anticipated revenues over the mid and long-term and because a high percentage of our operating expenses are relatively fixed,
a shortfall or delay in recognizing revenues can cause our operating results to vary significantly from quarter-to-quarter and can result
in significant operating losses or declines in profit margins in any particular quarter. If our revenues fall below our expectations in
any particular quarter, we may not be able, or it may not be prudent for us, to reduce our expenses rapidly in response to the revenue
shortfall, which can result in us suffering significant operating losses or declines in profit margins in that quarter.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Due to these factors and the other risks discussed
in this Annual Report on Form 10-K, you should not rely on quarter-to-quarter, period-to-period or year-to-year comparisons of our results
of operations as an indication of our future performance. Quarterly, period and annual comparisons of our operating results are not necessarily
meaningful or indicative of future performance. As a result, it is likely that, from time to time, our results of operations or our revenue
backlog could fall below historical levels or the expectations of public market analysts and investors, which could cause the trading
price of our common stock to decline significantly.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>The market price of our common stock has been and may continue
to be volatile.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">The market price of our common stock has been
volatile and fluctuates widely in response to various factors that are beyond our control. The price of our common stock is not necessarily
indicative of our operating performance or long-term business prospects. In addition, the securities markets have from time-to-time experienced
significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations
may also materially and adversely affect the market price of our common stock. Factors such as the following could cause the market price
of our common stock to fluctuate substantially:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify; width: 90%"><span style="font-family: Cambria,serif; font-size: 11pt">the underlying price of the commodities, materials, equipment that affect our key markets;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">announcements of capital budget changes by major customers;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the introduction of new products by our competitors;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">announcements of technology advances by us or our competitors;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">current events affecting the political and economic environment in the United States, Europe or Asia;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">conditions or industry trends, including demand for our products, services and technological advances;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">changes to financial estimates by us or by any securities analysts who might cover our stock;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">additions or departures of our key personnel;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">seasonal, economic, or financial conditions;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">our quarterly operating and financial results; or</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">litigation or public concern about the safety of our products;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the impact of inflation;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">war in Ukraine; or</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">&#8226;</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">the effect of COVID-19.</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">The realization of any of these risks and other
factors beyond our control could cause the market price of our common stock to decline significantly. The stock market in general experiences,
from time to time, extreme price and volume fluctuations. Periodic and/or continuous market fluctuations could result in extreme volatility
in the price of our common stock, which could cause a decline in the value of our common stock. Price volatility may be worse if the trading
volume of our common stock is low.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Future sales of our common stock, or the perception that future
sales may occur, may cause the market price of our common stock to decline.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">If any significant number of our outstanding shares
are sold, such sales could have a depressive effect on the market price of our stock. We are unable to predict the effect, if any, that
the sale of shares, or the availability of shares for future sale, will have on the market price of the shares prevailing from time to
time. Sales of substantial numbers of shares in the public market, or the perception that such sales could occur, could depress prevailing
market prices for the shares. Such sales may also make it more difficult for us to sell equity securities or equity-related securities
in the future at a time and price that we deem appropriate.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>The Company is considered a&#160;</i></b>&#8220;<b><i>smaller
reporting company</i></b>&#8221;<b><i>&#160;and is exempt from certain disclosure requirements, which could make our common stock less
attractive to potential investors.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">Rule 12b-2 of the Securities Exchange Act of 1934
(&#34;Exchange Act&#34;) defines a &#8220;smaller reporting company&#8221; as an issuer that is not an investment company, an asset-backed
issuer, or a majority-owned subsidiary of a parent, that is not a smaller reporting company, and that had a public float of less than
$250 million as of the last business day of its most recently completed second fiscal quarter, computed by multiplying the aggregate worldwide
number of shares of its voting and non-voting common equity held by non-affiliates by the price at which the common equity was last sold,
or the average of the bid and asked prices of common equity, in the principal market for the common equity.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">As a &#8220;smaller reporting company,&#8221;
we are subject to reduced disclosure requirements that are less comprehensive than applicable to issuers that are not &#8220;smaller reporting
companies,&#8221; which could make our stock less attractive to potential investors and could make it more difficult for shareholders
to sell their shares.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We have no current plan to pay dividends on our common stock,
and investors may lose the entire amount of their investment.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;We have no current plans to pay dividends
on our common stock; therefore, investors will not receive any funds absent a sale of their shares. We cannot assure investors of a positive
return on their investment when they sell their shares, nor can we assure that investors will not lose the entire amount of their investment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">GENERAL RISK FACTORS</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>We will continue to incur significant costs as a result of operating
as a public company, and our management may be required to devote substantial time to compliance initiatives that ultimately could have
a material adverse effect on our financial condition and results of operations.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">As a public company, we expect to continue to
incur significant legal, accounting and other expenses. In addition, the Sarbanes-Oxley Act, as well as rules subsequently implemented
by the SEC, have imposed various requirements on public companies, including requiring establishment and maintenance of effective disclosure
and financial controls as well as mandating certain corporate governance practices. Our management and other personnel will continue to
devote a substantial amount of time and financial resources to these compliance initiatives.</p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">As a &#8220;smaller reporting company&#8221; we
are able to take advantage of certain exceptions to disclosure requirements, including, but not limited to, reduced disclosure obligations
regarding executive compensation in our periodic reports and proxy statements and the exemption from providing a &#8220;Compensation Discussion
and Analysis&#8221; section in our proxy statements; providing only three years of business information; and other &#8220;scaled&#8221;
disclosure requirements that are less comprehensive than issuers that are not smaller reporting companies.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;If we fail to staff our accounting and finance
function adequately or maintain internal control systems adequate to meet the demands that are placed upon us as a public company, we
may be unable to report our financial results accurately or in a timely manner and our business and stock price may suffer. The costs
of being a public company, as well as diversion of management&#8217;s time and attention, may have a material adverse effect on our future
business, financial condition and results of operations.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Changes in U.S. Generally Accepted Accounting Principles (</i></b>&#8220;<b><i>GAAP</i></b>&#8221;<b><i>)
could adversely affect our financial results and may require significant changes to our internal accounting systems and processes.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We prepare our consolidated financial statements
in conformity with GAAP. These principles are subject to interpretation by the Financial Accounting Standards Board (&#8220;FASB&#8221;),
the SEC and various bodies formed to interpret and create appropriate accounting principles and guidance. The FASB periodically issues
new accounting standards on a variety of topics. For information regarding new accounting standards, please refer to Note&#160;1 and 2,
&#8220;Business Description and Significant Accounting Policies,&#8221;&#160;of the Notes to Consolidated Financial Statements in Part&#160;II,
Item&#160;8, &#8220;Financial Statements and Supplementary Data,&#8221; of this Annual Report on Form&#160;10-K. These and other such
standards generally result in different accounting principles, which may significantly impact our reported results or could result in
variability of our financial results.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>In preparing our financial statements we make certain assumptions,
judgments and estimates that affect amounts reported in our consolidated financial statements, which, if not accurate, may significantly
impact our financial results.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">We make assumptions, judgments and estimates for
a number of items, including the fair value of financial instruments, long-lived assets and other intangible assets; the realizability
of deferred tax assets; the recognition of revenue and the fair value of stock option awards; and others. We also make assumptions, judgments
and estimates in determining the accruals for revenue recognition, product warranties, employee-related liabilities, including commissions
and variable compensation, and in determining the allowance or provisions for uncertain tax positions, doubtful accounts, excess or obsolete
inventory, and legal contingencies. These assumptions, judgments and estimates are drawn from historical experience and various other
factors that we believe are reasonable under the circumstances as of the date of the consolidated financial statements. Actual results
could differ materially from our estimates, and such differences could significantly impact our financial results.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Our business could be negatively affected as a result of actions
of activist shareholders, and such activism could impact the trading value of our securities.</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">In recent years, shareholder activists have become
involved in numerous public companies. Shareholder activists frequently propose to involve themselves in the governance, strategic direction
and operations of the Company. Such proposals may disrupt our business and divert the attention of our Board of Directors, management
and employees, and any perceived uncertainties as to our future direction resulting from such a situation could result in the loss of
potential business opportunities, interfere with our ability to execute our strategic plan, be exploited by our competitors, cause concern
to our current or potential customers, and make it more difficult to attract and retain qualified personnel and business partners, all
of which could adversely affect our business. A proxy contest for the election of directors at our annual meeting could also require us
to incur significant legal fees and proxy solicitation expenses. In addition, actions of activist shareholders may cause significant fluctuations
in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the underlying
fundamentals and prospects of our business.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"><b><i>Major bank failure&#160;or sustained
financial market illiquidity, or illiquidity at our clearing, cash management and custodial financial institutions, could adversely affect
our business, financial condition and results of operations.</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">We face certain risks
in the event of a sustained deterioration of financial market liquidity, as well as in the event of sustained deterioration in the liquidity,
or failure, of our clearing, cash management and custodial financial institutions. In particular:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white; color: #333333">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">We may be unable to access funds in our investment
portfolio, deposit accounts and clearing accounts on a timely basis to settle our payments or to make money transfers. Any resulting need
to access other sources of liquidity or short-term borrowing would increase our costs. Any delay or inability to settle our payments or
to make money transfers could adversely impact our business, financial condition and results of operations.</span></td></tr></table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: -0.25in; background-color: white; color: #333333">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol; font-size: 11pt; color: #333333">&#183;</span></td><td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">In the event of a major bank failure, we could
face major risks to the recovery of our bank deposits used for the purpose of settling our payments and to the recovery of a significant
portion of our investment portfolio. A substantial portion of our cash, cash equivalents and interest-bearing deposits are either held
at financial institutions that are not subject to insurance protection against loss or exceed the deposit insurance limit.</span></td></tr></table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: -0.25in; background-color: white; color: #333333">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">We may be unable to borrow from financial institutions
or institutional investors on favorable terms, which could adversely impact our ability to pursue our growth strategy and fund key strategic
initiatives.</span></td></tr></table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white; color: #333333">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in">If financial liquidity deteriorates, there can
be no assurance we will not experience an adverse effect, which may be material, on our ability to access capital and on our business,
financial condition and results of operations.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item1b"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 1B</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>UNRESOLVED STAFF COMMENTS - None.</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item2"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 2</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>DESCRIPTION OF PROPERTIES</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We own an industrial park located in Milton, New York. The industrial
park consists of approximately 50,000 square feet of office and warehouse space. Our offices, product development, manufacturing and assembly
facilities are located in the industrial park. We presently utilize 37,000 square feet or 74% of the park for our operations. We believe
our facilities will be adequate for the foreseeable future and the ownership of the industrial park provides us opportunity to expand
as we grow.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Approximately 13,000 square feet of the park is leased or available
for lease to unrelated third parties at any given time.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item3"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 3</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>LEGAL PROCEEDINGS &#8211; None</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item4"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 4</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>MINE SAFETY DISCLOSURES &#8211; Not Applicable</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">PART II</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item5"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 5</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our common stock currently trades on the Nasdaq Capital Market.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">As of May 18, 2023, there were 97 record holders of our common stock
and approximately 1,519 beneficial shareholders of our Common Stock.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We have not paid any cash dividends on our Common Stock since inception.
We intend to retain earnings, if any, for use in our business and for other corporate purposes.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item6"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 6</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>RESERVED</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item7"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 7</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Forward-Looking Statements</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We discuss expectations regarding our future performance, such as
our business outlook, in our annual and quarterly reports, news releases, and other written and oral statements. These &#8220;forward-looking
statements&#8221; are based on currently available competitive, financial and economic data and our operating plans. They are inherently
uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause
actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political,
regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; inflationary and
supply chain pressures; the continued abatement of the COVID-19 pandemic; the extent and duration of the pandemic&#8217;s adverse effect
on economic and social activity, consumer confidence, discretionary spending and preferences, labor and healthcare costs, and unemployment
rates, any of which may reduce demand for some of our products and impair the ability of those with whom we do business to satisfy their
obligations to us; our ability to sell and provide our services and products, including as a result of continued pandemic related travel
restrictions, mandatory business closures, and stay-at home or similar orders; any temporary reduction in our workforce, closures of our
offices and facilities and our ability to adequately staff and maintain our operations resulting from the pandemic; the ability of our
customers and suppliers to continue their operations as result of the pandemic, which could result in terminations of contracts, losses
of revenue; the recovery of the Electronics/Microelectronics and Medical markets following COVID-19 related slowdowns; and further adverse
effects to our supply chain; maintenance of increased order backlog, including effects of any COVID-19 related cancellations; the imposition
of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy
of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; maintenance of increased order backlog;
consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the medical and alternative
energy markets; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete
machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range of sales guidance.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">We undertake no obligation to update any forward-looking statement.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Highlights</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Highlights for fiscal 2023 include:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Cambria,serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="text-align: left; width: 0.25in; vertical-align: top"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Net sales for fiscal 2023 decreased 12% from
$17.1 million to $15.1 million, due to supply chain challenges which delayed the receipt of necessary parts to complete several customer
shipments. Our customized complex coating systems, which typically require longer than average delivery lead times, were especially impacted
by these remaining supply chain issues.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Cambria,serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="text-align: left; width: 0.25in; vertical-align: top"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Gross profit margin for fiscal 2023 increased
to 50.8% compared to 50.3% in fiscal 2022.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Cambria,serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="text-align: left; width: 0.25in; vertical-align: top"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Operating income for fiscal 2023 decreased 64%
to $683,000 compared to $1.9 million in fiscal 2022, due to the current period&#8217;s decrease in net sales combined with an increase
in operating expenses.</span></td></tr><tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: left; vertical-align: top"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="text-align: justify">Backlog at February 28, 2023
reached a historical high of $8.5 million compared to the backlog at February 28, 2022 of $5.3 million, an increase of 60%.  The large increase in backlog resulted
from the receipt of several large, complex system orders with longer than typical build delivery time frames and higher than average selling prices from the clean
energy sector during the year and from ongoing supply chain issues which slowed the rate at which we completed our backlog of orders. </td></tr><tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: left; vertical-align: top"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td><td style="text-align: justify">Cash, cash equivalents and marketable securities increased to $11.4 million on February
28, 2023 from $10.7 million on February 28, 2022.</td></tr>
                                                                                                                        </table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 11pt Cambria,serif; margin: 0"><b><span style="text-decoration: underline">Market and Geographic Diversity</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We have invested significant resources to enhance our market diversity.
By leveraging our core ultrasonic coating technology, we&#8217;ve expanded our portfolio of products, the industries we serve, and the
countries in which we sell our products.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Today, we serve five industries: microelectronics/electronics, medical,
alternative energy, industrial markets, and emerging research and development and other.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We are a geographically diverse company with a presence either directly
or through distributors and trade representatives in the United States and Canada, EMEA (Europe, Middle East and Africa), APAC (Asia Pacific)
and Latin America (including Mexico). In fiscal 2023, approximately 55% of sales originated outside of the United States and Canada.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We have an established infrastructure of application process development
laboratories located at our distributor sites in Japan, China, Germany, Taiwan, Korea and our home office in New York, USA. These laboratories
are equipped with Sono-Tek systems and technical personnel to conduct customer demonstrations and process development for new coating
applications that our customers bring to us. Our engineering, service and sales teams all continue to grow as we expand our addressable
markets and enhance our product line to include larger more sophisticated machinery and systems with increased capabilities.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We believe that the new products we have introduced, the new markets
we have penetrated, and the expanded regions in which we now sell our products, are a strong foundation for our future sales growth and
enhanced profitability.</p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">Results of Operations</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0"><b><i>Sales and Gross Profit:</i></b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Fiscal Year Ended</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February&#160;28,</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February&#160;28,</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Change</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">$</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">%</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; text-align: left">Net Sales</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">15,058,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">17,133,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">(2,075,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">)</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">(12%</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Cost of Goods Sold</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">7,406,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">8,520,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(1,114,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right">(13%</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Gross Profit</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">7,652,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">8,613,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(961,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: right">(11%</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Gross Profit %</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">50.8%</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">50.3%</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Gross profit decreased $961,000, or 11% to $7,652,000 for fiscal 2023
compared with $8,613,000 in fiscal 2022. Gross profit margin increased to 50.8% for fiscal 2023, compared to 50.3% for fiscal 2022. The
improvement in the gross profit margin is due to a sales product mix with higher sales margins combined with lower than expected warranty
and installation costs.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In fiscal 2023, our sales included approximately $2,120,000 for orders
that were delivered to two customers.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b><i>Product Sales:</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 8pt Times New Roman,serif; text-align: center">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Twelve Months Ended</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: 8pt Times New Roman,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: 8pt Times New Roman,serif; text-align: center">&#160;</td><td style="font: 8pt Times New Roman,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 8pt Times New Roman,serif">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 8pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: italic bold 8pt Cambria,serif; text-align: center">% of</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 8pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: italic bold 8pt Cambria,serif; text-align: center">% of</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Change</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 8pt Times New Roman,serif">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">2023</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 8pt Cambria,serif; text-align: center">Total</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">2022</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 8pt Cambria,serif; text-align: center">total</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">$</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">%</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; width: 28%; text-align: left">Fluxing Systems</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">1,179,000</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 8%; text-align: right">8%</td><td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">691,000</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 8%; text-align: right">4%</td><td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">488,000</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">71%</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">Integrated Coating Systems</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">1,114,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">7%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">1,182,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">7%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(68,000</td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(6%</td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Multi-Axis Coating Systems</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">6,785,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">45%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">9,912,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">58%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(3,127,000</td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(32%</td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">OEM Systems</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">2,144,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">14%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">2,381,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">14%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(237,000</td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(10%</td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 1pt">Other</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">3,836,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: right">26%</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">2,967,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: right">17%</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">869,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: right">29%</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right">15,058,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right">17,133,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right">(2,075,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: right">(12%</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Sales of Multi-Axis coating systems recorded a 32% decrease due
to lingering supply chain challenges, resulting in several large system orders being pushed from planned fiscal 2023 shipments into
planned fiscal 2024 shipments, and are included in our year end fiscal 2023 backlog. Fluxing Systems sales showed an increase of
71%, due to the continued adoption of a newly released spray fluxing platform, SonoFlux X2, which continues to be implemented with
several large printed circuit board contract manufacturers. Sales of the &#8220;Other&#8221; product basket increased by 29%, or
$869,000, in large part due to increased sales of high value spare parts packages to support our high ASP multi-axis machines
already in the field.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b><i>Market Sales:</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 8pt Times New Roman,serif; text-align: center">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Twelve Months Ended</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: 8pt Times New Roman,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: 8pt Times New Roman,serif">&#160;</td><td style="font: 8pt Times New Roman,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 8pt Times New Roman,serif">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 8pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: italic bold 8pt Cambria,serif; text-align: center">% of</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 8pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: italic bold 8pt Cambria,serif; text-align: center">% of</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Change</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 8pt Times New Roman,serif">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">2023</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 8pt Cambria,serif; text-align: center">Total</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">2022</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 8pt Cambria,serif; text-align: center">total</td><td style="font: italic bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">$</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">%</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; width: 28%">Electronics/Microelectronics</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">5,509,000</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 8%; text-align: right">37%</td><td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">7,134,000</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; width: 8%; text-align: right">42%</td><td style="font: italic 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">(1,625,000</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">)</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 8%; text-align: right">(23%</td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif">Medical</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">3,702,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">25%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">4,338,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">25%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(636,000</td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(15%</td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Alternative Energy</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">3,060,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">20%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">3,688,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">22%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(628,000</td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(17%</td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">Emerging R&amp;D and Other</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">347,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">2%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">918,000</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right">5%</td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(571,000</td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(62%</td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 1pt">Industrial</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">2,440,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: right">16%</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">1,055,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: right">6%</td><td style="font: italic 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">1,385,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: right">131%</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right">15,058,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right">17,133,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right">(2,075,000</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: right">(12%</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Sales to the Alternative Energy, Electronics, and Medical markets decreased by 17%, 23%
and 15% respectively. Large portions of all these markets use our multi-axis systems which experienced delayed deliveries due to supply
chain challenges, and moving several planned fiscal 2023 orders into fiscal 2024. The industrial market grew by 131% due to a large multi-system
order valued at $1,540,000, $1,080,000 of this order was shipped in fiscal 2023 and the remaining $460,000 of the order shipped after the completion of fiscal 2023.</p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0"><b><i>Geographic Sales:</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 9pt Times New Roman,serif">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Twelve Months Ended</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: 9pt Times New Roman,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: 9pt Times New Roman,serif; text-align: center">&#160;</td><td style="font: 9pt Times New Roman,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 9pt Times New Roman,serif">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February&#160;28,</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February&#160;28,</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Change</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 9pt Times New Roman,serif">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">$</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">%</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 48%; text-align: left">U.S. &amp; Canada</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 9%; text-align: right">6,804,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 9%; text-align: right">5,480,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 9%; text-align: right">1,324,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 9%; text-align: right">24%</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Asia Pacific (APAC)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">3,260,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">5,301,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(2,041,000</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(39%</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Europe, Middle East, Asia (EMEA)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">3,448,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">5,255,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(1,807,000</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(34%</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Latin America</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">1,546,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">1,097,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">449,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right">41%</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">15,058,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">17,133,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(2,075,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: right">(12%</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In fiscal 2023, approximately 45% of our sales were to US and Canadian customers. This
is compared to 32% in fiscal 2022. The increased sales to the US and Canada were positively impacted by several US Government initiatives
to invest in the green energy sector and advanced research markets. APAC revenue decreased by 39% in fiscal 2023, impacted by reduced
sales in China due to several China-based manufacturing sites moving operations back to the US and Mexico. Also, the currently strong
US Dollar has made Sono-Tek products more expensive in Japan and South Korea, resulting in several delayed purchases.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b><i><span style="text-decoration: underline">Operating Expenses:</span></i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Twelve
    Months Ended</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February&#160;28,</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February&#160;28,</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Change</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>2023</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>2022</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>$</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>%</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="width: 48%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Research and product development</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="width: 9%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">2,149,000</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="width: 9%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">1,730,000</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="width: 9%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">419,000</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 9%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">24%</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Marketing and selling</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">3,170,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">3,367,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">(197,000</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">)&#160;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">(6%</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">)&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">General and administrative</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">1,650,000</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">1,626,000</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">24,000</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">2%</span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Total Operating Expenses</span></td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">6,969,000</span></td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">6,723,000</span></td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">246,000</span></td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">4%</span></td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; color: #0070C0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Research and Product Development:</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Research and product development costs increased $419,000 to $2,149,000
for fiscal 2023 due to increased salaries and related costs and an increase in research and development materials and supplies as we continue
the development of new products for new and existing markets.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Marketing and Selling:</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Marketing and selling costs decreased $197,000 to $3,170,000 for fiscal 2023 primarily
due to a decrease in commission expense. This decrease was partially offset by increased travel and trade show expenses.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023, we expended approximately $623,000 for commissions
as compared with $974,000 for the prior fiscal year, a decrease of $351,000. The decrease in commission expense is due to a decrease in
international sales being generated by our external distributors, which are commissioned at a higher rate than our in-house sales team.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023, we expended approximately $398,000 for travel
and trade show expenses compared with $205,000 for the prior fiscal year, an increase of $193,000. The increased travel and trade show
expenses are a result of the global lifting of COVID-19 restrictions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>General and Administrative:</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">General and Administrative costs increased $24,000 to $1,650,000 for
fiscal 2023 due to an increase in stock-based compensation expense. This increase was partially offset by decreases in corporate expenses
and bad debt expense.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In fiscal 2023 stock-based compensation expense increased $78,000
to $257,000 compared with $179,000 in fiscal 2022. The increase in stock-based compensation expense in fiscal 2023 is due to option awards
that were issued in the prior fiscal year. Option awards are expensed over three years based on vesting terms.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Operating Income:</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our operating income decreased $1,206,000 or 64%, to $683,000 in fiscal
2023 compared with $1,889,000 for the prior fiscal year due to the current period&#8217;s decrease in gross profit. Operating margin for
fiscal 2023 decreased to 5% compared with 11% in the prior fiscal year. As a percentage of net sales, operating expenses increased 700
basis points to 46% in fiscal 2023 compared with 39% in fiscal 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Interest and Dividend Income:</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Interest and dividend income increased $131,000 to $140,000 for fiscal
2023 as compared with $9,000 for the prior fiscal year. The increase in interest and dividend income is due to the reallocation of our
investments into US Treasury securities and certificates of deposit combined with the increase in current interest rates. Our present
investment policy is to invest excess cash in highly liquid, low risk US Treasury securities and certificates of deposit. At February
28, 2023, the majority of our holdings are rated at or above investment grade.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Income Tax Expense:</i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We recorded income tax expense of $154,000 for fiscal 2023 compared
with $362,000 for the prior fiscal year. The decrease in income tax expense in fiscal 2023 is due to the current period&#8217;s decrease
in operating profit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Net Income:</span></i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Net income decreased by $1,907,000 or 75%, to $636,000 for fiscal
2023 compared with $2,543,000 for the prior fiscal year. The decrease in net income in fiscal 2023 is a result of a decrease in operating
income and income tax expense combined with the PPP Loan forgiveness recorded in the prior year.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Impact of COVID-19</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In response to the COVID-19 pandemic and related government actions,
we began implementing changes in our business in March 2020 to protect our employees and customers. These changes include adjusting our
policies on social distancing, flexing our workforce hours, enhanced cleaning and sanitary procedures, limiting travel when appropriate,
and restricting access of non-employees to our facility when necessary. These policies continue to be modified and adjusted dependent
upon government regulations and CDC guidelines.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">While these measures are necessary and appropriate, they may result
in additional costs and may adversely impact our business and financial performance. As our response to the pandemic evolves, we may incur
additional costs and will potentially experience adverse impacts to our business, each of which may be significant. In addition, an extended
period of remote work arrangements could impair our ability to effectively manage our business, and introduce additional operational risks,
including, but not limited to, cybersecurity risks and increased vulnerability to security breaches, cyber-attacks, computer viruses,
ransomware, or other similar events and intrusions. We may<b>&#160;</b>experience, decreases in demand and customer orders for our products
in all sales channels, as well as temporary disruptions and closures of our facilities due to decreased demand and government mandates.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">COVID-19 has also impacted various aspects of the supply chain as
our suppliers experience similar business disruptions due to operating restrictions from government mandates. We continue to monitor procurement
of raw materials and components used in the manufacturing, distribution and sale of our products, but continued disruptions in the supply
chain due to COVID-19 may cause difficulty in sourcing materials or unexpected shortages or delays in delivery of raw materials and components,
and may result in increased costs in our supply chain.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We have implemented plans to reduce spending in certain areas of our
business, including reductions or delays in capital expenditures, reduced trade show participation costs, reduced travel expenditures
and may need to take additional actions to reduce spending in the future.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We are closely monitoring and assessing the impact of the pandemic
on our business. The extent of the impact on our results of operations, cash flow, liquidity, and financial performance, as well as our
ability to execute near- and long-term business strategies and initiatives, will depend on numerous evolving factors and future developments,
which are highly uncertain and cannot be reasonably predicted.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Given the inherent uncertainty surrounding COVID-19, the pandemic
may continue to have an adverse impact on our business in the near term. Should these conditions persist for a prolonged period, the COVID-19
pandemic, including any of the above factors and others that are currently unknown, may have a material adverse effect on our business,
results of operations, cash flow, liquidity, and financial condition.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Liquidity and Capital Resources</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Working Capital &#8211;</i></b> Our working capital increased
$335,000 to $11,117,000 at February 28, 2023 from $10,782,000 at February 28, 2022. The increase in working capital was primarily the
result of the current period&#8217;s net income and non-cash charges partially offset by purchases of equipment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We aggregate cash and cash equivalents and marketable securities in
managing our balance sheet and liquidity. For purposes of the following analysis, the total is referred to as &#8220;Cash.&#8221; At February
28, 2023 and February 28, 2022, our working capital included:</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February&#160;28,<br /> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February&#160;28,<br /> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Cash<br /> Increase</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 58%; text-align: left">Cash and cash equivalents</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">3,355,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">4,841,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">(1,486,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Marketable securities</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">8,090,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">5,868,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">2,222,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Total</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">11,445,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">10,709,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">736,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The following table summarizes the accounts and the major reasons
for the $736,000 increase in &#8220;Cash&#8221;:</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Impact on Cash</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: left"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Reason</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="width: 33%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Net income, adjusted for non-cash items</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="width: 10%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">853,000</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 51%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">To reconcile increase in cash.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Accounts receivable increase</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">(497,000</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">)&#160;</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Increase primarily due to shipments in the last month of the fiscal year.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Cambria,serif; font-size: 11pt">Inventories increase</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">(875,000</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-size: 11pt">)&#160;</span></td>
    <td>&#160;</td>
    <td>Additional inventory purchases and increase in work in process due to supply chain delays in receipt of required components.</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Customer deposits increase</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">1,670,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Received for new orders.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Accounts payable </span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">126,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Timing of disbursements.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Accrued expenses</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">(376,000</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Timing of disbursements.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Prepaid and Other Assets decrease</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">69,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Decreased prepaid expenses.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Income taxes payable increase</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">322,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Timing of disbursements.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Equipment purchases</span></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">(556,000</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">)</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Equipment and facilities upgrade.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Net increase in cash</span></td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 11pt">736,000</span></td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman,serif">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Stockholders&#8217; Equity &#8211;</i></b> Stockholders&#8217;
equity increased $893,000 from $13,741,000 at February 28, 2022 to $14,634,000 at February 28, 2023. The increase was a result of the
current year&#8217;s net income of $636,000 and $257,000 in additional equity related to stock-based compensation awards. The details
of stock-based compensation are explained in Note 4 in our financial statements.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Operating Activities &#8211;</i></b> We generated $1,325,000
of cash in our operating activities in fiscal 2023 compared with generating $2,319,000 in fiscal 2022. The decrease in cash generated
by operating activities was the result of increases in accounts receivable and inventories, a decrease in accrued expenses combined with
the current period&#8217;s decrease in net income. These uses of cash were partially offset by increases in customer deposits, income
taxes payable, an increase in accounts payable and a decrease in prepaid expenses.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Investing Activities &#8211;</i></b> In fiscal 2023, we used
$2,811,000 in our investing activities compared with using $1,631,000 of cash in fiscal 2022. Capital spending in fiscal 2023 was
$556,000 for the purchase or manufacture of equipment, furnishings and leasehold improvements and patent costs. This compares with $327,000
for the purchase of equipment and furnishings in fiscal 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In fiscal 2023, we used $2,255,000 of cash compared with using $1,304,000
for the purchase of marketable securities in fiscal 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Financing Activities &#8211; </i></b>In fiscal years 2023 and
2022, we received $0 and $69,000 from the exercise of stock options.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Bank Credit Facilities:</span></i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We currently have a revolving credit line of $1,500,000 and a $750,000
equipment purchase facility, both of which are with a bank. The revolving credit line is collateralized by the Company&#8217;s accounts
receivable and inventory. The revolving line of credit is payable on demand and must be retired for a 30-day period, once annually. As
of February 28, 2023, there were no outstanding borrowings under the line of credit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">As of February 28, 2023, $145,000 of the Company&#8217;s credit line
was being utilized to collateralize letters of credit issued to customers that have remitted cash deposits to the Company on existing
orders. The unused portion of the credit line was $1,355,000 as of February 28, 2023. The letters of credit expire in fiscal year 2024.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Paycheck Protection Program Loan Forgiveness:</span></i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2021, we entered into a loan transaction pursuant to
which we received proceeds of $1,001,640 (the &#8220;PPP Loan&#8221;) under the Paycheck Protection Program (&#8220;PPP&#8221;). The PPP,
established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;), provides for loans to qualifying
companies and is administered by the U.S. Small Business Administration (the &#8220;SBA&#8221;).</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company applied for forgiveness of the PPP Loan in December 2020.
On April 1, 2021, the Company received notice from the Bank that the Bank had received confirmation from the SBA that the application
for forgiveness of the PPP Loan had been approved. The loan forgiveness request in the amount of $1,001,640 was applied to the Company&#8217;s
entire outstanding PPP Loan balance with the Bank.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2022, the Company recorded a gain on the forgiveness
of the PPP Loan and accrued interest in the amount of $1,005,372. The gain on the forgiveness of the PPP Loan is a non-taxable event.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Off - Balance Sheet Arrangements</span></i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">We do not have any Off - Balance Sheet Arrangements as of February
28, 2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Critical Accounting Policies</span></i></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The discussion and analysis of the Company&#8217;s financial condition
and results of operations are based upon the Company&#8217;s consolidated financial statements, which have been prepared in accordance
with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires
the Company to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related
disclosure on contingent assets and liabilities at the date of the financial statements. Actual results may differ from these estimates
under different assumptions and conditions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Critical accounting policies are defined as those that are reflective
of significant judgments and uncertainties and may potentially result in materially different results under different assumptions and
conditions. As of February 28, 2023, management believes that there are no critical accounting policies applicable to the Company that
are reflective of significant judgments and or uncertainties.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Accounting for Income Taxes</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company accounts for income taxes under the asset and liability
method. Under this method, deferred income taxes are recognized for the tax consequences of &#8220;temporary differences&#8221; by applying
enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis
of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax asset will not be realized,
a valuation allowance is recognized. We use a recognition threshold and a measurement attribute for financial statement recognition and
measurement tax positions taken or expected to be taken in a return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. As of February 28, 2023 and February 28, 2022, there were no uncertain
tax provisions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Stock-Based Compensation</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The computation of the expense associated with stock-based compensation
requires the use of a valuation model. ASC 718 is a complex accounting standard, the application of which requires significant judgment
and the use of estimates, particularly surrounding Black-Scholes assumptions such as stock price volatility, expected option lives, and
expected option forfeiture rates, to value equity-based compensation. The Company currently uses a Black-Scholes option pricing model
to calculate the fair value of its stock options. The Company primarily uses historical data to determine the assumptions to be used in
the Black-Scholes model and has no reason to believe that future data is likely to differ materially from historical data. However, changes
in the assumptions to reflect future stock price volatility and future stock award exercise experience could result in a change in the
assumptions used to value awards in the future and may result in a material change to the fair value calculation of stock-based awards.
ASC 718 requires the recognition of the fair value of stock compensation in net income.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Revenue Recognition</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="font-size: 8pt">&#160;</span><span style="font-size: 11pt">The
Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity
should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled to receive in exchange for those goods or services.</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">Impact of New Accounting Pronouncements</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Accounting pronouncements issued but not yet effective have been
deemed to be not applicable or the adoption of such accounting pronouncements is not expected to have a material impact on the financial
statements of the Company.&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item7a"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 7A</span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK &#8211; Not Required for Smaller Reporting Companies.</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item8"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 8</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our financial statements are presented on pages 43 to 60 of this Report.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item9"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 9</span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE &#8211; None.</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item9a"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 9A</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>CONTROLS AND PROCEDURES</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Evaluation of Disclosure Controls and Procedures</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Our management, with the participation of our Chief Executive Officer
and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as
defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Act&#8221;)) as of the end of the period covered
by this annual report on Form 10-K.&#160;&#160;Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded
that these disclosure controls and procedures were effective as of such date, at a reasonable level of assurance, in ensuring that the
information required to be disclosed by us in the reports we file or submit under the Act is (i) accumulated and communicated to our management
(including the Chief Executive Officer and Chief Financial Officer) in a timely manner, and (ii) recorded, processed, summarized and reported
within the time periods specified in the SEC&#8217;s rules and forms.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Internal Control Over Financial Reporting</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Management is responsible for establishing and maintaining adequate
internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Under the supervision and with the
participation of our management, including our Chairman &amp; CEO (principal executive officer) and Chief Financial Officer (principal
accounting officer), we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria
in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our
evaluation, management has concluded that our internal control over financial reporting was effective as of and for the year ended February
28, 2023.&#160;Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Changes in Internal Control Over Financial Reporting</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">There was no change in our internal control over financial reporting
(as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that has materially affected, or is reasonably likely
to materially affect, our internal control over financial reporting.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item9b"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 9B</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>OTHER INFORMATION - None.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: justify">&#160;</td></tr>


  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif; text-align: justify"><span id="item9c"></span><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 9C</span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. &#8211; Not Applicable.</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>PART III</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item10"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 10</span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0"><span style="text-decoration: underline">Identification of Directors</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 33%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Name</span></b></span></td>
    <td style="width: 10%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Age&#160;</span></b></span></td>
    <td style="width: 57%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Position with the Company</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Christopher L. Coccio, Ph.D.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">82</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Chief Executive Officer, Chairman and Director</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">R. Stephen Harshbarger</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">55</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">President and Director</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Eric Haskell, CPA</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">76</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Director*</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Donald F. Mowbray, Ph.D.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">85</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Carol O&#8217;Donnell</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">66</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Director*</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Joseph Riemer, Ph.D.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">74</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Philip A. Strasburg, CPA</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">84</span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">Director*</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">* Member of the Audit Committee.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Board of Directors is divided into two classes. The directors
in each class serve for a term of two years. The terms of the classes are staggered so that only one class of directors is elected at
each annual meeting of the Company. The terms of Drs. Coccio and Riemer and Messrs. Strasburg and Harshbarger run until the annual meeting
to be held in 2023. The terms of Dr. Mowbray, Mr. Haskell and Ms. O&#8217;Donnell run until the annual meeting to be held in 2024, and
in each case until their respective successors are duly elected and qualified.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Audit Committee</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company has a separate designated standing Audit Committee established
and administered in accordance with SEC rules. The three members of the Audit Committee are Philip A. Strasburg, CPA (who serves as Chairman
of the Audit Committee), Carol O&#8217;Donnell and Eric Haskell, CPA. The Board of Directors has determined that each member of the Audit
Committee meets the independence criteria prescribed by NASDAQ governing the qualifications for audit committee members and each Audit
Committee member meets NASDAQ&#8217;s financial knowledge requirements. The Board of Directors has determined that Mr. Strasburg qualifies
as an &#8220;audit committee financial expert,&#8221; as defined in the rules and regulations of the SEC.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Audit Committee is responsible for (i) selecting an independent
public accountant for ratification by the stockholders, (ii) reviewing material accounting items affecting the consolidated financial
statements of the Company, and (iii) reporting its findings to the Board of Directors.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Compensation Committee</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company&#8217;s executive compensation is administered by the
Compensation Committee of the Board of Directors. The members of the Compensation Committee are Drs. Mowbray and Riemer and Mr. Strasburg,
all of whom have been determined by the Board to be independent in accordance with NASDAQ&#8217;s requirement for independent director
oversight of executive officer compensation.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Nominating Committee</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">There have been no changes to the procedures by which shareholders
may recommend nominees to the Board of Directors.</p>

<p style="font: 11pt Cambria,serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&#160;</p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0"><span style="text-decoration: underline">Identification of Executive Officers</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 33%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Name</span></b></span></td>
    <td style="width: 10%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Age</span></b></span></td>
    <td style="width: 57%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b><span style="text-decoration: underline">Position with the Company</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Stephen J. Bagley, CPA</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">60</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Chief Financial Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Christopher C. Cichetti</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">41</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Vice President &#8211; Sales and Application Engineering</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Christopher L. Coccio, Ph.D.</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">82</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Chief Executive Officer, Chairman and a Director</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Robb W. Engle</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">52</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Executive Vice President</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">R. Stephen Harshbarger</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">55</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">President and Director</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Maria T. Kuha</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">46</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Vice President &#8211; Manufacturing Operations</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The foregoing officers are appointed for terms of one year or until
their successors are duly elected and qualified or until terminated by action of the Board of Directors. There are no arrangements or
understandings between any executive officer and any other persons pursuant to which he was or is to be selected as an officer.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Business Experience</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">STEPHEN J. BAGLEY, CPA was appointed Chief Financial Officer in June
2005. From 1987 to 1991 he worked in public accounting in various capacities. From 1992 to 2005, he held various leadership positions
as Controller, Chief Financial Officer and Vice President of Finance for companies with up to $45,000,000 in revenues. Mr. Bagley earned
a Bachelor of Science degree from The State University of NY at Oneonta and an MBA from Marist College. He was licensed as a CPA in 1990.
Mr. Bagley served on the OTCQX US Advisory Council from 2019 to 2020. Mr. Bagley is a past President of the Board of Education for the
New Paltz Central School District and a past Chairman of the Audit and Finance Committee for the District.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">CHRISTOPHER C. CICHETTI was appointed Vice President &#8211; Sales
and Application Engineering in August 2022. Mr. Cichetti joined Sono-Tek in 2005 as an Electrical Engineer and has served as Application
Engineer, Senior Application Engineer, Application Engineering Manager, and Vice President of Application Engineering. Mr. Cichetti has
experience in lab testing, process development, project management, and has successfully implemented several successful OEM relationships
with outside vendors. He is a graduate of Worcester Polytechnic Institute with a major in Computer and Electrical Engineering and a minor
in International Studies.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">DR. CHRISTOPHER L. COCCIO was appointed President and Chief Executive
Officer of Sono-Tek on April 30, 2001, has been a Director of the Company since June 1998, and was appointed Chairman in August 2007.
From 1964 to 1996, he held various engineering, sales, marketing and management positions at General Electric Company, with P&amp;L responsibilities
for up to $100 million in sales and 500 people throughout the United States. He also won an ASME Congressional Fellowship and served with
the Senate Energy Committee in 1976. His business experience includes both domestic and international markets and customers. He founded
a management consulting business in 1996, and was appointed a legislative Fellow on the New York State Assembly&#8217;s Legislative Commission
on Science and Technology from 1996 to 1998. From 1998 to 2001, he worked with Accumetrics Associates, Inc., a manufacturer of digital
wireless telemetry systems, as Vice President of Business Development and member of the Board of Advisors. Dr. Coccio received a B.S.M.E.
from Stevens Institute of Technology, an M.S.M.E. from the University of Colorado, and a Ph.D. from Rensselaer Polytechnic Institute in
Chemical Engineering.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Key attributes, Experience and Skills:</span></i>
Dr. Coccio brings his strategic vision for our Company to the Board together with his leadership, business experience and investor relations
skills. Dr. Coccio has an immense knowledge of our Company and its related applications which is beneficial to the Board. Dr. Coccio&#8217;s
service as Chairman and CEO bridges a critical gap between the Company&#8217;s management and the Board, enabling the Board to benefit
from management&#8217;s perspective on the Company&#8217;s business while the Board performs its oversight function.</p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">ROBB W. ENGLE <span style="background-color: white">joined Sono-Tek
in 2000 as a Field Service Technician, became Vice President of Engineering in January 2013 and was appointed Executive Vice President
in September 2019. Mr. Engle created the Sono-Tek Service Department and led the development of key products in his leadership role of
our engineering resources. As Vice President of Engineering, he directs the engineering department, service department, IT and coordinates
the Company&#8217;s intellectual property. Mr. Engle was formally trained and certified by the U.S. Navy as a Nuclear Operator where he
was recognized with an induction into the Navy League Memorial for meritorious service and the advancement of training techniques. He
also served with honors on board a submarine and earned the prestigious Sub-Surface Warfare (E) Insignia.</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">R. STEPHEN HARSHBARGER <span style="background-color: white">joined
Sono-Tek in 1993. He was appointed President of the Company in 2012 and became a Director in August 2013. As President, he directs the
Company&#8217;s Sales, Marketing, Engineering, Service, and Manufacturing Operations. Prior to assuming his present position, Mr. Harshbarger
served as Sales Engineer, World-Wide Sales and Marketing Manager, Vice President &amp; Director of Electronics and Advanced Energy (E&amp;AE)
and Executive Vice President. In his years managing the sales organization, he established a worldwide distribution and representative
network in more than 40 countries consisting of more than 300 persons, with revenue growth of greater than 300%. He has over 30 years
of experience in ultrasonic coating equipment for the electronics, medical device and advanced energy industries.&#160;Prior to joining
Sono-Tek, Mr. Harshbarger was the Sales and Marketing Manager for Plasmaco Inc., a world leader in the development of flat panel displays.
In that position, he established their distribution network, participated in venture capital funding, and introduced the first flat panel
technology to Wall Street trading floors.&#160; He is a graduate of Bentley University, with a major in Finance and a minor in Marketing.</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Key attributes, Experience and Skills:</span></i>
Mr. Harshbarger is among a small handful of ultrasonic coating experts in the world. He has a proven track record of identifying, developing
and implementing the technology for new markets and applications. His expertise in establishing strong distribution networks and knowledge
of ultrasonic coating for new product developments, targeted at specific advanced technology applications, bring insights to the Board.
Mr. Harshbarger also brings leadership and oversight experience to the Board.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">ERIC HASKELL, CPA has been a Director since August 2009. He has over
40 years of experience in senior financial positions at several public and private companies.&#160;&#160;He has significant expertise
in the areas of acquisitions and divestitures, strategic planning and investor relations.&#160;&#160;From December 2005 through March
2008, Mr. Haskell served as the Executive Vice President and Chief Financial Officer of SunCom Wireless Holdings, Inc., a company providing
digital wireless communications services which was publicly traded until its merger with a wholly-owned subsidiary of T-Mobile USA, Inc.
in February 2008.&#160;&#160;He also served as a member of SunCom&#8217;s Board of Directors from November 2003 through May 2007.&#160;&#160;From
1989 until April 2004, Mr. Haskell served as the Chief Financial Officer of Systems &amp; Computer Technology Corp., a NASDAQ listed software
and services corporation.&#160;&#160;Mr. Haskell received a Bachelors Degree in Business Administration from Adelphi University in 1969.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Key attributes, Experience and Skills:</span></i>
Mr. Haskell&#8217;s training and extensive experience in financial management at both public and private companies provide the Board with
valuable insights. Mr. Haskell&#8217;s significant experience in acquisitions and divestitures and investor relations bring strategic
judgment and experience to the Board. Mr. Haskell&#8217;s strong operational and business background complement his accounting and finance
experience and are valuable resources to the Board as it exercises its oversight duties and support of the Company&#8217;s growth strategies.</p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; text-align: justify; margin-right: 0; margin-left: 0">MARIA T. KUHA joined Sono-Tek in 2007. Mrs.
Kuha was appointed VP, Manufacturing Operations, Procurement &amp; Logistics in September 2022. Prior to assuming her present position,
Mrs. Kuha served as Operations Director, Purchasing Manager, and several other positions within the procurement aspects of Sono-Tek; providing
extensive expertise in several vital areas of Sono-Tek operations.</p>

<p style="font: 11pt Cambria,serif; text-align: justify; margin-right: 0; margin-left: 0">Prior to joining Sono-Tek, Mrs. Kuha held various
positions in high tech manufacturing companies revolving around purchasing and operations. She holds an AAS in business from Dutchess
County Community College.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">DR. DONALD F. MOWBRAY has been a Director since August 2003. He has
been an independent consultant since August 1997. From September 1992 to August 1997, he was the Manager of the General Electric Company&#8217;s
Corporate Research and Development Mechanical Engineering Laboratory. From 1962 to 1992 he worked for the General Electric Company in
a variety of engineering and managerial positions. Dr. Mowbray received a B.S. in Aeronautical Engineering from the University of Minnesota
in 1960, a Master of Science in Engineering Mechanics from the University of Minnesota in 1962 and a Ph.D. from Rensselaer Polytechnic
Institute in Engineering Mechanics in 1968.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Key attributes, Experience and Skills:</span></i>
Dr. Mowbray&#8217;s extensive research and managerial experience enables him to bring valuable insights to the Board. His knowledge of
the Company&#8217;s products and the materials sciences technology underlying them has enabled him to contribute to the Company&#8217;s
advanced products development and designs. Dr. Mowbray also brings leadership and oversight experience to the Board from his General Electric
management background.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">CAROL O&#8217;DONNELL has been a Director since November 2018. Ms.
O&#8217;Donnell joined&#160;Prot&#233;g&#233; Partners, an industry leading firm investing in and seeding smaller and emerging hedge
fund managers in 2016 and has served as Chief Executive Officer since 2018. Prior to joining Prot&#233;g&#233; Partners, Ms. O&#8217;Donnell
was the Director of Legal and Compliance with DARA Capital US, Inc., a Swiss-owned boutique registered investment advisory and wealth
management firm from 2013 to 2016. She also served as General Counsel to Boothbay Fund Management LLC, a registered investment adviser,
from December 2019 through May 2021, and was General Counsel and Chief Compliance Officer of each of the Permal Group and Framework Investment
Group from 2004 through 2011 and from 2002 to 2004, respectively. &#160;Ms. O&#8217;Donnell is admitted to practice law in the States
of New York and Connecticut.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Key attributes, Experience and Skills: </span></i>Ms.
O&#8217;Donnell&#8217;s extensive experience as an attorney enables her to bring valuable strategic insights to the Board in the areas
of corporate governance, finance and securities law. Ms. O&#8217;Donnell also brings leadership and oversight experience to the Board.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">DR. JOSEPH RIEMER joined the Company in January 2007 as Vice President
of Engineering and has been a Director since August 2007. Dr. Riemer served as President from September 2007 until August 2012 when he
became Vice President of Food Business Development, which position he held until June 2016. Dr. Riemer holds a Ph.D. in Food Science and
Technology from the Massachusetts Institute of Technology (MIT), focusing on food technology, food chemistry, biochemical analysis, and
food microbiology. His experience includes seven years with Pfizer in its Adams Confectionary Division, where he was Director, Global
Operations Development. Dr. Riemer has also held leading positions with several food, food ingredients, and personal care products companies.
He has served in the capacities of research and development, operations, and general management. Prior to joining the Company, he was
a management consultant serving clients in the food, biotech and pharmaceutical industries.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Key attributes, Experience and Skills:</span></i>
Dr. Riemer&#8217;s extensive research and management experience enables him to bring valuable insights to the Board. His considerable
experience in the biotech, food and pharmaceutical industries bring specific product application insights to the Board. Dr. Riemer&#8217;s
previous service as Vice President of Food Business Development helps to provide focus to the Board on this important marketing area.
Dr. Riemer also brings leadership and oversight experience to the Board.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">PHILIP STRASBURG, CPA, has been a Director since August 2004. He is
a retired partner from the firm of Anchin Block and Anchin, LLP and has 40 years of experience in auditing. He has served as Audit Committee
Chairman since 2005. He was the lead partner on the Sono-Tek account from fiscal 1994 to fiscal 1996. Mr. Strasburg is a certified public
accountant in New York State. He has a Master of Science in economics from The London School of Economics and Political Science and a
Bachelor of Science degree from Lehigh University, where he majored in business administration.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Key attributes, Experience and Skills:</span></i>
Mr. Strasburg&#8217;s training and extensive experience in auditing provide the Board with valuable insights and skills necessary to lead
the Audit Committee. Mr. Strasburg&#8217;s strong operational and business background complement his accounting and finance experience,
and are valuable resources to the Board as it exercises its oversight duties and support of the Company&#8217;s growth strategies.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Section 16(a) Beneficial Ownership Reporting Compliance</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Section 16(a) of the Securities Exchange Act of 1934 requires
the Company's Directors, executive officers and persons who own more than ten percent of the Company's common stock to file with the
Securities and Exchange Commission initial reports of beneficial ownership and reports of changes of beneficial ownership of common
stock. Such persons are also required by Securities and Exchange Commission regulations to furnish the Company with copies of
all such reports. Based solely on a review of such filings, during the year ended February 28, 2023, all of the Company's Directors
and executive officers and holders of more than ten percent of the Company&#8217;s stock have made timely filings of such reports,
with the exception of four late filings by Philip Strasburg.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Code of Ethics</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company has adopted a Code of Business Conduct and Ethics that
applies to all directors, officers, and employees. This code of ethics is designed to comply with the NASDAQ marketplace rules related
to codes of conduct. A copy of the Company's Code of Ethics is posted on the &#34;information for investors&#34; web page located at
http://www.sono-tek.com/code-of-ethics/ and is available in print to any shareholder who requests a copy. The Company intends to satisfy
any disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or waiver from, a provision of our code of ethics by
posting such information on the Company&#8217;s website.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item11"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 11</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>EXECUTIVE COMPENSATION</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The following table sets forth the aggregate remuneration paid or
accrued by the Company for fiscal 2023 and fiscal 2022 for each named officer of the Company.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">Summary Compensation Table</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Name and <br />
Principal Position</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Year</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Salary<br />
($)</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Bonus<br />
($)</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Stock <br />
Awards</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Option<br />
Awards<br />
($)</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>All Other<br />
Compensation<br />
($)</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Total<br />
($)</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="width: 30%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">Christopher L. Coccio</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 6%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">2023</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 8%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">192,200</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 8%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">20,200</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 8%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">0</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 9%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">15,000</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 9%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">6,373</span></td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 8%; font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">233,773</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 10pt">CEO, Chairman and Director</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">2022</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">150,000</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">42,200</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">54,520</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">5,766</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">252,486</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 10pt">R. Stephen Harshbarger</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">2023</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">249,200</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">23,000</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">15,000</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">8,167</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">295,367</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 10pt">President and Director</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">2022</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">227,500</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">48,700</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">3,667</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">8,286</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">288,153</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Stephen J. Bagley</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">2023</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">174,800</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">18,500</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">7,500</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">5,799</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">206,599</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">2022</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">165,000</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">38,900</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">6,383</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">6,117</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">216,400</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">All Other Compensation represents Company contributions to the Company&#8217;s
401K plan.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Option awards in the above table are calculated using the Black-Scholes
options pricing model which is further discussed in Note 4 &#8211; Stock Based Compensation, in the Company&#8217;s consolidated financial
statements.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Officer Compensation Arrangements</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023, Dr. Coccio was compensated at the rate of $150,000
per annum, until May 2022, at which time his annual base compensation increased to $200,000.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023, Mr. Harshbarger was compensated at the rate of
$235,000 per annum, until November 2022, at which time his annual base compensation increased to $250,000.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023, Mr. Bagley was compensated at the rate of $165,000
per annum, until November 2022, at which time his annual base compensation increased to $175,000.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In addition, each named officer earned bonus compensation based on
the achievement of certain operating objectives.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">Outstanding Equity Awards at Fiscal Year End</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 47%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Name</b></span></td>
    <td style="width: 2%; padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 11%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Number of Securities<br />
Underlying Unexercised<br />
Options (#) Exercisable</b></span></td>
    <td style="width: 2%; padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 13%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Number of Securities<br />
Underlying Unexercised<br />
Options (#) Unexercisable</b></span></td>
    <td style="width: 2%; padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 8%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Option <br />
Exercise Price ($)</b></span></td>
    <td style="width: 2%; padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 13%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Option <br />
Expiration Date</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Christopher L. Coccio</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">2,617</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">3,198</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">6.05</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">11/18/2031&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">CEO, Chairman and Director</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">16,340</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">-</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">6.26</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">02/17/2032&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">16,340</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">-</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">6.26</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">02/17/2032&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">-</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">4,505</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">5.96</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">11/17/2032</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">R. Stephen Harshbarger</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">2,617</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">3,198</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">6.05</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">11/18/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">President</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">7,353</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">8,987&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">6.26&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">02/17/2032&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">-</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">3,937</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">5.96</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">11/17/2032</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Stephen J. Bagley</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">1,750</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">1,000</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">4.45</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">01/15/2031</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">4,412</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">5,392</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">6.26</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">02/17/2032</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">-</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">1,969</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">5.96</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt">11/17/2032</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Estimated Payments and Benefits Upon Termination or Change in Control</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">On September 1, 2007, the Company entered into identical Executive
Agreements with Stephen J. Bagley, Chief Financial Officer and Christopher L. Coccio, Chief Executive Officer.&#160;The Company also entered
into an Executive Agreement with R. Stephen Harshbarger, President, on March 5, 2008. The agreements, as subsequently amended, provide
that in the event of a change of control of the Company followed by a termination of the executives&#8217; employment under certain circumstances,
the officers shall receive severance payments equal to two years of the executive&#8217;s annual base, commissions and bonus compensation
paid by the Company for the previous calendar year.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Based on last year&#8217;s salary arrangements, if the rights of the
foregoing officers were to be triggered following a change of control, they would be entitled to the following payments from the Company:
Stephen J. Bagley $411,000, Christopher L. Coccio $442,000 and R. Stephen Harshbarger $572,000.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Severance Agreements</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">On October 20, 2017, the Company entered into identical Executive
Agreements with Stephen J. Bagley, Chief Financial Officer, Christopher L. Coccio, Chief Executive Officer and R. Stephen Harshbarger,
President. The agreements provide that in the event of termination of the executive&#8217;s employment, other than for the cause, the
officers shall receive severance payments equal to two weeks of compensation for each full year employed by the Company.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Compensation of Directors</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 0 6pt; text-align: justify">Each non-employee director receives $2,500 for each meeting
attended. Directors who are employees of the Company receive no additional compensation for serving as directors. For the year ended February
28, 2023, director compensation was as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">2023 Director Compensation</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Cambria, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold">Name</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Fees <br /> Earned <br /> or Paid in <br /> Cash ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Stock <br /> Awards<br /> ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Option <br /> Awards<br /> ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Non-Equity <br /> Incentive Plan<br /> Compensation<br /> ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Nonqualified <br /> Deferred <br /> Compensation<br /> Earnings ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">All Other <br /> Compensation<br /> ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Total ($)</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="width: 23%; font-size: 10pt; text-align: left">Eric Haskell</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">10,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">9,900<sup>1</sup></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">&#8212;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 7%; font-size: 10pt; text-align: right">19,900</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Donald F. Mowbray</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">9,900<sup>2</sup></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">19,900</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font-size: 10pt; text-align: left">Carol O&#8217;Donnell</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">9,900<sup>3</sup></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">19,900</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Philip Strasburg</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">9,900<sup>4</sup></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">19,900</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font-size: 10pt; text-align: left">Joseph Riemer</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">10,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">9,900<sup>5</sup></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">19,900</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 20px; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt"><sup>1</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 10pt">During fiscal 2023, Mr. Haskell received a grant of 3,300 options exercisable at $5.50 per share.&#160; At the end of fiscal 2023, Mr. Haskell held an aggregate of 19,350 stock options.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>2</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 10pt">During fiscal 2023, Dr. Mowbray received a grant of 3,300 options exercisable at $5.50 per share.&#160;&#160;At the end of fiscal 2023, Dr. Mowbray held an aggregate of 19,350 stock options.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>3</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 10pt">During fiscal 2023, Ms. O&#8217;Donnell received a grant of 3,300 options exercisable at $5.50 per share.&#160; At the end of fiscal 2023, Ms. O&#8217;Donnell held an aggregate of 9,350 stock options.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>4</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 10pt">During fiscal 2023, Mr. Strasburg received a grant of 3,300 options exercisable at $5.50 per share.&#160; At the end of fiscal 2023, Mr. Strasburg held an aggregate of 6,627 stock options.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>5</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Cambria,serif; font-size: 10pt">During fiscal 2023, Dr. Riemer received a grant of 3,300 options exercisable at $5.50 per share.&#160; At the end of fiscal 2023, Dr. Riemer held an aggregate of 11,350 stock options.</span></td></tr>
  </table>
<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Option awards in the above table are calculated using the Black-Scholes
options pricing model which is further discussed in Note 4 &#8211; Stock Based Compensation, in the Company&#8217;s consolidated financial
statements.</p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item12"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 12</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The following information is furnished as of May 23, 2023 to indicate
beneficial ownership of the Company's Common Stock by each Director, by each named executive officer, by all Directors and executive officers
as a group, and by each person known to the Company to be the beneficial owner of more than 5% of the Company's outstanding Common Stock.
Such information has been furnished to the Company by the indicated owners. Unless otherwise indicated, the named person has sole voting
and investment power.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: bottom">
    <td style="width: 75%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 10%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Amount</b></span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 10%; font-family: Times New Roman,serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Beneficially</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Name (and address if more than 5%) of Beneficial owner</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Owned</b></span></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Percent</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><span style="text-decoration: underline">Directors and Officers</span></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*Stephen J. Bagley</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">60,844</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>1</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">**</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*Christopher L. Coccio</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">387,296</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>2</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">2.45%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*R. Stephen Harshbarger</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">291,748</span></td>
    <td style="font-family: Times New Roman,serif; text-indent: 0.85pt"><span style="font-family: Cambria,serif; font-size: 11pt"><sup>3</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">1.85%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*Eric Haskell</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">15,310</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>4</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">**</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*Donald F. Mowbray</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">69,913</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>5</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">**</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*Carol O&#8217;Donnell</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">24,723</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>6</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">**</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*Joseph Riemer</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">47,029</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><sup>7</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">**</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">*Philip A. Strasburg</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">42,118</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>8</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">**</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 10pt">All Executive Officers and Directors as a Group</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">1,034,122</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>9</sup>&#160;</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">6.53%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><span style="text-decoration: underline">Additional 5% owners</span></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">Emancipation Management LLC<sup>11</sup><br />
Charles Frumberg<sup>11</sup><br />
Circle N Advisors, LLC<sup>12</sup></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">6,628,393</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>10</sup></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">42.11%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">V. Adah Nicklin<sup>13</sup></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">915,599</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">5.82%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-left: 0.2in; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt">Richard A. Bayles<sup>14</sup></span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">840,536</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: right"><span style="font-family: Cambria,serif; font-size: 10pt">5.34%</span></td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">The above ownership percentages are based on 15,742,073 shares outstanding as of May 23,
2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0"><i>*c/o Sono-Tek Corporation, 2012 Route 9W, Milton, NY 12547.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i>** Less than 1%</i></p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0"><sup>1</sup> <i>Includes 6,162 options currently exercisable issued under the Company&#8217;s
Stock Incentive Plans.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>2</sup> Includes 4,000 shares held in the name of Dr. Coccio&#8217;s wife and 35,297
options currently exercisable issued under the Company&#8217;s Stock Incentive Plans.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>3</sup> Includes 9,970 options currently exercisable issued under the Company&#8217;s
Stock Incentive Plans.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>4</sup> Includes 10,723 options currently exercisable issued under the Company&#8217;s
Stock Incentive Plans.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>5 </sup>Includes 10,723 options currently exercisable issued under the Company&#8217;s
Stock Incentive Plans.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>6</sup> Includes 2,723 options currently exercisable issued under the Company&#8217;s
Stock Incentive Plans.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><sup>7</sup> <i>Includes 4,723 options currently exercisable issued under the Company&#8217;s
Stock Incentive Plans.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>8 </sup>Includes 10,000 shares in the name of Mr. Strasburg&#8217;s wife.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>9 </sup>The group total includes 93,695 options currently exercisable issued under
the Company&#8217;s Stock Incentive Plans. The group total does not include 88,612 options that are currently unexercisable. The group
total includes 81,167 shares and 6,162 currently exercisable options held by Robb Engle, Executive Vice President, 600 shares and 1,050
currently exercisable options held by Maria Kuha, a Vice President and 6,162 currently exercisable options held by Christopher Cichetti,
a Vice President. </i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>10</sup> Emancipation Management LLC, Charles Frumberg and Circle N Advisors share
the power to dispose or to direct the disposition of these shares. The Company does not consider these holders to be &#8220;affiliates&#8221;
of the Company.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>11</sup> The address of this person is 299 Park Avenue, New York, NY 10171.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>12 </sup>The address of this person is 1065 Main Street, Suite F, PO Box 336, Fishkill,
NY 12524.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>13</sup> The address of this person is 3 Rivers Edge, Newburgh, NY 12550.</i></p>

<p style="font: 10pt Cambria,serif; margin: 0"><i><sup>14</sup> The address of this person is 3697 Se Doubleton Drive, Stuart, FL 34997.</i></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 11pt Cambria,serif; margin: 0"><b>Securities Authorized for Issuance Under Equity Compensation Plans:</b></p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>EQUITY COMPENSATION PLAN INFORMATION</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Cambria, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 9pt; font-weight: bold; text-align: center">Number of<br /> securities to be<br /> issued upon<br /> exercise of<br /> outstanding options,<br /> warrants and rights<br /> (a)</td><td style="padding-bottom: 1pt; font-size: 9pt; font-weight: bold">&#160;</td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 9pt; font-weight: bold; text-align: center">Weighted-<br /> average exercise<br /> price of<br /> outstanding options,<br /> warrants and rights<br /> (b)</td><td style="padding-bottom: 1pt; font-size: 9pt; font-weight: bold">&#160;</td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 9pt; font-weight: bold; text-align: center">Number of<br /> securities remaining<br /> available for future<br /> issuance under equity<br /> compensation plans<br /> (excluding securities<br /> reflected in column (a))<br /> (c)</td><td style="padding-bottom: 1pt; font-size: 9pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="text-align: left">Equity compensation plans approved by security holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt; padding-left: 9pt">2013 Stock Incentive Plan</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right">250,759</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left">$</td><td style="width: 11%; padding-bottom: 1pt; text-align: right">4.84</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 11%; text-align: right">1,212,793</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 27pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">250,759</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,212,793</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>Description of Equity Compensation Plans:</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">2013 Stock Incentive Plan</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Under the 2013 Stock Incentive Plan (the &#34;2013 Plan&#34;),
up to 2,500,000 options and shares can be granted to officers, directors, consultants and employees of the Company and its subsidiaries
.. Under the 2013 Plan options expire ten years after the date of grant. As of February 28, 2023, there were 250,759 options outstanding
under the 2013 plan.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"><span style="text-decoration: underline">2023 Stock Incentive Plan</span></p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt">In
May 2023, the Company&#8217;s Board of Directors authorized the creation of the 2023 Stock Incentive Plan (the &#8220;2023 Plan&#8221;)
pursuant to which the Company may grant up to 2,500,000 options or shares to officers, directors, employees and consultants</span> of
the Company <span style="font-family: Cambria,serif; font-size: 11pt">and its subsidiaries. The 2023 Plan is intended to supplement and
replace the 2013 Plan under which no additional options or shares may be granted after June 2023. Under the 2023 Plan, options expire
ten years after the date of grant. Adoption of the 2023 Plan remains subject to shareholder approval which shall be sought at the Company&#8217;s
annual meeting in August 2023. No options or shares have been granted under the 2023 Plan.</span></p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Under the 2013 Plan and the 2023 Plan, option prices
must be at least 100% of the fair market value of the common stock at time of grant. For qualified employees, except under certain
circumstances specified in the plan or unless otherwise specified at the discretion of the Board of Directors, no option may be
exercised prior to one year after date of grant, with the balance becoming exercisable in cumulative installments over a three-year
period during the term of the option and terminating at a stipulated period of time after an employee's termination of
employment.</p>


<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item13"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 13</span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Transactions with Related Persons &#8211; None</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Independence of Directors</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company&#8217;s Board of Directors is comprised of five &#8220;independent
directors&#8221;, as that term is defined under NASDAQ rules, and two directors who are not &#8220;independent directors&#8221;. The Company&#8217;s
&#8220;independent directors&#8221; are Donald Mowbray, Eric Haskell, Carol O&#8217;Donnell, Philip Strasburg and Joseph Riemer. Christopher
L. Coccio and R. Stephen Harshbarger are current employees of the Company and therefore are not considered independent.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item14"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 14</span></b></span></td>
    <td style="font-family: Times New Roman,serif; text-align: justify"><span style="font-family: Cambria,serif; font-size: 11pt"><b>PRINCIPAL ACCOUNTING FEES AND SERVICES</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Audit Fees</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For fiscal 2023 the Company paid or accrued fees of approximately
$100,000 for services rendered by Marcum LLP, its independent auditors. These fees included audit and review services.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For fiscal 2023 and 2022, the Company paid or accrued fees of approximately
$46,000 and $129,000, respectively, for services rendered by Friedman LLP, its independent auditors. These fees included audit and review
services.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Audit Related Fees - None</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Tax Fees</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For fiscal 2023 and 2022, the Company paid or accrued tax preparation
fees of approximately $18,000 and $14,000, respectively, for services rendered by RBSM, LLP.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">All Other Fees &#8211; None</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Pre-Approval Policies and Procedures</span></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Audit Committee&#8217;s current policy is to pre-approve all audit
and non-audit services that are to be performed and fees to be charged by the Company&#8217;s independent auditor to assure that the provision
of these services does not impair the independence of the auditor. The Audit Committee pre-approved all audit and non-audit services rendered
by the Company&#8217;s principal accountants in fiscal 2023 and fiscal 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">PART IV</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item15"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 11%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 15</span></b></span></td>
    <td style="width: 89%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><b>EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Cambria,serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 12%"><b><span style="text-decoration: underline">Ex. No</span>.</b></td>
    <td style="width: 88%"><b><span style="text-decoration: underline">Description</span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">3(a)<sup>1</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000080617204000003/s-8.txt">Certificate of Incorporation of the Company and all amendments thereto.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">3(b)<sup>2</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152019000143/ex3-1.htm">By-laws of the Company as amended.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(d) <sup>3</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152007000607/ex10-1.txt">Executive Agreement between Sono-Tek Corporation and Stephen J. Bagley dated September 1, 2007.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(e) <sup>3</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152007000607/ex10-2.txt">Executive Agreement between Sono-Tek Corporation and Christopher L. Coccio dated September 1, 2007.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(g) <sup>4</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152008000396/ex10-1.txt">Executive Agreement between Sono-Tek Corporation and R. Stephen Harshbarger dated March 5, 2008.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(h)<sup>5</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152012000416/ex10m.htm">Amended Executive Agreement between Sono-Tek Corporation and R. Stephen Harshbarger dated March 8, 2012.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(j)<sup>6</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152013000480/eps5215.htm">Sono-Tek Corporation 2013 Stock Incentive Plan.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(p)<sup>7</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152015000345/ex10s.htm">Amended Executive Agreement between Sono-Tek Corporation and Christopher L. Coccio dated August 24, 2014.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(q)<sup>7</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152015000345/ex10t.htm">Amended Executive Agreement between Sono-Tek Corporation and R. Stephen Harshbarger dated August 24, 2014.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(r)<sup>8</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152016000935/ex10u.htm">Amended Executive Agreement between Sono-Tek Corporation and Stephen J. Bagley dated May 21, 2015.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(s)<sup>10</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152017000259/ex10v.htm">Amended Executive Agreement between Sono-Tek Corporation and Christopher L. Coccio dated November 17, 2016.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(t)<sup>9</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152017000259/ex10w.htm">Amended Executive Agreement between Sono-Tek Corporation and R. Stephen Harshbarger dated November 17, 2016.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(u)<sup>9</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152017000259/ex10x.htm">Amended Executive Agreement between Sono-Tek Corporation and Stephen J. Bagley dated November 17, 2016.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(v)<sup>10</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152018000264/ex10v.htm">Letter Agreement between Sono-Tek Corporation and Christopher L. Coccio dated October 20, 2017.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(w)<sup>10</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152018000264/ex10w.htm">Letter Agreement between Sono-Tek Corporation and R. Stephen Harshbarger dated October 20, 2017.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(x)<sup>10</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152018000264/ex10x.htm">Letter Agreement between Sono-Tek Corporation and Stephen J. Bagley dated October 20, 2017.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(y)<sup>11</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152019000214/ex10y.htm">Amended and Restated Loan Agreement between Sono-Tek Corporation and M&amp;T Bank dated January 17, 2019.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 12%">10(z)<sup>11</sup></td>
    <td style="width: 88%"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152019000214/ex10z.htm">Addendum to Loan Agreement (Flexline) between Sono-Tek Corporation and M&amp;T Bank dated January 17, 2019.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(aa)<sup>11</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152019000214/ex10aa.htm">Addendum to Loan Agreement (Loan Limit) between Sono-Tek Corporation and M&amp;T Bank dated January 17, 2019.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(bb)<sup>11</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152019000214/ex10bb.htm">Loan Agreement between Sono-Tek Corporation and M&amp;T Bank dated January 17, 2019.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">10(cc)<sup>11</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152019000214/ex10cc.htm">Amended and Restated Revolving Demand Note between Sono-Tek Corporation and M&amp;T Bank dated January 17, 2019 .</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">10(dd)<sup>11</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000117152019000214/ex10dd.htm">Security Agreement between Sono-Tek Corporation and M&amp;T Bank dated January 17, 2019.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">14<sup>12</sup></td>
    <td style="font-family: Cambria,serif"><a href="http://www.sec.gov/Archives/edgar/data/806172/000142050620001016/ex14.htm">Code of Ethics.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">21<sup>13</sup></td>
    <td style="font-family: Cambria,serif"><a href="ex21.htm">Subsidiaries of Issuer.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">23.1<sup>13</sup></td>
    <td style="font-family: Cambria,serif"><a href="ex23-1.htm">Consent of Marcum LLP</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">23.2<sup>13</sup></td>
    <td style="font-family: Cambria,serif"><a href="ex23-2.htm">Consent of Friedman LLP</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">31.1<sup>13</sup></td>
    <td style="font-family: Cambria,serif"><a href="ex31-1.htm">Rule 13a-14/15d &#8211; 14(a) Certification.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">31.2<sup>13</sup></td>
    <td style="font-family: Cambria,serif"><a href="ex31-2.htm">Rule 13a-14/15d &#8211; 14(a) Certification.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">32.1<sup>13</sup></td>
    <td style="font-family: Cambria,serif"><a href="ex32-1.htm">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">32.2<sup>13</sup></td>
    <td style="font-family: Cambria,serif"><a href="ex32-2.htm">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">101.INS<sup>13</sup></td>
    <td style="font-family: Cambria,serif">XBRL Instance Document     &#8212; This instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">101.SCH<sup>13</sup></td>
    <td style="font-family: Cambria,serif">XBRL Taxonomy Extension Schema Document.</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">101.CAL<sup>13</sup></td>
    <td style="font-family: Cambria,serif">XBRL Taxonomy Calculation Linkbase Document.</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">101.DEF<sup>13</sup></td>
    <td style="font-family: Cambria,serif">XBRL Taxonomy Extension Definition Linkbase Document.</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="font-family: Cambria,serif">101.LAB<sup>13</sup></td>
    <td style="font-family: Cambria,serif">XBRL Extension Label Linkbase Document.</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">101.PRE<sup>13</sup></td>
    <td style="font-family: Cambria,serif">XBRL Taxonomy Extension Presentation Linkbase Document.</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Cambria,serif">104<sup>13</sup></td>
    <td style="font-family: Cambria,serif">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 20px; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 10pt"><sup>1</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Registration Statement No. 333-11913 on Form S-8 filed on February 18, 2004.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>2</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Current Report on Form 8-K dated March 7, 2019 and filed with the Securities and Exchange Commission on March 13, 2019.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>3</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-QSB for the quarter ended August 31, 2007 </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>4</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-Q for the quarter ended May 31, 2008. </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>5</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-K for the year ended February 29, 2012.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>6</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to Exhibit A to the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on July 25, 2013.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>7</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-K for the year ended February 29, 2015.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>8</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-K for the year ended February 29, 2016.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>9</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-K for the year ended February 28, 2017.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>10</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-K for the year ended February 28, 2018.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>11</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Form 10-K for the year ended February 28, 2019.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>12</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Incorporated herein by reference to the Company&#8217;s Current Report on Form 8-K dated September 24, 2020 and filed with the Securities and Exchange Commission on September 17, 2020.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 10pt"><sup>13</sup></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 10pt">Filed herewith.</span></td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>&#160;</b></p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span id="item16"></span></p><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><b><span style="text-decoration: underline">ITEM 16</span></b></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><b>10-K SUMMARY</b></span></td></tr>
  </table>
<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0">None.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">SONO-TEK CORPORATION</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">FORM 10-K</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">ITEM 8</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND NOTES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">FOR THE YEARS ENDED FEBRUARY 28, 2023 and 2022</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify"><b>REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS <br />
<span id="xdx_90F_edei--AuditorName_c20220301__20230228_zWJhaAYGSZAg"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:AuditorName">Marcum LLP</ix:nonNumeric></span> (PCAOB ID No: <span id="xdx_909_edei--AuditorFirmId_c20220301__20230228_zFOWDJt0ZWa4"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:AuditorFirmId">688</ix:nonNumeric></span>) </b></p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify"><b><span id="xdx_903_edei--AuditorName_c20210301__20220228_zo339uCbH0E3"><ix:nonNumeric contextRef="From2021-03-012022-02-28" name="dei:AuditorName">Friedman LLP</ix:nonNumeric></span> (PCAOB ID No: <span id="xdx_907_edei--AuditorFirmId_c20210301__20220228_zOgU8GpnHBa7"><ix:nonNumeric contextRef="From2021-03-012022-02-28" name="dei:AuditorFirmId">711</ix:nonNumeric></span>)</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>CONSOLIDATED FINANCIAL STATEMENTS:</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Consolidated Balance Sheets as of February 28, 2023 and 2022</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Consolidated Statements of Income</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For the Years Ended February 28, 2023 and 2022</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Consolidated Statements of Stockholders' Equity</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For the Years Ended February 28, 2023 and 2022</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Consolidated Statements of Cash Flows</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For the Years Ended February 28, 2023 and 2022</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Notes to Consolidated Financial Statements</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Cambria,serif; margin: 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">To the Shareholders and Board of Directors of<br />
Sono-Tek Corporation</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">We have audited the accompanying consolidated balance sheet of Sono-Tek
Corporation (the &#8220;Company&#8221;) as of February 28, 2023, the related consolidated statements of income, stockholders&#8217; equity
and cash flows for the year ended February 28, 2023, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of February
28, 2023, and the results of its operations and its cash flows for the year ended February 28, 2023, in conformity with accounting principles
generally accepted in the United States of America.</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0"><b>Basis for Opinion</b></p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting
firm registered with the Public Company Accounting Oversight Board (United States) (&#34;PCAOB&#34;) and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">We conducted our audit in accordance with the standards of the PCAOB.
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free
of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit
of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control
over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over
financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">Our audit included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0"><b>Critical Audit Matters</b></p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">Critical audit matters are matters arising from the current period
audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to
accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex
judgments. We determined that there are no critical audit matters.</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0">/s/ Marcum <span style="font-variant: small-caps">llp</span></p>

<p style="font: 10pt Cambria,serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 10pt Cambria,serif; margin: 0">Marcum <span style="font-variant: small-caps">llp</span></p>

<p style="font: 10pt Cambria,serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 10pt Cambria,serif; margin: 0">We have served as the Company&#8217;s auditor since 2020 (such date takes into account
the acquisition of certain assets of Friedman LLP by Marcum LLP effective September 1, 2022).</p>

<p style="font: 10pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Cambria,serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 10pt Cambria,serif; margin: 0"><span id="xdx_90D_edei--AuditorLocation_c20220301__20230228_zXsJqITcQE8e"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" name="dei:AuditorLocation">East Hanover, New Jersey</ix:nonNumeric></span><br />
May 25, 2023</p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->


<p style="font: 10pt Cambria,serif; margin: 6pt 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font: 10pt Cambria,serif; margin: 6pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: left">To the Board of Directors and</p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: left">Stockholders of Sono-Tek Corporation</p>

<p style="font: 10pt Cambria,serif; margin: 6pt 0; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">We have audited the accompanying consolidated balance sheet of Sono-Tek
Corporation (the &#8220;Company&#8221;) as of February 28, 2022, and the related consolidated statements of income, stockholders&#8217;
equity, and cash flows for the year ended February 28, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of February
28, 2022, and the results of its operations and its cash flows for the year ended February 28, 2022, in conformity with accounting principles
generally accepted in the United States of America.</p>

<p style="font: 10pt Cambria,serif; margin: 6pt 0; text-align: justify"><b>Basis for Opinion</b></p>

<p style="font: 10pt Cambria,serif; margin: 6pt 0; text-align: justify">These financial statements are the responsibility of the Company&#8217;s
management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public
accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Cambria,serif; margin: 6pt 0; text-align: justify">We conducted our audit in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal
control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal
control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Cambria,serif; margin: 6pt 0; text-align: justify">Our audit included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks.
Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit
also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall
presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 10pt Cambria,serif; margin: 0">/s/ Friedman LLP</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0">We served as the Company&#8217;s auditor from 2020 through 2022.</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 10pt Cambria,serif; margin: 0"><span id="xdx_907_edei--AuditorLocation_c20210301__20220228_zoyskDYLhm4c"><ix:nonNumeric contextRef="From2021-03-012022-02-28" name="dei:AuditorLocation">East Hanover, New Jersey</ix:nonNumeric></span></p>

<p style="font: 10pt Cambria,serif; margin: 0">May 24, 2022</p>

<p style="font: 10pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>SONO-TEK CORPORATION</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_111_z7omIhKpxrd9" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20230228" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220228" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">February 28, <br /> 2023</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">February 28, <br /> 2022</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsAbstract_iB_zaTAnHGJOFT3" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: bold 10pt Cambria,serif; text-align: center">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrentAbstract_iB_zYa49ZIESV5f" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">Current Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maCzaQU_zIxbcFbGdzZf" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; width: 72%; text-align: left; padding-left: 0.3in">Cash and cash equivalents</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,354,601</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,840,558</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--MarketableSecuritiesCurrent_i01I_maCzaQU_zh5SGlE2huVe" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.3in">Marketable securities</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,090,000</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,867,990</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_i01I_maCzaQU_zAHPqDLootrd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.3in">Accounts receivable (less allowance of $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_c20230228_pp0p0" title="Allowance for doubtful accounts receivable"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,225</ix:nonFraction></span> and <span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_c20220228_pp0p0" title="Allowance for doubtful accounts receivable"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">56,123</ix:nonFraction></span>, respectively)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,633,866</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,505</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--InventoryNet_i01I_maCzaQU_zgxBEEhNjAE5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; padding-left: 0.3in">Inventories</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,242,909</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,373,242</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maCzaQU_zAiiZeBIM4y" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.3in">Prepaid expenses and other current assets</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,046</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">323,304</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsCurrent_iTI_mtCzaQU_maCzwmy_zjL1xO63nKx4" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.6in">Total current assets</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,575,422</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,497,599</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Land_iI_maCzwmy_zmVFRiS4YDYk" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif">Land</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Land" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Land" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet_iI_maCzwmy_z7SOjm9mT2uf" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Buildings, equipment, furnishings and leasehold improvements, net</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,624,996</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,561,184</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maCzwmy_z1h3Wu0h6z9e" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">Intangible assets, net</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,202</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,015</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredIncomeTaxAssetsNet_iI_maCzwmy_zpD0xKV7mOPc" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Deferred tax asset</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">667,098</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxAssetsNet" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">240,736</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Assets_iTI_mtCzwmy_zR8owjdFgOq8" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,174,718</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,625,534</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: bold 10pt Cambria,serif; text-align: center">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesCurrentAbstract_iB_z5c5AXdqlpM5" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Current Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccountsPayableCurrent_i01I_maCzUdS_zGk4uQimO53a" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.3in">Accounts payable</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">$</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">810,863</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">$</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">684,511</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccruedLiabilitiesCurrent_i01I_maCzUdS_zBAZ1TKj1iR7" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.3in">Accrued expenses</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,427,446</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,804,028</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--CustomerDeposits_i01I_maCzUdS_z8wK3McaRJrl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.3in">Customer deposits</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:CustomerDeposits" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,838,165</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:CustomerDeposits" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,968</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i01I_maCzUdS_zKSxMAORKzR2" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.3in">Income taxes payable</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">381,421</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,874</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrent_iTI_mtCzUdS_maCzUKw_z4sI7Pok5Zv1" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.6in">Total current liabilities</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,457,895</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,715,381</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilitiesNet_iI_maCzUKw_z1CxtpR6zST7" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Deferred tax liability</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,865</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,840</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--Liabilities_iTI_mtCzUKw_maCzE03_zd4R4cvjtaHl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.3in">Total Liabilities</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,540,760</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,884,221</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CommitmentsAndContingencies_iI_zHOLTquDuNoi" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">Commitments and Contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_i01I_maCzz7A_zkVrFafAXGlj" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.3in">Common stock, $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_c20230228_pdd" title="Common stock, par value"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20220228_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-02-28" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-02-28" decimals="INF" unitRef="USDPShares">.01</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_c20230228_pdd" title="Common stock, authorized"><span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_c20220228_pdd" title="Common stock, authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_909_eus-gaap--CommonStockSharesIssued_c20230228_pdd" title="Common stock, issued shares"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_c20230228_pdd" title="Common stock, outstanding shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,742,073</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_c20220228_pdd" title="Common stock, issued shares"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_c20220228_pdd" title="Common stock, outstanding shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,729,175</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding as February 28, 2023, and 2022, respectively</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,421</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,292</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AdditionalPaidInCapital_i01I_maCzz7A_zEfvKbjGpvZ1" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.3in">Additional paid-in capital</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,566,898</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,310,287</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maCzz7A_zWCwOfUgeCL" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.3in">Accumulated earnings</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,909,639</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,273,734</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockholdersEquity_iTI_mtCzz7A_maCzE03_zlRXcrlpWege" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; equity</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,633,958</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,741,313</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzE03_zpOqYS6G1JPh" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,174,718</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,625,534</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">See accompanying notes to consolidated financial statements.</p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>SONO-TEK CORPORATION</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF INCOME</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_113_z6MdEwAfQuxj" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF INCOME" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220301_20230228">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_496_20210301_20220228">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Fiscal Year Ended</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">February 28, <br /> 2023</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">February 28, <br /> 2022</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Revenues_maCzNlG_zqsh8HaLhnCi" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; width: 72%; text-align: left">Net Sales</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,058,203</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,132,710</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CostOfRevenue_msCzNlG_zlgTfzpoChm4" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Cost of Goods Sold</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,406,196</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,520,156</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GrossProfit_iT_mtCzNlG_maOILzwIl_z6ZYEr0elOY7" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.5in">Gross Profit</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,652,007</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,612,554</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_zapa2XqfNDO1" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzqIz_zVNQQJgafPm9" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.2in">Research and product development</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,149,525</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,729,509</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SellingAndMarketingExpense_i01_maCzqIz_zFnCl73BmnF1" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.2in">Marketing and selling</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,169,730</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,367,403</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzqIz_z55Fz9uHcFe9" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.2in">General and administrative</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,649,761</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,626,306</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_iT_mtCzqIz_msOILzwIl_zbEkJHrMhQC2" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.5in">Total Operating Expenses</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,969,016</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,723,218</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingIncomeLoss_iT_mtOILzwIl_maCzoWN_z2nEBpaykoG8" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Operating Income</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">682,991</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,889,336</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z06KWTt3ftHh" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Other Income (Expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InvestmentIncomeInterestAndDividend_maCzoWN_zQqdRRVOTUG2" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left">Interest and Dividend Income</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,042</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterestAndDividend" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,496</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_maCzoWN_znff5KwJh1M5" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Net unrealized loss on marketable securities</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,119</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0192">&#8212;</span></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--GainFromForgivenessOfPaycheckProtectionProgramLoan_maCzoWN_zry1fhTJQY77" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Paycheck Protection Program Loan Forgiveness</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0194">&#8212;</span></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:GainFromForgivenessOfPaycheckProtectionProgramLoan" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,005,372</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_iT_mtCzoWN_maCz8Pg_zl75nbpIOGE2" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Income before Income Taxes</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,914</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,904,204</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_msCz8Pg_zDr9iOyBpUTg" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Income Tax Expense</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,009</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">361,631</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProfitLoss_iT_mtCz8Pg_zk1jvmv9pfli" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Net Income</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,905</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,542,573</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--EarningsPerShareBasic_zfuF2bMo5iU6" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">Basic Earnings Per Share</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--EarningsPerShareDiluted_zPsArzAV0irk" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">Diluted Earnings Per Share</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">Weighted Average Shares &#8211; Basic</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,735,451</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,586,404</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">Weighted Average Shares &#8211; Diluted</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,769,499</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,623,485</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>SONO-TEK CORPORATION</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>YEARS ENDED FEBRUARY 28, 2023 AND 2022</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_301_zynH65FHi25f" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zDN8NPLfSrB1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zVdPye0NBC46" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zH8oEiwWW1pl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BE_zWYu17sO4Mve" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Common Stock<br /> Par Value $.01</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Shares</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Amount</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Additional<br /> Paid &#8211; In <br /> Capital</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Accumulated <br /> Earnings</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Total Stockholders&#8217;<br /> Equity</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_43A_c20210301__20220228_eus-gaap--StockholdersEquity_iS_znTookmHcQri" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; width: 35%; padding-bottom: 1pt">Balance - February 28, 2021</td><td style="font: 10pt Cambria,serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20210301__20220228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpbaIBTE8y44" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,452,656</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,527</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,064,994</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-28_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,731,161</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,950,682</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Stock based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,283</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,283</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif">Cashless exercise of stock options</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesCashlessExerciseStockOptions_c20210301__20220228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSM9twoKALC1" title="Cashless exercise of stock options (shares)" style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">249,019</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,490</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,490</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif">&#160;</td>
    <td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: italic 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0233">&#8212;</span></td><td style="font: italic 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromStockOptionsExercised_zUEWvw1KNXk5" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Proceeds from exercise of stock options</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--ProceedsFromExerciseOfStockOptionsShares_c20210301__20220228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKvnA7YvqVq1" title="Proceeds from exercise of stock options (shares)" style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:ProceedsFromExerciseOfStockOptionsShares" contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,500</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,500</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,775</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Net Income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-03-012022-02-28_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,542,573</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,542,573</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_437_c20220301__20230228_eus-gaap--StockholdersEquity_iS_zf4YMtphyp7b" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2022</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20220301__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCwmSeH2nEoa" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,729,175</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,292</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,310,287</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,273,734</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,741,313</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zn5Le77lPE2h" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left">Stock based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,740</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,740</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zE3yjssrjD84" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif">Cashless exercise of stock options</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesCashlessExerciseStockOptions_c20220301__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNqyCKWcm2j" title="Cashless exercise of stock options (shares)" style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,898</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">129</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0264">&#8212;</span></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_zZpU7VofD542" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt">Net Income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,905</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,905</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20220301__20230228_eus-gaap--StockholdersEquity_iE_zeme0ipheFW1" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2023</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20220301__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFCH7oatyIcf" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,742,073</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,421</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,566,898</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,909,639</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,633,958</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>SONO-TEK CORPORATION</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_301_122_zQ6nZyU8ehcg" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.2in">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49B_20220301__20230228_zMGvtAHY7tB5" style="font: 10pt Cambria,serif; text-align: right">&#160;</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_493_20210301__20220228_zEB63Gtq3n35" style="font: 10pt Cambria,serif; text-align: right">&#160;</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman,serif">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Fiscal Year Ended</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman,serif">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">February 28, <br /> 2023</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">February&#160;28,<br /> 2022</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zSBiWgQyA4X4" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: bold 10pt Cambria,serif; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES:</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--ProfitLoss_i01_maCzSqh_zLTzJYxrEGg7" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; width: 72%; text-align: left; padding-left: 0.2in">Net Income</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,905</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 10pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 10pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,542,573</ix:nonFraction></td><td style="font: 10pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zlWFwEGLwXhj" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.2in">Adjustments to reconcile net income to net cash provided by operating activities:</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i01_maCzSqh_zrVH5oTxGIUk" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Depreciation and amortization</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">510,868</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">435,525</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockOptionPlanExpense_i01_maCzSqh_zl3DhOcgPt97" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Stock based compensation expense</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,740</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,283</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--AccountsReceivableReserve_i01N_di_msCzSqh_zt8wZSSZkfPl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Accounts receivable reserve</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="sotk:AccountsReceivableReserve" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,898</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0296">&#8212;</span></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryLIFOReservePeriodCharge_i01_maCzSqh_zT1WLlun9tw3" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Inventory reserve</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryLIFOReservePeriodCharge" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,864</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryLIFOReservePeriodCharge" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,381</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PaycheckProtectionProgramLoanForgiveness_i01N_di_msCzSqh_zovn6a3FJC21" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Paycheck Protection Program Loan Forgiveness</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0301">&#8212;</span></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="sotk:PaycheckProtectionProgramLoanForgiveness" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,005,372</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_i01N_di_msCzSqh_z7mDhSpq1rj5" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Unrealized loss on marketable securities</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,119</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">&#160;</td><td style="font: 10pt Cambria,serif; text-align: left">_</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maCzSqh_zfeIF3uSSRRj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Deferred tax asset, net</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">512,337</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,620</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_i01B_zQMz8NLERIXa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.2in">(Increase) Decrease in:</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">&#160;</td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_di_msCzSqh_zJyBSv2v4tIh" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Accounts receivable</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">497,463</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">665,297</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInInventories_i02N_di_msCzSqh_zePHQ46QPTt6" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Inventories</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">874,531</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">194,483</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i02N_di_msCzSqh_zkuRCUYtjZr" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Prepaid expenses and other assets</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">69,258</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">171,988</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_i01B_z8uovAtr3Ocd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.2in">(Decrease) Increase in:</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccountsPayable_i02_maCzSqh_zjFtBkg6obel" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Accounts payable</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,352</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">606,241</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i02_maCzSqh_z68QxgZrMUQ8" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Accrued expenses</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">376,582</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,112</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IncreaseDecreaseInCustomerDeposit_i02_maCzSqh_zCLPRZ47zxoh" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 32pt">Customer deposits</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:IncreaseDecreaseInCustomerDeposit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,670,197</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:IncreaseDecreaseInCustomerDeposit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,427</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInAccruedTaxesPayable_i02_maCzSqh_zH5SxKOCALk3" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 32pt">Income taxes payable</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">322,547</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,307</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtCzSqh_maCzoiZ_zakosCo64s62" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 32pt">Net Cash Provided by Operating Activities</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,325,039</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,319,167</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Times New Roman,serif">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zwKNvu2deGLh" style="vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Cambria,serif; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES:</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzVog_zy07MnmooGy" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-left: 0.2in">Purchase of equipment, furnishings and leasehold improvements</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">555,867</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">326,942</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsToAcquireMarketableSecurities_i01N_di_msCzVog_zl396Dd2Wlsk" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.2in">Purchase of marketable securities, net</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,255,129</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,304,520</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtCzVog_maCzoiZ_zToYa0FTZVoa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.4in">Net Cash Used In Investing Activities</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,810,996</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,631,462</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Times New Roman,serif; padding-left: 0.1in">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zYXfhxojDb5a" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: bold 10pt Cambria,serif; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromStockOptionsExercised_maNCPBUzs1V_zdhAervRpZ46" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.2in">Proceeds from exercise of stock options</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0355">&#8212;</span></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,775</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtNCPBUzs1V_maCzoiZ_zMlzZu0xn0Vg" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 1pt; padding-left: 0.4in">Net Cash Provided By Financing Activities</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0358">&#8212;</span></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,775</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Times New Roman,serif">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCzoiZ_zbHekAkNsr6i" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: bold 10pt Cambria,serif; text-align: left">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,485,957</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">)</td><td style="font: 10pt Cambria,serif">&#160;</td>
    <td style="font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">756,480</ix:nonFraction></td><td style="font: 10pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Times New Roman,serif; padding-left: 0.1in">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashAndCashEquivalentsAbstract_iB_zTnhm0k5efd4" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: bold 10pt Cambria,serif; text-align: left">CASH AND CASH EQUIVALENTS:</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_z7Y66iRov1kj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; padding-bottom: 1pt; padding-left: 0.2in">Beginning of year</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,840,558</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,084,078</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_zi9HqtKLpuv4" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; padding-left: 0.2in">End of year</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,354,601</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,840,558</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Times New Roman,serif; padding-left: 0.2in">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zPomdoEXqs2j" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: bold 10pt Cambria,serif; text-align: left">Supplemental Cash Flow Disclosure:</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif">&#160;</td>
    <td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: right">&#160;</td><td style="font: 11pt Times New Roman,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--InterestPaidNet_i01_z3eOev61I6h" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 0.2in">Interest Paid</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Times New Roman,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Times New Roman,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">&#8212;</span></td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Times New Roman,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Times New Roman,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8212;</span></td><td style="font: 11pt Times New Roman,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxesPaidNet_i01_zi6BMOIiduab" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 10pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 0.2in">Income Taxes Paid</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">363,590</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">373,928</ix:nonFraction></td><td style="font: 10pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center">See accompanying notes to consolidated financial statements.</p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>SONO-TEK CORPORATION</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">YEARS ENDED FEBRUARY 28, 2023 AND FEBRUARY 28, 2022</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: center"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zJqva0ih9kT8" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 1: <span id="xdx_821_zYEznXNYoBx1">BUSINESS DESCRIPTION</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Sono-Tek Corporation (the &#8220;Company&#8221;, &#8220;Sono-Tek&#8221;,
&#8220;We&#8221; or &#8220;Our&#8221;) was incorporated in New York on March 21, 1975. We are the world leader in the design and manufacture
of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on
parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research &amp; development/other
markets. We design and manufacture custom-engineered ultrasonic coating systems incorporating our patented technology, in combination
with strong applications engineering knowledge, to assist our customers in achieving their desired coating solutions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zxc7AH0IcNog" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 2: <span id="xdx_826_ze2bHIrtG39j">SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_ztIK889gJFO" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86E_zyPQdQSUUMO8">Advertising Expenses</span></i></b><i> - </i>The Company expenses the
cost of advertising in the period in which the advertising takes place. Advertising expense for fiscal 2023 and fiscal 2022 was $<span id="xdx_909_eus-gaap--AdvertisingExpense_c20220301__20230228_pp0p0" title="Advertising expense"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">297,500</ix:nonFraction></span>
and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_c20210301__20220228_pp0p0" title="Advertising expense"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">178,500</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ReceivablesPolicyTextBlock"><p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zdVbq1h4tR22" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zAzk3cdHk974">Accounts Receivable, net</span> - </i></b>In the normal course of business,
the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value
of receivables and approximate fair value. The Company records a bad debt expense/allowance based on management&#8217;s estimate of uncollectible
accounts. All outstanding accounts receivable accounts are reviewed for collectability on an individual basis.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z076pfobOQ0h" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86A_zZPlbcJPMu0j">Cash and Cash Equivalents</span></i></b><i> - </i>Cash and cash equivalents consist of money market mutual funds, short term commercial paper
and short-term certificates of deposit with original maturities of 90 days or less. At February 28, 2023, the Company had <span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20230228_zBJYVfIDMfnc" title="Cash in excess of the FDIC insured limit"><ix:nonFraction name="us-gaap:CashUninsuredAmount" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,892,000</ix:nonFraction></span> of
cash in excess of the FDIC insured limit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zKy5jPPT87l" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_z8mSdoE2VOJ1">Consolidation</span></i></b> - The accompanying consolidated financial
statements of the Company include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (&#8220;SIP&#8221;)
in conformity with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). SIP operates as a real estate holding
company for the Company&#8217;s real estate operations. All intercompany accounts and transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z5QMYx36mYof" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zjVIWjHUTqPl">Earnings Per Share</span></i></b><i> - </i>Basic earnings per share
(&#8220;EPS&#8221;) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted
EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted
into common stock under the treasury stock method.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="sotk:EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock"><p id="xdx_848_ecustom--EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock_zDBQyxOP37Jc" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span id="xdx_86C_zu7nVrb9VSNc"><b><i>Equipment,
Furnishings and Leasehold Improvements</i></b></span> - Equipment, furnishings and leasehold improvements are stated at cost. Depreciation
of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which
range from three <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MinimumMember_zEa4tQmNJJ25" style="display: none"><ix:nonNumeric contextRef="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric>
</span>to five years <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MaximumMember_zODz3BLGnR62" title="Estimated useful lives" style="display: none"><ix:nonNumeric contextRef="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 51; Value: 1 -->
    <div id="xdx_23B_zT4inyvu01ea" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zEMo4ndMwhTk" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOJNu1gdDiDd" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_865_zR9AhMBu2XG7">Fair Value of Financial Instruments</span> -</i></b> The Company applies
Accounting Standards Codification (&#8220;ASC&#8221;) 820,&#160;<i>Fair Value Measurement&#160;</i>(&#8220;ASC 820&#8221;), which establishes
a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an
exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company&#8217;s principal or
most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established
in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring
fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed
based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity&#8217;s own assumptions
based on market data and the entity&#8217;s judgments about the assumptions that market participants would use in pricing the asset or
liability and are to be developed based on the best information available in the circumstances.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The carrying amounts of financial instruments reported in the accompanying
consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term
maturities of the financial instruments.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The valuation hierarchy is composed of three levels. The classification
within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within
the valuation hierarchy are described below:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 1 &#8212; Assets and liabilities with unadjusted, quoted prices
listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets
for identical assets or liabilities.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 2 &#8212; Inputs to the fair value measurement are determined
using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs,
such as interest rates and yield curves that are observable at commonly quoted intervals.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 3 &#8212; Inputs to the fair value measurement are unobservable
inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">The fair values of financial assets of the
Company were determined using the following categories at February 28, 2023 and February 28, 2022, respectively:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z9W5C1Atvvv9" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B9_z2EWxR77nGMd" style="display: none">Significant accounting policies - fair values of financial assets of the company</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 1</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 2</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 3</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Total</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2023</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-02-28_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,361,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-02-28_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">729,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8212;</span></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,090,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2022</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2022-02-28_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,716,338</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2022-02-28_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,652</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8212;</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" title="Marketable Securities" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,867,990</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">Marketable Securities include certificates
of deposit and US Treasury securities, totaling $<span id="xdx_90D_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" title="Marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,090,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" title="Marketable securities"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,867,990</ix:nonFraction></span> that are considered to be highly liquid and easily tradeable
as of February 28, 2023 and February 28, 2022, respectively. US Treasury securities are valued using inputs observable in active markets
for identical securities and are therefore classified as Level&#160;1 and certificates of deposit are classified as Level 2 within the
Company&#8217;s fair value hierarchy. The Company&#8217;s marketable securities are considered to be trading securities as defined under
ASC 320 &#8220;Investments &#8211; Debt and Equity Securities.&#8221;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 52; Value: 1 -->
    <div id="xdx_234_zHcDz45jacX6" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_237_zi7hIUlItAN1" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zPcYB0NOuqQg" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_866_z86KLktVApA9">Income Taxes</span></i></b> - The Company accounts for income taxes
under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of &#34;temporary
differences&#34; by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying
amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax
asset will not be realized, a valuation allowance is recognized. The Company uses a recognition threshold and a measurement attribute
for financial statement recognition and measurement of tax positions taken or expected to be taken in a return. For those benefits to
be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. As of February 28,
2023 and February 28, 2022, there were <span id="xdx_90E_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20230228_zaSL115rYzZc" title="Uncertain tax positions"><span id="xdx_901_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20220228_zW9qX9qkcMFk" title="Uncertain tax positions"><ix:nonFraction name="us-gaap:LiabilityForUncertainTaxPositionsCurrent" contextRef="AsOf2023-02-28" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:LiabilityForUncertainTaxPositionsCurrent" contextRef="AsOf2022-02-28" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> uncertain tax positions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z6UkSEsuRQCj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zBX8vf7mtbP2">Intangible
Assets</span></i></b><i> - </i>Include costs of patent applications which are deferred and charged to operations over seventeen <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230228_zUdtN3M69Jt" title="Useful life of intangible assets" style="display: none"><ix:nonNumeric contextRef="AsOf2023-02-28" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">17</ix:nonNumeric></span>
years for domestic patents and <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220228_zYouIz3hltu4" title="Useful life of intangible assets" style="display: none"><ix:nonNumeric contextRef="AsOf2022-02-28" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">12</ix:nonNumeric></span> twelve years for foreign patents, which is considered the useful life. The accumulated
amortization of patents is $<span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230228_pp0p0" title="Accumulated amortization of patents"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,681</ix:nonFraction></span>
and $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220228_pp0p0" title="Accumulated amortization of patents"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">192,490</ix:nonFraction></span>
at February 28, 2023 and February 28, 2022, respectively. Annual amortization expense of such intangible assets is expected to be
approximately $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20230228_zxHdm0XiH7t2" title="Annual amortization expense this year"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20230228_zy6RjLyI5bUl" title="Annual amortization expense year two"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20230228_zcwkd9gGjWk9" title="Annual amortization expense year three"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20230228_zozE9sfhoIfj" title="Annual amortization expense year four"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20230228_zZU2wpZwxuVd" title="Annual amortization expense year five"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span>
per year for the next five years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zmkyuYg7s9G3" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86E_zBBEbTbjquLg">Inventories</span></i></b><i> - </i>Inventories are stated at the lower
of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress
and the specific identification method for finished goods. Management compares the cost of inventory with the net realizable value and,
if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis,
inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand
and market conditions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7VsoQGl5Vs4" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zCNQ9vneYrwa">Land and Buildings</span> - </i></b>Land and buildings are stated at
cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228_z0jmoiIsj9Yk" title="Estimated useful life" style="display: none"><ix:nonNumeric contextRef="AsOf2023-02-28" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">40</ix:nonNumeric></span> forty years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">At February 28, 2023 and 2022, the Company had Land, stated at cost of $<span id="xdx_90C_eus-gaap--Land_iI_pp0p0_c20230228_zjmgpsXCaY24" title="Land"><ix:nonFraction name="us-gaap:Land" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zzpIvtRvLyHb" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_znxkHFIK9wDe">Long-Lived Assets</span></i></b><i> - </i>The Company periodically
evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The
carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately
identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value
exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted
at a rate commensurate with the risk involved. <span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220301__20230228_zFxQK6IuMbYc" title="Impairment losses"><span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210301__20220228_z8J444mb3QPd" title="Impairment losses"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2022-03-01to2023-02-28" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2021-03-012022-02-28" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">No</ix:nonFraction></ix:nonFraction></span></span> impairment losses were identified or recorded for the years ended February 28, 2023
and February 28, 2022 on the Company&#8217;s long-lived assets.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84C_eus-gaap--UseOfEstimates_zOpTtxHycy01" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zoN7be49pejc">Management Estimates</span></i></b><i> - </i>The preparation of the
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zPZG0luBwcOe" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zUSjXTGxMbai">New
Accounting Pronouncements </span></i></b>&#8211; In June 2016, the FASB issued ASU 2016-13 - Financial Instruments-Credit
Losses-Measurement of Credit Losses on Financial Instruments. Codification Improvements to Topic 326, Financial Instruments &#8211;
Credit Losses, have been released in November 2018 (2018-19), November 2019 (2019-10 and 2019-11) and a January 2020 Update
(2020-02) that provided additional guidance on this Topic. This guidance replaces the current incurred loss impairment methodology
with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable
information to inform credit loss estimates. For SEC filers meeting certain criteria, the amendments in this ASU are effective for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For SEC filers that meet the
criteria of a smaller reporting company (including this Company) and for non-SEC registrant public companies and other
organizations, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning
after December 15, 2022. Early adoption will be permitted for all organizations for fiscal years, and interim periods within those
fiscal years, beginning after December 15, 2019. The Company has adopted ASU 2016-13 as updated and does not expect the adoption of
this guidance to have a material impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Other than Accounting Standards Update (&#8220;ASU&#8221;) ASU 2016-13 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable
to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>


<ix:exclude><!-- Field: Page; Sequence: 53; Value: 1 -->
    <div id="xdx_231_z3n8N5YcWWjg" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_231_z5qQcjxNH4N5" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:StandardProductWarrantyPolicy"><p id="xdx_84D_eus-gaap--StandardProductWarrantyPolicy_zhJptZDW8Pvf" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zmlpsxgIaJu7">Product Warranty</span></i></b> - Expected future product warranty expense is recorded when revenue is recognized for product
sales.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhZzJAtMVTv" style="font: 11pt Cambria,serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><b><i><span id="xdx_867_zGz3lzCZGSB5">Reclassifications</span> - </i></b>Building,
equipment, leasehold improvements reclassifications have been made to the fiscal 2022 consolidated financial statements to conform to
the fiscal 2023 consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously
reported.</p>



<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zMGnwl1QLy93" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_z0stfiIeUEd1">Research and Product Development Expenses</span></i></b><i> - </i>Research
and product development expenses represent engineering and other expenditures incurred for developing new products, for refining the Company's
existing products and for developing systems to meet unique customer specifications for potential orders or for new industry applications
and are expensed as incurred.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023 and fiscal 2022, the Company spent approximately
$<span id="xdx_90A_eus-gaap--OtherResearchAndDevelopmentExpense_c20220301__20230228_zviNPQgZkrnj" title="Research and development expenses"><ix:nonFraction name="us-gaap:OtherResearchAndDevelopmentExpense" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,149,000</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--OtherResearchAndDevelopmentExpense_c20210301__20220228_zGKjaalDo0wd" title="Research and development expenses"><ix:nonFraction name="us-gaap:OtherResearchAndDevelopmentExpense" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,730,000</ix:nonFraction></span>, respectively, on research and development activities related to new products and services and the ongoing improvement
of existing products and services.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zBXVmzTPbQ6d" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86B_zxWqMSmHzcX9">Revenue Recognition</span> -</i></b> The Company recognizes
revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should
recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to
which the entity expects to be entitled to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Identification of the contract, or contracts, with a customer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Identification of the performance obligations in the contract</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Determination of the transaction price</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Recognition of revenue when, or as, performance obligations are satisfied</span></td></tr>
  </table>
<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zmkBHO9dWhj6" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zbnfr1OxsiV6">Stock-Based Compensation</span></i></b> - The Company currently uses
a Black-Scholes option pricing model to calculate the fair value of its stock options. The fair value of each option is estimated on the
date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility;
and expected lives of the awards. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes
model. The assumptions used in calculating the fair value of share-based payment awards represent management&#8217;s best estimates, but
these estimates involve inherent uncertainties and the application of management judgment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">ASC 718 requires the recognition of the fair value of stock compensation
expense to be recognized over the vesting term of such award. The Company accounts for forfeitures as they occur.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="sotk:UncertaintiesPolicyTextBlock"><p id="xdx_84A_ecustom--UncertaintiesPolicyTextBlock_z4eTRDL6drs2" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86A_zaWtAF5TttVf">Uncertainties</span> - </i></b>Since early 2020, when the World Health
Organization established the transmissible and pathogenic coronavirus a global pandemic, there have been business slowdowns. The outbreak
of such a communicable disease has resulted in a widespread health crisis which has adversely affected general commercial activity and
the economies and financial markets of many countries, including the United States. As the outbreak of the disease has continued through
fiscal 2022 and into fiscal 2023, the measures taken by the governments of impacted countries have, at times, adversely affected the
Company&#8217;s business, financial condition, and results of operations. Pandemic related supply shortages and increased energy expenses
resulting from the war in Ukraine have recently created worldwide inflationary pressures which may have a material adverse effect on
the Company's business, financial condition, and results of operations if such factors continue unabated.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company has encountered challenges in procuring supplies of various materials and components,
and electronic components in particular, due to well-documented shortages and constraints in the global supply chain. Lead times for ordered
components may vary significantly, and some components used to manufacture our products are provided by a limited number of sources. The
Company experienced lengthened lead times throughout its supply chain as a result of supply chain constraints and material shortages that
have occurred through fiscal year 2023. This has been exacerbated by the recent resurgence of the COVID-19 pandemic in certain parts of
China, which has resulted in the temporary closure of manufacturing facilities, including those that manufacture electronic parts that
the Company includes in its products.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>


<ix:exclude><!-- Field: Page; Sequence: 54; Value: 1 -->
    <div id="xdx_232_zv8NssVToWEl" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23D_z5LLF7H04jJ6" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock"><p id="xdx_80A_eus-gaap--RevenueFromContractWithCustomerTextBlock_zcbd8sViFNJ8" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 3: <span id="xdx_82C_zu1sV27A9xm9">REVENUE RECOGNITION</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company&#8217;s sales revenue is derived primarily from short
term contracts with customers, which, on average, are in effect for less than twelve months. Sales revenue from manufactured equipment
transferred at a single point in time accounts for a majority of the Company&#8217;s revenue.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Sales revenue is recognized when control of the Company&#8217;s manufactured
equipment is transferred to its customers in an amount that reflects the consideration the Company expects to receive based upon the agreed
transaction price. The Company&#8217;s performance obligations are satisfied when its customers take control of the purchased equipment,
in accordance with the contract terms. Based on prior experience, the Company reasonably estimates its sales returns and warranty reserves.
Sales are presented net of discounts and allowances. Discounts and allowances are determined when a transaction is negotiated. The Company
does not grant its customers or independent representatives the ability to return equipment nor does it grant price adjustments after
a sale is complete.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company does not capitalize any sales commission costs related
to the acquisition of a contract. All commissions related to a performance obligation that are satisfied at a point in time are expensed
when the customer takes control of the purchased equipment and revenue is recognized.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company applies the practical expedient in paragraph ASC 606-10-50-14
and does not disclose information about remaining performance obligations that have original expected durations of one-year or less.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">At February 28, 2023, the Company had received $<span id="xdx_900_ecustom--CashDeposits_iI_pp0p0_c20230228_zQRXA1Ogluob" title="Cash deposits"><ix:nonFraction name="sotk:CashDeposits" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,838,000</ix:nonFraction></span> in cash
deposits, representing contract liabilities, and had issued Letters of Credit in the amount of $<span id="xdx_90B_eus-gaap--LineOfCredit_c20230228_pp0p0" title="Letter of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">145,000</ix:nonFraction></span> to secure these cash deposits.
At February 28, 2023, the Company was utilizing $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20220301__20230228_zA3QWzHJgrgj" title="Line of credit collateral amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCollateralFeesAmount" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,000</ix:nonFraction></span> of its available credit line to collateralize these letters of credit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">At February 28, 2022, the Company had received $<span id="xdx_90E_ecustom--CashDeposits_iI_pp0p0_c20220228_zb3HUCxxJt43" title="Cash deposits"><ix:nonFraction name="sotk:CashDeposits" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,168,000</ix:nonFraction></span> in cash
deposits, representing contract liabilities, and had issued Letters of Credit in the amount of $<span id="xdx_908_eus-gaap--LineOfCredit_c20220228_pp0p0" title="Letter of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> to secure these cash deposits. At
February 28, 2022, the Company was utilizing $<span id="xdx_900_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20210301__20220228_zi9Tqg7WTXql" title="Line of credit collateral amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCollateralFeesAmount" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000</ix:nonFraction></span> of its available credit line to collateralize these letters of credit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company&#8217;s sales revenue, by product line is as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zbUbcc6jXoc9" summary="xdx: Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B2_z91GIQ06Awl3" style="display: none">Revenue recognition - sales revenue by product line</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Twelve Months Ended</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center">% of total</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center">% of total</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; text-align: left">Fluxing Systems</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-012023-02-28_custom_FluxingSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,179,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><span id="xdx_903_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2022-03-012023-02-28_custom_FluxingSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28_custom_FluxingSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">691,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2021-03-012022-02-28_custom_FluxingSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Integrated Coating Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-012023-02-28_custom_IntegratedCoatingSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,114,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_909_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2022-03-012023-02-28_custom_IntegratedCoatingSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28_custom_IntegratedCoatingSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,182,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2021-03-012022-02-28_custom_IntegratedCoatingSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Multi-Axis Coating Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-012023-02-28_custom_MultiAxisCoatingSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,785,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_907_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2022-03-012023-02-28_custom_MultiAxisCoatingSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28_custom_MultiAxisCoatingSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,912,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_905_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2021-03-012022-02-28_custom_MultiAxisCoatingSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">58</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">OEM Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-012023-02-28_custom_OemSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,144,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2022-03-012023-02-28_custom_OemSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" title="Sales revenue" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28_custom_OemSystemsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,381,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_903_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2021-03-012022-02-28_custom_OemSystemsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" title="Sales revenue" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-012023-02-28_custom_OtherProductLineMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,836,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2022-03-012023-02-28_custom_OtherProductLineMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">26</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" title="Sales revenue" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28_custom_OtherProductLineMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,967,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90F_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2021-03-012022-02-28_custom_OtherProductLineMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction>%</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" title="Sales revenue" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-012023-02-28_custom_ProductLineMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,058,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" title="Sales revenue" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28_custom_ProductLineMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,133,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock"><p id="xdx_801_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_zw0LNsBVaS2a" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 4: <span id="xdx_820_zCZYFpa6VmI6">STOCK-BASED COMPENSATION</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Stock Options</i></b> &#8211; Under the 2013 Stock
Incentive Plan, as amended (the &#34;2013 Plan&#34;), options can be granted to officers, directors, consultants and employees of the
Company and its subsidiaries to purchase up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_pdd" title="Number of shares available for purchase"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500,000</ix:nonFraction></span> shares of the Company's common stock. Under the 2013 Plan options expire ten
years <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20220301__20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_z96DDFnsUmph" title="Options, expiration period" style="display: none"><ix:nonNumeric contextRef="From2022-03-012023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">10</ix:nonNumeric></span> after the date of grant. As of February 28, 2023, there were <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_pdd" title="Options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,759</ix:nonFraction></span> options outstanding under the 2013 plan.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 55; Value: 1 -->
    <div id="xdx_23C_zJSV0Pob0XR9" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23E_zH2U2LtDHfm5" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">Under the 2013 Stock Incentive Plan, option prices must
be at least 100% of the fair market value of the common stock at time of grant. For qualified employees, except under certain circumstances
specified in the plan or unless otherwise specified at the discretion of the Board of Directors, no option may be exercised prior to one
year after date of grant, with the balance becoming exercisable in cumulative installments over a three-year period during the term of
the option and terminating at a stipulated period of time after an employee's termination of employment.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">During fiscal 2023, the Company granted options to
acquire <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" title="Options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,239</ix:nonFraction></span>
shares to employees exercisable at prices ranging from $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_pdd" title="Options, exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.45</ix:nonFraction></span>
to $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_pdd" title="Options, exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.96</ix:nonFraction></span>
and options to acquire <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-03-012023-02-28_custom_NonEmployeeDirectorsStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,500</ix:nonFraction></span>
shares to the non-employee members of the board of directors with an exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options, exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-012023-02-28_custom_NonEmployeeDirectorsStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.50</ix:nonFraction></span>.
The options granted to employees and directors vest over three years <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zd9cIaMSPa41" title="Options, vesting period" style="display: none"><ix:nonNumeric contextRef="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">3</ix:nonNumeric></span> and expire in ten years <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zoQcTwBf4pJ2" title="Options, expiration period" style="display: none"><ix:nonNumeric contextRef="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">10</ix:nonNumeric></span>.
The options granted by the Company during fiscal 2023 had a combined weighted average grant date fair value of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_pdd" title="Weighted average grant date fair value, per share"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.44</ix:nonFraction></span> per share.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">During fiscal 2022, the Company granted options to
acquire <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" title="Options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">138,085</ix:nonFraction></span>
shares to employees exercisable at prices ranging from $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_pdd" title="Options, exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.19</ix:nonFraction></span>
to $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_pdd" title="Options, exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.26</ix:nonFraction></span>
and options to acquire <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-03-012022-02-28_custom_NonEmployeeDirectorsStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,250</ix:nonFraction></span>
shares to the non-employee members of the board of directors with an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options, exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-03-012022-02-28_custom_NonEmployeeDirectorsStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.19</ix:nonFraction></span>.
The options granted to employees and directors vest over three years <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zzlx2jiT6zq9" title="Options, vesting period" style="display: none"><ix:nonNumeric contextRef="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">3</ix:nonNumeric></span>
and expire in ten years <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zunttfEZwJga" title="Options, expiration period" style="display: none"><ix:nonNumeric contextRef="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">10</ix:nonNumeric></span>. The options granted by the Company during fiscal 2022 had a combined weighted average grant date fair
value of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_pdd" title="Weighted average grant date fair value, per share"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.76</ix:nonFraction></span> per share.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">A summary of the activity for fiscal 2023 and fiscal 2022 is as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zZkAmVWrdgB6" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif"><span id="xdx_8B4_z6I1Bec18f2i" style="display: none">Stock-based compensation - summary of stock options</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Weighted Average</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Stock Options</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercise Price $</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">Remaining</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Outstanding</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercisable</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Outstanding</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercisable</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Term - Years</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 35%">Balance - February 28, 2021</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210301__20220228_zE30H90Femk9" title="Stock Options outstanding at beginning of period (in shares)" style="font: 11pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">508,459</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20210301__20220228_z4kWatz5zhx1" title="Stock Options exercisable at beginning of period (in shares)" style="font: 11pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">333,500</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210301__20220228_zJW05n3Vk49d" title="Weighted Average outstanding at beginning of period (in dollars per share)" style="font: 11pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.35</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20210301__20220228_z684LR6idVha" title="Weighted Average exercisable at beginning of period (in dollars per share)" style="font: 11pt Cambria,serif; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.17</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 9%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200301__20210228_zw79MWxt1hJe" title="Weighted average remaining term outstanding"><ix:nonNumeric contextRef="From2020-03-012021-02-28" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">6.99</ix:nonNumeric></span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Granted</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228_pdd" title="Granted (in shares)" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">168,335</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228_pdd" title="Granted (in dollars per share)" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.10</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Exercised</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210301__20220228_zLGT7VHWCAL7" title="Exercised (in shares)" style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">403,334</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zgqKdd0y3Boi" title="Exercised (in dollars per share)" style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.12</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Cancelled</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20210301__20220228_zKrJjndN7yn7" title="Cancelled (in shares)" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,750</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zvIv8kUPKaW2" title="Cancelled (in dollars per share)" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.27</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2022</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220301__20230228_zJ86AJ2Mo11g" title="Stock Options outstanding at beginning of period (in shares)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">253,710</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20220301__20230228_zXRMycy4g36g" title="Stock Options exercisable at beginning of period (in shares)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">61,690</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220301__20230228_z6X2RiH04sG9" title="Weighted Average outstanding at beginning of period (in dollars per share)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.46</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20220301__20230228_zx24UyvWYxBi" title="Weighted Average exercisable at beginning of period (in dollars per share)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.53</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210301__20220228_zUAE1Uypk6Ta" title="Weighted average remaining term outstanding"><ix:nonNumeric contextRef="From2021-03-012022-02-28" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.94</ix:nonNumeric></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Granted</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228_pdd" title="Granted (in shares)" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">44,739</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228_pdd" title="Granted (in dollars per share)" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.71</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Exercised</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220301__20230228_z5SzFxXaUo7g" title="Exercised (in shares)" style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,973</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zQtD2LTtdTKc" title="Exercised (in dollars per share)" style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.77</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Cancelled</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220301__20230228_zFxx7wlizET1" title="Cancelled (in shares)" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,717</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zTHt9YCvFr81" title="Cancelled (in dollars per share)" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.66</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2023</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220301__20230228_zdBTcJX7oaL5" title="Stock Options outstanding at end of period (in shares)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,759</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220301__20230228_zVAaCqMxpmfb" title="Stock Options exercisable at end of period (in shares)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,609</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220301__20230228_z8TZsHGBm2gf" title="Weighted Average outstanding at end of period (in dollars per share)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.84</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220301__20230228_zzj00G6CnJq1" title="Weighted Average exercisable at end of period (in dollars per share)" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.62</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220301__20230228_zJ5ddbmycB56" title="Weighted average remaining term outstanding"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.52</ix:nonNumeric></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zyfTQDE2hqn9" style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The aggregate intrinsic value of the Company&#8217;s vested and exercisable
options at February 28, 2023 was $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20230228_zqSTYPzAxhQ" title="Aggregate intrinsic value of options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,077</ix:nonFraction></span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For the years ended February 28, 2023 and 2022 the Company
recognized $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20220301__20230228_pp0p0" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">256,740</ix:nonFraction></span>
and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20210301__20220228_pp0p0" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,283</ix:nonFraction></span>
in stock based compensation expense, respectively. Such amounts are included in general and administrative expenses on the
consolidated statements of income. Total compensation expense related to non-vested options not yet recognized as of February 28,
2023 was $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20230228_pp0p0" title="Compensation expense not yet recognized"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,000</ix:nonFraction> </span>and
will be recognized over the next three years <span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220301__20230228_zn67qxfRc9u4" title="Compensation expense, period for recognition" style="display: none"><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">3</ix:nonNumeric></span> based on vesting date. The amount of future stock option compensation expense could
be affected by any future option grants or by any forfeitures. During the year ended February 28, 2023, the Company had net
settlement exercises of stock options, whereby, the optionee did not pay cash for the options but instead received the number of
shares equal to the difference between the exercise price and the market price on the date of exercise. Net settlement exercises
during the year ended February 28, 2023 resulted in <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220301__20230228_pdd" title="Options cancelled in settlement of shares issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,898</ix:nonFraction></span> shares of common stock issued.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 56; Value: 1 -->
    <div id="xdx_23F_zEkStn3JwMa" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23D_z7GEGvYQSkXl" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Determining the appropriate fair value of the stock-based awards requires
the input of subjective assumptions, including the fair value of the Company&#8217;s common stock, and for stock options, the expected
life of the option, and the expected stock price volatility. The Company uses the Black-Scholes option pricing model to value its stock
option awards. The assumptions used in calculating the fair value of stock-based awards represent management&#8217;s best estimates and
involve inherent uncertainties and the application of management&#8217;s judgment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The expected term of the options is estimated based on the Company&#8217;s
historical exercise rate. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued.
For stock price volatility, the Company uses its expected volatility of the price of the Company&#8217;s common stock based on historical
activity. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option at the
grant-date.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">The weighted-average fair value of options has been estimated
on the date of grant using the Black-Scholes options-pricing model. The weighted-average Black-Scholes assumptions are as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zB8iJOzONpQ7" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BC_zEb026tMpqa" style="display: none">Stock-based compensation - weighted-average black-scholes assumptions</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td colspan="4" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Fiscal Year Ended</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February 28, <br />
2023</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February 28, <br />
2022</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="width: 61%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Expected life</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 18%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zPCjUX11Hosf" title="Expected life (in years)"><ix:nonNumeric contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span> - <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_ztZnKxWTd8g5" title="Expected life (in years)"><ix:nonNumeric contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">8</ix:nonNumeric></span> years</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="width: 16%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zdaG9Stx5At2" title="Expected life (in years)"><ix:nonNumeric contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span> - <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zn0ULfQNqU27" title="Expected life (in years)"><ix:nonNumeric contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">8</ix:nonNumeric></span> years</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Risk free interest rate</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20220301__20230228_pdd" title="Risk free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.82</ix:nonFraction>%</span> - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20220301__20230228_pdd" title="Risk free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.02</ix:nonFraction>%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20210301__20220228_pdd" title="Risk free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.78</ix:nonFraction>%</span> &#8211; <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20210301__20220228_pdd" title="Risk free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction>%</span></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20220301__20230228_pdd" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">55.02</ix:nonFraction>%</span> - <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20220301__20230228_pdd" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">62.01</ix:nonFraction>%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20210301__20220228_pdd" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.73</ix:nonFraction>%</span> - <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20210301__20220228_pdd" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">57.13</ix:nonFraction>%</span></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Expected dividend yield</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220301__20230228_pdd" title="Expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction>%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20210301__20220228_pdd" title="Expected dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction>%</span></span></td>
    <td>&#160;</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zKObb5CyTbg8" style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_808_eus-gaap--InventoryDisclosureTextBlock_zslgZSQJmrUf" style="font: 11pt Cambria,serif; margin: 0"><b>NOTE 5: <span id="xdx_82E_z9qKEG5XDN39">INVENTORIES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Inventories consist of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zlanOsxunWb" summary="xdx: Disclosure - INVENTORIES (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B0_zVjTzpl5noSi" style="display: none">Inventories</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49C_20230228_zUsT23pXgeTd" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_497_20220228_z165FX9yuq7a" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Raw materials and subassemblies</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,868,689</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,250,589</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Finished goods</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">613,915</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">779,533</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InventoryWorkInProcess_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Work in process</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">760,305</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">343,120</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryGross_iI_pp0p0_z03kbIJjZeO5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Total</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryGross" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,242,909</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:InventoryGross" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,373,242</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">The Company maintains an allowance for slow moving inventory for raw materials and finished
goods. The recorded allowances at February 28, 2023 and 2022, totaled $332,525 and $327,661, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zcmNBFFFI8og" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 6: <span id="xdx_827_zLaRUe54vgw8">BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Buildings, equipment, furnishings and leasehold improvements
consist of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zR2bDCkmUh47" summary="xdx: Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BF_zJVVRvU5kWz3" style="display: none">Buildings, equipment, furnishings and leasehold improvements</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%">Buildings</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,250,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-02-28_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,250,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Laboratory equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_custom_LaboratoryEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,647,951</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-02-28_custom_LaboratoryEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,421,845</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Machinery and equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,807,817</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-02-28_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,729,587</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Leasehold improvements</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">789,044</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-02-28_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">715,999</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Tradeshow and demonstration equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_custom_TradeshowAndDemonstrationEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,137,346</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-02-28_custom_TradeshowAndDemonstrationEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,137,346</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Furniture and fixtures</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Totals" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,302,545</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Totals" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-02-28_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,206,918</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Totals</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20230228_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,934,703</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220228_pp0p0" title="Totals" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,461,695</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20230228_zp5Sg1Rn3tYd" title="Less: Accumulated depreciation" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,309,707</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220228_zKbmWHTVtHsi" title="Less: Accumulated depreciation" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,900,511</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20230228_pp0p0" title="Equipment, furnishings and leasehold improvements, net" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,624,996</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220228_pp0p0" title="Equipment, furnishings and leasehold improvements, net" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,561,184</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 57; Value: 1 -->
    <div id="xdx_238_zFzapog0mJ2k" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_230_zAz63DA7vEi9" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Depreciation expense for the years ended February 28, 2023 and February
28, 2022 was $<span id="xdx_907_eus-gaap--Depreciation_c20220301__20230228_pp0p0" title="Depreciation Expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">492,055</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--Depreciation_c20210301__20220228_pp0p0" title="Depreciation Expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">416,083</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zNsVHxjSjdwj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 7: <span id="xdx_82B_z9dLsNPhCuj6">ACCRUED EXPENSES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Accrued expenses consist of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zNa8OZfAbERi" summary="xdx: Disclosure - ACCRUED EXPENSES (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B8_zRQEmE58L03j" style="display: none">Accrued expenses</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_492_20230228_zXdwIKpIJSFl" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49E_20220228_zvrSI9ca9dHf" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maALCzpsS_z8zEMzXZ9VQa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Accrued compensation</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">352,619</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">449,673</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProductWarrantyAccrual_iI_pp0p0_maALCzpsS_z3bHoHUOORD9" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Estimated warranty costs</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrual" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,650</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ProductWarrantyAccrual" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">622,775</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedSalesCommissionCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zBSP0Ci6jcjh" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Accrued commissions</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">157,927</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,540</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zT0Y3Rv1Wxzb" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Professional fees</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,921</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,850</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zLSIQ7kNBdze" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Other accrued expenses</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">315,329</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">431,190</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzpsS_zTGS3ySstipe" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 2.5pt">Total accrued expenses</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,427,446</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,804,028</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ShortTermDebtTextBlock"><p id="xdx_807_eus-gaap--ShortTermDebtTextBlock_z7XRU2X4I887" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 8: <span id="xdx_827_z1iXkNWIb8a5">REVOLVING LINE OF CREDIT</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company has a $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20230228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pp0p0" title="Revolving line of credit"><span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20220228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pp0p0" title="Revolving line of credit"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-02-28_us-gaap_RevolvingCreditFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500,000</ix:nonFraction></ix:nonFraction></span></span> revolving line of credit at prime which
was <span id="xdx_90C_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_c20230228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pdd" title="Interest rate"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" contextRef="AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.75</ix:nonFraction>%</span> at February 28, 2023 and <span id="xdx_90D_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_c20220228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pdd" title="Interest rate"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" contextRef="AsOf2022-02-28_us-gaap_RevolvingCreditFacilityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.25</ix:nonFraction>%</span> at February 28, 2022. The revolving credit line is collateralized by the Company&#8217;s accounts
receivable and inventory. The revolving credit line is payable on demand and must be retired for a 30-day period, once annually. If the
Company fails to perform the 30-day annual pay down or if the bank elects to terminate the credit line, the bank may, at its option, convert
the outstanding balance to a 36-month term note with payments including interest in 36 equal installments.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">As of February 28, 2023, $<span id="xdx_905_ecustom--CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_c20230228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Credit line utilized to collateralize letter of credit issued to customers"><ix:nonFraction name="sotk:CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" contextRef="AsOf2023-02-28_us-gaap_LetterOfCreditMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">145,000</ix:nonFraction></span> of the Company&#8217;s credit
line was being utilized to collateralize Letters of Credit issued to customers that have remitted cash deposits to the Company on
existing orders. The Letters of Credit expire in May and July 2023. As of February 28, 2023, there were no outstanding borrowings
under the line of credit and the unused portion of the credit line was $<span id="xdx_905_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_c20230228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Unused portion of credit line"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="AsOf2023-02-28_us-gaap_LetterOfCreditMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,355,000</ix:nonFraction></span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">As of February 28, 2022, $<span id="xdx_906_ecustom--CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_c20220228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Credit line utilized to collateralize letter of credit issued to customers"><ix:nonFraction name="sotk:CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" contextRef="AsOf2022-02-28_us-gaap_LetterOfCreditMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> of the Company&#8217;s credit
line was being utilized to collateralize letters of credit issued to customers that have remitted cash deposits to the Company on
existing orders. The letters of credit expire in May 2023. As of February 28, 2022, there were no outstanding borrowings under the
line of credit and the unused portion of the credit line was $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_c20220228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Unused portion of credit line"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="AsOf2022-02-28_us-gaap_LetterOfCreditMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,495,000</ix:nonFraction></span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_809_eus-gaap--LongTermDebtTextBlock_zDD9m6AQL9jl" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 9: <span id="xdx_821_zFFE1aQou1Bj">LONG-TERM DEBT</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In fiscal year 2021, the Company obtained a loan under the Paycheck
Protection Program for $<span id="xdx_90C_eus-gaap--LongTermDebt_c20220228__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_pp0p0" title="Long term debt"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-02-28_us-gaap_UnsecuredDebtMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,001,640</ix:nonFraction></span>. In April 2021, the Company received notice from the SBA that the loan was forgiven in full and recorded
a gain on forgiveness of $<span id="xdx_900_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_c20220401__20220430__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zwok1S2DHTl4" title="Gain on forgiveness of debt"><ix:nonFraction name="us-gaap:DebtInstrumentDecreaseForgiveness" contextRef="From2022-04-012022-04-30_us-gaap_UnsecuredDebtMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,005,372</ix:nonFraction></span>, which is recorded on the consolidated statements of income in fiscal 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zDqKgjVLBI6b" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 10: <span id="xdx_828_zIKMeBpNAhU9">INCOME TAXES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The annual provision (benefit) for income taxes differs from amounts
computed by applying the maximum U.S. Federal income tax rate of 21% to pre-tax income as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zWIrddinDmXl" summary="xdx: Disclosure - INCOME TAXES - Income tax reconciliation (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BE_zXeRmo71DkQc" style="display: none">Income taxes - income tax reconciliation</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49B_20220301__20230228_zOABXeAqaEy3" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49B_20210301__20220228_z8RU5Xa11oZj" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman,serif">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maITEBzsB7_zmhc1KC4aPsj" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Expected federal income tax</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,882</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">609,883</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_maITEBzsB7_zVutWv5ipXnf" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">State tax, net of federal</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,204</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,894</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationTaxCreditsResearch_iN_pp0p0_di_msITEBzsB7_zBQ8ApzR2AUc" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Research and development tax credits</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">127,329</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">101,573</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pp0p0_maITEBzsB7_zeLnOUwmvdIi" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Permanent differences</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,252</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">179,320</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pp0p0_maITEBzsB7_zWfCwsGb4vGi" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#8212;</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,253</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzsB7_zEqR0e6o5GJ5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">154,009</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">361,631</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zHVmRTg9uGjk" style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 58; Value: 1 -->
    <div id="xdx_235_zkeBJCmeVXWa" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_237_z3yAqddd9s75" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Cambria,serif; margin: 0">Components of the current and deferred tax expense are as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zSaiHlmH6prc" summary="xdx: Disclosure - INCOME TAXES - Current and deferred tax expense (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif"><span id="xdx_8BD_z9AhiVHxsgz" style="display: none">Income taxes - current and deferred tax expense</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_491_20220301__20230228_zRxvZwcCjUNb" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_493_20210301__20220228_z4D8GLwnpJeg" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>February
    28,</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>2023</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>2022</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td></tr>
  <tr id="xdx_402_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zVF9uE6WnMna" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Current:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz4dN_zHY1IR2sngXg" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; width: 72%">Federal</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">438,263</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">341,882</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz4dN_zVJvEIB7uRF7" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">State</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,525</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,536</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz4dN_maITEBz5ma_zzwYywLl16Cj" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Total current income tax</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">521,788</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">380,418</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzDG5_zAwszYiUk68d" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Federal</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">321,458</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,787</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzDG5_zL0kKFl9UZy5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">State</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,321</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">&#8212;</span></td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzDG5_maITEBz5ma_zQJd3XyNSAOa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Total deferred income tax</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">367,779</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,787</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBz5ma_z1W7r0e6Hve4" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,009</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">361,631</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A2_zT17onUWeVdi" style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In assessing the realizability of deferred tax assets, management
considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization
of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences
become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and projections
for future taxable income over periods in which the deferred tax assets are deductible. Management believes it is more likely than not
that the Company will realize the benefits of these deductible differences.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The incorporation of the new tax laws for 2023, requires the Company
to capitalize for income tax purposes research and development expenses incurred during the year and for such expenses to be amortized
over a five year period. As a result, a deferred tax asset &#8220;Capitalized R&amp;D expenses &#8211; IRC Section 174&#8221; has been
recorded.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company does not have any uncertain tax
positions in 2023. There are no interest and penalties related to uncertain tax positions in 2023. As of February 28, 2023, open years
related to the federal and state jurisdictions are 2022, 2021 and 2020.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The deferred tax asset and liability are comprised of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zfnz0YvUahNi" summary="xdx: Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BD_zSWkGUdJawL2" style="display: none">Income taxes - deferred tax asset and liability components</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_499_20230228_ziGzPWlt4Gi" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_497_20220228_zi7igFRzhsd2" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Allowance for inventory</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">76,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">69,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Allowance for accounts receivable</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CapitalizedRdExpensesIrcSection174_iI_pp0p0_z5jxT9YPHkEg" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Capitalized R&amp;D expenses &#8211; IRC Section 174</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="sotk:CapitalizedRdExpensesIrcSection174" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">441,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">&#8212;</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Accrued expenses and other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">147,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">160,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iIC_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Deferred tax asset &#8211; Long Term</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">667,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">241,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_zzwMRAS8V7Hf" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Building and leasehold depreciation</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zJoJNt2675Ke" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Deferred tax liability &#8211; Long Term</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zbW3LTi4DT4d" style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 59; Value: 1 -->
    <div id="xdx_235_z2MnzR2SXAZb" style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_23B_zOjha7RVvbk5" style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zX4D7VcTtw06" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 11: <span id="xdx_82E_zXY8K5WhAwn5">EARNINGS PER SHARE</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The following table sets forth the computation of basic and diluted
earnings per share:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3Hf5T0a7PGg" summary="xdx: Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;<span id="xdx_8B9_zmVIV1SCeWOg" style="display: none">Earnings per share - the computation of basic and diluted earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220301__20230228_zTSpMW9EH2nb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210301__20220228_zqwCURZvyqKd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zCzKLzsh0T3e" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left; padding-bottom: 2.5pt">Numerator for basic and diluted earnings per share</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,905</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,542,573</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zaSep3GRNYCe" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Denominator for basic earnings per share - weighted average</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,735,451</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,586,404</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Effects of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Stock options for employees, directors and outside consultants</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,048</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">37,081</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zsXHAIHJXQFi" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,769,499</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,623,485</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Basic Earnings Per Share &#8211; Weighted Average</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Diluted Earnings Per Share &#8211; Weighted Average</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p id="xdx_8AD_z8DPqzOm3S5j" style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_80B_eus-gaap--ConcentrationRiskDisclosureTextBlock_z5xhXpBYhGqk" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 12: <span id="xdx_828_z8yYal242OP3">CUSTOMER CONCENTRATIONS AND FOREIGN SALES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Export sales to customers located outside the United States and Canada
were approximately as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgJ0hZYW4Mti" summary="xdx: Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B5_zfi7fc0zqkZ1" style="display: none">Schedule of customer concentrations and foreign sales</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br /> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Asia Pacific (APAC)</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" title="Total sales" style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-03-012023-02-28_srt_AsiaPacificMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,260,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" title="Total sales" style="font: 11pt Cambria,serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-03-012022-02-28_srt_AsiaPacificMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,301,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Europe, Middle East, Asia (EMEA)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" title="Total sales" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-03-012023-02-28_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,448,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" title="Total sales" style="font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-03-012022-02-28_us-gaap_MiddleEastMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,255,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Latin America</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" title="Total sales" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-03-012023-02-28_srt_LatinAmericaMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,546,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" title="Total sales" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-03-012022-02-28_srt_LatinAmericaMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,097,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228_pp0p0" title="Total sales" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2022-03-01to2023-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,254,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228_pp0p0" title="Total sales" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2021-03-012022-02-28" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,653,000</ix:nonFraction></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023 and fiscal 2022, sales to foreign customers accounted
for approximately $<span id="xdx_901_eus-gaap--Revenues_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pp0p0" title="Sales revenue"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,254,000</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--Revenues_c20210301__20220228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pp0p0" title="Sales revenue"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-03-012022-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,653,000</ix:nonFraction></span>, or <span id="xdx_90D_ecustom--SalesRevenuePercent_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">55</ix:nonFraction>%</span> and <span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pdd" title="Sales revenue, percent"><ix:nonFraction name="sotk:SalesRevenuePercent" contextRef="From2021-03-012022-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">68</ix:nonFraction>%</span> respectively, of total revenues.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company had two customers which accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_c20220301__20230228__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-03-012023-02-28_custom_TwoCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14</ix:nonFraction>%</span> of sales during
fiscal 2023. Four customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_c20220301__20230228__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-03-012023-02-28_custom_ThreeCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction>%</span> of the outstanding accounts receivables at February 28, 2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company had two customers which accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20210301__20220228__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-03-012022-02-28_custom_ThreeCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction>%</span> of sales during
fiscal 2022. Three customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20210301__20220228__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-03-012022-02-28_custom_TwoCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">41</ix:nonFraction>%</span> of the outstanding accounts receivables at February 28, 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-03-01to2023-02-28" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zAAFWGYoiLwj" style="font: 11pt Cambria,serif; margin: 0"><b>NOTE 13: <span id="xdx_82A_zWxEBBOfOw2c">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">Other than the letters of credit discussed in Notes 3 and 8, the Company did not have any
material commitments or contingencies as of February 28, 2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company is subject, from time to time, to claims by third parties under various
legal disputes. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on
the Company&#8217;s liquidity, financial condition, and cash flows. As of February 28, 2023, the Company did not have any pending legal
actions.</p>

</ix:nonNumeric><p id="xdx_810_zJSle15fzPW9" style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 11pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 0"><b>SIGNATURES</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In accordance with Section 13 or 15(d) of the Exchange Act, the Registrant
has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">Dated: May 25, 2023</p>

<p style="font: 11pt Cambria,serif; margin: 0">Sono-Tek Corporation</p>

<p style="font: 11pt Cambria,serif; margin: 0">(Registrant)</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">By: <span style="text-decoration: underline">/s/ Dr. Christopher L. Coccio</span></p>

<p style="font: 11pt Cambria,serif; margin: 0">Dr. Christopher L. Coccio,</p>

<p style="font: 11pt Cambria,serif; margin: 0">Chief Executive Officer and Chairman</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In accordance with the Exchange Act, this report has been signed below
by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 34%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><span style="text-decoration: underline">/s/ Dr. Christopher L Coccio</span></span></td>
    <td style="width: 23%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td>
    <td style="width: 28%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt"><span style="text-decoration: underline">/s/ Eric Haskell</span></span></td>
    <td style="width: 15%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Christopher L. Coccio</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Eric Haskell</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Chief Executive Officer, Chairman and Director</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Director</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><span style="text-decoration: underline">/s/ Stephen J. Bagley</span></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">/<span style="text-decoration: underline">s/ Dr. Joseph Riemer</span></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Stephen J. Bagley</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Dr. Joseph Riemer</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Director</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><span style="text-decoration: underline">/s/ Carol O&#8217;Donnell</span></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><span style="text-decoration: underline">/s/ Philip A. Strasburg</span></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Carol O&#8217;Donnell</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Philip A. Strasburg</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Director</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Director</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><span style="text-decoration: underline">/s/ R. Stephen Harshbarger</span></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt"><span style="text-decoration: underline">/s/ Dr. Donald F. Mowbray</span></span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">May 25, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">R. Stephen Harshbarger</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Donald F. Mowbray</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">President and Director</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Director</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: rgb(98,145,178) 2pt solid; margin-top: 11pt; margin-bottom: 6pt; padding-bottom: 2pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Cambria,serif; margin: 5.1pt 7.45pt 0 0; text-align: left"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>ex21.htm
<DESCRIPTION>SUBSIDIARIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Cambria,serif; margin: 5.1pt 7.45pt 0 0; text-align: right"><B>Exhibit 21</B></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0.1pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 11pt Cambria,serif; margin: 5.1pt 154.05pt 0 154.3pt; text-align: center"><U>Subsidiaries of the Registrant</U></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0.1pt 0 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 12pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; padding-top: 5.1pt; font-family: Times New Roman,serif"><FONT STYLE="font-family: Cambria,serif; font-size: 11pt"><U>Name</U></FONT></TD>
    <TD STYLE="width: 51%; padding-top: 5.1pt; font-family: Times New Roman,serif"><FONT STYLE="font-family: Cambria,serif; font-size: 11pt"><U>State of Organization</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-family: Cambria,serif; font-size: 11pt">Sono-Tek Industrial Park LLC</FONT></TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-family: Cambria,serif; font-size: 11pt">New York</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right"></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex23-1.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">Exhibit 23.1</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><U>Independent Registered Public
Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0; text-align: justify">We consent to the incorporation by reference in the Registration
Statements of Sono-Tek Corporation on Form S-8 (File No. 333-216504), and Form S-3 (File No. 333-267067) of our report dated May 25,
2023 with respect to our audit of the consolidated financial statements as of and for the year ended February 28, 2023, which report
is included in this Annual Report on Form 10-K of Sono-Tek Corporation for the year ended February 28, 2023.</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">/s/ Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">East Hanover, New Jersey</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">May 25, 2023</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: left"></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: left"></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0; text-align: left"></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0; text-align: left">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ex23-2.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">Exhibit 23.2</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: right">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><U>Independent Registered Public
Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0; text-align: justify">We consent to the incorporation by reference in the Registration Statements
of Sono-Tek Corporation on Form S-8 (File No. 333-216504) and Form S-3 (File No. 333-267067) of our report dated May 24, 2022, with respect
to our audit of the consolidated financial statements of Sono-Tek Corporation as of and for the year ended February 28, 2022, which report
is included in this Annual Report on Form 10-K of Sono-Tek Corporation for the year ended February 28, 2023.</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">We were dismissed as auditors on December 19, 2022, and, accordingly, we have not performed
any audit or review procedures with respect to any financial statements for the periods after the date of our dismissal.</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">/s/ Friedman <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0"><FONT STYLE="font-variant: small-caps">Friedman llp</FONT></P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">East Hanover, New Jersey</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: left">May 25, 2023</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0 7.15pt 0 0; text-align: left">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex31-1.htm
<DESCRIPTION>RULE 13A-14/15D 14(A) CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 9pt Cambria,serif; margin: 5.1pt 7.3pt 0 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.5pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 154pt 0 154.3pt; text-align: center">RULE 13a-14/15d &ndash; 14(a) CERTIFICATION</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 0 0 7.55pt">I, Christopher L. Coccio (principal executive officer), certify that:</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">1.</FONT></TD><TD><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">I have reviewed this Annual Report on Form 10-K of Sono-Tek Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">2.</FONT></TD><TD STYLE="padding-right: 15.3pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Based on my knowledge, this report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">3.</FONT></TD><TD STYLE="padding-right: 23.2pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for the periods presented in this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">4.</FONT></TD><TD STYLE="padding-right: 20.15pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Sono-Tek Corporation&rsquo;s other certifying
officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d &ndash; 15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the
registrant and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.2pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 9.55pt 0 73.1pt; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">a)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report
is being prepared;</FONT></P>

<P STYLE="font: 8.5pt Cambria,serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0.05pt 9.7pt 0 73.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">b)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Designed such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles;</FONT></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0.05pt 21.5pt 0 73.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">c)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls
and procedures and presented in this report our conclusions about the effectiveness of disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</FONT></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 11.2pt 0 73.1pt; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">d)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Disclosed in this report any change in the registrant&rsquo;s internal
control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth
fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s
internal control over financial reporting; and</FONT></P>

<P STYLE="font: 8.5pt Cambria,serif; margin: 0.5pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">5.</FONT></TD><TD STYLE="padding-right: 19.65pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Sono-Tek Corporation&rsquo;s other certifying
officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 73.05pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">a.</FONT></TD><TD STYLE="padding-right: 14.7pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 73.05pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">b.</FONT></TD><TD STYLE="padding-right: 21.55pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal controls over financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 0 0 23.9pt">Date: May 25, 2023</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 355.5pt 0 23.9pt"><U>/s/ Christopher L. Coccio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 5.25in 0 23.9pt">Christopher L. Coccio</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.3pt 333pt 0 23.9pt">Chief Executive Officer and Chairman</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.3pt 333pt 0 23.9pt">(principal executive officer)</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex31-2.htm
<DESCRIPTION>RULE 13A-14/15D 14(A) CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 9pt Cambria,serif; margin: 5.1pt 7.3pt 0 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.5pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 154pt 0 154.3pt; text-align: center">RULE 13a-14/15d &ndash; 14(a) CERTIFICATION</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 0 0 7.55pt">I, Stephen J. Bagley (principal accounting officer), certify that:</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">1.</FONT></TD><TD><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">I have reviewed this Annual Report on Form 10-K of Sono-Tek Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">2.</FONT></TD><TD STYLE="padding-right: 15.3pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Based on my knowledge, this report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">3.</FONT></TD><TD STYLE="padding-right: 23.2pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for the periods presented in this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">4.</FONT></TD><TD STYLE="padding-right: 20.15pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Sono-Tek Corporation&rsquo;s other certifying
officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d &ndash; 15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the
registrant and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.2pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 9.55pt 0 73.1pt; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">a)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report
is being prepared;</FONT></P>

<P STYLE="font: 8.5pt Cambria,serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0.05pt 9.7pt 0 73.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">b)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Designed such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles;</FONT></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0.05pt 21.5pt 0 73.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">c)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls
and procedures and presented in this report our conclusions about the effectiveness of disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</FONT></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 11.2pt 0 73.1pt; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">d)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Disclosed in this report any change in the registrant&rsquo;s internal
control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth
fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s
internal control over financial reporting; and</FONT></P>

<P STYLE="font: 8.5pt Cambria,serif; margin: 0.5pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">5.</FONT></TD><TD STYLE="padding-right: 19.65pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Sono-Tek Corporation&rsquo;s other certifying
officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0.05pt 31.15pt 0 73.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">a)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability
to record, process, summarize and report financial information; and</FONT></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.15pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0.05pt 12.8pt 0 73.1pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">b)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant&rsquo;s internal controls over financial reporting.</FONT></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 0 0 23.9pt">Date: May 25, 2023</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 5in 0 23.9pt"><U>/s/ Stephen J. Bagley&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 373.5pt 0 23.9pt">Stephen J. Bagley</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.3pt 364.5pt 0 23.9pt">Chief Financial Officer</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.3pt 364.5pt 0 23.9pt">(principal accounting officer)</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ex32-1.htm
<DESCRIPTION>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 9pt Cambria,serif; margin: 5.1pt 7.3pt 0 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.5pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 189pt 0 202.5pt; text-align: center; text-indent: -0.25in">CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350,</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 153.95pt 0 154.3pt; text-align: center">AS ADOPTED PURSUANT TO</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 135pt 0 154.3pt; text-align: center">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.05pt 23pt 0 7.55pt">In connection with the Annual Report of Sono-Tek Corporation on Form
10-K for the year ended February 28 2023 as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;).
I, Christopher L. Coccio, Chief Executive Officer and Chairman (principal executive officer) of the Company, certify, pursuant to 18 U.S.C.
section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 8.5pt Cambria,serif; margin: 0.45pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">(1)</FONT></TD><TD><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">The Report fully complies with the requirements of section 13(a) and 15(d)
of the Securities Exchange Act of 1934; and</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">(2)</FONT></TD><TD STYLE="padding-right: 12.65pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">The information contained in the Report fairly
presents, in all material respects, the financial condition and result of operations of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.05pt 0 0 7.55pt">Date: May 25, 2023</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.2pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.05pt 5in 0 7.6pt"><U>/s/ Christopher L. Coccio&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.05pt 5.5in 0 7.6pt">Christopher L. Coccio</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 346.5pt 0 7.6pt">Chief Executive Officer and Chairman</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 346.5pt 0 7.6pt">(principal executive officer)</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>ex32-2.htm
<DESCRIPTION>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 9pt Cambria,serif; margin: 5.15pt 7.3pt 0 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 166.5pt 0 211.8pt; text-align: center">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 153.95pt 0 154.3pt; text-align: center">AS ADOPTED PURSUANT TO</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 130.5pt 0 154.3pt; text-align: center">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</P>

<P STYLE="font: 4.5pt Cambria,serif; margin: 0.45pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 5.1pt 13.3pt 0 7.55pt">In connection with the Annual Report of Sono-Tek Corporation on Form
10-K for the year ended February 28, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;).
I, Stephen J. Bagley, Chief Financial Officer (principal accounting officer) of the Company, certify, pursuant to 18 U.S.C. section 1350,
as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 8.5pt Cambria,serif; margin: 0.5pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">(1)</FONT></TD><TD><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">The Report fully complies with the requirements of section 13(a) and 15(d)
of the Securities Exchange Act of 1934; and</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.85pt"></TD><TD STYLE="width: 16.6pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">(2)</FONT></TD><TD STYLE="padding-right: 12.65pt"><FONT STYLE="font-family: Cambria,serif; font-size: 9pt">The information contained in the Report fairly
presents, in all material respects, the financial condition and result of operations of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt Cambria,serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 0 0 7.55pt">Date: May 25, 2023</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 0 0">&nbsp;</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 355.5pt 0 23.9pt; text-indent: -0.05pt"><U>/s/ Stephen J. Bagley&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 9pt Cambria,serif; margin: 0 391.5pt 0 23.9pt; text-indent: -0.05pt">Stephen J. Bagley</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 5in 0 23.9pt">Chief Financial Officer</P>

<P STYLE="font: 9pt Cambria,serif; margin: 0.25pt 5in 0 23.9pt">(principal accounting officer)</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Cambria,serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>sotk-logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sotk-logo.jpg
M_]C_X0G,17AI9@  34T *@    @ " $2  ,    !  $   $:  4    !
M;@$;  4    !    =@$H  ,    !  (   $Q  (    >    ?@$R  (    4
M    G $[  (    $:FUP (=I  0    !    L    -P +<;    G$  MQL
M "<0061O8F4@4&AO=&]S:&]P($-3-2XQ(%=I;F1O=W, ,C Q-3HP-3HQ-2 Q
M-3HS.#HT,@   Z !  ,    !  $  * "  0    !   '&J #  0    !
MG          & 0,  P    $ !@   1H !0    $   $J 1L !0    $   $R
M 2@  P    $  @   @$ !     $   $Z @( !     $   B*         $@
M   !    2     '_V/_M  Q!9&]B95]#30 !_^X #D%D;V)E &2      ?_;
M (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01
M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ #@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,
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M       0CL_8NKN=$M$"\\9T40!D)3A"24T$.@      CP   !     !
M   +<')I;G1/=71P=70    $     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4    #0!, &4 > !M &$ <@!K "  5  V #( ,@   #A"
M24T$.P     !L@   !     !       2<')I;G1/=71P=71/<'1I;VYS
M$@    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9        .$))30/M
M       0 2P    !  $!+     $  3A"24T$)@      #@             _
M@   .$))300-       $    >#A"24T$&0      !    !XX0DE- _,
M  D           $ .$))32<0       *  $          CA"24T#]0
M2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M    !@       0 U     0 M    !@       3A"24T#^       <   ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H   X0DE-!         (  #A"24T$ @       @
M.$))300P       ! 0 X0DE-!"T       8  0    (X0DE-! @      !
M   !   "0    D      .$))300>       $     #A"24T$&@     #40
M  8              )P   <:    #@!& &\ <@!M #$ , !+ #( ,@ X #$
M-0 M #$    !                          $             !QH   "<
M                      $                         $     $
M  !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   "<
M     %)G:'1L;VYG   '&@    9S;&EC97-6;$QS     4]B:F,    !
M   %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N
M9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E
M;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &
M8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M    3&5F=&QO;F<          $)T;VUL;VYG    G     !29VAT;&]N9P
M!QH    #=7)L5$585     $       !N=6QL5$585     $       !-<V=E
M5$585     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(
M5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N
M=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N
M96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R
M5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/
M=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M
M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
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M# P,# P,# P,# P,# S_P  1"  . * # 2(  A$! Q$!_]T !  *_\0!/P
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M@M]3[(<YF+Z6S[/Z_P"C]'UOM"K='Z9]7K&LNZ!U;K-73C>748^,RXX8=O\
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MNV5_^&4E/__9.$))300A      !9     0$    / $$ 9 !O &( 90 @ %
M: !O '0 ;P!S &@ ;P!P    %0!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H
M &\ <  @ $, 4P U "X ,0    $ .$))300&       '  @    ! 0#_X1%
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M( ?.  ( "0 & #$  &%C<W!-4T94     $E%0R!S4D="
M  #VU@ !     -,M2% @(
M                        $6-P<G0   %0    ,V1E<V,   &$    ;'=T
M<'0   'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L
M%&)865H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
M    AG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@
M  0P    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E
M>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP
M86YY  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0
M$G-21T(@245#-C$Y-C8M,BXQ
M                              !865H@        \U$  0    $6S%A9
M6B                      6%E:(        &^B   X]0   Y!865H@
M    8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6
M245#(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W
M=W<N:65C+F-H
M             &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR
M+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M              !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD
M:71I;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M                =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X
M   !6%E:(       3 E6 %    !7'^=M96%S          $
M           "CP    )S:6<@     $-25"!C=7)V        !      %  H
M#P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\
M ($ A@"+ )  E0": )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L
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MMGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#
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M7W['6_!/2:_Z"_NS_P#O'OKO_P!!G?7_ -DWOV.M^#U[_H+^[/\ ^\>^N_\
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M_#K1X'K[&N(_XM=!_P!0D'_6L>]](3QZ<??NO=:!W_"O,D=_] 6/_-)<,?\
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M_P!][Z2]>]^Z]U[W[KW1:?F;_P!DC_)[_P 5][G_ /?;9/W[K8XCKXX&\_\
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MX;:FUL/C-O[<V]CJ7$X3"8;'T6*Q6*QM%$(:2AQ^-QT<4$$,: *D4,:HH%@
M/>^DW3Y[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NFO-YG';=P
M^7S^9JZ?'X;!8NOS.5R%9404E)0X[&4KUM=5U575,D44<42,[R2.JJH)9@ 3
M[]U[CU\X#^?_ /S?]\?*GNG<_P 9NE=[9;#=%=:YS*;;W'6;0W)E\=1;XS^V
ML_E\4*LU&T]S9'#Y/'5N-K4CEDGH(I)E 72L0 ;U>E4<8 U'K6:2*.%1'$BH
MB^D*BJH ' X6P]ZZ>ZY>_=:ZXLZ*5#.JL[!(U+ -)(QLD<8/U8G@ <GW[KW0
MW=>?&7Y-=M^)^L/C=WYOVCG*"'*[/Z>[ W3B'$HC,<BUVWJ"I0J5EC<$?56!
M'U%_=:+*.)Z-#COY2_\ ,FRE(E92_#[O]() N@5'Q^[Z68:T#C6(]ML/H>;'
MW[K6M/7J9_PT-_,N_P"\0>_/_1 =^_\ V->_=>UIZCKW_#0W\RW_ +Q![]_]
M$!W[_P#8U[]U[6GJ/V]>_P"&AOYEO_>(/?O_ *(#OW_[&O?NO:T]1^WK'-_*
M%_F7&&4#X@]^DF-P!_H []Y)4@?3;/OW6]:>HZWKO^$UGQQ[Q^-/P\W]L[OC
MKC=W6FZ,AVA2Y6BPV\=H;OV;D*C'+UWA,<U5%C]Y4-!4.@G@EC+I$5U*5OJ!
M WTFE(+8ZV,_?NFNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJV_P";9_V0/\A?_$:]C?\ OL<Y[V.K
M)\77R*(OHW_!S_O0]UZ6]9??NO=;?/\ PD4_YGKW+_VK=_\ _N/M;WX=-S_"
M.M_WWOI)U[W[KW7O?NO=%P^8=+65WQ0^2M#CZ*KR-?6="=Q4M%04%/+5UU;5
MU'7.2BIJ2CI8 7DED<JD<: LS$  D^_=;'$=?(3WA\>_D?)O?>DL?QN^0,D4
MFY<F\4J=/;[>.5&F)5XW6BLRG\$>]=+013CTP?[+Q\DO^\:_D'_Z)S?G_P!1
M>_=>J/7JU3^21TIWKMS^9)U1E]S=$]T[9PL&*H%GS.XNL-X8;$T[#LO 3$3Y
M'(4D<2$(CN=3?I5C] ??J=5=AI/7U1O>^D?7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]/?X]^Z
M]U\KC_A0/VWE.UOYEG;V,JLC+64G4^X-^]:TT#U=141T<>([$R55%3K%)4U*
MQZ?,;(JP@7XB'U.CTKC^'JE$_4_Z_OW3G7%F"J68@*H+,20  !<DD^_=>ZV.
MOY$'\F>F_F!;ER/=?=Z9K'=$;%SIQD&.H5CHYMUYV@CPNZL4)Z3=VULUAJ[%
M55'55$-1:KCDE'H0!-3G=.FI)-.!UO[]1_R^_A;TE@<;@=A?&+H3'C&4U-31
MY@=+=44F=JOM88X%J*W(8;"TFN5O$C.X078 V%A;W2;4Q\^AS_T%])?\^=ZL
M_P#1>[2_^H_?NO5/KU[_ $%])?\ /G>K/_1>[2_^I/?NO5/KU[_07TE_SYWJ
MS_T7NTO_ *D]^Z]4^O7O]!?27_/G>K/_ $7NTO\ ZD]^Z]4^O7O]!?27_/G>
MK/\ T7NTO_J3W[KU3Z]>_P!!?27_ #YWJS_T7NTO_J3W[KU3Z]>_T%])?\^=
MZL_]%[M+_P"I/?NO5/KT^;?ZRZWVG6G)[5Z^V1MG(M"].V0V_M3 X:M:"5E>
M2 U6.IXY"C%$++JL2H)' ]^ZUTM_?NO=1,A74N+H*W)5TT=/18ZDJ:ZLJ)I(
MX8H*6DA:HJ)I99BJ*JHI9F9@ !<D#GW[KW7R[O\ A0?\ULQ\K?G3O+9-!G9J
MWKOHK)[FZTH<?2Y.JJ<)75^V-^96IQV96DARN1H991!5E4J$BIVT\+$B\G72
MN-:+7JB8_4_Z_OW3G77OW7NCQ?R^_@CVO_,$^0&V^H.NL7D1@(ZZBR.^]U14
M6Y!C</MFBW!C:#<T$6<P6'S4-/7I29 3PK64WB4#7*0@LWJ=:9@HJ>OIW? S
M^5Q\6/@?UIMO;&Q.LME9G?E!C\8,[V?GME]=9'?N0RU)C:2CK*A=ZX?;^'K)
M4FDHXJAWFC#O*/(UC8+OI&SECU9,/?NJ]>]^Z]U[W[KW1$OF=_+K^+OS;Z\W
M)M+M7JG8D^Y<KC\DN*[$I]C=>2[\Q.3J,96TM%44F[=QX3+5$"QU%:]5KCC+
MK*!*MV!#>ZLK%>'7S&_YGO\ +A[*_EP_('-]=[AHLSD.L\S793)=;;TJZ;/U
M=-6[8.XJS"8"FR^XZ[!X/'R9"=**24I00-$Z^J,VNJZZ5JP88ZK;/^^O[]U;
MKWOW7NKH_P"0]\U<W\/OG/LC'SYF6EZ_[<J:'K_*XNIR-7!A/[Q]@;WV_@XL
MQ/0OE<91>>.FIV45$BS2JMP(Y%](\.FY5U+7TZ^J/0UU'DZ.ER&/J8*RBK8(
MZFEJJ6:*HIZB"5=<<L,\)9'5@;AE8@_@^]]).I?OW7NOGJ_\*YS_ ,Y?]!#C
M_F0U+S^?^9H;B]^\NE4/P]:F?O73O7B;<G@#DD_CW[KW6>2EJX8X99Z*LIXJ
MA%EIIYZ:6*"JA?\ 1+32N '5N=+*2#[]U[K#S_CQ_O'OW7NK'/Y57S<W5\$O
MF%UQV-B\S74.R]U9S [#WYCTR.1IL4,#NO>N'.X\Y5TE/EL12>2*BHV!J:R=
MXU46EC=/T^''JKC4O7UE>J.S]I]S==;,[0V-DJ;+;4WSMS%;FP==2UF-KXYL
M;F*1:VC?[G$5%53-JC=6O#42*?JKL.?>^D1X]")[]U[KWOW7NM<?_A4'C*2O
M_EM,]2FHTW=&S:B'TQ-:6#9>YWC)\BM]#_2Q_H??NG(OCZ^9U2DFGA)M<QH3
M;Z?3WKI7UG]^Z]ULO?\ "5+_ +>-Y_\ \01V1_[U.UO?NFI?AZ^DQ[WTEZ:-
MP9N@VU@<WN/*S)38O;^(R6;R51))##'!08JC>OK)GEJ7CC4+'&S%I'50!=F
MN??NO=?*B_GA?,S._,/YY=HE-Q5F4Z]Z@W/O#K79U#_%ZRMQ$^)P^^,AD\1D
M(*893)T+,(ZME26E\* &R1*"2='I9&M%ZI^/U/\ KG_>_?NK]=>_=>ZL:_EF
M?RZ>T_YC7?V#Z[VC0UN/Z\PU=39/L/>CTVXJ7%TF(Q&=Q<>X\#1;CQF#SE#'
MDY*#(>:EI:Z!4:VN4K&/5[JKOI'7TY?A7_+B^+GP>Z\V]M#JOJ[9(W'B\;CJ
M7*=B5^R>NQO[,UE)CZ:BJ*S);MVY@\3/4/.U+%--))$&>0!R!8 ;Z2,Q;CT?
M?W[JO7O?NO==$!@58 J0001<$'@@@^_=>ZKJ^=/\L7XL?.KKC<NV>Q.L-E4.
M^*W'9-]O]E8C9775-OG'YN3&5\.,:3>6<P&7K(J85=::J8P1F02*LJ>L>KW5
ME8KPZ^8;_,0^!':/\O3Y#[FZ<WYC\I+MA\AF:SKO=]72[ADHMP;2I=PU6!Q%
M;)G\SA\)3U<]0:25Q)0TOAD NA%BHUTK5@PZ(E[]U;KKW[KW6P)_PG4^<N5^
M*OS2Q?6>;S4L/6?<D<N$?%UN1J8\2=^[SW3MS:N)K5HJO+X['^=:>)E20T\]
M0!<(KK=![IN505KY]?3OCDCFC26&1)8I%#QR1NKQNC"ZLCK<$'\$'WOI)US]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=<)(TE1XI422.1&CDCD4.DB.-+HZ-
M<$$&Q!^OOW7NDXVRMFNS.^TMLL[DLS-@<4S,Q^K,QBN3_B??NO=<?[D;+_YY
M#:__ )X,5_UZ]^Z]4]>_N1LO_GD-K_\ G@Q7_7KW[KU3U[^Y&R_^>1VO_P">
M#%?]>O?NO5ZT7O\ A79A\/B-^= IB<3C,6LFQ]L-)_#J"EHM9.]-RJ2WVRK>
MX !O_0>_'I1#P/6FE[UT_P!='Z'_ %C_ +U[]U[K=5_X2/8?#9:F[T3*X?%9
M31O'=.A\CCZ6M>-1MG;)"(U2K66Y)L/R3[\.D\W6[U_<C9?_ #R&U_\ SP8K
M_KU[WTQ4]>_N1LO_ )Y#:_\ YX,5_P!>O?NO5/7O[D;+_P">0VO_ .>#%?\
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MU_\ SP8K_KU[]UJIZ]_<C9?_ #R&U_\ SP8K_KU[]UZIZ]_<C9?_ #R&U_\
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M0;@C^H(]^Z]UW[]U[KWOW7NO>_=>ZQ&> $@S1 C@@R("/]<7]^Z]UU]Q3_\
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M_=>ZS>_=>Z][]U[KWOW7NO>_=>Z\2 "2; <DG@ #ZDGW[KW6'[BG_P".\/\
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M[]U[KWOW7NO>_=>Z][]U[KHD*+L0 /J20 /]B??NO=8ON*?_ ([P_P#4U/\
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MLUF,D;V8^Z<C;2W7RW?!5TCR4>0B>GR%&YIJZGE26*6"JCXEBEBG =6!X*N
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M3)XXJ#%1TS&^G0]U.QTGF6AJ.MQKW[ICKWOW7NM=7_A3Q_V[6JO_ !,.T_\
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M_OW5.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K0._X5Z?\
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M+=5!/'%+%(T4]*-X4X;4(])74 0[C^UQZO6C&IZV<_Y7W_"G?!=];VVIT?\
M,+;>!Z^WGGI<7@<!O/:V'H]I[&R&7R%;C<!C:?);B[0W_65<M3/6551)HAI&
M=X4#*I=64[Z:>*F1UM]8_(4&6H:7)XJNH\GC:^".JH<ACZF&MH:RFF77%44M
M73,T<D; W5T8@CD'W[IGIDWO55%#LS=U;22O!5T>V,_54L\;O%)#44^*EEAE
MCDB(965@"&4@@\@@^_=>'7R[/G%_-0_F'['^8_R7V9M'Y4]VX+:^V>X]^8;
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MN?\ P[Q_,P_[R^[[_P#1_P#?W_V2^_5Z]X:>G7O^'>/YF'_>7W??_H_^_O\
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M\IMC=6#V#OO(8C-8;*Y7"Y&AK:#KW,9&CJ*;)86:GJ8FCGABD5XI5964,I#
M$;'5E^+KYB<?\WK^9BP8GY?]]\,1_P S_P"_O_LF]UZ5>&GIUD_X=X_F8?\
M>7W??_H_^_O_ +)??J]>\-/3KW_#O'\S#_O+[OO_ -'_ -_?_9+[]7KWAIZ=
M>_X=X_F8?]Y?=]_^C_[^_P#LE]^KU[PT].O?\.\?S,/^\ON^_P#T?_?W_P!D
MOOU>O>&GITXX[^<-_,TQM1'50_+?NZJ="I,%?WUW_/3. P<K)&FYU)!M8B_T
M)]^KU[PT].CA=.?\*0OYEG4]90OE]P[&[)QU--3O5)V#EN_-XU]1%$\/E4+5
M;YID<LD3<-8%G:_#&WJ]:,*DXZV+/@=_PJ?Z1[FS6$V#\J]K5'4^[<O5T&-B
MW;C,'M'8G5\-5634..62MSW8_8=54J@J*B>4D0L?!&6L61@=]--$1D=;6.Q=
M_;*[-VOB-Z=?;JV[O/:F>H:7)8C<&ULYB=Q8;(4-= M525-'EL)-44TJ21LK
MH\4K*RD$$@@^_=,]*_W[KW7O?NO=?__5W^/?NO=?)8_G6[*K=E?S/?EY)D(Z
MB$;X[Q[5WIC_ +A)8Q-05N^:RFCEI_/%%JC)0V9/(O\ M9^GO1Z61FJ@=58G
MZG_7]^ZOUBF0RPRQJ=+/&ZJU[%692%8$?2QYO[]U[K?D_P"$S/\ ,VZ;J.C/
M]E&[?W_M[8W8&T*RAH=BOO7=6UMLX[.;8V]M;!;;HZ/'-N?/FMJ:NIK972GC
MH\:D4FE@H60%3ORZ3RH:U'6X=2U=+74T-915-/64E3&DU/54LT=135$,@U)+
M#/"2KJ1R&4D'W[ICJ1[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>ZH(_X4B]EOUS_ "W-S-3U4E-/NC?N+V@QBF,+2T^XMA;EI)(24G@+
M!M(!7U@_E&^GOW3D7Q=?+UH(_#14L7Y2"-3?ZW"V-_I[UTKZE^_=>Z&OXV;(
M/8_R0^/FR/$\\>XNZ^J<;50*GE$U)DM^4&-J(I(O#.&1EF*LK1,I^A!^A]UI
ML ]?8J^/FPJ;JWH_JGKFCIHZ2EV5L7;NVZ>EBACIXX(L5CDI4B2&*&G50 M@
MJP1@?ZD?3WOI$34UZ&'W[K77O?NO=>]^Z]U[W[KW7O?NO=!]VSMB'>G5?9>S
MIX(ZF+=>P-Y;;D@EB6:.9,[MVIQ;QO$\<H8,)2"#$][VTM]#[KPP:]?'P^<7
M67^AWYE?)SKE*=:.GVSW3O[$T5(D7V\5/2XW.RT4<,$ IZ545=%@J0(!^ /I
M[T>/2Y350>BM>_=;ZCU88TM2$)#^";01<$/XSI((YO?^GOW7NOID?\)C.R*G
M??\ +QH,55UTE9+L#.;9V9$LU5)4/!%CNL\+-X566>8J 9"=(6,#_4#\[Z2R
M@!\=;&OOW377SU?^%<Y_YR_Z"''_ #(:EY_/_,T-Q>_>72J'X>M3/WKIWJ-6
M\T=6!R333V'_ $Z/O76QQZ^DU_PFZVOMOL?^5YG=B9^GI,K@MS"CVGGZ&:*@
MKHS1YSI[%8K(TTM-6QSPZC#,ZE)H76QLR,I(-ATEFP]>M.?^=1\!<]\$OF7O
MR@H=OU5!U-VAF]S;\Z^K8<564N%QF#RN\<ABL!@EJ8<-A\;#+X:-F2EH5ECT
M\QR%;A='IY&U#JH?W[J_1C/B-\C]Z?$OY%]8=X;*R^1Q,NW-V;5&YTH*_+4*
MY/9=-NZ@SNX\94KB:[&F:.>*B5'AJ*M8''$MAZE]UIEU"G7UP_AE\G]F_+[X
MZ]8=Y[.RF*KHMZ;/VWG,Q0XRMQ55)@<MFL+#EY</D:;%Y#)BEGC29"U/+5NZ
M@B[,"&.^D;+I-.C3>_=5ZU]_^%+6%AR_\M3-M+))&:+M# 5J>-U34]+L3<TB
MHVI&N#?D"W^N/?NG(OCZ^8/1&]'3'^L,9_VZ^]=*^I7OW7NME[_A*E_V\;S_
M /X@CLC_ -ZG:WOW34OP]?28][Z2]:T7_"I'M.;9?\OFDVU051IZ_<O;>S::
M=$G>)Y<7DMJ[GQU5&5AJ(G96( (,;(?R#]/?NG8OBZ^;!3((J>&-18)&J@6M
M8 <<#WKI5UF]^Z]T:'X2=;R=M?+_ ..&QA3"L@K>Z.IZO(4[PM41MC!V1BZ*
MM:2(05(*Z)B&+PE+?J-N#X=:8T4]?8?ZVV=0]>[ V?L;&0PT^.VGM[&8&B@I
MXX888:;'4JTT4<45/% BJ M@$A0?T4?3WOI">/2V]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW0,?(S:5)OSH#NW9U91PUT6Y>I.R,$*>>GBJ5:3+[,K<:I6*6.8%OW
M2!^TQY_2WT/NMCCU\=;Y([#?J[Y'=[]=&F-'#LSM/=VWJ2F\)IQ#2XK)M2)&
ML)AIPH&FUE@0#_4CZ>]=+1D= S[]UOK!5.T5/+-'P\$;S(1>X>)"ZD6L;W'X
M/OW6^OJ2?\)W.T*WLG^6]U-#65CU4FQ]O;%V>JR5$LYIHZ'KS%U'VZB6HG*6
M,A.BT8_V@?4[Z1RBCGJ]GW[IOI#=C=@[;ZOV;G][[KR-)C<1@L9DL@[U5704
M;54F/QTV1%#1MDIJ>)YY4A<11&52Q_(%R%NV[?<[I>1V-JI9Y& P": D"IH"
M0HKDTQT'.;.:=IY-Y?NN8MZE6*"VCD?N9%U%(VDT)XCHK.P0A5U"I\QQ&I!\
MT?Y@_:'R*W=F<-M;<F<VEUC15U928K&X',;AP,F9QT=94BCJ<Y1X[-5V/J))
M*>H\4SQJ%90%4:1SEQR5[>[9R]:)/=1I-<D LS*CZ31:A"8U8 $5%<USUPS^
M\-]ZCG'W1WJXV_9KJ6RVA'=8XX99X?$C#2:3.B7<L+N4?2Q4:2  ,<:XI"9)
M'DE8S2NQ:264^261B;EWD;DD_DGW)   HHH.L0WEDD8N[$DY-2>N!1#]54_Z
MZ@^]]5U,.!Z76PNR=^=89RAW#L+=FX=L9"@K*:K"X//9G"P5AIJB.J^VKQAI
MZ=Y(9#%&LJ:QJ4 7%@0AW#;+'=+=K>^A256!'<BM2H(J-0(!%30TZ$_*W.?,
MW)FY1[IRY?3VDL;J_P"C-+%KTLK:7\)T+(VD!A45 X\.MI[^7-\_Z#Y&[>BZ
M^[#K*#']I8&D6-6>HAI%SV/QM#0P561)SF9KLC532U52RK-X55K6-G^N*_N-
M[?R\N7!W#;U)M7/H3I8EB!VQJB@*.%:C[.NU7W4/O06ONQM:\K\T2)'O%N@I
M5@OC1QI"K.?&NYIY':20C5H"G@:-QM@]Q/UFYU[W[KW7O?NO=>]^Z]UHC_\
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M]UPDKJ+QR?Y92_H;_E(B_P!3_K^_=>Z^A+_PD6FAF^'/>IAEBE [[D!,<BN
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MWOV.M>''U[_H(._F=_\ /S\;_P"AA\@O_LV]^QU[PX^O?]!!W\SO_GY^-_\
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M]^Z]QZ^5'_.@_F ;Q^=GS"[ F_CU?-U'UAN;<FRM@8.',YFJP-?A\3N[(9/
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M>NC_ "%_Y9Q!!^/'7MB"#_QB7H'Z'_R3_?J=>\1_7H]OQ9^'/07PUVIFMD=
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M5W\E:G?7R5ZVZ$Q.3D_N]M39,&1S>,CJG,+;HVWO_<&,$\E/!4-'J$,P6\D
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MU\]7_A7/_P!E?]!#_OPU+_K_ /,T-Q>_>72J'X>M3/WKIWK%4"\$X_K#(/\
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MIUU_PYC\^?\ O)SMS_T:_:O_ ->O?JGKVA?3KW_#F/SY_P"\G.W/_1K]J_\
MUZ]^J>O:%].DMO7Y\_,KLC;=?L[???O9.Y=L92.:'(8C+=B]BY2BJHJBEDH9
MXYJ/*96:%PT,LB$/&00Q!X)!]U[0O11U4* J@  6    M_@/?NK==^_=>ZVE
M_P#A)O\ ]ES[Y_\ $2=C_P#NXVM[\.F9OAZ^B_[WTFZ][]U[JMO^;9_V0/\
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MCCD>GW[KU!6O1>*>%*>"*!+Z(8UC6_ULHL+^_=;ZR^_=:ZV7O^$J?_;QO/\
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M@,4GFW*V$W%C8:A/MY?-1Q5^+BD1EE@#1L&NMV_)]QQS%[G<P;XI@5O!B/\
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M-E+LL85CKFVQJY///OU.FO%?IT_Z!B?Y:W_*GV__ .A7LC_[&??NO>*_7O\
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MZB.IIY1C^P,C7PR0/#-*F@K."/T'_:1^='I7$*+U3O[]TYTYX+&2YK<VTL#
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MEC8<HN,K)M"*94BGC9B@MR+>]])""IH>C%>_=:ZZ)M<G@ 7)_''OW7NM<_\
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MWJ3)4%&D,<:[NQ^1W14F"".*(*T^2K"2=,2\G\DG\GW[JIC4]'&B_P"%+/\
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MR]X__5GOU3U[2OIU[_2[W)_S^;M[_P!&7O'_ .K/?JGKVE?3K%/V[W)X)O\
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MCS?0WR2[PZBS]#+CZS8W96[=NP4\Z>.1J;#963'^0*23;4A'//'O72U2",=
M3[]UOJ125=7CZNDR&/JZF@R&/J8*VAK:.>6EJJ2LI)1/35$%1 5=61PKJ58$
M$ @W]^Z]U='\5/Y^?S\^*6VL;LW";QPN[]L8BFIJ.@AW+MU=R9=*6CI:>C@C
MFR>;JF9F\<'J-N68M]2??J]-F)3T=MO^%8'SN5&/]W=HDJI/_'A;9Y(%_P#C
MM[W7JO@CK:@_D3_S(.X?YDG0/979W<=#C:#-;1[.;9^/CQF&H,-$V.&S,3N
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M]UM\_P#"13_F>O<O_:MW_P#^X^UO?ATW/\(ZW_?>^DG7O?NO=>]^Z]UHC_\
M"OW_ (_[X_?^&-M?_P![7<WO1Z4P\.M,'W[I[KWOW7NOKP?RB?\ MU]\"?\
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M  KT_P"9_= ?^(DPW_OPMR>_'I3#UI]>]=/=8I_\Q-_RRD_Z$/OW7NOHO_\
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MMH[@V/O/#T6<VWN;$9/"92@K::FJ4:CR^.EQ=6\(JD=4E\,TBI(%NM^/?NO
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M>'5]6QNM=A=:8:BP.Q-H;<VKC*&FBI(8,#A,7B0T4,2P(9OX=#$';2B@DCD
M?T'OW3=:]+CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4I_S6/Y.>P_YGV<V+FMX;KEV[)LK"8W
M#TZ1Y',T7FCQ^8R.61R,6"#=L@PNW]/];W[IQ)"@H.JC/^@1OH__ )^?5?\
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MW_1OO=!UOQCU[_H$;Z/_ .?GU7_G_P!W?]&^_4'7O&/7O^@1OH__ )^?5?\
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M CW[IT3,.BS'_A(WT=<V[.JK?C_<_N[_ *-]^^WK?C'KW_0(WT?_ ,_/JO\
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D>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>sotk-20230228.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9K0po7xRiXhun8uEbXxcOa2EOcOdwpB0uYlBtG59ffkq7y4mJ3dY3iS/1OHGIakK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:sotk="http://sono-tek.com/20230228" elementFormDefault="qualified" targetNamespace="http://sono-tek.com/20230228">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://sono-tek.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/BusinessDescription" id="BusinessDescription">
	  <link:definition>00000007 - Disclosure - BUSINESS DESCRIPTION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/RevenueRecognition" id="RevenueRecognition">
	  <link:definition>00000009 - Disclosure - REVENUE RECOGNITION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Stock-basedCompensation" id="Stock-basedCompensation">
	  <link:definition>00000010 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Inventories" id="Inventories">
	  <link:definition>00000011 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements" id="BuildingsEquipmentFurnishingsAndLeaseholdImprovements">
	  <link:definition>00000012 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/AccruedExpenses" id="AccruedExpenses">
	  <link:definition>00000013 - Disclosure - ACCRUED EXPENSES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/RevolvingLineOfCredit" id="RevolvingLineOfCredit">
	  <link:definition>00000014 - Disclosure - REVOLVING LINE OF CREDIT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Long-termDebt" id="Long-termDebt">
	  <link:definition>00000015 - Disclosure - LONG-TERM DEBT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000016 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/EarningsPerShare" id="EarningsPerShare">
	  <link:definition>00000017 - Disclosure - EARNINGS PER SHARE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales" id="CustomerConcentrationsAndForeignSales">
	  <link:definition>00000018 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
	  <link:definition>00000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
	  <link:definition>00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/RevenueRecognitionTables" id="RevenueRecognitionTables">
	  <link:definition>00000022 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Stock-basedCompensationTables" id="Stock-basedCompensationTables">
	  <link:definition>00000023 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000024 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" id="BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables">
	  <link:definition>00000025 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
	  <link:definition>00000026 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000027 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
	  <link:definition>00000028 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables" id="CustomerConcentrationsAndForeignSalesTables">
	  <link:definition>00000029 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" id="SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails">
	  <link:definition>00000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails" id="RevenueRecognition-SalesRevenueByProductLineDetails">
	  <link:definition>00000032 - Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/RevenueRecognitionDetailsNarrative" id="RevenueRecognitionDetailsNarrative">
	  <link:definition>00000033 - Disclosure - REVENUE RECOGNITION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails" id="Stock-basedCompensation-SummaryOfStockOptionsDetails">
	  <link:definition>00000034 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" id="Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails">
	  <link:definition>00000035 - Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative" id="Stock-basedCompensationDetailsNarrative">
	  <link:definition>00000036 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/InventoriesDetails" id="InventoriesDetails">
	  <link:definition>00000037 - Disclosure - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" id="BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails">
	  <link:definition>00000038 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" id="BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative">
	  <link:definition>00000039 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
	  <link:definition>00000040 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative" id="RevolvingLineOfCreditDetailsNarrative">
	  <link:definition>00000041 - Disclosure - REVOLVING LINE OF CREDIT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/Long-termDebtDetailsNarrative" id="Long-termDebtDetailsNarrative">
	  <link:definition>00000042 - Disclosure - LONG-TERM DEBT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails" id="IncomeTaxes-IncomeTaxReconciliationDetails">
	  <link:definition>00000043 - Disclosure - INCOME TAXES - Income tax reconciliation (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" id="IncomeTaxes-CurrentAndDeferredTaxExpenseDetails">
	  <link:definition>00000044 - Disclosure - INCOME TAXES - Current and deferred tax expense (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" id="IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails">
	  <link:definition>00000045 - Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" id="EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails">
	  <link:definition>00000046 - Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" id="CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails">
	  <link:definition>00000047 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative" id="CustomerConcentrationsAndForeignSalesDetailsNarrative">
	  <link:definition>00000048 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="sotk-20230228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="sotk-20230228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="sotk-20230228_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="sotk-20230228_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="sotk_EquipmentAndFurnishingsMember" name="EquipmentAndFurnishingsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_FluxingSystemsMember" name="FluxingSystemsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_IntegratedCoatingSystemsMember" name="IntegratedCoatingSystemsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_MultiAxisCoatingSystemsMember" name="MultiAxisCoatingSystemsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_OemSystemsMember" name="OemSystemsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_OtherProductLineMember" name="OtherProductLineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_ProductLineMember" name="ProductLineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_TwoThousandThirteenStockIncentivePlanMember" name="TwoThousandThirteenStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_NonEmployeeDirectorsStockOptionMember" name="NonEmployeeDirectorsStockOptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_EmployeesAndDirectorsMember" name="EmployeesAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_TradeshowAndDemonstrationEquipmentMember" name="TradeshowAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_ForeignCustomersMember" name="ForeignCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_TwoCustomersMember" name="TwoCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_ThreeCustomersMember" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" name="BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan" name="GainFromForgivenessOfPaycheckProtectionProgramLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" name="StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_ProceedsFromExerciseOfStockOptionsShares" name="ProceedsFromExerciseOfStockOptionsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_AccountsReceivableReserve" name="AccountsReceivableReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_PaycheckProtectionProgramLoanForgiveness" name="PaycheckProtectionProgramLoanForgiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_IncreaseDecreaseInCustomerDeposit" name="IncreaseDecreaseInCustomerDeposit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" name="EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_UncertaintiesPolicyTextBlock" name="UncertaintiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_SalesRevenuePercent" name="SalesRevenuePercent" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_CashDeposits" name="CashDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" name="CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="sotk_CapitalizedRdExpensesIrcSection174" name="CapitalizedRdExpensesIrcSection174" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>sotk-20230228_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sono-tek.com/role/Cover" xlink:href="sotk-20230228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheets" xlink:href="sotk-20230228.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="sotk-20230228.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfIncome" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BusinessDescription" xlink:href="sotk-20230228.xsd#BusinessDescription" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPolicies" xlink:href="sotk-20230228.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognition" xlink:href="sotk-20230228.xsd#RevenueRecognition" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation" xlink:href="sotk-20230228.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Inventories" xlink:href="sotk-20230228.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpenses" xlink:href="sotk-20230228.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevolvingLineOfCredit" xlink:href="sotk-20230228.xsd#RevolvingLineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Long-termDebt" xlink:href="sotk-20230228.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes" xlink:href="sotk-20230228.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShare" xlink:href="sotk-20230228.xsd#EarningsPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSales" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CommitmentsAndContingencies" xlink:href="sotk-20230228.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesPolicies" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesTables" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognitionTables" xlink:href="sotk-20230228.xsd#RevenueRecognitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensationTables" xlink:href="sotk-20230228.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/InventoriesTables" xlink:href="sotk-20230228.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpensesTables" xlink:href="sotk-20230228.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxesTables" xlink:href="sotk-20230228.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShareTables" xlink:href="sotk-20230228.xsd#EarningsPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSalesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:href="sotk-20230228.xsd#SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails" xlink:href="sotk-20230228.xsd#RevenueRecognition-SalesRevenueByProductLineDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognitionDetailsNarrative" xlink:href="sotk-20230228.xsd#RevenueRecognitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:href="sotk-20230228.xsd#Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:href="sotk-20230228.xsd#Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="sotk-20230228.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/InventoriesDetails" xlink:href="sotk-20230228.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpensesDetails" xlink:href="sotk-20230228.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative" xlink:href="sotk-20230228.xsd#RevolvingLineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Long-termDebtDetailsNarrative" xlink:href="sotk-20230228.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-IncomeTaxReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="sotk-20230228.xsd#EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land" xlink:label="loc_us-gaapLand" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapLand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" xlink:label="loc_sotkBuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_sotkBuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CustomerDeposits" xlink:label="loc_sotkCustomerDeposits" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_sotkCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan" xlink:label="loc_sotkGainFromForgivenessOfPaycheckProtectionProgramLoan" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_sotkGainFromForgivenessOfPaycheckProtectionProgramLoan" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_AccountsReceivableReserve" xlink:label="loc_sotkAccountsReceivableReserve" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_sotkAccountsReceivableReserve" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryLIFOReservePeriodCharge" xlink:label="loc_us-gaapInventoryLIFOReservePeriodCharge" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryLIFOReservePeriodCharge" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_PaycheckProtectionProgramLoanForgiveness" xlink:label="loc_sotkPaycheckProtectionProgramLoanForgiveness" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_sotkPaycheckProtectionProgramLoanForgiveness" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_IncreaseDecreaseInCustomerDeposit" xlink:label="loc_sotkIncreaseDecreaseInCustomerDeposit" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_sotkIncreaseDecreaseInCustomerDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaapPaymentsToAcquireMarketableSecurities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireMarketableSecurities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BusinessDescription" xlink:title="00000007 - Disclosure - BUSINESS DESCRIPTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognition" xlink:title="00000009 - Disclosure - REVENUE RECOGNITION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation" xlink:title="00000010 - Disclosure - STOCK-BASED COMPENSATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Inventories" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:title="00000012 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - ACCRUED EXPENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevolvingLineOfCredit" xlink:title="00000014 - Disclosure - REVOLVING LINE OF CREDIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Long-termDebt" xlink:title="00000015 - Disclosure - LONG-TERM DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShare" xlink:title="00000017 - Disclosure - EARNINGS PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales" xlink:title="00000018 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognitionTables" xlink:title="00000022 - Disclosure - REVENUE RECOGNITION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensationTables" xlink:title="00000023 - Disclosure - STOCK-BASED COMPENSATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:title="00000025 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpensesTables" xlink:title="00000026 - Disclosure - ACCRUED EXPENSES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxesTables" xlink:title="00000027 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShareTables" xlink:title="00000028 - Disclosure - EARNINGS PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables" xlink:title="00000029 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:title="00000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails" xlink:title="00000032 - Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognitionDetailsNarrative" xlink:title="00000033 - Disclosure - REVENUE RECOGNITION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:title="00000034 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:title="00000035 - Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="00000036 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/InventoriesDetails" xlink:title="00000037 - Disclosure - INVENTORIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:title="00000038 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000039 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpensesDetails" xlink:title="00000040 - Disclosure - ACCRUED EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaapProductWarrantyAccrual" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapProductWarrantyAccrual" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrentAndNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative" xlink:title="00000041 - Disclosure - REVOLVING LINE OF CREDIT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Long-termDebtDetailsNarrative" xlink:title="00000042 - Disclosure - LONG-TERM DEBT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails" xlink:title="00000043 - Disclosure - INCOME TAXES - Income tax reconciliation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:title="00000044 - Disclosure - INCOME TAXES - Current and deferred tax expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:title="00000045 - Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:title="00000046 - Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:title="00000047 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:title="00000048 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>sotk-20230228_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sono-tek.com/role/Cover" xlink:href="sotk-20230228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheets" xlink:href="sotk-20230228.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="sotk-20230228.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfIncome" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BusinessDescription" xlink:href="sotk-20230228.xsd#BusinessDescription" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPolicies" xlink:href="sotk-20230228.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognition" xlink:href="sotk-20230228.xsd#RevenueRecognition" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation" xlink:href="sotk-20230228.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Inventories" xlink:href="sotk-20230228.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpenses" xlink:href="sotk-20230228.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevolvingLineOfCredit" xlink:href="sotk-20230228.xsd#RevolvingLineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Long-termDebt" xlink:href="sotk-20230228.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes" xlink:href="sotk-20230228.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShare" xlink:href="sotk-20230228.xsd#EarningsPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSales" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CommitmentsAndContingencies" xlink:href="sotk-20230228.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesPolicies" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesTables" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognitionTables" xlink:href="sotk-20230228.xsd#RevenueRecognitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensationTables" xlink:href="sotk-20230228.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/InventoriesTables" xlink:href="sotk-20230228.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpensesTables" xlink:href="sotk-20230228.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxesTables" xlink:href="sotk-20230228.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShareTables" xlink:href="sotk-20230228.xsd#EarningsPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSalesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:href="sotk-20230228.xsd#SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails" xlink:href="sotk-20230228.xsd#RevenueRecognition-SalesRevenueByProductLineDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognitionDetailsNarrative" xlink:href="sotk-20230228.xsd#RevenueRecognitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:href="sotk-20230228.xsd#Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:href="sotk-20230228.xsd#Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="sotk-20230228.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/InventoriesDetails" xlink:href="sotk-20230228.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpensesDetails" xlink:href="sotk-20230228.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative" xlink:href="sotk-20230228.xsd#RevolvingLineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Long-termDebtDetailsNarrative" xlink:href="sotk-20230228.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-IncomeTaxReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="sotk-20230228.xsd#EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" xlink:label="loc_sotkStockIssuedDuringPeriodSharesCashlessExerciseStockOptions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_sotkStockIssuedDuringPeriodSharesCashlessExerciseStockOptions_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ProceedsFromExerciseOfStockOptionsShares" xlink:label="loc_sotkProceedsFromExerciseOfStockOptionsShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_sotkProceedsFromExerciseOfStockOptionsShares_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_50" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BusinessDescription" xlink:title="00000007 - Disclosure - BUSINESS DESCRIPTION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognition" xlink:title="00000009 - Disclosure - REVENUE RECOGNITION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation" xlink:title="00000010 - Disclosure - STOCK-BASED COMPENSATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Inventories" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:title="00000012 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - ACCRUED EXPENSES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevolvingLineOfCredit" xlink:title="00000014 - Disclosure - REVOLVING LINE OF CREDIT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Long-termDebt" xlink:title="00000015 - Disclosure - LONG-TERM DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShare" xlink:title="00000017 - Disclosure - EARNINGS PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales" xlink:title="00000018 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognitionTables" xlink:title="00000022 - Disclosure - REVENUE RECOGNITION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensationTables" xlink:title="00000023 - Disclosure - STOCK-BASED COMPENSATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:title="00000025 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpensesTables" xlink:title="00000026 - Disclosure - ACCRUED EXPENSES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxesTables" xlink:title="00000027 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShareTables" xlink:title="00000028 - Disclosure - EARNINGS PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables" xlink:title="00000029 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:title="00000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsCurrent" xlink:label="loc_us-gaapLiabilityForUncertainTaxPositionsCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilityForUncertainTaxPositionsCurrent_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EquipmentAndFurnishingsMember" xlink:label="loc_sotkEquipmentAndFurnishingsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_sotkEquipmentAndFurnishingsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdvertisingExpense_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashUninsuredAmount_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land" xlink:label="loc_us-gaapLand_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLand_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails" xlink:title="00000032 - Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_FluxingSystemsMember" xlink:label="loc_sotkFluxingSystemsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkFluxingSystemsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_IntegratedCoatingSystemsMember" xlink:label="loc_sotkIntegratedCoatingSystemsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkIntegratedCoatingSystemsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_MultiAxisCoatingSystemsMember" xlink:label="loc_sotkMultiAxisCoatingSystemsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkMultiAxisCoatingSystemsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_OemSystemsMember" xlink:label="loc_sotkOemSystemsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkOemSystemsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_OtherProductLineMember" xlink:label="loc_sotkOtherProductLineMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkOtherProductLineMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ProductLineMember" xlink:label="loc_sotkProductLineMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkProductLineMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_SalesRevenuePercent" xlink:label="loc_sotkSalesRevenuePercent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_sotkSalesRevenuePercent_130" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognitionDetailsNarrative" xlink:title="00000033 - Disclosure - REVENUE RECOGNITION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:title="00000034 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:title="00000035 - Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="00000036 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TwoThousandThirteenStockIncentivePlanMember" xlink:label="loc_sotkTwoThousandThirteenStockIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_sotkTwoThousandThirteenStockIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_NonEmployeeDirectorsStockOptionMember" xlink:label="loc_sotkNonEmployeeDirectorsStockOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_sotkNonEmployeeDirectorsStockOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EmployeesAndDirectorsMember" xlink:label="loc_sotkEmployeesAndDirectorsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_sotkEmployeesAndDirectorsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_160" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/InventoriesDetails" xlink:title="00000037 - Disclosure - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:title="00000038 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_LaboratoryEquipmentMember" xlink:label="loc_sotkLaboratoryEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_sotkLaboratoryEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TradeshowAndDemonstrationEquipmentMember" xlink:label="loc_sotkTradeshowAndDemonstrationEquipmentMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_sotkTradeshowAndDemonstrationEquipmentMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000039 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpensesDetails" xlink:title="00000040 - Disclosure - ACCRUED EXPENSES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative" xlink:title="00000041 - Disclosure - REVOLVING LINE OF CREDIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaapLetterOfCreditMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapLetterOfCreditMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" xlink:label="loc_sotkCreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_sotkCreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Long-termDebtDetailsNarrative" xlink:title="00000042 - Disclosure - LONG-TERM DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails" xlink:title="00000043 - Disclosure - INCOME TAXES - Income tax reconciliation (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:title="00000044 - Disclosure - INCOME TAXES - Current and deferred tax expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:title="00000045 - Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:title="00000046 - Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:title="00000047 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember" xlink:label="loc_srtAsiaPacificMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaPacificMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MiddleEastMember" xlink:label="loc_us-gaapMiddleEastMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapMiddleEastMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember" xlink:label="loc_srtLatinAmericaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtLatinAmericaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:title="00000048 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ForeignCustomersMember" xlink:label="loc_sotkForeignCustomersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_sotkForeignCustomersMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TwoCustomersMember" xlink:label="loc_sotkTwoCustomersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_sotkTwoCustomersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ThreeCustomersMember" xlink:label="loc_sotkThreeCustomersMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_sotkThreeCustomersMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapRevenues_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_SalesRevenuePercent" xlink:label="loc_sotkSalesRevenuePercent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_sotkSalesRevenuePercent_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_70" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>sotk-20230228_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EquipmentAndFurnishingsMember" xlink:label="sotk_EquipmentAndFurnishingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_EquipmentAndFurnishingsMember" xlink:to="sotk_EquipmentAndFurnishingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_EquipmentAndFurnishingsMember_lbl" xml:lang="en-US">Equipment and Furnishings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_FluxingSystemsMember" xlink:label="sotk_FluxingSystemsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_FluxingSystemsMember" xlink:to="sotk_FluxingSystemsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_FluxingSystemsMember_lbl" xml:lang="en-US">Fluxing Systems [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_IntegratedCoatingSystemsMember" xlink:label="sotk_IntegratedCoatingSystemsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_IntegratedCoatingSystemsMember" xlink:to="sotk_IntegratedCoatingSystemsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_IntegratedCoatingSystemsMember_lbl" xml:lang="en-US">Integrated Coating Systems [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_MultiAxisCoatingSystemsMember" xlink:label="sotk_MultiAxisCoatingSystemsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_MultiAxisCoatingSystemsMember" xlink:to="sotk_MultiAxisCoatingSystemsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_MultiAxisCoatingSystemsMember_lbl" xml:lang="en-US">Multi Axis Coating Systems [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_OemSystemsMember" xlink:label="sotk_OemSystemsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_OemSystemsMember" xlink:to="sotk_OemSystemsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_OemSystemsMember_lbl" xml:lang="en-US">Oem Systems [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_OtherProductLineMember" xlink:label="sotk_OtherProductLineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_OtherProductLineMember" xlink:to="sotk_OtherProductLineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_OtherProductLineMember_lbl" xml:lang="en-US">Other Product Line [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ProductLineMember" xlink:label="sotk_ProductLineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ProductLineMember" xlink:to="sotk_ProductLineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_ProductLineMember_lbl" xml:lang="en-US">Total Product Line</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TwoThousandThirteenStockIncentivePlanMember" xlink:label="sotk_TwoThousandThirteenStockIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_TwoThousandThirteenStockIncentivePlanMember" xlink:to="sotk_TwoThousandThirteenStockIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_TwoThousandThirteenStockIncentivePlanMember_lbl" xml:lang="en-US">the "2013 Plan"</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_NonEmployeeDirectorsStockOptionMember" xlink:label="sotk_NonEmployeeDirectorsStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_NonEmployeeDirectorsStockOptionMember" xlink:to="sotk_NonEmployeeDirectorsStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_NonEmployeeDirectorsStockOptionMember_lbl" xml:lang="en-US">Non-Employee Directors</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EmployeesAndDirectorsMember" xlink:label="sotk_EmployeesAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_EmployeesAndDirectorsMember" xlink:to="sotk_EmployeesAndDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_EmployeesAndDirectorsMember_lbl" xml:lang="en-US">Employee and Directors</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_LaboratoryEquipmentMember" xlink:label="sotk_LaboratoryEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_LaboratoryEquipmentMember" xlink:to="sotk_LaboratoryEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_LaboratoryEquipmentMember_lbl" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TradeshowAndDemonstrationEquipmentMember" xlink:label="sotk_TradeshowAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_TradeshowAndDemonstrationEquipmentMember" xlink:to="sotk_TradeshowAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_TradeshowAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Tradeshow And Demonstration Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US">Credit Facility [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LetterOfCreditMember_lbl" xml:lang="en-US">Letter of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="us-gaap_UnsecuredDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtMember" xlink:to="us-gaap_UnsecuredDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebtMember_lbl" xml:lang="en-US">Unsecured Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember" xlink:label="srt_AsiaPacificMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaPacificMember" xlink:to="srt_AsiaPacificMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaPacificMember_lbl" xml:lang="en-US">Asia Pacific [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MiddleEastMember" xlink:label="us-gaap_MiddleEastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MiddleEastMember" xlink:to="us-gaap_MiddleEastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MiddleEastMember_lbl" xml:lang="en-US">Middle East [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember" xlink:label="srt_LatinAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LatinAmericaMember" xlink:to="srt_LatinAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LatinAmericaMember_lbl" xml:lang="en-US">Latin America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ForeignCustomersMember" xlink:label="sotk_ForeignCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ForeignCustomersMember" xlink:to="sotk_ForeignCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_ForeignCustomersMember_lbl" xml:lang="en-US">Foreign Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TwoCustomersMember" xlink:label="sotk_TwoCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_TwoCustomersMember" xlink:to="sotk_TwoCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_TwoCustomersMember_lbl" xml:lang="en-US">Two Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ThreeCustomersMember" xlink:label="sotk_ThreeCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ThreeCustomersMember" xlink:to="sotk_ThreeCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_ThreeCustomersMember_lbl" xml:lang="en-US">Three Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US">Marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable (less allowance of $12,225 and 56,123, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land" xlink:label="us-gaap_Land" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Land" xlink:to="us-gaap_Land_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Land_lbl" xml:lang="en-US">Land</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" xlink:label="sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" xlink:to="sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet_lbl" xml:lang="en-US">Buildings, equipment, furnishings and leasehold improvements, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CustomerDeposits" xlink:label="sotk_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_CustomerDeposits" xlink:to="sotk_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 13)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.01 par value; 25,000,000 shares authorized, 15,742,073 and 15,729,175 issued and outstanding as February 28, 2023, and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, issued shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, outstanding shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Net Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of Goods Sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and product development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Marketing and selling</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income (Expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Interest and Dividend Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Net unrealized loss on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan" xlink:label="sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan" xlink:to="sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan_lbl" xml:lang="en-US">Paycheck Protection Program Loan Forgiveness</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Income before Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income Tax Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Shares &#8211; Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Shares &#8211; Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance - February 28, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Cashless exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" xlink:label="sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" xlink:to="sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions_lbl" xml:lang="en-US">Cashless exercise of stock options (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ProceedsFromExerciseOfStockOptionsShares" xlink:label="sotk_ProceedsFromExerciseOfStockOptionsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ProceedsFromExerciseOfStockOptionsShares" xlink:to="sotk_ProceedsFromExerciseOfStockOptionsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_ProceedsFromExerciseOfStockOptionsShares_lbl" xml:lang="en-US">Proceeds from exercise of stock options (shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance - February 28, 2023</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_AccountsReceivableReserve" xlink:label="sotk_AccountsReceivableReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_AccountsReceivableReserve" xlink:to="sotk_AccountsReceivableReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="sotk_AccountsReceivableReserve_lbl" xml:lang="en-US">Accounts receivable reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryLIFOReservePeriodCharge" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge_lbl" xml:lang="en-US">Inventory reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_PaycheckProtectionProgramLoanForgiveness" xlink:label="sotk_PaycheckProtectionProgramLoanForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_PaycheckProtectionProgramLoanForgiveness" xlink:to="sotk_PaycheckProtectionProgramLoanForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="sotk_PaycheckProtectionProgramLoanForgiveness_lbl" xml:lang="en-US">Paycheck Protection Program Loan Forgiveness</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_2_lbl" xml:lang="en-US">Unrealized loss on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) Decrease in:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">(Decrease) Increase in:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_IncreaseDecreaseInCustomerDeposit" xlink:label="sotk_IncreaseDecreaseInCustomerDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_IncreaseDecreaseInCustomerDeposit" xlink:to="sotk_IncreaseDecreaseInCustomerDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="sotk_IncreaseDecreaseInCustomerDeposit_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of equipment, furnishings and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US">Purchase of marketable securities, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net Cash Used In Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net Cash Provided By Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">End of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Disclosure:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">BUSINESS DESCRIPTION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">REVENUE RECOGNITION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_lbl" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCRUED EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">REVOLVING LINE OF CREDIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">LONG-TERM DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">EARNINGS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">CUSTOMER CONCENTRATIONS AND FOREIGN SALES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" xlink:label="sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" xlink:to="sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock_lbl" xml:lang="en-US">Equipment, Furnishings and Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Land and Buildings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Management Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="us-gaap_StandardProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyPolicy" xlink:to="us-gaap_StandardProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyPolicy_lbl" xml:lang="en-US">Product Warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Product Development Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_UncertaintiesPolicyTextBlock" xlink:label="sotk_UncertaintiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_UncertaintiesPolicyTextBlock" xlink:to="sotk_UncertaintiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_UncertaintiesPolicyTextBlock_lbl" xml:lang="en-US">Uncertainties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Significant accounting policies - fair values of financial assets of the company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_lbl" xml:lang="en-US">Revenue recognition - sales revenue by product line</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Stock-based compensation - summary of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Stock-based compensation - weighted-average black-scholes assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Buildings, equipment, furnishings and leasehold improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Income taxes - income tax reconciliation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Income taxes - current and deferred tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Income taxes - deferred tax asset and liability components</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Earnings per share - the computation of basic and diluted earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedule of customer concentrations and foreign sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="srt_PlatformOperatorCryptoAssetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetTable" xlink:to="srt_PlatformOperatorCryptoAssetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetTable_lbl" xml:lang="en-US">Platform Operator, Crypto-Asset [Table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_MarketableSecuritiesCurrent_2_lbl" xml:lang="en-US">Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsCurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsCurrent" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsCurrent_lbl" xml:lang="en-US">Uncertain tax positions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Useful life of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">Annual amortization expense this year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">Annual amortization expense year two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">Annual amortization expense year three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">Annual amortization expense year four</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">Annual amortization expense year five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US">Impairment losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashUninsuredAmount_lbl" xml:lang="en-US">Cash in excess of the FDIC insured limit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xml:lang="en-US">Estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Sales revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_SalesRevenuePercent" xlink:label="sotk_SalesRevenuePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_SalesRevenuePercent" xlink:to="sotk_SalesRevenuePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_SalesRevenuePercent_lbl" xml:lang="en-US">Sales revenue, percent</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CashDeposits" xlink:label="sotk_CashDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_CashDeposits" xlink:to="sotk_CashDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_CashDeposits_lbl" xml:lang="en-US">Cash deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Letter of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:label="us-gaap_LineOfCreditFacilityCollateralFeesAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:to="us-gaap_LineOfCreditFacilityCollateralFeesAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCollateralFeesAmount_lbl" xml:lang="en-US">Line of credit collateral amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Stock Options outstanding at beginning of period (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Stock Options exercisable at beginning of period (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average outstanding at beginning of period (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average exercisable at beginning of period (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining term outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Cancelled (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Stock Options outstanding at end of period (in shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Stock Options exercisable at end of period (in shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average outstanding at end of period (in dollars per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average exercisable at end of period (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Number of shares available for purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Options, expiration period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Options outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Options granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Options, exercisable price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Options, vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average grant date fair value, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Compensation expense not yet recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Compensation expense, period for recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options cancelled in settlement of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials and subassemblies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in process</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryGross" xlink:label="us-gaap_InventoryGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Totals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Equipment, furnishings and leasehold improvements, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="us-gaap_ProductWarrantyAccrual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrual" xlink:to="us-gaap_ProductWarrantyAccrual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrual_lbl" xml:lang="en-US">Estimated warranty costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued commissions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Other accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Revolving line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" xlink:label="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" xlink:to="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_lbl" xml:lang="en-US">Credit line utilized to collateralize letter of credit issued to customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xml:lang="en-US">Unused portion of credit line</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xml:lang="en-US">Gain on forgiveness of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Expected federal income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State tax, net of federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xml:lang="en-US">Research and development tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Current:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Total current income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Total deferred income tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Allowance for inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CapitalizedRdExpensesIrcSection174" xlink:label="sotk_CapitalizedRdExpensesIrcSection174" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_CapitalizedRdExpensesIrcSection174" xlink:to="sotk_CapitalizedRdExpensesIrcSection174_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_CapitalizedRdExpensesIrcSection174_lbl" xml:lang="en-US">Capitalized R&amp;D expenses &#8211; IRC Section 174</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl" xml:lang="en-US">Accrued expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset &#8211; Long Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Building and leasehold depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liability &#8211; Long Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Numerator for basic and diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Denominator for basic earnings per share - weighted average</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="us-gaap_DilutiveSecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_DilutiveSecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecuritiesAbstract_lbl" xml:lang="en-US">Effects of dilutive securities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Stock options for employees, directors and outside consultants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic Earnings Per Share &#8211; Weighted Average</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted Earnings Per Share &#8211; Weighted Average</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Total sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Outstanding accounts receivables, percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_EquipmentAndFurnishingsMember" xlink:to="sotk_EquipmentAndFurnishingsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_EquipmentAndFurnishingsMember_doc" xml:lang="en-US">Equipment and Furnishings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_FluxingSystemsMember" xlink:to="sotk_FluxingSystemsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_FluxingSystemsMember_doc" xml:lang="en-US">Fluxing Systems</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_SalesRevenuePercent" xlink:to="sotk_SalesRevenuePercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_SalesRevenuePercent_doc" xml:lang="en-US">Percent of Sales Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_IntegratedCoatingSystemsMember" xlink:to="sotk_IntegratedCoatingSystemsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_IntegratedCoatingSystemsMember_doc" xml:lang="en-US">Integrated Coating Systems</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_MultiAxisCoatingSystemsMember" xlink:to="sotk_MultiAxisCoatingSystemsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_MultiAxisCoatingSystemsMember_doc" xml:lang="en-US">Multi Axis Coating Systems</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_OemSystemsMember" xlink:to="sotk_OemSystemsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_OemSystemsMember_doc" xml:lang="en-US">OEM Systems</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_OtherProductLineMember" xlink:to="sotk_OtherProductLineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_OtherProductLineMember_doc" xml:lang="en-US">Other Product Line</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ProductLineMember" xlink:to="sotk_ProductLineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_ProductLineMember_doc" xml:lang="en-US">Total Product Line</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_TwoThousandThirteenStockIncentivePlanMember" xlink:to="sotk_TwoThousandThirteenStockIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_TwoThousandThirteenStockIncentivePlanMember_doc" xml:lang="en-US">the "2013 Plan"</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_NonEmployeeDirectorsStockOptionMember" xlink:to="sotk_NonEmployeeDirectorsStockOptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_NonEmployeeDirectorsStockOptionMember_doc" xml:lang="en-US">Non-Employee Directors</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_EmployeesAndDirectorsMember" xlink:to="sotk_EmployeesAndDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_EmployeesAndDirectorsMember_doc" xml:lang="en-US">Employee and Directors</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_LaboratoryEquipmentMember" xlink:to="sotk_LaboratoryEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_LaboratoryEquipmentMember_doc" xml:lang="en-US">Laboratory Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_TradeshowAndDemonstrationEquipmentMember" xlink:to="sotk_TradeshowAndDemonstrationEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_TradeshowAndDemonstrationEquipmentMember_doc" xml:lang="en-US">Trade Show and Demonstration Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" xlink:to="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_doc" xml:lang="en-US">Amount borrowed under the credit facility being utilized to collateralize letters of credit issued to customers for cash deposits on existing orders during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ForeignCustomersMember" xlink:to="sotk_ForeignCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_ForeignCustomersMember_doc" xml:lang="en-US">Foreign Customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_TwoCustomersMember" xlink:to="sotk_TwoCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_TwoCustomersMember_doc" xml:lang="en-US">Two Customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ThreeCustomersMember" xlink:to="sotk_ThreeCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_ThreeCustomersMember_doc" xml:lang="en-US">Three Customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_ProceedsFromExerciseOfStockOptionsShares" xlink:to="sotk_ProceedsFromExerciseOfStockOptionsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sotk_ProceedsFromExerciseOfStockOptionsShares_doc" xml:lang="en-US">Number of shares issued as a result of exercise of stock options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_2_lbl" xml:lang="en-US">Stock or Unit Option Plan Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_AccountsReceivableReserve" xlink:to="sotk_AccountsReceivableReserve_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_AccountsReceivableReserve_2_lbl" xml:lang="en-US">AccountsReceivableReserve</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_PaycheckProtectionProgramLoanForgiveness" xlink:to="sotk_PaycheckProtectionProgramLoanForgiveness_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_PaycheckProtectionProgramLoanForgiveness_2_lbl" xml:lang="en-US">PaycheckProtectionProgramLoanForgiveness</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sotk_IncreaseDecreaseInCustomerDeposit" xlink:to="sotk_IncreaseDecreaseInCustomerDeposit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sotk_IncreaseDecreaseInCustomerDeposit_2_lbl" xml:lang="en-US">IncreaseDecreaseInCustomerDeposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedTaxesPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_2_lbl" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>sotk-20230228_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sono-tek.com/role/Cover" xlink:href="sotk-20230228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheets" xlink:href="sotk-20230228.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="sotk-20230228.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfIncome" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="sotk-20230228.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BusinessDescription" xlink:href="sotk-20230228.xsd#BusinessDescription" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPolicies" xlink:href="sotk-20230228.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognition" xlink:href="sotk-20230228.xsd#RevenueRecognition" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation" xlink:href="sotk-20230228.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Inventories" xlink:href="sotk-20230228.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpenses" xlink:href="sotk-20230228.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevolvingLineOfCredit" xlink:href="sotk-20230228.xsd#RevolvingLineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Long-termDebt" xlink:href="sotk-20230228.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes" xlink:href="sotk-20230228.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShare" xlink:href="sotk-20230228.xsd#EarningsPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSales" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CommitmentsAndContingencies" xlink:href="sotk-20230228.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesPolicies" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesTables" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognitionTables" xlink:href="sotk-20230228.xsd#RevenueRecognitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensationTables" xlink:href="sotk-20230228.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/InventoriesTables" xlink:href="sotk-20230228.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpensesTables" xlink:href="sotk-20230228.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxesTables" xlink:href="sotk-20230228.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShareTables" xlink:href="sotk-20230228.xsd#EarningsPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSalesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:href="sotk-20230228.xsd#SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="sotk-20230228.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails" xlink:href="sotk-20230228.xsd#RevenueRecognition-SalesRevenueByProductLineDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevenueRecognitionDetailsNarrative" xlink:href="sotk-20230228.xsd#RevenueRecognitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:href="sotk-20230228.xsd#Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:href="sotk-20230228.xsd#Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="sotk-20230228.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/InventoriesDetails" xlink:href="sotk-20230228.xsd#InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:href="sotk-20230228.xsd#BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/AccruedExpensesDetails" xlink:href="sotk-20230228.xsd#AccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative" xlink:href="sotk-20230228.xsd#RevolvingLineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/Long-termDebtDetailsNarrative" xlink:href="sotk-20230228.xsd#Long-termDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-IncomeTaxReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:href="sotk-20230228.xsd#IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="sotk-20230228.xsd#EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:href="sotk-20230228.xsd#CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land" xlink:label="loc_us-gaapLand" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" xlink:label="loc_sotkBuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_sotkBuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet" xlink:label="loc_us-gaapDeferredIncomeTaxAssetsNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CustomerDeposits" xlink:label="loc_sotkCustomerDeposits" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_sotkCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan" xlink:label="loc_sotkGainFromForgivenessOfPaycheckProtectionProgramLoan" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_sotkGainFromForgivenessOfPaycheckProtectionProgramLoan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions" xlink:label="loc_sotkStockIssuedDuringPeriodSharesCashlessExerciseStockOptions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_sotkStockIssuedDuringPeriodSharesCashlessExerciseStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ProceedsFromExerciseOfStockOptionsShares" xlink:label="loc_sotkProceedsFromExerciseOfStockOptionsShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_sotkProceedsFromExerciseOfStockOptionsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_AccountsReceivableReserve" xlink:label="loc_sotkAccountsReceivableReserve" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_sotkAccountsReceivableReserve" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryLIFOReservePeriodCharge" xlink:label="loc_us-gaapInventoryLIFOReservePeriodCharge" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryLIFOReservePeriodCharge" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_PaycheckProtectionProgramLoanForgiveness" xlink:label="loc_sotkPaycheckProtectionProgramLoanForgiveness" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_sotkPaycheckProtectionProgramLoanForgiveness" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_IncreaseDecreaseInCustomerDeposit" xlink:label="loc_sotkIncreaseDecreaseInCustomerDeposit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_sotkIncreaseDecreaseInCustomerDeposit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaapPaymentsToAcquireMarketableSecurities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireMarketableSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaapCashAndCashEquivalentsAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BusinessDescription" xlink:title="00000007 - Disclosure - BUSINESS DESCRIPTION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognition" xlink:title="00000009 - Disclosure - REVENUE RECOGNITION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation" xlink:title="00000010 - Disclosure - STOCK-BASED COMPENSATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Inventories" xlink:title="00000011 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements" xlink:title="00000012 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - ACCRUED EXPENSES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevolvingLineOfCredit" xlink:title="00000014 - Disclosure - REVOLVING LINE OF CREDIT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Long-termDebt" xlink:title="00000015 - Disclosure - LONG-TERM DEBT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShare" xlink:title="00000017 - Disclosure - EARNINGS PER SHARE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales" xlink:title="00000018 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" xlink:label="loc_sotkEquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_sotkEquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaapStandardProductWarrantyPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_UncertaintiesPolicyTextBlock" xlink:label="loc_sotkUncertaintiesPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_sotkUncertaintiesPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognitionTables" xlink:title="00000022 - Disclosure - REVENUE RECOGNITION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensationTables" xlink:title="00000023 - Disclosure - STOCK-BASED COMPENSATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables" xlink:title="00000025 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpensesTables" xlink:title="00000026 - Disclosure - ACCRUED EXPENSES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxesTables" xlink:title="00000027 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShareTables" xlink:title="00000028 - Disclosure - EARNINGS PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables" xlink:title="00000029 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails" xlink:title="00000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsCurrent" xlink:label="loc_us-gaapLiabilityForUncertainTaxPositionsCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilityForUncertainTaxPositionsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EquipmentAndFurnishingsMember" xlink:label="loc_sotkEquipmentAndFurnishingsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_sotkEquipmentAndFurnishingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashUninsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land" xlink:label="loc_us-gaapLand" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails" xlink:title="00000032 - Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_FluxingSystemsMember" xlink:label="loc_sotkFluxingSystemsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkFluxingSystemsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_IntegratedCoatingSystemsMember" xlink:label="loc_sotkIntegratedCoatingSystemsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkIntegratedCoatingSystemsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_MultiAxisCoatingSystemsMember" xlink:label="loc_sotkMultiAxisCoatingSystemsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkMultiAxisCoatingSystemsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_OemSystemsMember" xlink:label="loc_sotkOemSystemsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkOemSystemsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_OtherProductLineMember" xlink:label="loc_sotkOtherProductLineMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkOtherProductLineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ProductLineMember" xlink:label="loc_sotkProductLineMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_sotkProductLineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_SalesRevenuePercent" xlink:label="loc_sotkSalesRevenuePercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_sotkSalesRevenuePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevenueRecognitionDetailsNarrative" xlink:title="00000033 - Disclosure - REVENUE RECOGNITION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CashDeposits" xlink:label="loc_sotkCashDeposits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_sotkCashDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCollateralFeesAmount" xlink:label="loc_us-gaapLineOfCreditFacilityCollateralFeesAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityCollateralFeesAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails" xlink:title="00000034 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails" xlink:title="00000035 - Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="00000036 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TwoThousandThirteenStockIncentivePlanMember" xlink:label="loc_sotkTwoThousandThirteenStockIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_sotkTwoThousandThirteenStockIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_NonEmployeeDirectorsStockOptionMember" xlink:label="loc_sotkNonEmployeeDirectorsStockOptionMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_sotkNonEmployeeDirectorsStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_EmployeesAndDirectorsMember" xlink:label="loc_sotkEmployeesAndDirectorsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_sotkEmployeesAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/InventoriesDetails" xlink:title="00000037 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails" xlink:title="00000038 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_LaboratoryEquipmentMember" xlink:label="loc_sotkLaboratoryEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_sotkLaboratoryEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TradeshowAndDemonstrationEquipmentMember" xlink:label="loc_sotkTradeshowAndDemonstrationEquipmentMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_sotkTradeshowAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative" xlink:title="00000039 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/AccruedExpensesDetails" xlink:title="00000040 - Disclosure - ACCRUED EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaapProductWarrantyAccrual" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapProductWarrantyAccrual" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative" xlink:title="00000041 - Disclosure - REVOLVING LINE OF CREDIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaapLetterOfCreditMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_us-gaapLetterOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" xlink:label="loc_sotkCreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_sotkCreditLineUtilizedForCollateralizeLettersOfCreditToCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/Long-termDebtDetailsNarrative" xlink:title="00000042 - Disclosure - LONG-TERM DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails" xlink:title="00000043 - Disclosure - INCOME TAXES - Income tax reconciliation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails" xlink:title="00000044 - Disclosure - INCOME TAXES - Current and deferred tax expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails" xlink:title="00000045 - Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_CapitalizedRdExpensesIrcSection174" xlink:label="loc_sotkCapitalizedRdExpensesIrcSection174" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_sotkCapitalizedRdExpensesIrcSection174" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:title="00000046 - Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:label="loc_us-gaapDilutiveSecuritiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapDilutiveSecuritiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails" xlink:title="00000047 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember" xlink:label="loc_srtAsiaPacificMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaPacificMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MiddleEastMember" xlink:label="loc_us-gaapMiddleEastMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_us-gaapMiddleEastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember" xlink:label="loc_srtLatinAmericaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtLatinAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative" xlink:title="00000048 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ForeignCustomersMember" xlink:label="loc_sotkForeignCustomersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_sotkForeignCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_TwoCustomersMember" xlink:label="loc_sotkTwoCustomersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_sotkTwoCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_ThreeCustomersMember" xlink:label="loc_sotkThreeCustomersMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_sotkThreeCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="sotk-20230228.xsd#sotk_SalesRevenuePercent" xlink:label="loc_sotkSalesRevenuePercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_sotkSalesRevenuePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379194896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>May 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 28,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--02-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-16035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Sono Tek Corp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000806172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">14-1568099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2012 Route 9W<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Milton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">795-2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SOTK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81,462,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,742,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">None.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Marcum LLP<span></span>
</td>
<td class="text">Friedman LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">688<span></span>
</td>
<td class="text">711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">East Hanover, New Jersey<span></span>
</td>
<td class="text">East Hanover, New Jersey<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068380703552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,354,601<span></span>
</td>
<td class="nump">$ 4,840,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">8,090,000<span></span>
</td>
<td class="nump">5,867,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (less allowance of $12,225 and 56,123, respectively)</a></td>
<td class="nump">1,633,866<span></span>
</td>
<td class="nump">1,092,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,242,909<span></span>
</td>
<td class="nump">2,373,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">254,046<span></span>
</td>
<td class="nump">323,304<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">16,575,422<span></span>
</td>
<td class="nump">14,497,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet', window );">Buildings, equipment, furnishings and leasehold improvements, net</a></td>
<td class="nump">2,624,996<span></span>
</td>
<td class="nump">2,561,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">57,202<span></span>
</td>
<td class="nump">76,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">667,098<span></span>
</td>
<td class="nump">240,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">20,174,718<span></span>
</td>
<td class="nump">17,625,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">810,863<span></span>
</td>
<td class="nump">684,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,427,446<span></span>
</td>
<td class="nump">1,804,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">2,838,165<span></span>
</td>
<td class="nump">1,167,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">381,421<span></span>
</td>
<td class="nump">58,874<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,457,895<span></span>
</td>
<td class="nump">3,715,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">82,865<span></span>
</td>
<td class="nump">168,840<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">5,540,760<span></span>
</td>
<td class="nump">3,884,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value; 25,000,000 shares authorized, 15,742,073 and 15,729,175 issued and outstanding as February 28, 2023, and 2022, respectively</a></td>
<td class="nump">157,421<span></span>
</td>
<td class="nump">157,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">9,566,898<span></span>
</td>
<td class="nump">9,310,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated earnings</a></td>
<td class="nump">4,909,639<span></span>
</td>
<td class="nump">4,273,734<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">14,633,958<span></span>
</td>
<td class="nump">13,741,313<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 20,174,718<span></span>
</td>
<td class="nump">$ 17,625,534<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377792528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts receivable</a></td>
<td class="nump">$ 12,225<span></span>
</td>
<td class="nump">$ 56,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued shares</a></td>
<td class="nump">15,742,073<span></span>
</td>
<td class="nump">15,729,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding shares</a></td>
<td class="nump">15,742,073<span></span>
</td>
<td class="nump">15,729,175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379758416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">$ 15,058,203<span></span>
</td>
<td class="nump">$ 17,132,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Goods Sold</a></td>
<td class="nump">7,406,196<span></span>
</td>
<td class="nump">8,520,156<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">7,652,007<span></span>
</td>
<td class="nump">8,612,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and product development</a></td>
<td class="nump">2,149,525<span></span>
</td>
<td class="nump">1,729,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Marketing and selling</a></td>
<td class="nump">3,169,730<span></span>
</td>
<td class="nump">3,367,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,649,761<span></span>
</td>
<td class="nump">1,626,306<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">6,969,016<span></span>
</td>
<td class="nump">6,723,218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income</a></td>
<td class="nump">682,991<span></span>
</td>
<td class="nump">1,889,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and Dividend Income</a></td>
<td class="nump">140,042<span></span>
</td>
<td class="nump">9,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized loss on marketable securities</a></td>
<td class="num">(33,119)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan', window );">Paycheck Protection Program Loan Forgiveness</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,005,372<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income before Income Taxes</a></td>
<td class="nump">789,914<span></span>
</td>
<td class="nump">2,904,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense</a></td>
<td class="nump">154,009<span></span>
</td>
<td class="nump">361,631<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 635,905<span></span>
</td>
<td class="nump">$ 2,542,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Earnings Per Share</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Earnings Per Share</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares &#8211; Basic</a></td>
<td class="nump">15,735,451<span></span>
</td>
<td class="nump">15,586,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares &#8211; Diluted</a></td>
<td class="nump">15,769,499<span></span>
</td>
<td class="nump">15,623,485<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377652352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - February 28, 2022 at Feb. 28, 2021</a></td>
<td class="nump">$ 154,527<span></span>
</td>
<td class="nump">$ 9,064,994<span></span>
</td>
<td class="nump">$ 1,731,161<span></span>
</td>
<td class="nump">$ 10,950,682<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Feb. 28, 2021</a></td>
<td class="nump">15,452,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Cashless exercise of stock options</a></td>
<td class="nump">$ 2,490<span></span>
</td>
<td class="num">(2,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions', window );">Cashless exercise of stock options (shares)</a></td>
<td class="nump">249,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">68,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_ProceedsFromExerciseOfStockOptionsShares', window );">Proceeds from exercise of stock options (shares)</a></td>
<td class="nump">27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,542,573<span></span>
</td>
<td class="nump">2,542,573<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - February 28, 2023 at Feb. 28, 2022</a></td>
<td class="nump">$ 157,292<span></span>
</td>
<td class="nump">9,310,287<span></span>
</td>
<td class="nump">4,273,734<span></span>
</td>
<td class="nump">13,741,313<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Feb. 28, 2022</a></td>
<td class="nump">15,729,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Cashless exercise of stock options</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions', window );">Cashless exercise of stock options (shares)</a></td>
<td class="nump">12,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">635,905<span></span>
</td>
<td class="nump">635,905<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance - February 28, 2023 at Feb. 28, 2023</a></td>
<td class="nump">$ 157,421<span></span>
</td>
<td class="nump">$ 9,566,898<span></span>
</td>
<td class="nump">$ 4,909,639<span></span>
</td>
<td class="nump">$ 14,633,958<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Feb. 28, 2023</a></td>
<td class="nump">15,742,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_ProceedsFromExerciseOfStockOptionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued as a result of exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_ProceedsFromExerciseOfStockOptionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377452048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 635,905<span></span>
</td>
<td class="nump">$ 2,542,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">510,868<span></span>
</td>
<td class="nump">435,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock based compensation expense</a></td>
<td class="nump">256,740<span></span>
</td>
<td class="nump">179,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_AccountsReceivableReserve', window );">Accounts receivable reserve</a></td>
<td class="num">(43,898)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Inventory reserve</a></td>
<td class="nump">4,864<span></span>
</td>
<td class="nump">43,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_PaycheckProtectionProgramLoanForgiveness', window );">Paycheck Protection Program Loan Forgiveness</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,005,372)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized loss on marketable securities</a></td>
<td class="nump">33,119<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax asset, net</a></td>
<td class="num">(512,337)<span></span>
</td>
<td class="num">(17,620)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) Decrease in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(497,463)<span></span>
</td>
<td class="nump">665,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(874,531)<span></span>
</td>
<td class="nump">194,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">69,258<span></span>
</td>
<td class="num">(171,988)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>(Decrease) Increase in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">126,352<span></span>
</td>
<td class="num">(606,241)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(376,582)<span></span>
</td>
<td class="nump">53,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_IncreaseDecreaseInCustomerDeposit', window );">Customer deposits</a></td>
<td class="nump">1,670,197<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">322,547<span></span>
</td>
<td class="nump">5,307<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">1,325,039<span></span>
</td>
<td class="nump">2,319,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment, furnishings and leasehold improvements</a></td>
<td class="num">(555,867)<span></span>
</td>
<td class="num">(326,942)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities, net</a></td>
<td class="num">(2,255,129)<span></span>
</td>
<td class="num">(1,304,520)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used In Investing Activities</a></td>
<td class="num">(2,810,996)<span></span>
</td>
<td class="num">(1,631,462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">68,775<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided By Financing Activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">68,775<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(1,485,957)<span></span>
</td>
<td class="nump">756,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>CASH AND CASH EQUIVALENTS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of year</a></td>
<td class="nump">4,840,558<span></span>
</td>
<td class="nump">4,084,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of year</a></td>
<td class="nump">3,354,601<span></span>
</td>
<td class="nump">4,840,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest Paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income Taxes Paid</a></td>
<td class="nump">$ 363,590<span></span>
</td>
<td class="nump">$ 373,928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_AccountsReceivableReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_AccountsReceivableReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_IncreaseDecreaseInCustomerDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_IncreaseDecreaseInCustomerDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_PaycheckProtectionProgramLoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_PaycheckProtectionProgramLoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068383327504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS DESCRIPTION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">BUSINESS DESCRIPTION</a></td>
<td class="text"><p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zJqva0ih9kT8" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 1: <span id="xdx_821_zYEznXNYoBx1">BUSINESS DESCRIPTION</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Sono-Tek Corporation (the &#8220;Company&#8221;, &#8220;Sono-Tek&#8221;,
&#8220;We&#8221; or &#8220;Our&#8221;) was incorporated in New York on March 21, 1975. We are the world leader in the design and manufacture
of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on
parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research &amp; development/other
markets. We design and manufacture custom-engineered ultrasonic coating systems incorporating our patented technology, in combination
with strong applications engineering knowledge, to assist our customers in achieving their desired coating solutions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068383342384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zxc7AH0IcNog" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 2: <span id="xdx_826_ze2bHIrtG39j">SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_ztIK889gJFO" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86E_zyPQdQSUUMO8">Advertising Expenses</span></i></b><i> - </i>The Company expenses the
cost of advertising in the period in which the advertising takes place. Advertising expense for fiscal 2023 and fiscal 2022 was $<span id="xdx_909_eus-gaap--AdvertisingExpense_c20220301__20230228_pp0p0" title="Advertising expense">297,500</span>
and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_c20210301__20220228_pp0p0" title="Advertising expense">178,500</span>, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zdVbq1h4tR22" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zAzk3cdHk974">Accounts Receivable, net</span> - </i></b>In the normal course of business,
the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value
of receivables and approximate fair value. The Company records a bad debt expense/allowance based on management&#8217;s estimate of uncollectible
accounts. All outstanding accounts receivable accounts are reviewed for collectability on an individual basis.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z076pfobOQ0h" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86A_zZPlbcJPMu0j">Cash and Cash Equivalents</span></i></b><i> - </i>Cash and cash equivalents consist of money market mutual funds, short term commercial paper
and short-term certificates of deposit with original maturities of 90 days or less. At February 28, 2023, the Company had <span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20230228_zBJYVfIDMfnc" title="Cash in excess of the FDIC insured limit">2,892,000</span> of
cash in excess of the FDIC insured limit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zKy5jPPT87l" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_z8mSdoE2VOJ1">Consolidation</span></i></b> - The accompanying consolidated financial
statements of the Company include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (&#8220;SIP&#8221;)
in conformity with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). SIP operates as a real estate holding
company for the Company&#8217;s real estate operations. All intercompany accounts and transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z5QMYx36mYof" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zjVIWjHUTqPl">Earnings Per Share</span></i></b><i> - </i>Basic earnings per share
(&#8220;EPS&#8221;) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted
EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted
into common stock under the treasury stock method.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_848_ecustom--EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock_zDBQyxOP37Jc" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span id="xdx_86C_zu7nVrb9VSNc"><b><i>Equipment,
Furnishings and Leasehold Improvements</i></b></span> - Equipment, furnishings and leasehold improvements are stated at cost. Depreciation
of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which
range from three <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MinimumMember_zEa4tQmNJJ25" style="display: none">3
</span>to five years <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MaximumMember_zODz3BLGnR62" style="display: none" title="Estimated useful lives">5</span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>




<p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOJNu1gdDiDd" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_865_zR9AhMBu2XG7">Fair Value of Financial Instruments</span> -</i></b> The Company applies
Accounting Standards Codification (&#8220;ASC&#8221;) 820,&#160;<i>Fair Value Measurement&#160;</i>(&#8220;ASC 820&#8221;), which establishes
a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an
exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company&#8217;s principal or
most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established
in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring
fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed
based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity&#8217;s own assumptions
based on market data and the entity&#8217;s judgments about the assumptions that market participants would use in pricing the asset or
liability and are to be developed based on the best information available in the circumstances.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The carrying amounts of financial instruments reported in the accompanying
consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term
maturities of the financial instruments.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The valuation hierarchy is composed of three levels. The classification
within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within
the valuation hierarchy are described below:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 1 &#8212; Assets and liabilities with unadjusted, quoted prices
listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets
for identical assets or liabilities.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 2 &#8212; Inputs to the fair value measurement are determined
using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs,
such as interest rates and yield curves that are observable at commonly quoted intervals.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 3 &#8212; Inputs to the fair value measurement are unobservable
inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">The fair values of financial assets of the
Company were determined using the following categories at February 28, 2023 and February 28, 2022, respectively:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z9W5C1Atvvv9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B9_z2EWxR77nGMd" style="display: none">Significant accounting policies - fair values of financial assets of the company</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 1</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 2</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 3</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Total</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2023</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">7,361,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">729,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8212;</span></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">8,090,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2022</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">5,716,338</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">151,652</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8212;</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">5,867,990</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">Marketable Securities include certificates
of deposit and US Treasury securities, totaling $<span id="xdx_90D_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" title="Marketable securities">8,090,000</span> and $<span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" title="Marketable securities">5,867,990</span> that are considered to be highly liquid and easily tradeable
as of February 28, 2023 and February 28, 2022, respectively. US Treasury securities are valued using inputs observable in active markets
for identical securities and are therefore classified as Level&#160;1 and certificates of deposit are classified as Level 2 within the
Company&#8217;s fair value hierarchy. The Company&#8217;s marketable securities are considered to be trading securities as defined under
ASC 320 &#8220;Investments &#8211; Debt and Equity Securities.&#8221;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>




<p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zPcYB0NOuqQg" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_866_z86KLktVApA9">Income Taxes</span></i></b> - The Company accounts for income taxes
under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of "temporary
differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying
amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax
asset will not be realized, a valuation allowance is recognized. The Company uses a recognition threshold and a measurement attribute
for financial statement recognition and measurement of tax positions taken or expected to be taken in a return. For those benefits to
be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. As of February 28,
2023 and February 28, 2022, there were <span id="xdx_90E_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20230228_zaSL115rYzZc" title="Uncertain tax positions"><span id="xdx_901_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20220228_zW9qX9qkcMFk" title="Uncertain tax positions">no</span></span> uncertain tax positions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z6UkSEsuRQCj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zBX8vf7mtbP2">Intangible
Assets</span></i></b><i> - </i>Include costs of patent applications which are deferred and charged to operations over seventeen <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230228_zUdtN3M69Jt" style="display: none" title="Useful life of intangible assets">17</span>
years for domestic patents and <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220228_zYouIz3hltu4" style="display: none" title="Useful life of intangible assets">12</span> twelve years for foreign patents, which is considered the useful life. The accumulated
amortization of patents is $<span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230228_pp0p0" title="Accumulated amortization of patents">202,681</span>
and $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220228_pp0p0" title="Accumulated amortization of patents">192,490</span>
at February 28, 2023 and February 28, 2022, respectively. Annual amortization expense of such intangible assets is expected to be
approximately $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20230228_zxHdm0XiH7t2" title="Annual amortization expense this year"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20230228_zy6RjLyI5bUl" title="Annual amortization expense year two"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20230228_zcwkd9gGjWk9" title="Annual amortization expense year three"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20230228_zozE9sfhoIfj" title="Annual amortization expense year four"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20230228_zZU2wpZwxuVd" title="Annual amortization expense year five">11,000</span></span></span></span></span>
per year for the next five years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zmkyuYg7s9G3" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86E_zBBEbTbjquLg">Inventories</span></i></b><i> - </i>Inventories are stated at the lower
of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress
and the specific identification method for finished goods. Management compares the cost of inventory with the net realizable value and,
if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis,
inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand
and market conditions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7VsoQGl5Vs4" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zCNQ9vneYrwa">Land and Buildings</span> - </i></b>Land and buildings are stated at
cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228_z0jmoiIsj9Yk" style="display: none" title="Estimated useful life">40</span> forty years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">At February 28, 2023 and 2022, the Company had Land, stated at cost of $<span id="xdx_90C_eus-gaap--Land_iI_pp0p0_c20230228_zjmgpsXCaY24" title="Land">250,000</span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zzpIvtRvLyHb" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_znxkHFIK9wDe">Long-Lived Assets</span></i></b><i> - </i>The Company periodically
evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The
carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately
identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value
exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted
at a rate commensurate with the risk involved. <span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220301__20230228_zFxQK6IuMbYc" title="Impairment losses"><span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210301__20220228_z8J444mb3QPd" title="Impairment losses">No</span></span> impairment losses were identified or recorded for the years ended February 28, 2023
and February 28, 2022 on the Company&#8217;s long-lived assets.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84C_eus-gaap--UseOfEstimates_zOpTtxHycy01" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zoN7be49pejc">Management Estimates</span></i></b><i> - </i>The preparation of the
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zPZG0luBwcOe" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zUSjXTGxMbai">New
Accounting Pronouncements </span></i></b>&#8211; In June 2016, the FASB issued ASU 2016-13 - Financial Instruments-Credit
Losses-Measurement of Credit Losses on Financial Instruments. Codification Improvements to Topic 326, Financial Instruments &#8211;
Credit Losses, have been released in November 2018 (2018-19), November 2019 (2019-10 and 2019-11) and a January 2020 Update
(2020-02) that provided additional guidance on this Topic. This guidance replaces the current incurred loss impairment methodology
with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable
information to inform credit loss estimates. For SEC filers meeting certain criteria, the amendments in this ASU are effective for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For SEC filers that meet the
criteria of a smaller reporting company (including this Company) and for non-SEC registrant public companies and other
organizations, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning
after December 15, 2022. Early adoption will be permitted for all organizations for fiscal years, and interim periods within those
fiscal years, beginning after December 15, 2019. The Company has adopted ASU 2016-13 as updated and does not expect the adoption of
this guidance to have a material impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Other than Accounting Standards Update (&#8220;ASU&#8221;) ASU 2016-13 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable
to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>




<p id="xdx_84D_eus-gaap--StandardProductWarrantyPolicy_zhJptZDW8Pvf" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zmlpsxgIaJu7">Product Warranty</span></i></b> - Expected future product warranty expense is recorded when revenue is recognized for product
sales.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhZzJAtMVTv" style="font: 11pt Cambria,serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><b><i><span id="xdx_867_zGz3lzCZGSB5">Reclassifications</span> - </i></b>Building,
equipment, leasehold improvements reclassifications have been made to the fiscal 2022 consolidated financial statements to conform to
the fiscal 2023 consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously
reported.</p>



<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zMGnwl1QLy93" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_z0stfiIeUEd1">Research and Product Development Expenses</span></i></b><i> - </i>Research
and product development expenses represent engineering and other expenditures incurred for developing new products, for refining the Company's
existing products and for developing systems to meet unique customer specifications for potential orders or for new industry applications
and are expensed as incurred.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023 and fiscal 2022, the Company spent approximately
$<span id="xdx_90A_eus-gaap--OtherResearchAndDevelopmentExpense_c20220301__20230228_zviNPQgZkrnj" title="Research and development expenses">2,149,000</span> and $<span id="xdx_906_eus-gaap--OtherResearchAndDevelopmentExpense_c20210301__20220228_zGKjaalDo0wd" title="Research and development expenses">1,730,000</span>, respectively, on research and development activities related to new products and services and the ongoing improvement
of existing products and services.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zBXVmzTPbQ6d" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86B_zxWqMSmHzcX9">Revenue Recognition</span> -</i></b> The Company recognizes
revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should
recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to
which the entity expects to be entitled to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Identification of the contract, or contracts, with a customer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Identification of the performance obligations in the contract</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Determination of the transaction price</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Recognition of revenue when, or as, performance obligations are satisfied</span></td></tr>
  </table>
<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zmkBHO9dWhj6" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zbnfr1OxsiV6">Stock-Based Compensation</span></i></b> - The Company currently uses
a Black-Scholes option pricing model to calculate the fair value of its stock options. The fair value of each option is estimated on the
date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility;
and expected lives of the awards. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes
model. The assumptions used in calculating the fair value of share-based payment awards represent management&#8217;s best estimates, but
these estimates involve inherent uncertainties and the application of management judgment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">ASC 718 requires the recognition of the fair value of stock compensation
expense to be recognized over the vesting term of such award. The Company accounts for forfeitures as they occur.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84A_ecustom--UncertaintiesPolicyTextBlock_z4eTRDL6drs2" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86A_zaWtAF5TttVf">Uncertainties</span> - </i></b>Since early 2020, when the World Health
Organization established the transmissible and pathogenic coronavirus a global pandemic, there have been business slowdowns. The outbreak
of such a communicable disease has resulted in a widespread health crisis which has adversely affected general commercial activity and
the economies and financial markets of many countries, including the United States. As the outbreak of the disease has continued through
fiscal 2022 and into fiscal 2023, the measures taken by the governments of impacted countries have, at times, adversely affected the
Company&#8217;s business, financial condition, and results of operations. Pandemic related supply shortages and increased energy expenses
resulting from the war in Ukraine have recently created worldwide inflationary pressures which may have a material adverse effect on
the Company's business, financial condition, and results of operations if such factors continue unabated.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company has encountered challenges in procuring supplies of various materials and components,
and electronic components in particular, due to well-documented shortages and constraints in the global supply chain. Lead times for ordered
components may vary significantly, and some components used to manufacture our products are provided by a limited number of sources. The
Company experienced lengthened lead times throughout its supply chain as a result of supply chain constraints and material shortages that
have occurred through fiscal year 2023. This has been exacerbated by the recent resurgence of the COVID-19 pandemic in certain parts of
China, which has resulted in the temporary closure of manufacturing facilities, including those that manufacture electronic parts that
the Company includes in its products.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>




<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068380680624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--RevenueFromContractWithCustomerTextBlock_zcbd8sViFNJ8" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 3: <span id="xdx_82C_zu1sV27A9xm9">REVENUE RECOGNITION</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company&#8217;s sales revenue is derived primarily from short
term contracts with customers, which, on average, are in effect for less than twelve months. Sales revenue from manufactured equipment
transferred at a single point in time accounts for a majority of the Company&#8217;s revenue.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Sales revenue is recognized when control of the Company&#8217;s manufactured
equipment is transferred to its customers in an amount that reflects the consideration the Company expects to receive based upon the agreed
transaction price. The Company&#8217;s performance obligations are satisfied when its customers take control of the purchased equipment,
in accordance with the contract terms. Based on prior experience, the Company reasonably estimates its sales returns and warranty reserves.
Sales are presented net of discounts and allowances. Discounts and allowances are determined when a transaction is negotiated. The Company
does not grant its customers or independent representatives the ability to return equipment nor does it grant price adjustments after
a sale is complete.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company does not capitalize any sales commission costs related
to the acquisition of a contract. All commissions related to a performance obligation that are satisfied at a point in time are expensed
when the customer takes control of the purchased equipment and revenue is recognized.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company applies the practical expedient in paragraph ASC 606-10-50-14
and does not disclose information about remaining performance obligations that have original expected durations of one-year or less.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">At February 28, 2023, the Company had received $<span id="xdx_900_ecustom--CashDeposits_iI_pp0p0_c20230228_zQRXA1Ogluob" title="Cash deposits">2,838,000</span> in cash
deposits, representing contract liabilities, and had issued Letters of Credit in the amount of $<span id="xdx_90B_eus-gaap--LineOfCredit_c20230228_pp0p0" title="Letter of credit">145,000</span> to secure these cash deposits.
At February 28, 2023, the Company was utilizing $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20220301__20230228_zA3QWzHJgrgj" title="Line of credit collateral amount">145,000</span> of its available credit line to collateralize these letters of credit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">At February 28, 2022, the Company had received $<span id="xdx_90E_ecustom--CashDeposits_iI_pp0p0_c20220228_zb3HUCxxJt43" title="Cash deposits">1,168,000</span> in cash
deposits, representing contract liabilities, and had issued Letters of Credit in the amount of $<span id="xdx_908_eus-gaap--LineOfCredit_c20220228_pp0p0" title="Letter of credit">5,000</span> to secure these cash deposits. At
February 28, 2022, the Company was utilizing $<span id="xdx_900_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20210301__20220228_zi9Tqg7WTXql" title="Line of credit collateral amount">5,000</span> of its available credit line to collateralize these letters of credit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company&#8217;s sales revenue, by product line is as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zbUbcc6jXoc9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B2_z91GIQ06Awl3" style="display: none">Revenue recognition - sales revenue by product line</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Twelve Months Ended</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center">% of total</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center">% of total</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; text-align: left">Fluxing Systems</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue">1,179,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><span id="xdx_903_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent">8%</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue">691,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent">4%</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Integrated Coating Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">1,114,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_909_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent">7%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">1,182,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent">7%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Multi-Axis Coating Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">6,785,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_907_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent">45%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">9,912,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_905_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent">58%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">OEM Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">2,144,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent">14%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">2,381,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_903_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent">14%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">3,836,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent">26%</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">2,967,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90F_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent">17%</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">15,058,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">17,133,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068383387792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_zw0LNsBVaS2a" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 4: <span id="xdx_820_zCZYFpa6VmI6">STOCK-BASED COMPENSATION</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>Stock Options</i></b> &#8211; Under the 2013 Stock
Incentive Plan, as amended (the "2013 Plan"), options can be granted to officers, directors, consultants and employees of the
Company and its subsidiaries to purchase up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_pdd" title="Number of shares available for purchase">2,500,000</span> shares of the Company's common stock. Under the 2013 Plan options expire ten
years <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20220301__20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_z96DDFnsUmph" style="display: none" title="Options, expiration period">10</span> after the date of grant. As of February 28, 2023, there were <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_pdd" title="Options outstanding">250,759</span> options outstanding under the 2013 plan.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>




<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">Under the 2013 Stock Incentive Plan, option prices must
be at least 100% of the fair market value of the common stock at time of grant. For qualified employees, except under certain circumstances
specified in the plan or unless otherwise specified at the discretion of the Board of Directors, no option may be exercised prior to one
year after date of grant, with the balance becoming exercisable in cumulative installments over a three-year period during the term of
the option and terminating at a stipulated period of time after an employee's termination of employment.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">During fiscal 2023, the Company granted options to
acquire <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" title="Options granted">28,239</span>
shares to employees exercisable at prices ranging from $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_pdd" title="Options, exercisable price">5.45</span>
to $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_pdd" title="Options, exercisable price">5.96</span>
and options to acquire <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options granted">16,500</span>
shares to the non-employee members of the board of directors with an exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options, exercisable price">5.50</span>.
The options granted to employees and directors vest over three years <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zd9cIaMSPa41" style="display: none" title="Options, vesting period">3</span> and expire in ten years <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zoQcTwBf4pJ2" style="display: none" title="Options, expiration period">10</span>.
The options granted by the Company during fiscal 2023 had a combined weighted average grant date fair value of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_pdd" title="Weighted average grant date fair value, per share">3.44</span> per share.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">During fiscal 2022, the Company granted options to
acquire <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" title="Options granted">138,085</span>
shares to employees exercisable at prices ranging from $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_pdd" title="Options, exercisable price">3.19</span>
to $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_pdd" title="Options, exercisable price">6.26</span>
and options to acquire <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options granted">30,250</span>
shares to the non-employee members of the board of directors with an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options, exercisable price">3.19</span>.
The options granted to employees and directors vest over three years <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zzlx2jiT6zq9" style="display: none" title="Options, vesting period">3</span>
and expire in ten years <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zunttfEZwJga" style="display: none" title="Options, expiration period">10</span>. The options granted by the Company during fiscal 2022 had a combined weighted average grant date fair
value of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_pdd" title="Weighted average grant date fair value, per share">2.76</span> per share.</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">A summary of the activity for fiscal 2023 and fiscal 2022 is as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zZkAmVWrdgB6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif"><span id="xdx_8B4_z6I1Bec18f2i" style="display: none">Stock-based compensation - summary of stock options</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Weighted Average</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Stock Options</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercise Price $</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">Remaining</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Outstanding</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercisable</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Outstanding</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercisable</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Term - Years</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 35%">Balance - February 28, 2021</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210301__20220228_zE30H90Femk9" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options outstanding at beginning of period (in shares)">508,459</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20210301__20220228_z4kWatz5zhx1" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options exercisable at beginning of period (in shares)">333,500</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210301__20220228_zJW05n3Vk49d" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)">2.35</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20210301__20220228_z684LR6idVha" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)">2.17</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 9%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200301__20210228_zw79MWxt1hJe" title="Weighted average remaining term outstanding">6.99</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Granted</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)">168,335</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)">5.10</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Exercised</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210301__20220228_zLGT7VHWCAL7" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)">(403,334</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zgqKdd0y3Boi" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)">(2.12</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Cancelled</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20210301__20220228_zKrJjndN7yn7" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)">(19,750</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zvIv8kUPKaW2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)">(3.27</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2022</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220301__20230228_zJ86AJ2Mo11g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at beginning of period (in shares)">253,710</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20220301__20230228_zXRMycy4g36g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at beginning of period (in shares)">61,690</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220301__20230228_z6X2RiH04sG9" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)">4.46</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20220301__20230228_zx24UyvWYxBi" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)">3.53</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210301__20220228_zUAE1Uypk6Ta" title="Weighted average remaining term outstanding">8.94</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Granted</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)">44,739</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)">5.71</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Exercised</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220301__20230228_z5SzFxXaUo7g" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)">(16,973</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zQtD2LTtdTKc" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)">(1.77</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Cancelled</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220301__20230228_zFxx7wlizET1" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)">(30,717</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zTHt9YCvFr81" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)">(4.66</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2023</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220301__20230228_zdBTcJX7oaL5" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at end of period (in shares)">250,759</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220301__20230228_zVAaCqMxpmfb" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at end of period (in shares)">133,609</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220301__20230228_z8TZsHGBm2gf" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at end of period (in dollars per share)">4.84</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220301__20230228_zzj00G6CnJq1" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at end of period (in dollars per share)">4.62</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220301__20230228_zJ5ddbmycB56" title="Weighted average remaining term outstanding">8.52</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zyfTQDE2hqn9" style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The aggregate intrinsic value of the Company&#8217;s vested and exercisable
options at February 28, 2023 was $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20230228_zqSTYPzAxhQ" title="Aggregate intrinsic value of options outstanding">155,077</span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">For the years ended February 28, 2023 and 2022 the Company
recognized $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20220301__20230228_pp0p0" title="Stock-based compensation expense">256,740</span>
and $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20210301__20220228_pp0p0" title="Stock-based compensation expense">179,283</span>
in stock based compensation expense, respectively. Such amounts are included in general and administrative expenses on the
consolidated statements of income. Total compensation expense related to non-vested options not yet recognized as of February 28,
2023 was $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20230228_pp0p0" title="Compensation expense not yet recognized">288,000 </span>and
will be recognized over the next three years <span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220301__20230228_zn67qxfRc9u4" style="display: none" title="Compensation expense, period for recognition">3</span> based on vesting date. The amount of future stock option compensation expense could
be affected by any future option grants or by any forfeitures. During the year ended February 28, 2023, the Company had net
settlement exercises of stock options, whereby, the optionee did not pay cash for the options but instead received the number of
shares equal to the difference between the exercise price and the market price on the date of exercise. Net settlement exercises
during the year ended February 28, 2023 resulted in <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220301__20230228_pdd" title="Options cancelled in settlement of shares issued">12,898</span> shares of common stock issued.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>




<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Determining the appropriate fair value of the stock-based awards requires
the input of subjective assumptions, including the fair value of the Company&#8217;s common stock, and for stock options, the expected
life of the option, and the expected stock price volatility. The Company uses the Black-Scholes option pricing model to value its stock
option awards. The assumptions used in calculating the fair value of stock-based awards represent management&#8217;s best estimates and
involve inherent uncertainties and the application of management&#8217;s judgment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The expected term of the options is estimated based on the Company&#8217;s
historical exercise rate. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued.
For stock price volatility, the Company uses its expected volatility of the price of the Company&#8217;s common stock based on historical
activity. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option at the
grant-date.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">The weighted-average fair value of options has been estimated
on the date of grant using the Black-Scholes options-pricing model. The weighted-average Black-Scholes assumptions are as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zB8iJOzONpQ7" style="width: 100%; border-collapse: collapse; font-size: 11pt" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BC_zEb026tMpqa" style="display: none">Stock-based compensation - weighted-average black-scholes assumptions</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td colspan="4" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Fiscal Year Ended</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February 28, <br/>
2023</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February 28, <br/>
2022</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="width: 61%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Expected life</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 18%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zPCjUX11Hosf" title="Expected life (in years)">5</span> - <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_ztZnKxWTd8g5" title="Expected life (in years)">8</span> years</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="width: 16%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zdaG9Stx5At2" title="Expected life (in years)">5</span> - <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zn0ULfQNqU27" title="Expected life (in years)">8</span> years</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Risk free interest rate</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20220301__20230228_pdd" title="Risk free interest rate, minimum">2.82%</span> - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20220301__20230228_pdd" title="Risk free interest rate, maximum">4.02%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20210301__20220228_pdd" title="Risk free interest rate, minimum">0.78%</span> &#8211; <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20210301__20220228_pdd" title="Risk free interest rate, maximum">2.0%</span></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20220301__20230228_pdd" title="Expected volatility, minimum">55.02%</span> - <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20220301__20230228_pdd" title="Expected volatility, maximum">62.01%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20210301__20220228_pdd" title="Expected volatility, minimum">50.73%</span> - <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20210301__20220228_pdd" title="Expected volatility, maximum">57.13%</span></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Expected dividend yield</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220301__20230228_pdd" title="Expected dividend yield">0%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20210301__20220228_pdd" title="Expected dividend yield">0%</span></span></td>
    <td>&#160;</td></tr>
  </table>
<p id="xdx_8A2_zKObb5CyTbg8" style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377789936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--InventoryDisclosureTextBlock_zslgZSQJmrUf" style="font: 11pt Cambria,serif; margin: 0"><b>NOTE 5: <span id="xdx_82E_z9qKEG5XDN39">INVENTORIES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Inventories consist of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zlanOsxunWb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B0_zVjTzpl5noSi" style="display: none">Inventories</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49C_20230228_zUsT23pXgeTd" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_497_20220228_z165FX9yuq7a" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Raw materials and subassemblies</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">1,868,689</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">1,250,589</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Finished goods</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">613,915</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">779,533</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InventoryWorkInProcess_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Work in process</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">760,305</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">343,120</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryGross_iI_pp0p0_z03kbIJjZeO5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Total</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">3,242,909</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">2,373,242</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">The Company maintains an allowance for slow moving inventory for raw materials and finished
goods. The recorded allowances at February 28, 2023 and 2022, totaled $332,525 and $327,661, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068382087280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS</a></td>
<td class="text"><p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zcmNBFFFI8og" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 6: <span id="xdx_827_zLaRUe54vgw8">BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Buildings, equipment, furnishings and leasehold improvements
consist of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zR2bDCkmUh47" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BF_zJVVRvU5kWz3" style="display: none">Buildings, equipment, furnishings and leasehold improvements</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%">Buildings</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals">2,250,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals">2,250,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Laboratory equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,647,951</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,421,845</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Machinery and equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,807,817</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,729,587</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Leasehold improvements</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">789,044</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">715,999</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Tradeshow and demonstration equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,137,346</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,137,346</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Furniture and fixtures</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals">1,302,545</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals">1,206,918</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Totals</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20230228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">8,934,703</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">8,461,695</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20230228_zp5Sg1Rn3tYd" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation">(6,309,707</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220228_zKbmWHTVtHsi" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation">(5,900,511</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net">2,624,996</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net">2,561,184</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>




<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Depreciation expense for the years ended February 28, 2023 and February
28, 2022 was $<span id="xdx_907_eus-gaap--Depreciation_c20220301__20230228_pp0p0" title="Depreciation Expense">492,055</span> and $<span id="xdx_909_eus-gaap--Depreciation_c20210301__20220228_pp0p0" title="Depreciation Expense">416,083</span>, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068381798864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text"><p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zNsVHxjSjdwj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 7: <span id="xdx_82B_z9dLsNPhCuj6">ACCRUED EXPENSES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Accrued expenses consist of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zNa8OZfAbERi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCRUED EXPENSES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B8_zRQEmE58L03j" style="display: none">Accrued expenses</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_492_20230228_zXdwIKpIJSFl" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49E_20220228_zvrSI9ca9dHf" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maALCzpsS_z8zEMzXZ9VQa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Accrued compensation</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">352,619</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">449,673</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProductWarrantyAccrual_iI_pp0p0_maALCzpsS_z3bHoHUOORD9" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Estimated warranty costs</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">500,650</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">622,775</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedSalesCommissionCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zBSP0Ci6jcjh" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Accrued commissions</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">157,927</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">195,540</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zT0Y3Rv1Wxzb" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Professional fees</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">100,921</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">104,850</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zLSIQ7kNBdze" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Other accrued expenses</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">315,329</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">431,190</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzpsS_zTGS3ySstipe" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 2.5pt">Total accrued expenses</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">1,427,446</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">1,804,028</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068383375424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVOLVING LINE OF CREDIT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">REVOLVING LINE OF CREDIT</a></td>
<td class="text"><p id="xdx_807_eus-gaap--ShortTermDebtTextBlock_z7XRU2X4I887" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 8: <span id="xdx_827_z1iXkNWIb8a5">REVOLVING LINE OF CREDIT</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company has a $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20230228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pp0p0" title="Revolving line of credit"><span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20220228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pp0p0" title="Revolving line of credit">1,500,000</span></span> revolving line of credit at prime which
was <span id="xdx_90C_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_c20230228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pdd" title="Interest rate">7.75%</span> at February 28, 2023 and <span id="xdx_90D_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_c20220228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pdd" title="Interest rate">3.25%</span> at February 28, 2022. The revolving credit line is collateralized by the Company&#8217;s accounts
receivable and inventory. The revolving credit line is payable on demand and must be retired for a 30-day period, once annually. If the
Company fails to perform the 30-day annual pay down or if the bank elects to terminate the credit line, the bank may, at its option, convert
the outstanding balance to a 36-month term note with payments including interest in 36 equal installments.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">As of February 28, 2023, $<span id="xdx_905_ecustom--CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_c20230228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Credit line utilized to collateralize letter of credit issued to customers">145,000</span> of the Company&#8217;s credit
line was being utilized to collateralize Letters of Credit issued to customers that have remitted cash deposits to the Company on
existing orders. The Letters of Credit expire in May and July 2023. As of February 28, 2023, there were no outstanding borrowings
under the line of credit and the unused portion of the credit line was $<span id="xdx_905_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_c20230228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Unused portion of credit line">1,355,000</span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">As of February 28, 2022, $<span id="xdx_906_ecustom--CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_c20220228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Credit line utilized to collateralize letter of credit issued to customers">5,000</span> of the Company&#8217;s credit
line was being utilized to collateralize letters of credit issued to customers that have remitted cash deposits to the Company on
existing orders. The letters of credit expire in May 2023. As of February 28, 2022, there were no outstanding borrowings under the
line of credit and the unused portion of the credit line was $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_c20220228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Unused portion of credit line">1,495,000</span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068381011296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG-TERM DEBT</a></td>
<td class="text"><p id="xdx_809_eus-gaap--LongTermDebtTextBlock_zDD9m6AQL9jl" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 9: <span id="xdx_821_zFFE1aQou1Bj">LONG-TERM DEBT</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In fiscal year 2021, the Company obtained a loan under the Paycheck
Protection Program for $<span id="xdx_90C_eus-gaap--LongTermDebt_c20220228__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_pp0p0" title="Long term debt">1,001,640</span>. In April 2021, the Company received notice from the SBA that the loan was forgiven in full and recorded
a gain on forgiveness of $<span id="xdx_900_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_c20220401__20220430__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zwok1S2DHTl4" title="Gain on forgiveness of debt">1,005,372</span>, which is recorded on the consolidated statements of income in fiscal 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068381009904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zDqKgjVLBI6b" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 10: <span id="xdx_828_zIKMeBpNAhU9">INCOME TAXES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The annual provision (benefit) for income taxes differs from amounts
computed by applying the maximum U.S. Federal income tax rate of 21% to pre-tax income as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zWIrddinDmXl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Income tax reconciliation (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BE_zXeRmo71DkQc" style="display: none">Income taxes - income tax reconciliation</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49B_20220301__20230228_zOABXeAqaEy3" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49B_20210301__20220228_z8RU5Xa11oZj" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman,serif">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maITEBzsB7_zmhc1KC4aPsj" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Expected federal income tax</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">165,882</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">609,883</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_maITEBzsB7_zVutWv5ipXnf" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">State tax, net of federal</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">37,204</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">37,894</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationTaxCreditsResearch_iN_pp0p0_di_msITEBzsB7_zBQ8ApzR2AUc" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Research and development tax credits</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(127,329</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(101,573</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pp0p0_maITEBzsB7_zeLnOUwmvdIi" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Permanent differences</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">78,252</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(179,320</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pp0p0_maITEBzsB7_zWfCwsGb4vGi" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#8212;</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(5,253</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzsB7_zEqR0e6o5GJ5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">154,009</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">361,631</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zHVmRTg9uGjk" style="font: 11pt Cambria,serif; margin: 0">&#160;</p>




<p style="font: 11pt Cambria,serif; margin: 0">Components of the current and deferred tax expense are as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zSaiHlmH6prc" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Current and deferred tax expense (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif"><span id="xdx_8BD_z9AhiVHxsgz" style="display: none">Income taxes - current and deferred tax expense</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_491_20220301__20230228_zRxvZwcCjUNb" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_493_20210301__20220228_z4D8GLwnpJeg" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>February
    28,</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>2023</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>2022</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td></tr>
  <tr id="xdx_402_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zVF9uE6WnMna" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Current:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz4dN_zHY1IR2sngXg" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; width: 72%">Federal</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">438,263</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">341,882</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz4dN_zVJvEIB7uRF7" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">State</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">83,525</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">38,536</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz4dN_maITEBz5ma_zzwYywLl16Cj" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Total current income tax</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">521,788</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">380,418</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzDG5_zAwszYiUk68d" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Federal</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(321,458</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(18,787</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzDG5_zL0kKFl9UZy5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">State</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(46,321</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">&#8212;</span></td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzDG5_maITEBz5ma_zQJd3XyNSAOa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Total deferred income tax</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(367,779</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(18,787</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBz5ma_z1W7r0e6Hve4" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">154,009</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">361,631</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A2_zT17onUWeVdi" style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">In assessing the realizability of deferred tax assets, management
considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization
of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences
become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and projections
for future taxable income over periods in which the deferred tax assets are deductible. Management believes it is more likely than not
that the Company will realize the benefits of these deductible differences.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The incorporation of the new tax laws for 2023, requires the Company
to capitalize for income tax purposes research and development expenses incurred during the year and for such expenses to be amortized
over a five year period. As a result, a deferred tax asset &#8220;Capitalized R&amp;D expenses &#8211; IRC Section 174&#8221; has been
recorded.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company does not have any uncertain tax
positions in 2023. There are no interest and penalties related to uncertain tax positions in 2023. As of February 28, 2023, open years
related to the federal and state jurisdictions are 2022, 2021 and 2020.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The deferred tax asset and liability are comprised of the following:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zfnz0YvUahNi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BD_zSWkGUdJawL2" style="display: none">Income taxes - deferred tax asset and liability components</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_499_20230228_ziGzPWlt4Gi" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_497_20220228_zi7igFRzhsd2" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Allowance for inventory</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">76,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">69,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Allowance for accounts receivable</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">3,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">12,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CapitalizedRdExpensesIrcSection174_iI_pp0p0_z5jxT9YPHkEg" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Capitalized R&amp;D expenses &#8211; IRC Section 174</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">441,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">&#8212;</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Accrued expenses and other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">147,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">160,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iIC_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Deferred tax asset &#8211; Long Term</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">667,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">241,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_zzwMRAS8V7Hf" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Building and leasehold depreciation</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(83,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(169,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zJoJNt2675Ke" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Deferred tax liability &#8211; Long Term</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(83,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(169,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A7_zbW3LTi4DT4d" style="font: 11pt Cambria,serif; margin: 0">&#160;</p>




<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068462670304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text"><p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zX4D7VcTtw06" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 11: <span id="xdx_82E_zXY8K5WhAwn5">EARNINGS PER SHARE</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The following table sets forth the computation of basic and diluted
earnings per share:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3Hf5T0a7PGg" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;<span id="xdx_8B9_zmVIV1SCeWOg" style="display: none">Earnings per share - the computation of basic and diluted earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220301__20230228_zTSpMW9EH2nb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210301__20220228_zqwCURZvyqKd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zCzKLzsh0T3e" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left; padding-bottom: 2.5pt">Numerator for basic and diluted earnings per share</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right">635,905</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right">2,542,573</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zaSep3GRNYCe" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Denominator for basic earnings per share - weighted average</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">15,735,451</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">15,586,404</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Effects of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Stock options for employees, directors and outside consultants</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">34,048</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">37,081</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zsXHAIHJXQFi" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">15,769,499</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">15,623,485</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Basic Earnings Per Share &#8211; Weighted Average</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.04</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.16</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Diluted Earnings Per Share &#8211; Weighted Average</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.04</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.16</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_z8DPqzOm3S5j" style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068381004336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CUSTOMER CONCENTRATIONS AND FOREIGN SALES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CUSTOMER CONCENTRATIONS AND FOREIGN SALES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--ConcentrationRiskDisclosureTextBlock_z5xhXpBYhGqk" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b>NOTE 12: <span id="xdx_828_z8yYal242OP3">CUSTOMER CONCENTRATIONS AND FOREIGN SALES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Export sales to customers located outside the United States and Canada
were approximately as follows:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgJ0hZYW4Mti" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B5_zfi7fc0zqkZ1" style="display: none">Schedule of customer concentrations and foreign sales</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Asia Pacific (APAC)</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales">3,260,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales">5,301,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Europe, Middle East, Asia (EMEA)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales">3,448,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales">5,255,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Latin America</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales">1,546,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales">1,097,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales">8,254,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales">11,653,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023 and fiscal 2022, sales to foreign customers accounted
for approximately $<span id="xdx_901_eus-gaap--Revenues_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pp0p0" title="Sales revenue">8,254,000</span> and $<span id="xdx_90F_eus-gaap--Revenues_c20210301__20220228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pp0p0" title="Sales revenue">11,653,000</span>, or <span id="xdx_90D_ecustom--SalesRevenuePercent_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pdd" title="Sales revenue, percent">55%</span> and <span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pdd" title="Sales revenue, percent">68%</span> respectively, of total revenues.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company had two customers which accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_c20220301__20230228__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent">14%</span> of sales during
fiscal 2023. Four customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_c20220301__20230228__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent">44%</span> of the outstanding accounts receivables at February 28, 2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company had two customers which accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20210301__20220228__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent">24%</span> of sales during
fiscal 2022. Three customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20210301__20220228__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent">41%</span> of the outstanding accounts receivables at February 28, 2022.</p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068382149536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zAAFWGYoiLwj" style="font: 11pt Cambria,serif; margin: 0"><b>NOTE 13: <span id="xdx_82A_zWxEBBOfOw2c">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 11pt Cambria,serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Cambria,serif; margin: 0">Other than the letters of credit discussed in Notes 3 and 8, the Company did not have any
material commitments or contingencies as of February 28, 2023.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company is subject, from time to time, to claims by third parties under various
legal disputes. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on
the Company&#8217;s liquidity, financial condition, and cash flows. As of February 28, 2023, the Company did not have any pending legal
actions.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379171568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Expenses</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_ztIK889gJFO" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86E_zyPQdQSUUMO8">Advertising Expenses</span></i></b><i> - </i>The Company expenses the
cost of advertising in the period in which the advertising takes place. Advertising expense for fiscal 2023 and fiscal 2022 was $<span id="xdx_909_eus-gaap--AdvertisingExpense_c20220301__20230228_pp0p0" title="Advertising expense">297,500</span>
and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_c20210301__20220228_pp0p0" title="Advertising expense">178,500</span>, respectively.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable, net</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zdVbq1h4tR22" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zAzk3cdHk974">Accounts Receivable, net</span> - </i></b>In the normal course of business,
the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value
of receivables and approximate fair value. The Company records a bad debt expense/allowance based on management&#8217;s estimate of uncollectible
accounts. All outstanding accounts receivable accounts are reviewed for collectability on an individual basis.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z076pfobOQ0h" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86A_zZPlbcJPMu0j">Cash and Cash Equivalents</span></i></b><i> - </i>Cash and cash equivalents consist of money market mutual funds, short term commercial paper
and short-term certificates of deposit with original maturities of 90 days or less. At February 28, 2023, the Company had <span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20230228_zBJYVfIDMfnc" title="Cash in excess of the FDIC insured limit">2,892,000</span> of
cash in excess of the FDIC insured limit.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zKy5jPPT87l" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_z8mSdoE2VOJ1">Consolidation</span></i></b> - The accompanying consolidated financial
statements of the Company include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (&#8220;SIP&#8221;)
in conformity with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). SIP operates as a real estate holding
company for the Company&#8217;s real estate operations. All intercompany accounts and transactions have been eliminated in consolidation.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z5QMYx36mYof" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zjVIWjHUTqPl">Earnings Per Share</span></i></b><i> - </i>Basic earnings per share
(&#8220;EPS&#8221;) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted
EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted
into common stock under the treasury stock method.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock', window );">Equipment, Furnishings and Leasehold Improvements</a></td>
<td class="text"><p id="xdx_848_ecustom--EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock_zDBQyxOP37Jc" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><span id="xdx_86C_zu7nVrb9VSNc"><b><i>Equipment,
Furnishings and Leasehold Improvements</i></b></span> - Equipment, furnishings and leasehold improvements are stated at cost. Depreciation
of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which
range from three <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MinimumMember_zEa4tQmNJJ25" style="display: none">3
</span>to five years <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MaximumMember_zODz3BLGnR62" style="display: none" title="Estimated useful lives">5</span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>




<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOJNu1gdDiDd" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_865_zR9AhMBu2XG7">Fair Value of Financial Instruments</span> -</i></b> The Company applies
Accounting Standards Codification (&#8220;ASC&#8221;) 820,&#160;<i>Fair Value Measurement&#160;</i>(&#8220;ASC 820&#8221;), which establishes
a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an
exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company&#8217;s principal or
most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established
in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring
fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed
based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity&#8217;s own assumptions
based on market data and the entity&#8217;s judgments about the assumptions that market participants would use in pricing the asset or
liability and are to be developed based on the best information available in the circumstances.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The carrying amounts of financial instruments reported in the accompanying
consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term
maturities of the financial instruments.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The valuation hierarchy is composed of three levels. The classification
within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within
the valuation hierarchy are described below:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 1 &#8212; Assets and liabilities with unadjusted, quoted prices
listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets
for identical assets or liabilities.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 2 &#8212; Inputs to the fair value measurement are determined
using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs,
such as interest rates and yield curves that are observable at commonly quoted intervals.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Level 3 &#8212; Inputs to the fair value measurement are unobservable
inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">The fair values of financial assets of the
Company were determined using the following categories at February 28, 2023 and February 28, 2022, respectively:</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z9W5C1Atvvv9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B9_z2EWxR77nGMd" style="display: none">Significant accounting policies - fair values of financial assets of the company</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 1</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 2</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 3</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Total</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2023</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">7,361,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">729,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8212;</span></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">8,090,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2022</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">5,716,338</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">151,652</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8212;</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">5,867,990</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">Marketable Securities include certificates
of deposit and US Treasury securities, totaling $<span id="xdx_90D_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" title="Marketable securities">8,090,000</span> and $<span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" title="Marketable securities">5,867,990</span> that are considered to be highly liquid and easily tradeable
as of February 28, 2023 and February 28, 2022, respectively. US Treasury securities are valued using inputs observable in active markets
for identical securities and are therefore classified as Level&#160;1 and certificates of deposit are classified as Level 2 within the
Company&#8217;s fair value hierarchy. The Company&#8217;s marketable securities are considered to be trading securities as defined under
ASC 320 &#8220;Investments &#8211; Debt and Equity Securities.&#8221;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white">&#160;</p>




<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zPcYB0NOuqQg" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_866_z86KLktVApA9">Income Taxes</span></i></b> - The Company accounts for income taxes
under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of "temporary
differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying
amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax
asset will not be realized, a valuation allowance is recognized. The Company uses a recognition threshold and a measurement attribute
for financial statement recognition and measurement of tax positions taken or expected to be taken in a return. For those benefits to
be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. As of February 28,
2023 and February 28, 2022, there were <span id="xdx_90E_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20230228_zaSL115rYzZc" title="Uncertain tax positions"><span id="xdx_901_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20220228_zW9qX9qkcMFk" title="Uncertain tax positions">no</span></span> uncertain tax positions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z6UkSEsuRQCj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zBX8vf7mtbP2">Intangible
Assets</span></i></b><i> - </i>Include costs of patent applications which are deferred and charged to operations over seventeen <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230228_zUdtN3M69Jt" style="display: none" title="Useful life of intangible assets">17</span>
years for domestic patents and <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220228_zYouIz3hltu4" style="display: none" title="Useful life of intangible assets">12</span> twelve years for foreign patents, which is considered the useful life. The accumulated
amortization of patents is $<span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230228_pp0p0" title="Accumulated amortization of patents">202,681</span>
and $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220228_pp0p0" title="Accumulated amortization of patents">192,490</span>
at February 28, 2023 and February 28, 2022, respectively. Annual amortization expense of such intangible assets is expected to be
approximately $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20230228_zxHdm0XiH7t2" title="Annual amortization expense this year"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20230228_zy6RjLyI5bUl" title="Annual amortization expense year two"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20230228_zcwkd9gGjWk9" title="Annual amortization expense year three"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20230228_zozE9sfhoIfj" title="Annual amortization expense year four"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20230228_zZU2wpZwxuVd" title="Annual amortization expense year five">11,000</span></span></span></span></span>
per year for the next five years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zmkyuYg7s9G3" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86E_zBBEbTbjquLg">Inventories</span></i></b><i> - </i>Inventories are stated at the lower
of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress
and the specific identification method for finished goods. Management compares the cost of inventory with the net realizable value and,
if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis,
inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand
and market conditions.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Land and Buildings</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7VsoQGl5Vs4" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zCNQ9vneYrwa">Land and Buildings</span> - </i></b>Land and buildings are stated at
cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228_z0jmoiIsj9Yk" style="display: none" title="Estimated useful life">40</span> forty years.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">At February 28, 2023 and 2022, the Company had Land, stated at cost of $<span id="xdx_90C_eus-gaap--Land_iI_pp0p0_c20230228_zjmgpsXCaY24" title="Land">250,000</span>.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zzpIvtRvLyHb" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_znxkHFIK9wDe">Long-Lived Assets</span></i></b><i> - </i>The Company periodically
evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The
carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately
identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value
exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted
at a rate commensurate with the risk involved. <span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220301__20230228_zFxQK6IuMbYc" title="Impairment losses"><span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210301__20220228_z8J444mb3QPd" title="Impairment losses">No</span></span> impairment losses were identified or recorded for the years ended February 28, 2023
and February 28, 2022 on the Company&#8217;s long-lived assets.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Management Estimates</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--UseOfEstimates_zOpTtxHycy01" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zoN7be49pejc">Management Estimates</span></i></b><i> - </i>The preparation of the
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zPZG0luBwcOe" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zUSjXTGxMbai">New
Accounting Pronouncements </span></i></b>&#8211; In June 2016, the FASB issued ASU 2016-13 - Financial Instruments-Credit
Losses-Measurement of Credit Losses on Financial Instruments. Codification Improvements to Topic 326, Financial Instruments &#8211;
Credit Losses, have been released in November 2018 (2018-19), November 2019 (2019-10 and 2019-11) and a January 2020 Update
(2020-02) that provided additional guidance on this Topic. This guidance replaces the current incurred loss impairment methodology
with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable
information to inform credit loss estimates. For SEC filers meeting certain criteria, the amendments in this ASU are effective for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For SEC filers that meet the
criteria of a smaller reporting company (including this Company) and for non-SEC registrant public companies and other
organizations, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning
after December 15, 2022. Early adoption will be permitted for all organizations for fiscal years, and interim periods within those
fiscal years, beginning after December 15, 2019. The Company has adopted ASU 2016-13 as updated and does not expect the adoption of
this guidance to have a material impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">Other than Accounting Standards Update (&#8220;ASU&#8221;) ASU 2016-13 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable
to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>




<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Product Warranty</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--StandardProductWarrantyPolicy_zhJptZDW8Pvf" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zmlpsxgIaJu7">Product Warranty</span></i></b> - Expected future product warranty expense is recorded when revenue is recognized for product
sales.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhZzJAtMVTv" style="font: 11pt Cambria,serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><b><i><span id="xdx_867_zGz3lzCZGSB5">Reclassifications</span> - </i></b>Building,
equipment, leasehold improvements reclassifications have been made to the fiscal 2022 consolidated financial statements to conform to
the fiscal 2023 consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously
reported.</p>



<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Product Development Expenses</a></td>
<td class="text"><p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zMGnwl1QLy93" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_z0stfiIeUEd1">Research and Product Development Expenses</span></i></b><i> - </i>Research
and product development expenses represent engineering and other expenditures incurred for developing new products, for refining the Company's
existing products and for developing systems to meet unique customer specifications for potential orders or for new industry applications
and are expensed as incurred.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">During fiscal 2023 and fiscal 2022, the Company spent approximately
$<span id="xdx_90A_eus-gaap--OtherResearchAndDevelopmentExpense_c20220301__20230228_zviNPQgZkrnj" title="Research and development expenses">2,149,000</span> and $<span id="xdx_906_eus-gaap--OtherResearchAndDevelopmentExpense_c20210301__20220228_zGKjaalDo0wd" title="Research and development expenses">1,730,000</span>, respectively, on research and development activities related to new products and services and the ongoing improvement
of existing products and services.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zBXVmzTPbQ6d" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86B_zxWqMSmHzcX9">Revenue Recognition</span> -</i></b> The Company recognizes
revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should
recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to
which the entity expects to be entitled to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 11pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font-family: Times New Roman,serif"><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Identification of the contract, or contracts, with a customer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Identification of the performance obligations in the contract</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Determination of the transaction price</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 11pt">&#183;</span></td>
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Recognition of revenue when, or as, performance obligations are satisfied</span></td></tr>
  </table>
<p style="font: 10pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zmkBHO9dWhj6" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_zbnfr1OxsiV6">Stock-Based Compensation</span></i></b> - The Company currently uses
a Black-Scholes option pricing model to calculate the fair value of its stock options. The fair value of each option is estimated on the
date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility;
and expected lives of the awards. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes
model. The assumptions used in calculating the fair value of share-based payment awards represent management&#8217;s best estimates, but
these estimates involve inherent uncertainties and the application of management judgment.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">ASC 718 requires the recognition of the fair value of stock compensation
expense to be recognized over the vesting term of such award. The Company accounts for forfeitures as they occur.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_UncertaintiesPolicyTextBlock', window );">Uncertainties</a></td>
<td class="text"><p id="xdx_84A_ecustom--UncertaintiesPolicyTextBlock_z4eTRDL6drs2" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_86A_zaWtAF5TttVf">Uncertainties</span> - </i></b>Since early 2020, when the World Health
Organization established the transmissible and pathogenic coronavirus a global pandemic, there have been business slowdowns. The outbreak
of such a communicable disease has resulted in a widespread health crisis which has adversely affected general commercial activity and
the economies and financial markets of many countries, including the United States. As the outbreak of the disease has continued through
fiscal 2022 and into fiscal 2023, the measures taken by the governments of impacted countries have, at times, adversely affected the
Company&#8217;s business, financial condition, and results of operations. Pandemic related supply shortages and increased energy expenses
resulting from the war in Ukraine have recently created worldwide inflationary pressures which may have a material adverse effect on
the Company's business, financial condition, and results of operations if such factors continue unabated.</p>

<p style="font: 11pt Cambria,serif; margin: 0">&#160;</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify">The Company has encountered challenges in procuring supplies of various materials and components,
and electronic components in particular, due to well-documented shortages and constraints in the global supply chain. Lead times for ordered
components may vary significantly, and some components used to manufacture our products are provided by a limited number of sources. The
Company experienced lengthened lead times throughout its supply chain as a result of supply chain constraints and material shortages that
have occurred through fiscal year 2023. This has been exacerbated by the recent resurgence of the COVID-19 pandemic in certain parts of
China, which has resulted in the temporary closure of manufacturing facilities, including those that manufacture electronic parts that
the Company includes in its products.</p>

<p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>




<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_UncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_UncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068382109872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Significant accounting policies - fair values of financial assets of the company</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z9W5C1Atvvv9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B9_z2EWxR77nGMd" style="display: none">Significant accounting policies - fair values of financial assets of the company</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 1</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 2</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Level 3</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center">Total</td><td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2023</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">7,361,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">729,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#8212;</span></td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities">8,090,000</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Marketable Securities &#8211; February 28, 2022</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">5,716,338</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">151,652</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8212;</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities">5,867,990</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068382083936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue recognition - sales revenue by product line</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zbUbcc6jXoc9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B2_z91GIQ06Awl3" style="display: none">Revenue recognition - sales revenue by product line</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Twelve Months Ended</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center">% of total</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center">% of total</td><td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 44%; text-align: left">Fluxing Systems</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue">1,179,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><span id="xdx_903_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent">8%</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue">691,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent">4%</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Integrated Coating Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">1,114,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_909_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent">7%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">1,182,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent">7%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Multi-Axis Coating Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">6,785,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_907_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent">45%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">9,912,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_905_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent">58%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">OEM Systems</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">2,144,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent">14%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue">2,381,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span id="xdx_903_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent">14%</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">3,836,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"><span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent">26%</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">2,967,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90F_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent">17%</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">TOTAL</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">15,058,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue">17,133,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068382204048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock-based compensation - summary of stock options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zZkAmVWrdgB6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif"><span id="xdx_8B4_z6I1Bec18f2i" style="display: none">Stock-based compensation - summary of stock options</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Weighted Average</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Stock Options</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercise Price $</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">Remaining</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Outstanding</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercisable</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Outstanding</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Exercisable</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">Term - Years</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 35%">Balance - February 28, 2021</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210301__20220228_zE30H90Femk9" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options outstanding at beginning of period (in shares)">508,459</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20210301__20220228_z4kWatz5zhx1" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options exercisable at beginning of period (in shares)">333,500</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210301__20220228_zJW05n3Vk49d" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)">2.35</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20210301__20220228_z684LR6idVha" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)">2.17</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 9%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200301__20210228_zw79MWxt1hJe" title="Weighted average remaining term outstanding">6.99</span></td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Granted</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)">168,335</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)">5.10</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Exercised</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210301__20220228_zLGT7VHWCAL7" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)">(403,334</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zgqKdd0y3Boi" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)">(2.12</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Cancelled</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20210301__20220228_zKrJjndN7yn7" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)">(19,750</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zvIv8kUPKaW2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)">(3.27</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2022</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220301__20230228_zJ86AJ2Mo11g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at beginning of period (in shares)">253,710</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20220301__20230228_zXRMycy4g36g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at beginning of period (in shares)">61,690</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220301__20230228_z6X2RiH04sG9" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)">4.46</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20220301__20230228_zx24UyvWYxBi" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)">3.53</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210301__20220228_zUAE1Uypk6Ta" title="Weighted average remaining term outstanding">8.94</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Granted</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)">44,739</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)">5.71</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Exercised</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220301__20230228_z5SzFxXaUo7g" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)">(16,973</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zQtD2LTtdTKc" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)">(1.77</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Cancelled</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220301__20230228_zFxx7wlizET1" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)">(30,717</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zTHt9YCvFr81" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)">(4.66</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Balance - February 28, 2023</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220301__20230228_zdBTcJX7oaL5" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at end of period (in shares)">250,759</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220301__20230228_zVAaCqMxpmfb" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at end of period (in shares)">133,609</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220301__20230228_z8TZsHGBm2gf" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at end of period (in dollars per share)">4.84</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220301__20230228_zzj00G6CnJq1" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at end of period (in dollars per share)">4.62</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220301__20230228_zJ5ddbmycB56" title="Weighted average remaining term outstanding">8.52</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock-based compensation - weighted-average black-scholes assumptions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zB8iJOzONpQ7" style="width: 100%; border-collapse: collapse; font-size: 11pt" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BC_zEb026tMpqa" style="display: none">Stock-based compensation - weighted-average black-scholes assumptions</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td colspan="4" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>Fiscal Year Ended</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February 28, <br/>
2023</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 9pt"><b>February 28, <br/>
2022</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="width: 61%; font-family: Times New Roman,serif"><span style="font-family: Cambria,serif; font-size: 11pt">Expected life</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td>
    <td style="width: 18%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zPCjUX11Hosf" title="Expected life (in years)">5</span> - <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_ztZnKxWTd8g5" title="Expected life (in years)">8</span> years</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="width: 16%; font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zdaG9Stx5At2" title="Expected life (in years)">5</span> - <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zn0ULfQNqU27" title="Expected life (in years)">8</span> years</span></td>
    <td style="width: 1%; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Risk free interest rate</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20220301__20230228_pdd" title="Risk free interest rate, minimum">2.82%</span> - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20220301__20230228_pdd" title="Risk free interest rate, maximum">4.02%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20210301__20220228_pdd" title="Risk free interest rate, minimum">0.78%</span> &#8211; <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20210301__20220228_pdd" title="Risk free interest rate, maximum">2.0%</span></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20220301__20230228_pdd" title="Expected volatility, minimum">55.02%</span> - <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20220301__20230228_pdd" title="Expected volatility, maximum">62.01%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20210301__20220228_pdd" title="Expected volatility, minimum">50.73%</span> - <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20210301__20220228_pdd" title="Expected volatility, maximum">57.13%</span></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Cambria,serif; font-size: 11pt">Expected dividend yield</span></td>
    <td>&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220301__20230228_pdd" title="Expected dividend yield">0%</span></span></td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman,serif; text-align: center"><span style="font-family: Cambria,serif; font-size: 11pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20210301__20220228_pdd" title="Expected dividend yield">0%</span></span></td>
    <td>&#160;</td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068381929552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zlanOsxunWb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B0_zVjTzpl5noSi" style="display: none">Inventories</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49C_20230228_zUsT23pXgeTd" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_497_20220228_z165FX9yuq7a" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Raw materials and subassemblies</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">1,868,689</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">1,250,589</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Finished goods</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">613,915</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">779,533</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InventoryWorkInProcess_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Work in process</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">760,305</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">343,120</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryGross_iI_pp0p0_z03kbIJjZeO5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Total</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">3,242,909</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">2,373,242</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068381900272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Buildings, equipment, furnishings and leasehold improvements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zR2bDCkmUh47" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BF_zJVVRvU5kWz3" style="display: none">Buildings, equipment, furnishings and leasehold improvements</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td><td style="font: bold 9pt Cambria,serif">&#160;</td>
    <td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center">February 28,</td><td style="font: bold 9pt Cambria,serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%">Buildings</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals">2,250,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals">2,250,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Laboratory equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,647,951</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,421,845</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Machinery and equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,807,817</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,729,587</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Leasehold improvements</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">789,044</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">715,999</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Tradeshow and demonstration equipment</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,137,346</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">1,137,346</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Furniture and fixtures</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals">1,302,545</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals">1,206,918</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Totals</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20230228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">8,934,703</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals">8,461,695</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20230228_zp5Sg1Rn3tYd" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation">(6,309,707</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220228_zKbmWHTVtHsi" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation">(5,900,511</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net">2,624,996</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net">2,561,184</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068381951216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zNa8OZfAbERi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCRUED EXPENSES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B8_zRQEmE58L03j" style="display: none">Accrued expenses</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_492_20230228_zXdwIKpIJSFl" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49E_20220228_zvrSI9ca9dHf" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maALCzpsS_z8zEMzXZ9VQa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Accrued compensation</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">352,619</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">449,673</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProductWarrantyAccrual_iI_pp0p0_maALCzpsS_z3bHoHUOORD9" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Estimated warranty costs</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">500,650</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">622,775</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedSalesCommissionCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zBSP0Ci6jcjh" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Accrued commissions</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">157,927</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">195,540</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zT0Y3Rv1Wxzb" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Professional fees</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">100,921</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">104,850</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zLSIQ7kNBdze" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Other accrued expenses</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">315,329</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">431,190</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzpsS_zTGS3ySstipe" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 2.5pt">Total accrued expenses</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">1,427,446</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">1,804,028</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379368496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Income taxes - income tax reconciliation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zWIrddinDmXl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Income tax reconciliation (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BE_zXeRmo71DkQc" style="display: none">Income taxes - income tax reconciliation</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49B_20220301__20230228_zOABXeAqaEy3" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_49B_20210301__20220228_z8RU5Xa11oZj" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman,serif">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maITEBzsB7_zmhc1KC4aPsj" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Expected federal income tax</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">165,882</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">609,883</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_maITEBzsB7_zVutWv5ipXnf" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">State tax, net of federal</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">37,204</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">37,894</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationTaxCreditsResearch_iN_pp0p0_di_msITEBzsB7_zBQ8ApzR2AUc" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Research and development tax credits</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(127,329</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(101,573</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pp0p0_maITEBzsB7_zeLnOUwmvdIi" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Permanent differences</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">78,252</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(179,320</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pp0p0_maITEBzsB7_zWfCwsGb4vGi" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 1pt">Other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#8212;</span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(5,253</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzsB7_zEqR0e6o5GJ5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">154,009</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">361,631</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income taxes - current and deferred tax expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zSaiHlmH6prc" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Current and deferred tax expense (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif"><span id="xdx_8BD_z9AhiVHxsgz" style="display: none">Income taxes - current and deferred tax expense</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_491_20220301__20230228_zRxvZwcCjUNb" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_493_20210301__20220228_z4D8GLwnpJeg" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>February
    28,</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>2023</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"><span style="font-size: 9pt"><b>2022</b></span></td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt"><span style="font-size: 9pt"><b>&#160;</b></span></td></tr>
  <tr id="xdx_402_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zVF9uE6WnMna" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Current:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz4dN_zHY1IR2sngXg" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; width: 72%">Federal</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">438,263</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">341,882</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz4dN_zVJvEIB7uRF7" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">State</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">83,525</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">38,536</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz4dN_maITEBz5ma_zzwYywLl16Cj" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Total current income tax</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">521,788</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">380,418</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzDG5_zAwszYiUk68d" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Federal</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(321,458</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">(18,787</td><td style="font: 11pt Cambria,serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzDG5_zL0kKFl9UZy5" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif">State</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(46,321</td><td style="font: 11pt Cambria,serif; text-align: left">)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0835">&#8212;</span></td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzDG5_maITEBz5ma_zQJd3XyNSAOa" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Total deferred income tax</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(367,779</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(18,787</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBz5ma_z1W7r0e6Hve4" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">154,009</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">361,631</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Income taxes - deferred tax asset and liability components</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zfnz0YvUahNi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8BD_zSWkGUdJawL2" style="display: none">Income taxes - deferred tax asset and liability components</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_499_20230228_ziGzPWlt4Gi" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_497_20220228_zi7igFRzhsd2" style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Allowance for inventory</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">76,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="font: 11pt Cambria,serif; width: 10%; text-align: right">69,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Allowance for accounts receivable</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">3,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">12,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CapitalizedRdExpensesIrcSection174_iI_pp0p0_z5jxT9YPHkEg" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Capitalized R&amp;D expenses &#8211; IRC Section 174</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">441,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0855">&#8212;</span></td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Accrued expenses and other</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">147,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">160,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iIC_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Deferred tax asset &#8211; Long Term</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">667,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">241,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_zzwMRAS8V7Hf" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Building and leasehold depreciation</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(83,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">(169,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zJoJNt2675Ke" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Deferred tax liability &#8211; Long Term</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(83,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">(169,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377628560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings per share - the computation of basic and diluted earnings per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3Hf5T0a7PGg" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;<span id="xdx_8B9_zmVIV1SCeWOg" style="display: none">Earnings per share - the computation of basic and diluted earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220301__20230228_zTSpMW9EH2nb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210301__20220228_zqwCURZvyqKd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_zCzKLzsh0T3e" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left; padding-bottom: 2.5pt">Numerator for basic and diluted earnings per share</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right">635,905</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right">2,542,573</td><td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zaSep3GRNYCe" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif">Denominator for basic earnings per share - weighted average</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">15,735,451</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">15,586,404</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left">Effects of dilutive securities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_i_pdd" style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Stock options for employees, directors and outside consultants</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">34,048</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right">37,081</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zsXHAIHJXQFi" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt">Denominator for diluted earnings per share</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">15,769,499</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">15,623,485</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Basic Earnings Per Share &#8211; Weighted Average</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.04</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.16</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">Diluted Earnings Per Share &#8211; Weighted Average</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.04</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right">0.16</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068382149536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of customer concentrations and foreign sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgJ0hZYW4Mti" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left"><span id="xdx_8B5_zfi7fc0zqkZ1" style="display: none">Schedule of customer concentrations and foreign sales</span></td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; text-align: right">&#160;</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2023</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center">February 28,<br/> 2022</td><td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; width: 72%; text-align: left">Asia Pacific (APAC)</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales">3,260,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; width: 2%">&#160;</td>
    <td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales">5,301,000</td><td style="font: 11pt Cambria,serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Cambria,serif; text-align: left">Europe, Middle East, Asia (EMEA)</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales">3,448,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif">&#160;</td>
    <td style="font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales">5,255,000</td><td style="font: 11pt Cambria,serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(230,239,255)">
    <td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt">Latin America</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales">1,546,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales">1,097,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales">8,254,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales">11,653,000</td><td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377401216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable Securities</a></td>
<td class="nump">$ 8,090,000<span></span>
</td>
<td class="nump">$ 5,867,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsCurrent', window );">Uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of intangible assets</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of patents</a></td>
<td class="nump">$ 202,681<span></span>
</td>
<td class="nump">$ 192,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Annual amortization expense this year</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Annual amortization expense year two</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Annual amortization expense year three</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Annual amortization expense year four</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Annual amortization expense year five</a></td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable Securities</a></td>
<td class="nump">7,361,000<span></span>
</td>
<td class="nump">5,716,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable Securities</a></td>
<td class="nump">729,000<span></span>
</td>
<td class="nump">151,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable Securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379361136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 297,500<span></span>
</td>
<td class="nump">$ 178,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash in excess of the FDIC insured limit</a></td>
<td class="nump">$ 2,892,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">$ 8,090,000<span></span>
</td>
<td class="nump">5,867,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 2,149,000<span></span>
</td>
<td class="nump">$ 1,730,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_EquipmentAndFurnishingsMember', window );">Equipment and Furnishings | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_EquipmentAndFurnishingsMember', window );">Equipment and Furnishings | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_EquipmentAndFurnishingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_EquipmentAndFurnishingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068376696816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Sales Revenue by Product Line (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 15,058,203<span></span>
</td>
<td class="nump">$ 17,132,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sotk_FluxingSystemsMember', window );">Fluxing Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 1,179,000<span></span>
</td>
<td class="nump">$ 691,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_SalesRevenuePercent', window );">Sales revenue, percent</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sotk_IntegratedCoatingSystemsMember', window );">Integrated Coating Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 1,114,000<span></span>
</td>
<td class="nump">$ 1,182,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_SalesRevenuePercent', window );">Sales revenue, percent</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sotk_MultiAxisCoatingSystemsMember', window );">Multi Axis Coating Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 6,785,000<span></span>
</td>
<td class="nump">$ 9,912,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_SalesRevenuePercent', window );">Sales revenue, percent</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sotk_OemSystemsMember', window );">Oem Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 2,144,000<span></span>
</td>
<td class="nump">$ 2,381,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_SalesRevenuePercent', window );">Sales revenue, percent</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sotk_OtherProductLineMember', window );">Other Product Line [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 3,836,000<span></span>
</td>
<td class="nump">$ 2,967,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_SalesRevenuePercent', window );">Sales revenue, percent</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sotk_ProductLineMember', window );">Total Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 15,058,000<span></span>
</td>
<td class="nump">$ 17,133,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_SalesRevenuePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Sales Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_SalesRevenuePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sotk_FluxingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sotk_FluxingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sotk_IntegratedCoatingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sotk_IntegratedCoatingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sotk_MultiAxisCoatingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sotk_MultiAxisCoatingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sotk_OemSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sotk_OemSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sotk_OtherProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sotk_OtherProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sotk_ProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sotk_ProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379392016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_CashDeposits', window );">Cash deposits</a></td>
<td class="nump">$ 2,838,000<span></span>
</td>
<td class="nump">$ 1,168,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letter of credit</a></td>
<td class="nump">145,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCollateralFeesAmount', window );">Line of credit collateral amount</a></td>
<td class="nump">$ 145,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_CashDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_CashDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCollateralFeesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fees associated with providing collateral for the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCollateralFeesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379699472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Summary of Stock Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options outstanding at beginning of period (in shares)</a></td>
<td class="nump">253,710<span></span>
</td>
<td class="nump">508,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock Options exercisable at beginning of period (in shares)</a></td>
<td class="nump">61,690<span></span>
</td>
<td class="nump">333,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 4.46<span></span>
</td>
<td class="nump">$ 2.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average exercisable at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining term outstanding</a></td>
<td class="text">8 years 6 months 7 days<span></span>
</td>
<td class="text">8 years 11 months 8 days<span></span>
</td>
<td class="text">6 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">44,739<span></span>
</td>
<td class="nump">168,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 5.71<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(16,973)<span></span>
</td>
<td class="num">(403,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="num">$ (1.77)<span></span>
</td>
<td class="num">$ (2.12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(30,717)<span></span>
</td>
<td class="num">(19,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="num">$ (4.66)<span></span>
</td>
<td class="num">$ (3.27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options outstanding at end of period (in shares)</a></td>
<td class="nump">250,759<span></span>
</td>
<td class="nump">253,710<span></span>
</td>
<td class="nump">508,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock Options exercisable at end of period (in shares)</a></td>
<td class="nump">133,609<span></span>
</td>
<td class="nump">61,690<span></span>
</td>
<td class="nump">333,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average outstanding at end of period (in dollars per share)</a></td>
<td class="nump">$ 4.84<span></span>
</td>
<td class="nump">$ 4.46<span></span>
</td>
<td class="nump">$ 2.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average exercisable at end of period (in dollars per share)</a></td>
<td class="nump">$ 4.62<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377336912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">2.82%<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">55.02%<span></span>
</td>
<td class="nump">50.73%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">62.01%<span></span>
</td>
<td class="nump">57.13%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068375962768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">250,759<span></span>
</td>
<td class="nump">253,710<span></span>
</td>
<td class="nump">508,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">44,739<span></span>
</td>
<td class="nump">168,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, exercisable price</a></td>
<td class="nump">$ 5.71<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="nump">$ 155,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">256,740<span></span>
</td>
<td class="nump">$ 179,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation expense not yet recognized</a></td>
<td class="nump">$ 288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation expense, period for recognition</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled in settlement of shares issued</a></td>
<td class="nump">12,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">28,239<span></span>
</td>
<td class="nump">138,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, exercisable price</a></td>
<td class="nump">$ 5.45<span></span>
</td>
<td class="nump">$ 3.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, exercisable price</a></td>
<td class="nump">$ 5.96<span></span>
</td>
<td class="nump">$ 6.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sotk_NonEmployeeDirectorsStockOptionMember', window );">Non-Employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">16,500<span></span>
</td>
<td class="nump">30,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, exercisable price</a></td>
<td class="nump">$ 5.50<span></span>
</td>
<td class="nump">$ 3.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=sotk_EmployeesAndDirectorsMember', window );">Employee and Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Options, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options, vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, per share</a></td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sotk_TwoThousandThirteenStockIncentivePlanMember', window );">the "2013 Plan"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares available for purchase</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Options, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="nump">250,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=sotk_NonEmployeeDirectorsStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=sotk_NonEmployeeDirectorsStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=sotk_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=sotk_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sotk_TwoThousandThirteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sotk_TwoThousandThirteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068376863008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials and subassemblies</a></td>
<td class="nump">$ 1,868,689<span></span>
</td>
<td class="nump">$ 1,250,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">613,915<span></span>
</td>
<td class="nump">779,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">760,305<span></span>
</td>
<td class="nump">343,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total</a></td>
<td class="nump">$ 3,242,909<span></span>
</td>
<td class="nump">$ 2,373,242<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068373501792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Totals</a></td>
<td class="nump">$ 8,934,703<span></span>
</td>
<td class="nump">$ 8,461,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(6,309,707)<span></span>
</td>
<td class="num">(5,900,511)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Equipment, furnishings and leasehold improvements, net</a></td>
<td class="nump">2,624,996<span></span>
</td>
<td class="nump">2,561,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Totals</a></td>
<td class="nump">2,250,000<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_LaboratoryEquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Totals</a></td>
<td class="nump">1,647,951<span></span>
</td>
<td class="nump">1,421,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Totals</a></td>
<td class="nump">1,807,817<span></span>
</td>
<td class="nump">1,729,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Totals</a></td>
<td class="nump">789,044<span></span>
</td>
<td class="nump">715,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_TradeshowAndDemonstrationEquipmentMember', window );">Tradeshow And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Totals</a></td>
<td class="nump">1,137,346<span></span>
</td>
<td class="nump">1,137,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Totals</a></td>
<td class="nump">$ 1,302,545<span></span>
</td>
<td class="nump">$ 1,206,918<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_TradeshowAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sotk_TradeshowAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068380675152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation Expense</a></td>
<td class="nump">$ 492,055<span></span>
</td>
<td class="nump">$ 416,083<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068379798864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 352,619<span></span>
</td>
<td class="nump">$ 449,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Estimated warranty costs</a></td>
<td class="nump">500,650<span></span>
</td>
<td class="nump">622,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Accrued commissions</a></td>
<td class="nump">157,927<span></span>
</td>
<td class="nump">195,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Professional fees</a></td>
<td class="nump">100,921<span></span>
</td>
<td class="nump">104,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Other accrued expenses</a></td>
<td class="nump">315,329<span></span>
</td>
<td class="nump">431,190<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 1,427,446<span></span>
</td>
<td class="nump">$ 1,804,028<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377638288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVOLVING LINE OF CREDIT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving line of credit</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate</a></td>
<td class="nump">7.75%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers', window );">Credit line utilized to collateralize letter of credit issued to customers</a></td>
<td class="nump">$ 145,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Unused portion of credit line</a></td>
<td class="nump">$ 1,355,000<span></span>
</td>
<td class="nump">$ 1,495,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount borrowed under the credit facility being utilized to collateralize letters of credit issued to customers for cash deposits on existing orders during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377763424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Details Narrative) - Unsecured Debt [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,001,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Gain on forgiveness of debt</a></td>
<td class="nump">$ 1,005,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377340928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Income tax reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Expected federal income tax</a></td>
<td class="nump">$ 165,882<span></span>
</td>
<td class="nump">$ 609,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax, net of federal</a></td>
<td class="nump">37,204<span></span>
</td>
<td class="nump">37,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="num">(127,329)<span></span>
</td>
<td class="num">(101,573)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Permanent differences</a></td>
<td class="nump">78,252<span></span>
</td>
<td class="num">(179,320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(5,253)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 154,009<span></span>
</td>
<td class="nump">$ 361,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068375931232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Current and deferred tax expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 438,263<span></span>
</td>
<td class="nump">$ 341,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">83,525<span></span>
</td>
<td class="nump">38,536<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit', window );">Total current income tax</a></td>
<td class="nump">521,788<span></span>
</td>
<td class="nump">380,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(321,458)<span></span>
</td>
<td class="num">(18,787)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(46,321)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Total deferred income tax</a></td>
<td class="num">(367,779)<span></span>
</td>
<td class="num">(18,787)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 154,009<span></span>
</td>
<td class="nump">$ 361,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068375917584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Deferred tax asset and liability components (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Allowance for inventory</a></td>
<td class="nump">$ 76,000<span></span>
</td>
<td class="nump">$ 69,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for accounts receivable</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_CapitalizedRdExpensesIrcSection174', window );">Capitalized R&amp;D expenses &#8211; IRC Section 174</a></td>
<td class="nump">441,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Accrued expenses and other</a></td>
<td class="nump">147,000<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset &#8211; Long Term</a></td>
<td class="nump">667,000<span></span>
</td>
<td class="nump">241,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Building and leasehold depreciation</a></td>
<td class="num">(83,000)<span></span>
</td>
<td class="num">(169,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liability &#8211; Long Term</a></td>
<td class="num">$ (83,000)<span></span>
</td>
<td class="num">$ (169,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_CapitalizedRdExpensesIrcSection174">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_CapitalizedRdExpensesIrcSection174</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068377720352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Numerator for basic and diluted earnings per share</a></td>
<td class="nump">$ 635,905<span></span>
</td>
<td class="nump">$ 2,542,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic earnings per share - weighted average</a></td>
<td class="nump">15,735,451<span></span>
</td>
<td class="nump">15,586,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effects of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options for employees, directors and outside consultants</a></td>
<td class="nump">34,048<span></span>
</td>
<td class="nump">37,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted earnings per share</a></td>
<td class="nump">15,769,499<span></span>
</td>
<td class="nump">15,623,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Earnings Per Share &#8211; Weighted Average</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Earnings Per Share &#8211; Weighted Average</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068378721088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total sales</a></td>
<td class="nump">$ 8,254,000<span></span>
</td>
<td class="nump">$ 11,653,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total sales</a></td>
<td class="nump">3,260,000<span></span>
</td>
<td class="nump">5,301,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember', window );">Middle East [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total sales</a></td>
<td class="nump">3,448,000<span></span>
</td>
<td class="nump">5,255,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember', window );">Latin America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total sales</a></td>
<td class="nump">$ 1,546,000<span></span>
</td>
<td class="nump">$ 1,097,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_MiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140068376053472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 15,058,203<span></span>
</td>
<td class="nump">$ 17,132,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Foreign Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="nump">$ 8,254,000<span></span>
</td>
<td class="nump">$ 11,653,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sotk_SalesRevenuePercent', window );">Sales revenue, percent</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Outstanding accounts receivables, percent</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Three Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Outstanding accounts receivables, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Outstanding accounts receivables, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Outstanding accounts receivables, percent</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sotk_SalesRevenuePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Sales Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sotk_SalesRevenuePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sotk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=sotk_ForeignCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=sotk_ForeignCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=sotk_TwoCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=sotk_TwoCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=sotk_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=sotk_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>eps10796_sotk_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sotk="http://sono-tek.com/20230228"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sotk-20230228.xsd" xlink:type="simple"/>
    <context id="From2022-03-01to2023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <instant>2023-05-23</instant>
        </period>
    </context>
    <context id="From2021-03-012022-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2021-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="AsOf2021-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="AsOf2021-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="AsOf2021-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:EquipmentAndFurnishingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:EquipmentAndFurnishingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_FluxingSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:FluxingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_FluxingSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:FluxingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_IntegratedCoatingSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:IntegratedCoatingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_IntegratedCoatingSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:IntegratedCoatingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_MultiAxisCoatingSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:MultiAxisCoatingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_MultiAxisCoatingSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:MultiAxisCoatingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_OemSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OemSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_OemSystemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OemSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_OtherProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OtherProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_OtherProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:OtherProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_ProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:ProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_ProductLineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sotk:ProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sotk:TwoThousandThirteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sotk:TwoThousandThirteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_NonEmployeeDirectorsStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:NonEmployeeDirectorsStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:EmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_NonEmployeeDirectorsStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:NonEmployeeDirectorsStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">sotk:EmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2020-03-012021-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_custom_LaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_TradeshowAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:TradeshowAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_custom_TradeshowAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sotk:TradeshowAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_LetterOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_LetterOfCreditMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_UnsecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="From2022-04-012022-04-30_us-gaap_UnsecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_MiddleEastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_srt_LatinAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_srt_LatinAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sotk:ForeignCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sotk:ForeignCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_TwoCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:TwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_custom_ThreeCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_ThreeCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="From2021-03-012022-02-28_custom_TwoCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000806172</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">sotk:TwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-03-01to2023-02-28">0000806172</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-03-01to2023-02-28">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2022-03-01to2023-02-28">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-03-01to2023-02-28">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentAnnualReport contextRef="From2022-03-01to2023-02-28">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport contextRef="From2022-03-01to2023-02-28">false</dei:DocumentTransitionReport>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2021-03-012022-02-28"
      id="xdx2ixbrl0192"
      unitRef="USD"
      xsi:nil="true"/>
    <sotk:GainFromForgivenessOfPaycheckProtectionProgramLoan
      contextRef="From2022-03-01to2023-02-28"
      id="xdx2ixbrl0194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-03-012022-02-28"
      id="xdx2ixbrl0233"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-03-01to2023-02-28"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <sotk:AccountsReceivableReserve
      contextRef="From2021-03-012022-02-28"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <sotk:PaycheckProtectionProgramLoanForgiveness
      contextRef="From2022-03-01to2023-02-28"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-03-01to2023-02-28"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-03-01to2023-02-28"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2022-03-01to2023-02-28"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2021-03-012022-02-28"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-02-28_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2022-02-28_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2022-03-01to2023-02-28"
      id="xdx2ixbrl0811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      id="xdx2ixbrl0835"
      unitRef="USD"
      xsi:nil="true"/>
    <sotk:CapitalizedRdExpensesIrcSection174
      contextRef="AsOf2022-02-28"
      id="xdx2ixbrl0855"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-03-01to2023-02-28">10-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-03-01to2023-02-28">2023-02-28</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-03-01to2023-02-28">--02-28</dei:CurrentFiscalYearEndDate>
    <dei:EntityFileNumber contextRef="From2022-03-01to2023-02-28">000-16035</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-03-01to2023-02-28">Sono Tek Corp</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-03-01to2023-02-28">NY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-03-01to2023-02-28">14-1568099</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-03-01to2023-02-28">2012 Route 9W</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-03-01to2023-02-28">Milton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-03-01to2023-02-28">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-03-01to2023-02-28">12547</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-03-01to2023-02-28">(845)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-03-01to2023-02-28">795-2020</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-03-01to2023-02-28">Common Stock $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-03-01to2023-02-28">SOTK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-03-01to2023-02-28">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2022-03-01to2023-02-28">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2022-03-01to2023-02-28">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2022-03-01to2023-02-28">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-03-01to2023-02-28">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-03-01to2023-02-28">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-03-01to2023-02-28">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-03-01to2023-02-28">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2022-03-01to2023-02-28">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2022-03-01to2023-02-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2022-03-01to2023-02-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2023-08-31" decimals="0" unitRef="USD">81462747</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-05-23" decimals="INF" unitRef="Shares">15742073</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2022-03-01to2023-02-28">None.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName contextRef="From2022-03-01to2023-02-28">Marcum LLP</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2022-03-01to2023-02-28">688</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2021-03-012022-02-28">Friedman LLP</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2021-03-012022-02-28">711</dei:AuditorFirmId>
    <dei:AuditorLocation contextRef="From2022-03-01to2023-02-28">East Hanover, New Jersey</dei:AuditorLocation>
    <dei:AuditorLocation contextRef="From2021-03-012022-02-28">East Hanover, New Jersey</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">3354601</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">4840558</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">8090000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">5867990</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">12225</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">56123</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">1633866</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">1092505</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">3242909</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">2373242</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">254046</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">323304</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">16575422</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">14497599</us-gaap:AssetsCurrent>
    <us-gaap:Land contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">250000</us-gaap:Land>
    <us-gaap:Land contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">250000</us-gaap:Land>
    <sotk:BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">2624996</sotk:BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet>
    <sotk:BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">2561184</sotk:BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">57202</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">76015</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">667098</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">240736</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:Assets contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">20174718</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">17625534</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">810863</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">684511</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">1427446</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">1804028</us-gaap:AccruedLiabilitiesCurrent>
    <sotk:CustomerDeposits contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">2838165</sotk:CustomerDeposits>
    <sotk:CustomerDeposits contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">1167968</sotk:CustomerDeposits>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">381421</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">58874</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">5457895</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">3715381</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">82865</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">168840</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">5540760</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">3884221</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-02-28"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-02-28"
      decimals="INF"
      unitRef="USDPShares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-02-28" decimals="INF" unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-02-28" decimals="INF" unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2023-02-28" decimals="INF" unitRef="Shares">15742073</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-02-28" decimals="INF" unitRef="Shares">15742073</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-02-28" decimals="INF" unitRef="Shares">15729175</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-02-28" decimals="INF" unitRef="Shares">15729175</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">157421</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">157292</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">9566898</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">9310287</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">4909639</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">4273734</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">14633958</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">13741313</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">20174718</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">17625534</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">15058203</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">17132710</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">7406196</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">8520156</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">7652007</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">8612554</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">2149525</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1729509</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">3169730</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">3367403</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">1649761</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1626306</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">6969016</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">6723218</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">682991</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1889336</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">140042</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">9496</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-33119</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <sotk:GainFromForgivenessOfPaycheckProtectionProgramLoan
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1005372</sotk:GainFromForgivenessOfPaycheckProtectionProgramLoan>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">789914</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">2904204</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">154009</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">361631</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">635905</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">2542573</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">15735451</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">15586404</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">15769499</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">15623485</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15452656</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-02-28_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">154527</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">9064994</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">1731161</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-02-28" decimals="0" unitRef="USD">10950682</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">179283</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">179283</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sotk:StockIssuedDuringPeriodSharesCashlessExerciseStockOptions
      contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">249019</sotk:StockIssuedDuringPeriodSharesCashlessExerciseStockOptions>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2490</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-2490</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sotk:ProceedsFromExerciseOfStockOptionsShares
      contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">27500</sotk:ProceedsFromExerciseOfStockOptionsShares>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-03-012022-02-28_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">275</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-03-012022-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">68500</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">68775</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProfitLoss
      contextRef="From2021-03-012022-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">2542573</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">2542573</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15729175</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">157292</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">9310287</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">4273734</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">13741313</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">256740</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">256740</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sotk:StockIssuedDuringPeriodSharesCashlessExerciseStockOptions
      contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">12898</sotk:StockIssuedDuringPeriodSharesCashlessExerciseStockOptions>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">129</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-129</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ProfitLoss
      contextRef="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">635905</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">635905</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15742073</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">157421</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">9566898</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">4909639</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">14633958</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">635905</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">2542573</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">510868</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">435525</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">256740</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">179283</us-gaap:StockOptionPlanExpense>
    <sotk:AccountsReceivableReserve
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">43898</sotk:AccountsReceivableReserve>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">4864</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">43381</us-gaap:InventoryLIFOReservePeriodCharge>
    <sotk:PaycheckProtectionProgramLoanForgiveness
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1005372</sotk:PaycheckProtectionProgramLoanForgiveness>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-33119</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-512337</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-17620</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">497463</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-665297</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">874531</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-194483</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-69258</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">171988</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">126352</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-606241</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-376582</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">53112</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <sotk:IncreaseDecreaseInCustomerDeposit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">1670197</sotk:IncreaseDecreaseInCustomerDeposit>
    <sotk:IncreaseDecreaseInCustomerDeposit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1427</sotk:IncreaseDecreaseInCustomerDeposit>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">322547</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">5307</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">1325039</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">2319167</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">555867</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">326942</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">2255129</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1304520</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-2810996</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-1631462</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">68775</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">68775</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-1485957</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">756480</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">4840558</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-02-28" decimals="0" unitRef="USD">4084078</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">3354601</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">4840558</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">363590</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">373928</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zJqva0ih9kT8" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 1: &lt;span id="xdx_821_zYEznXNYoBx1"&gt;BUSINESS DESCRIPTION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Sono-Tek Corporation (the &#x201c;Company&#x201d;, &#x201c;Sono-Tek&#x201d;,
&#x201c;We&#x201d; or &#x201c;Our&#x201d;) was incorporated in New York on March 21, 1975. We are the world leader in the design and manufacture
of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on
parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research &amp;amp; development/other
markets. We design and manufacture custom-engineered ultrasonic coating systems incorporating our patented technology, in combination
with strong applications engineering knowledge, to assist our customers in achieving their desired coating solutions.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zxc7AH0IcNog" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 2: &lt;span id="xdx_826_ze2bHIrtG39j"&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_ztIK889gJFO" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zyPQdQSUUMO8"&gt;Advertising Expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;The Company expenses the
cost of advertising in the period in which the advertising takes place. Advertising expense for fiscal 2023 and fiscal 2022 was $&lt;span id="xdx_909_eus-gaap--AdvertisingExpense_c20220301__20230228_pp0p0" title="Advertising expense"&gt;297,500&lt;/span&gt;
and $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_c20210301__20220228_pp0p0" title="Advertising expense"&gt;178,500&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zdVbq1h4tR22" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zAzk3cdHk974"&gt;Accounts Receivable, net&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;In the normal course of business,
the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value
of receivables and approximate fair value. The Company records a bad debt expense/allowance based on management&#x2019;s estimate of uncollectible
accounts. All outstanding accounts receivable accounts are reviewed for collectability on an individual basis.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z076pfobOQ0h" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zZPlbcJPMu0j"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Cash and cash equivalents consist of money market mutual funds, short term commercial paper
and short-term certificates of deposit with original maturities of 90 days or less. At February 28, 2023, the Company had &lt;span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20230228_zBJYVfIDMfnc" title="Cash in excess of the FDIC insured limit"&gt;2,892,000&lt;/span&gt; of
cash in excess of the FDIC insured limit.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zKy5jPPT87l" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_z8mSdoE2VOJ1"&gt;Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - The accompanying consolidated financial
statements of the Company include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (&#x201c;SIP&#x201d;)
in conformity with generally accepted accounting principles in the United States (&#x201c;GAAP&#x201d;). SIP operates as a real estate holding
company for the Company&#x2019;s real estate operations. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z5QMYx36mYof" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zjVIWjHUTqPl"&gt;Earnings Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Basic earnings per share
(&#x201c;EPS&#x201d;) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted
EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted
into common stock under the treasury stock method.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock_zDBQyxOP37Jc" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zu7nVrb9VSNc"&gt;&lt;b&gt;&lt;i&gt;Equipment,
Furnishings and Leasehold Improvements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt; - Equipment, furnishings and leasehold improvements are stated at cost. Depreciation
of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which
range from three &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MinimumMember_zEa4tQmNJJ25" style="display: none"&gt;3
&lt;/span&gt;to five years &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MaximumMember_zODz3BLGnR62" style="display: none" title="Estimated useful lives"&gt;5&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOJNu1gdDiDd" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zR9AhMBu2XG7"&gt;Fair Value of Financial Instruments&lt;/span&gt; -&lt;/i&gt;&lt;/b&gt; The Company applies
Accounting Standards Codification (&#x201c;ASC&#x201d;) 820,&#160;&lt;i&gt;Fair Value Measurement&#160;&lt;/i&gt;(&#x201c;ASC 820&#x201d;), which establishes
a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an
exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company&#x2019;s principal or
most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established
in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring
fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed
based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity&#x2019;s own assumptions
based on market data and the entity&#x2019;s judgments about the assumptions that market participants would use in pricing the asset or
liability and are to be developed based on the best information available in the circumstances.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The carrying amounts of financial instruments reported in the accompanying
consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term
maturities of the financial instruments.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The valuation hierarchy is composed of three levels. The classification
within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within
the valuation hierarchy are described below:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Level 1 &#x2014; Assets and liabilities with unadjusted, quoted prices
listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets
for identical assets or liabilities.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Level 2 &#x2014; Inputs to the fair value measurement are determined
using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs,
such as interest rates and yield curves that are observable at commonly quoted intervals.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Level 3 &#x2014; Inputs to the fair value measurement are unobservable
inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;The fair values of financial assets of the
Company were determined using the following categories at February 28, 2023 and February 28, 2022, respectively:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z9W5C1Atvvv9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B9_z2EWxR77nGMd" style="display: none"&gt;Significant accounting policies - fair values of financial assets of the company&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 44%; padding-bottom: 2.5pt"&gt;Marketable Securities &#x2013; February 28, 2023&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;7,361,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;729,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0415"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;8,090,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Marketable Securities &#x2013; February 28, 2022&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;5,716,338&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;151,652&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0423"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;5,867,990&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;Marketable Securities include certificates
of deposit and US Treasury securities, totaling $&lt;span id="xdx_90D_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" title="Marketable securities"&gt;8,090,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" title="Marketable securities"&gt;5,867,990&lt;/span&gt; that are considered to be highly liquid and easily tradeable
as of February 28, 2023 and February 28, 2022, respectively. US Treasury securities are valued using inputs observable in active markets
for identical securities and are therefore classified as Level&#160;1 and certificates of deposit are classified as Level 2 within the
Company&#x2019;s fair value hierarchy. The Company&#x2019;s marketable securities are considered to be trading securities as defined under
ASC 320 &#x201c;Investments &#x2013; Debt and Equity Securities.&#x201d;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;




&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zPcYB0NOuqQg" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z86KLktVApA9"&gt;Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - The Company accounts for income taxes
under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of "temporary
differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying
amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax
asset will not be realized, a valuation allowance is recognized. The Company uses a recognition threshold and a measurement attribute
for financial statement recognition and measurement of tax positions taken or expected to be taken in a return. For those benefits to
be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. As of February 28,
2023 and February 28, 2022, there were &lt;span id="xdx_90E_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20230228_zaSL115rYzZc" title="Uncertain tax positions"&gt;&lt;span id="xdx_901_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20220228_zW9qX9qkcMFk" title="Uncertain tax positions"&gt;no&lt;/span&gt;&lt;/span&gt; uncertain tax positions.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z6UkSEsuRQCj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zBX8vf7mtbP2"&gt;Intangible
Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Include costs of patent applications which are deferred and charged to operations over seventeen &lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230228_zUdtN3M69Jt" style="display: none" title="Useful life of intangible assets"&gt;17&lt;/span&gt;
years for domestic patents and &lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220228_zYouIz3hltu4" style="display: none" title="Useful life of intangible assets"&gt;12&lt;/span&gt; twelve years for foreign patents, which is considered the useful life. The accumulated
amortization of patents is $&lt;span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230228_pp0p0" title="Accumulated amortization of patents"&gt;202,681&lt;/span&gt;
and $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220228_pp0p0" title="Accumulated amortization of patents"&gt;192,490&lt;/span&gt;
at February 28, 2023 and February 28, 2022, respectively. Annual amortization expense of such intangible assets is expected to be
approximately $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20230228_zxHdm0XiH7t2" title="Annual amortization expense this year"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20230228_zy6RjLyI5bUl" title="Annual amortization expense year two"&gt;&lt;span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20230228_zcwkd9gGjWk9" title="Annual amortization expense year three"&gt;&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20230228_zozE9sfhoIfj" title="Annual amortization expense year four"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20230228_zZU2wpZwxuVd" title="Annual amortization expense year five"&gt;11,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
per year for the next five years.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zmkyuYg7s9G3" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zBBEbTbjquLg"&gt;Inventories&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Inventories are stated at the lower
of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress
and the specific identification method for finished goods. Management compares the cost of inventory with the net realizable value and,
if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis,
inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand
and market conditions.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7VsoQGl5Vs4" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zCNQ9vneYrwa"&gt;Land and Buildings&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;Land and buildings are stated at
cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228_z0jmoiIsj9Yk" style="display: none" title="Estimated useful life"&gt;40&lt;/span&gt; forty years.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;At February 28, 2023 and 2022, the Company had Land, stated at cost of $&lt;span id="xdx_90C_eus-gaap--Land_iI_pp0p0_c20230228_zjmgpsXCaY24" title="Land"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zzpIvtRvLyHb" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_znxkHFIK9wDe"&gt;Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;The Company periodically
evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The
carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately
identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value
exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted
at a rate commensurate with the risk involved. &lt;span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220301__20230228_zFxQK6IuMbYc" title="Impairment losses"&gt;&lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210301__20220228_z8J444mb3QPd" title="Impairment losses"&gt;No&lt;/span&gt;&lt;/span&gt; impairment losses were identified or recorded for the years ended February 28, 2023
and February 28, 2022 on the Company&#x2019;s long-lived assets.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zOpTtxHycy01" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zoN7be49pejc"&gt;Management Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;The preparation of the
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zPZG0luBwcOe" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zUSjXTGxMbai"&gt;New
Accounting Pronouncements &lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&#x2013; In June 2016, the FASB issued ASU 2016-13 - Financial Instruments-Credit
Losses-Measurement of Credit Losses on Financial Instruments. Codification Improvements to Topic 326, Financial Instruments &#x2013;
Credit Losses, have been released in November 2018 (2018-19), November 2019 (2019-10 and 2019-11) and a January 2020 Update
(2020-02) that provided additional guidance on this Topic. This guidance replaces the current incurred loss impairment methodology
with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable
information to inform credit loss estimates. For SEC filers meeting certain criteria, the amendments in this ASU are effective for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For SEC filers that meet the
criteria of a smaller reporting company (including this Company) and for non-SEC registrant public companies and other
organizations, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning
after December 15, 2022. Early adoption will be permitted for all organizations for fiscal years, and interim periods within those
fiscal years, beginning after December 15, 2019. The Company has adopted ASU 2016-13 as updated and does not expect the adoption of
this guidance to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Other than Accounting Standards Update (&#x201c;ASU&#x201d;) ASU 2016-13 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable
to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;




&lt;p id="xdx_84D_eus-gaap--StandardProductWarrantyPolicy_zhJptZDW8Pvf" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zmlpsxgIaJu7"&gt;Product Warranty&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - Expected future product warranty expense is recorded when revenue is recognized for product
sales.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhZzJAtMVTv" style="font: 11pt Cambria,serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zGz3lzCZGSB5"&gt;Reclassifications&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;Building,
equipment, leasehold improvements reclassifications have been made to the fiscal 2022 consolidated financial statements to conform to
the fiscal 2023 consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously
reported.&lt;/p&gt;



&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zMGnwl1QLy93" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_z0stfiIeUEd1"&gt;Research and Product Development Expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Research
and product development expenses represent engineering and other expenditures incurred for developing new products, for refining the Company's
existing products and for developing systems to meet unique customer specifications for potential orders or for new industry applications
and are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;During fiscal 2023 and fiscal 2022, the Company spent approximately
$&lt;span id="xdx_90A_eus-gaap--OtherResearchAndDevelopmentExpense_c20220301__20230228_zviNPQgZkrnj" title="Research and development expenses"&gt;2,149,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--OtherResearchAndDevelopmentExpense_c20210301__20220228_zGKjaalDo0wd" title="Research and development expenses"&gt;1,730,000&lt;/span&gt;, respectively, on research and development activities related to new products and services and the ongoing improvement
of existing products and services.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zBXVmzTPbQ6d" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zxWqMSmHzcX9"&gt;Revenue Recognition&lt;/span&gt; -&lt;/i&gt;&lt;/b&gt; The Company recognizes
revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should
recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to
which the entity expects to be entitled to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 11pt"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; font-family: Times New Roman,serif"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Identification of the contract, or contracts, with a customer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Recognition of revenue when, or as, performance obligations are satisfied&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zmkBHO9dWhj6" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zbnfr1OxsiV6"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - The Company currently uses
a Black-Scholes option pricing model to calculate the fair value of its stock options. The fair value of each option is estimated on the
date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility;
and expected lives of the awards. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes
model. The assumptions used in calculating the fair value of share-based payment awards represent management&#x2019;s best estimates, but
these estimates involve inherent uncertainties and the application of management judgment.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;ASC 718 requires the recognition of the fair value of stock compensation
expense to be recognized over the vesting term of such award. The Company accounts for forfeitures as they occur.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--UncertaintiesPolicyTextBlock_z4eTRDL6drs2" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zaWtAF5TttVf"&gt;Uncertainties&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;Since early 2020, when the World Health
Organization established the transmissible and pathogenic coronavirus a global pandemic, there have been business slowdowns. The outbreak
of such a communicable disease has resulted in a widespread health crisis which has adversely affected general commercial activity and
the economies and financial markets of many countries, including the United States. As the outbreak of the disease has continued through
fiscal 2022 and into fiscal 2023, the measures taken by the governments of impacted countries have, at times, adversely affected the
Company&#x2019;s business, financial condition, and results of operations. Pandemic related supply shortages and increased energy expenses
resulting from the war in Ukraine have recently created worldwide inflationary pressures which may have a material adverse effect on
the Company's business, financial condition, and results of operations if such factors continue unabated.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company has encountered challenges in procuring supplies of various materials and components,
and electronic components in particular, due to well-documented shortages and constraints in the global supply chain. Lead times for ordered
components may vary significantly, and some components used to manufacture our products are provided by a limited number of sources. The
Company experienced lengthened lead times throughout its supply chain as a result of supply chain constraints and material shortages that
have occurred through fiscal year 2023. This has been exacerbated by the recent resurgence of the COVID-19 pandemic in certain parts of
China, which has resulted in the temporary closure of manufacturing facilities, including those that manufacture electronic parts that
the Company includes in its products.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;




</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_ztIK889gJFO" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zyPQdQSUUMO8"&gt;Advertising Expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;The Company expenses the
cost of advertising in the period in which the advertising takes place. Advertising expense for fiscal 2023 and fiscal 2022 was $&lt;span id="xdx_909_eus-gaap--AdvertisingExpense_c20220301__20230228_pp0p0" title="Advertising expense"&gt;297,500&lt;/span&gt;
and $&lt;span id="xdx_90B_eus-gaap--AdvertisingExpense_c20210301__20220228_pp0p0" title="Advertising expense"&gt;178,500&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">297500</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">178500</us-gaap:AdvertisingExpense>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zdVbq1h4tR22" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zAzk3cdHk974"&gt;Accounts Receivable, net&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;In the normal course of business,
the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value
of receivables and approximate fair value. The Company records a bad debt expense/allowance based on management&#x2019;s estimate of uncollectible
accounts. All outstanding accounts receivable accounts are reviewed for collectability on an individual basis.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z076pfobOQ0h" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zZPlbcJPMu0j"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Cash and cash equivalents consist of money market mutual funds, short term commercial paper
and short-term certificates of deposit with original maturities of 90 days or less. At February 28, 2023, the Company had &lt;span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20230228_zBJYVfIDMfnc" title="Cash in excess of the FDIC insured limit"&gt;2,892,000&lt;/span&gt; of
cash in excess of the FDIC insured limit.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashUninsuredAmount contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">2892000</us-gaap:CashUninsuredAmount>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zKy5jPPT87l" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_z8mSdoE2VOJ1"&gt;Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - The accompanying consolidated financial
statements of the Company include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (&#x201c;SIP&#x201d;)
in conformity with generally accepted accounting principles in the United States (&#x201c;GAAP&#x201d;). SIP operates as a real estate holding
company for the Company&#x2019;s real estate operations. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z5QMYx36mYof" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zjVIWjHUTqPl"&gt;Earnings Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Basic earnings per share
(&#x201c;EPS&#x201d;) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted
EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted
into common stock under the treasury stock method.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <sotk:EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_848_ecustom--EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock_zDBQyxOP37Jc" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zu7nVrb9VSNc"&gt;&lt;b&gt;&lt;i&gt;Equipment,
Furnishings and Leasehold Improvements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt; - Equipment, furnishings and leasehold improvements are stated at cost. Depreciation
of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which
range from three &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MinimumMember_zEa4tQmNJJ25" style="display: none"&gt;3
&lt;/span&gt;to five years &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentAndFurnishingsMember__srt--RangeAxis__srt--MaximumMember_zODz3BLGnR62" style="display: none" title="Estimated useful lives"&gt;5&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;




</sotk:EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-02-28_custom_EquipmentAndFurnishingsMember_srt_MaximumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zOJNu1gdDiDd" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zR9AhMBu2XG7"&gt;Fair Value of Financial Instruments&lt;/span&gt; -&lt;/i&gt;&lt;/b&gt; The Company applies
Accounting Standards Codification (&#x201c;ASC&#x201d;) 820,&#160;&lt;i&gt;Fair Value Measurement&#160;&lt;/i&gt;(&#x201c;ASC 820&#x201d;), which establishes
a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an
exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company&#x2019;s principal or
most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established
in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring
fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed
based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity&#x2019;s own assumptions
based on market data and the entity&#x2019;s judgments about the assumptions that market participants would use in pricing the asset or
liability and are to be developed based on the best information available in the circumstances.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The carrying amounts of financial instruments reported in the accompanying
consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term
maturities of the financial instruments.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The valuation hierarchy is composed of three levels. The classification
within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within
the valuation hierarchy are described below:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Level 1 &#x2014; Assets and liabilities with unadjusted, quoted prices
listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets
for identical assets or liabilities.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Level 2 &#x2014; Inputs to the fair value measurement are determined
using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs,
such as interest rates and yield curves that are observable at commonly quoted intervals.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Level 3 &#x2014; Inputs to the fair value measurement are unobservable
inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;The fair values of financial assets of the
Company were determined using the following categories at February 28, 2023 and February 28, 2022, respectively:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z9W5C1Atvvv9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B9_z2EWxR77nGMd" style="display: none"&gt;Significant accounting policies - fair values of financial assets of the company&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 44%; padding-bottom: 2.5pt"&gt;Marketable Securities &#x2013; February 28, 2023&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;7,361,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;729,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0415"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;8,090,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Marketable Securities &#x2013; February 28, 2022&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;5,716,338&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;151,652&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0423"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;5,867,990&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;Marketable Securities include certificates
of deposit and US Treasury securities, totaling $&lt;span id="xdx_90D_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" title="Marketable securities"&gt;8,090,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" title="Marketable securities"&gt;5,867,990&lt;/span&gt; that are considered to be highly liquid and easily tradeable
as of February 28, 2023 and February 28, 2022, respectively. US Treasury securities are valued using inputs observable in active markets
for identical securities and are therefore classified as Level&#160;1 and certificates of deposit are classified as Level 2 within the
Company&#x2019;s fair value hierarchy. The Company&#x2019;s marketable securities are considered to be trading securities as defined under
ASC 320 &#x201c;Investments &#x2013; Debt and Equity Securities.&#x201d;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;




</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z9W5C1Atvvv9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B9_z2EWxR77nGMd" style="display: none"&gt;Significant accounting policies - fair values of financial assets of the company&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Cambria,serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 8pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 44%; padding-bottom: 2.5pt"&gt;Marketable Securities &#x2013; February 28, 2023&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;7,361,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;729,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_c20230228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0415"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--MarketableSecuritiesCurrent_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right" title="Marketable Securities"&gt;8,090,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Marketable Securities &#x2013; February 28, 2022&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;5,716,338&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;151,652&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_c20220228__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0423"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Marketable Securities"&gt;5,867,990&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-02-28_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      unitRef="USD">7361000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2023-02-28_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      unitRef="USD">729000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">8090000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2022-02-28_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      unitRef="USD">5716338</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="AsOf2022-02-28_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      unitRef="USD">151652</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">5867990</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">8090000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">5867990</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zPcYB0NOuqQg" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z86KLktVApA9"&gt;Income Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - The Company accounts for income taxes
under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of "temporary
differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying
amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax
asset will not be realized, a valuation allowance is recognized. The Company uses a recognition threshold and a measurement attribute
for financial statement recognition and measurement of tax positions taken or expected to be taken in a return. For those benefits to
be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. As of February 28,
2023 and February 28, 2022, there were &lt;span id="xdx_90E_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20230228_zaSL115rYzZc" title="Uncertain tax positions"&gt;&lt;span id="xdx_901_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20220228_zW9qX9qkcMFk" title="Uncertain tax positions"&gt;no&lt;/span&gt;&lt;/span&gt; uncertain tax positions.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LiabilityForUncertainTaxPositionsCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">0</us-gaap:LiabilityForUncertainTaxPositionsCurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">0</us-gaap:LiabilityForUncertainTaxPositionsCurrent>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z6UkSEsuRQCj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zBX8vf7mtbP2"&gt;Intangible
Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Include costs of patent applications which are deferred and charged to operations over seventeen &lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230228_zUdtN3M69Jt" style="display: none" title="Useful life of intangible assets"&gt;17&lt;/span&gt;
years for domestic patents and &lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220228_zYouIz3hltu4" style="display: none" title="Useful life of intangible assets"&gt;12&lt;/span&gt; twelve years for foreign patents, which is considered the useful life. The accumulated
amortization of patents is $&lt;span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230228_pp0p0" title="Accumulated amortization of patents"&gt;202,681&lt;/span&gt;
and $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220228_pp0p0" title="Accumulated amortization of patents"&gt;192,490&lt;/span&gt;
at February 28, 2023 and February 28, 2022, respectively. Annual amortization expense of such intangible assets is expected to be
approximately $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20230228_zxHdm0XiH7t2" title="Annual amortization expense this year"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20230228_zy6RjLyI5bUl" title="Annual amortization expense year two"&gt;&lt;span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20230228_zcwkd9gGjWk9" title="Annual amortization expense year three"&gt;&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20230228_zozE9sfhoIfj" title="Annual amortization expense year four"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20230228_zZU2wpZwxuVd" title="Annual amortization expense year five"&gt;11,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
per year for the next five years.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="AsOf2023-02-28">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="AsOf2022-02-28">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">202681</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">192490</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">11000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">11000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">11000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">11000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">11000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zmkyuYg7s9G3" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zBBEbTbjquLg"&gt;Inventories&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Inventories are stated at the lower
of cost or net realizable value. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress
and the specific identification method for finished goods. Management compares the cost of inventory with the net realizable value and,
if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis,
inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand
and market conditions.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7VsoQGl5Vs4" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zCNQ9vneYrwa"&gt;Land and Buildings&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;Land and buildings are stated at
cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230228_z0jmoiIsj9Yk" style="display: none" title="Estimated useful life"&gt;40&lt;/span&gt; forty years.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;At February 28, 2023 and 2022, the Company had Land, stated at cost of $&lt;span id="xdx_90C_eus-gaap--Land_iI_pp0p0_c20230228_zjmgpsXCaY24" title="Land"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-02-28">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Land contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">250000</us-gaap:Land>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zzpIvtRvLyHb" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_znxkHFIK9wDe"&gt;Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;The Company periodically
evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The
carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately
identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value
exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted
at a rate commensurate with the risk involved. &lt;span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220301__20230228_zFxQK6IuMbYc" title="Impairment losses"&gt;&lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210301__20220228_z8J444mb3QPd" title="Impairment losses"&gt;No&lt;/span&gt;&lt;/span&gt; impairment losses were identified or recorded for the years ended February 28, 2023
and February 28, 2022 on the Company&#x2019;s long-lived assets.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:UseOfEstimates contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zOpTtxHycy01" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zoN7be49pejc"&gt;Management Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;The preparation of the
consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zPZG0luBwcOe" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zUSjXTGxMbai"&gt;New
Accounting Pronouncements &lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&#x2013; In June 2016, the FASB issued ASU 2016-13 - Financial Instruments-Credit
Losses-Measurement of Credit Losses on Financial Instruments. Codification Improvements to Topic 326, Financial Instruments &#x2013;
Credit Losses, have been released in November 2018 (2018-19), November 2019 (2019-10 and 2019-11) and a January 2020 Update
(2020-02) that provided additional guidance on this Topic. This guidance replaces the current incurred loss impairment methodology
with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable
information to inform credit loss estimates. For SEC filers meeting certain criteria, the amendments in this ASU are effective for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For SEC filers that meet the
criteria of a smaller reporting company (including this Company) and for non-SEC registrant public companies and other
organizations, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning
after December 15, 2022. Early adoption will be permitted for all organizations for fiscal years, and interim periods within those
fiscal years, beginning after December 15, 2019. The Company has adopted ASU 2016-13 as updated and does not expect the adoption of
this guidance to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Other than Accounting Standards Update (&#x201c;ASU&#x201d;) ASU 2016-13 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable
to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;




</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84D_eus-gaap--StandardProductWarrantyPolicy_zhJptZDW8Pvf" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zmlpsxgIaJu7"&gt;Product Warranty&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - Expected future product warranty expense is recorded when revenue is recognized for product
sales.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhZzJAtMVTv" style="font: 11pt Cambria,serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zGz3lzCZGSB5"&gt;Reclassifications&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;Building,
equipment, leasehold improvements reclassifications have been made to the fiscal 2022 consolidated financial statements to conform to
the fiscal 2023 consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously
reported.&lt;/p&gt;



&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zMGnwl1QLy93" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_z0stfiIeUEd1"&gt;Research and Product Development Expenses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt; - &lt;/i&gt;Research
and product development expenses represent engineering and other expenditures incurred for developing new products, for refining the Company's
existing products and for developing systems to meet unique customer specifications for potential orders or for new industry applications
and are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;During fiscal 2023 and fiscal 2022, the Company spent approximately
$&lt;span id="xdx_90A_eus-gaap--OtherResearchAndDevelopmentExpense_c20220301__20230228_zviNPQgZkrnj" title="Research and development expenses"&gt;2,149,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--OtherResearchAndDevelopmentExpense_c20210301__20220228_zGKjaalDo0wd" title="Research and development expenses"&gt;1,730,000&lt;/span&gt;, respectively, on research and development activities related to new products and services and the ongoing improvement
of existing products and services.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">2149000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">1730000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zBXVmzTPbQ6d" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zxWqMSmHzcX9"&gt;Revenue Recognition&lt;/span&gt; -&lt;/i&gt;&lt;/b&gt; The Company recognizes
revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should
recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to
which the entity expects to be entitled to receive in exchange for those goods or services. To determine revenue recognition for
arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 11pt"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; font-family: Times New Roman,serif"&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Identification of the contract, or contracts, with a customer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Symbol; font-size: 11pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Recognition of revenue when, or as, performance obligations are satisfied&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zmkBHO9dWhj6" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zbnfr1OxsiV6"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; - The Company currently uses
a Black-Scholes option pricing model to calculate the fair value of its stock options. The fair value of each option is estimated on the
date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility;
and expected lives of the awards. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes
model. The assumptions used in calculating the fair value of share-based payment awards represent management&#x2019;s best estimates, but
these estimates involve inherent uncertainties and the application of management judgment.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;ASC 718 requires the recognition of the fair value of stock compensation
expense to be recognized over the vesting term of such award. The Company accounts for forfeitures as they occur.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <sotk:UncertaintiesPolicyTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_84A_ecustom--UncertaintiesPolicyTextBlock_z4eTRDL6drs2" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zaWtAF5TttVf"&gt;Uncertainties&lt;/span&gt; - &lt;/i&gt;&lt;/b&gt;Since early 2020, when the World Health
Organization established the transmissible and pathogenic coronavirus a global pandemic, there have been business slowdowns. The outbreak
of such a communicable disease has resulted in a widespread health crisis which has adversely affected general commercial activity and
the economies and financial markets of many countries, including the United States. As the outbreak of the disease has continued through
fiscal 2022 and into fiscal 2023, the measures taken by the governments of impacted countries have, at times, adversely affected the
Company&#x2019;s business, financial condition, and results of operations. Pandemic related supply shortages and increased energy expenses
resulting from the war in Ukraine have recently created worldwide inflationary pressures which may have a material adverse effect on
the Company's business, financial condition, and results of operations if such factors continue unabated.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company has encountered challenges in procuring supplies of various materials and components,
and electronic components in particular, due to well-documented shortages and constraints in the global supply chain. Lead times for ordered
components may vary significantly, and some components used to manufacture our products are provided by a limited number of sources. The
Company experienced lengthened lead times throughout its supply chain as a result of supply chain constraints and material shortages that
have occurred through fiscal year 2023. This has been exacerbated by the recent resurgence of the COVID-19 pandemic in certain parts of
China, which has resulted in the temporary closure of manufacturing facilities, including those that manufacture electronic parts that
the Company includes in its products.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;




</sotk:UncertaintiesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_80A_eus-gaap--RevenueFromContractWithCustomerTextBlock_zcbd8sViFNJ8" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 3: &lt;span id="xdx_82C_zu1sV27A9xm9"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s sales revenue is derived primarily from short
term contracts with customers, which, on average, are in effect for less than twelve months. Sales revenue from manufactured equipment
transferred at a single point in time accounts for a majority of the Company&#x2019;s revenue.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Sales revenue is recognized when control of the Company&#x2019;s manufactured
equipment is transferred to its customers in an amount that reflects the consideration the Company expects to receive based upon the agreed
transaction price. The Company&#x2019;s performance obligations are satisfied when its customers take control of the purchased equipment,
in accordance with the contract terms. Based on prior experience, the Company reasonably estimates its sales returns and warranty reserves.
Sales are presented net of discounts and allowances. Discounts and allowances are determined when a transaction is negotiated. The Company
does not grant its customers or independent representatives the ability to return equipment nor does it grant price adjustments after
a sale is complete.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company does not capitalize any sales commission costs related
to the acquisition of a contract. All commissions related to a performance obligation that are satisfied at a point in time are expensed
when the customer takes control of the purchased equipment and revenue is recognized.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company applies the practical expedient in paragraph ASC 606-10-50-14
and does not disclose information about remaining performance obligations that have original expected durations of one-year or less.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;At February 28, 2023, the Company had received $&lt;span id="xdx_900_ecustom--CashDeposits_iI_pp0p0_c20230228_zQRXA1Ogluob" title="Cash deposits"&gt;2,838,000&lt;/span&gt; in cash
deposits, representing contract liabilities, and had issued Letters of Credit in the amount of $&lt;span id="xdx_90B_eus-gaap--LineOfCredit_c20230228_pp0p0" title="Letter of credit"&gt;145,000&lt;/span&gt; to secure these cash deposits.
At February 28, 2023, the Company was utilizing $&lt;span id="xdx_90C_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20220301__20230228_zA3QWzHJgrgj" title="Line of credit collateral amount"&gt;145,000&lt;/span&gt; of its available credit line to collateralize these letters of credit.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;At February 28, 2022, the Company had received $&lt;span id="xdx_90E_ecustom--CashDeposits_iI_pp0p0_c20220228_zb3HUCxxJt43" title="Cash deposits"&gt;1,168,000&lt;/span&gt; in cash
deposits, representing contract liabilities, and had issued Letters of Credit in the amount of $&lt;span id="xdx_908_eus-gaap--LineOfCredit_c20220228_pp0p0" title="Letter of credit"&gt;5,000&lt;/span&gt; to secure these cash deposits. At
February 28, 2022, the Company was utilizing $&lt;span id="xdx_900_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20210301__20220228_zi9Tqg7WTXql" title="Line of credit collateral amount"&gt;5,000&lt;/span&gt; of its available credit line to collateralize these letters of credit.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s sales revenue, by product line is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zbUbcc6jXoc9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B2_z91GIQ06Awl3" style="display: none"&gt;Revenue recognition - sales revenue by product line&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Twelve Months Ended&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center"&gt;% of total&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center"&gt;% of total&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 44%; text-align: left"&gt;Fluxing Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue"&gt;1,179,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent"&gt;8%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue"&gt;691,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent"&gt;4%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Integrated Coating Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;1,114,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;1,182,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Multi-Axis Coating Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;6,785,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;9,912,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;58%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;OEM Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;2,144,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;2,381,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;3,836,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;2,967,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;TOTAL&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;15,058,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;17,133,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <sotk:CashDeposits contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">2838000</sotk:CashDeposits>
    <us-gaap:LineOfCredit contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">145000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCollateralFeesAmount
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">145000</us-gaap:LineOfCreditFacilityCollateralFeesAmount>
    <sotk:CashDeposits contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">1168000</sotk:CashDeposits>
    <us-gaap:LineOfCredit contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">5000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCollateralFeesAmount
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">5000</us-gaap:LineOfCreditFacilityCollateralFeesAmount>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zbUbcc6jXoc9" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B2_z91GIQ06Awl3" style="display: none"&gt;Revenue recognition - sales revenue by product line&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Twelve Months Ended&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center"&gt;% of total&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic bold 9pt Cambria,serif; text-align: center"&gt;% of total&lt;/td&gt;&lt;td style="font: italic bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 44%; text-align: left"&gt;Fluxing Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue"&gt;1,179,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent"&gt;8%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Sales revenue"&gt;691,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--FluxingSystemsMember_pdd" title="Sales revenue, percent"&gt;4%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Integrated Coating Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;1,114,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;1,182,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--IntegratedCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;7%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Multi-Axis Coating Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;6,785,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;45%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;9,912,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_905_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--MultiAxisCoatingSystemsMember_pdd" title="Sales revenue, percent"&gt;58%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;OEM Systems&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;2,144,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;2,381,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OemSystemsMember_pdd" title="Sales revenue, percent"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;3,836,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SalesRevenuePercent_c20220301__20230228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent"&gt;26%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;2,967,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SalesRevenuePercent_c20210301__20220228__srt--ProductOrServiceAxis__custom--OtherProductLineMember_pdd" title="Sales revenue, percent"&gt;17%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;TOTAL&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20220301__20230228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;15,058,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20210301__20220228__srt--ProductOrServiceAxis__custom--ProductLineMember_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Sales revenue"&gt;17,133,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="From2022-03-012023-02-28_custom_FluxingSystemsMember"
      decimals="0"
      unitRef="USD">1179000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2022-03-012023-02-28_custom_FluxingSystemsMember"
      decimals="INF"
      unitRef="Pure">0.08</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28_custom_FluxingSystemsMember"
      decimals="0"
      unitRef="USD">691000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2021-03-012022-02-28_custom_FluxingSystemsMember"
      decimals="INF"
      unitRef="Pure">0.04</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2022-03-012023-02-28_custom_IntegratedCoatingSystemsMember"
      decimals="0"
      unitRef="USD">1114000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2022-03-012023-02-28_custom_IntegratedCoatingSystemsMember"
      decimals="INF"
      unitRef="Pure">0.07</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28_custom_IntegratedCoatingSystemsMember"
      decimals="0"
      unitRef="USD">1182000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2021-03-012022-02-28_custom_IntegratedCoatingSystemsMember"
      decimals="INF"
      unitRef="Pure">0.07</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2022-03-012023-02-28_custom_MultiAxisCoatingSystemsMember"
      decimals="0"
      unitRef="USD">6785000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2022-03-012023-02-28_custom_MultiAxisCoatingSystemsMember"
      decimals="INF"
      unitRef="Pure">0.45</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28_custom_MultiAxisCoatingSystemsMember"
      decimals="0"
      unitRef="USD">9912000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2021-03-012022-02-28_custom_MultiAxisCoatingSystemsMember"
      decimals="INF"
      unitRef="Pure">0.58</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2022-03-012023-02-28_custom_OemSystemsMember"
      decimals="0"
      unitRef="USD">2144000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2022-03-012023-02-28_custom_OemSystemsMember"
      decimals="INF"
      unitRef="Pure">0.14</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28_custom_OemSystemsMember"
      decimals="0"
      unitRef="USD">2381000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2021-03-012022-02-28_custom_OemSystemsMember"
      decimals="INF"
      unitRef="Pure">0.14</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2022-03-012023-02-28_custom_OtherProductLineMember"
      decimals="0"
      unitRef="USD">3836000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2022-03-012023-02-28_custom_OtherProductLineMember"
      decimals="INF"
      unitRef="Pure">0.26</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28_custom_OtherProductLineMember"
      decimals="0"
      unitRef="USD">2967000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2021-03-012022-02-28_custom_OtherProductLineMember"
      decimals="INF"
      unitRef="Pure">0.17</sotk:SalesRevenuePercent>
    <us-gaap:Revenues
      contextRef="From2022-03-012023-02-28_custom_ProductLineMember"
      decimals="0"
      unitRef="USD">15058000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28_custom_ProductLineMember"
      decimals="0"
      unitRef="USD">17133000</us-gaap:Revenues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_801_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_zw0LNsBVaS2a" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 4: &lt;span id="xdx_820_zCZYFpa6VmI6"&gt;STOCK-BASED COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock Options&lt;/i&gt;&lt;/b&gt; &#x2013; Under the 2013 Stock
Incentive Plan, as amended (the "2013 Plan"), options can be granted to officers, directors, consultants and employees of the
Company and its subsidiaries to purchase up to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_pdd" title="Number of shares available for purchase"&gt;2,500,000&lt;/span&gt; shares of the Company's common stock. Under the 2013 Plan options expire ten
years &lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20220301__20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_z96DDFnsUmph" style="display: none" title="Options, expiration period"&gt;10&lt;/span&gt; after the date of grant. As of February 28, 2023, there were &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenStockIncentivePlanMember_pdd" title="Options outstanding"&gt;250,759&lt;/span&gt; options outstanding under the 2013 plan.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;Under the 2013 Stock Incentive Plan, option prices must
be at least 100% of the fair market value of the common stock at time of grant. For qualified employees, except under certain circumstances
specified in the plan or unless otherwise specified at the discretion of the Board of Directors, no option may be exercised prior to one
year after date of grant, with the balance becoming exercisable in cumulative installments over a three-year period during the term of
the option and terminating at a stipulated period of time after an employee's termination of employment.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;During fiscal 2023, the Company granted options to
acquire &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" title="Options granted"&gt;28,239&lt;/span&gt;
shares to employees exercisable at prices ranging from $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_pdd" title="Options, exercisable price"&gt;5.45&lt;/span&gt;
to $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_pdd" title="Options, exercisable price"&gt;5.96&lt;/span&gt;
and options to acquire &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options granted"&gt;16,500&lt;/span&gt;
shares to the non-employee members of the board of directors with an exercise price of $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options, exercisable price"&gt;5.50&lt;/span&gt;.
The options granted to employees and directors vest over three years &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zd9cIaMSPa41" style="display: none" title="Options, vesting period"&gt;3&lt;/span&gt; and expire in ten years &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zoQcTwBf4pJ2" style="display: none" title="Options, expiration period"&gt;10&lt;/span&gt;.
The options granted by the Company during fiscal 2023 had a combined weighted average grant date fair value of $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220301__20230228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_pdd" title="Weighted average grant date fair value, per share"&gt;3.44&lt;/span&gt; per share.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;During fiscal 2022, the Company granted options to
acquire &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_pdd" title="Options granted"&gt;138,085&lt;/span&gt;
shares to employees exercisable at prices ranging from $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_pdd" title="Options, exercisable price"&gt;3.19&lt;/span&gt;
to $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_pdd" title="Options, exercisable price"&gt;6.26&lt;/span&gt;
and options to acquire &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options granted"&gt;30,250&lt;/span&gt;
shares to the non-employee members of the board of directors with an exercise price of $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228__us-gaap--AwardTypeAxis__custom--NonEmployeeDirectorsStockOptionMember_pdd" title="Options, exercisable price"&gt;3.19&lt;/span&gt;.
The options granted to employees and directors vest over three years &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zzlx2jiT6zq9" style="display: none" title="Options, vesting period"&gt;3&lt;/span&gt;
and expire in ten years &lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_zunttfEZwJga" style="display: none" title="Options, expiration period"&gt;10&lt;/span&gt;. The options granted by the Company during fiscal 2022 had a combined weighted average grant date fair
value of $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210301__20220228__us-gaap--AwardTypeAxis__custom--EmployeesAndDirectorsMember_pdd" title="Weighted average grant date fair value, per share"&gt;2.76&lt;/span&gt; per share.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;A summary of the activity for fiscal 2023 and fiscal 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zZkAmVWrdgB6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;&lt;span id="xdx_8B4_z6I1Bec18f2i" style="display: none"&gt;Stock-based compensation - summary of stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Stock Options&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Exercise Price $&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Term - Years&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 35%"&gt;Balance - February 28, 2021&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210301__20220228_zE30H90Femk9" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options outstanding at beginning of period (in shares)"&gt;508,459&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20210301__20220228_z4kWatz5zhx1" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options exercisable at beginning of period (in shares)"&gt;333,500&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210301__20220228_zJW05n3Vk49d" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)"&gt;2.35&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20210301__20220228_z684LR6idVha" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)"&gt;2.17&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200301__20210228_zw79MWxt1hJe" title="Weighted average remaining term outstanding"&gt;6.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Granted&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)"&gt;168,335&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)"&gt;5.10&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210301__20220228_zLGT7VHWCAL7" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)"&gt;(403,334&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zgqKdd0y3Boi" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)"&gt;(2.12&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20210301__20220228_zKrJjndN7yn7" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)"&gt;(19,750&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zvIv8kUPKaW2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)"&gt;(3.27&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Balance - February 28, 2022&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220301__20230228_zJ86AJ2Mo11g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at beginning of period (in shares)"&gt;253,710&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20220301__20230228_zXRMycy4g36g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at beginning of period (in shares)"&gt;61,690&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220301__20230228_z6X2RiH04sG9" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)"&gt;4.46&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20220301__20230228_zx24UyvWYxBi" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)"&gt;3.53&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210301__20220228_zUAE1Uypk6Ta" title="Weighted average remaining term outstanding"&gt;8.94&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Granted&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)"&gt;44,739&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)"&gt;5.71&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220301__20230228_z5SzFxXaUo7g" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)"&gt;(16,973&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zQtD2LTtdTKc" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)"&gt;(1.77&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220301__20230228_zFxx7wlizET1" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)"&gt;(30,717&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zTHt9YCvFr81" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)"&gt;(4.66&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Balance - February 28, 2023&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220301__20230228_zdBTcJX7oaL5" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at end of period (in shares)"&gt;250,759&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220301__20230228_zVAaCqMxpmfb" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at end of period (in shares)"&gt;133,609&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220301__20230228_z8TZsHGBm2gf" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at end of period (in dollars per share)"&gt;4.84&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220301__20230228_zzj00G6CnJq1" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at end of period (in dollars per share)"&gt;4.62&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220301__20230228_zJ5ddbmycB56" title="Weighted average remaining term outstanding"&gt;8.52&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zyfTQDE2hqn9" style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The aggregate intrinsic value of the Company&#x2019;s vested and exercisable
options at February 28, 2023 was $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_c20230228_zqSTYPzAxhQ" title="Aggregate intrinsic value of options outstanding"&gt;155,077&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;For the years ended February 28, 2023 and 2022 the Company
recognized $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20220301__20230228_pp0p0" title="Stock-based compensation expense"&gt;256,740&lt;/span&gt;
and $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20210301__20220228_pp0p0" title="Stock-based compensation expense"&gt;179,283&lt;/span&gt;
in stock based compensation expense, respectively. Such amounts are included in general and administrative expenses on the
consolidated statements of income. Total compensation expense related to non-vested options not yet recognized as of February 28,
2023 was $&lt;span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20230228_pp0p0" title="Compensation expense not yet recognized"&gt;288,000 &lt;/span&gt;and
will be recognized over the next three years &lt;span id="xdx_904_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220301__20230228_zn67qxfRc9u4" style="display: none" title="Compensation expense, period for recognition"&gt;3&lt;/span&gt; based on vesting date. The amount of future stock option compensation expense could
be affected by any future option grants or by any forfeitures. During the year ended February 28, 2023, the Company had net
settlement exercises of stock options, whereby, the optionee did not pay cash for the options but instead received the number of
shares equal to the difference between the exercise price and the market price on the date of exercise. Net settlement exercises
during the year ended February 28, 2023 resulted in &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220301__20230228_pdd" title="Options cancelled in settlement of shares issued"&gt;12,898&lt;/span&gt; shares of common stock issued.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Determining the appropriate fair value of the stock-based awards requires
the input of subjective assumptions, including the fair value of the Company&#x2019;s common stock, and for stock options, the expected
life of the option, and the expected stock price volatility. The Company uses the Black-Scholes option pricing model to value its stock
option awards. The assumptions used in calculating the fair value of stock-based awards represent management&#x2019;s best estimates and
involve inherent uncertainties and the application of management&#x2019;s judgment.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The expected term of the options is estimated based on the Company&#x2019;s
historical exercise rate. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued.
For stock price volatility, the Company uses its expected volatility of the price of the Company&#x2019;s common stock based on historical
activity. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option at the
grant-date.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;The weighted-average fair value of options has been estimated
on the date of grant using the Black-Scholes options-pricing model. The weighted-average Black-Scholes assumptions are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0 4.5pt 0 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zB8iJOzONpQ7" style="width: 100%; border-collapse: collapse; font-size: 11pt" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BC_zEb026tMpqa" style="display: none"&gt;Stock-based compensation - weighted-average black-scholes assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 9pt"&gt;&lt;b&gt;Fiscal Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 9pt"&gt;&lt;b&gt;February 28, &lt;br/&gt;
2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 9pt"&gt;&lt;b&gt;February 28, &lt;br/&gt;
2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="width: 61%; font-family: Times New Roman,serif"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Expected life&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 18%; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zPCjUX11Hosf" title="Expected life (in years)"&gt;5&lt;/span&gt; - &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_ztZnKxWTd8g5" title="Expected life (in years)"&gt;8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zdaG9Stx5At2" title="Expected life (in years)"&gt;5&lt;/span&gt; - &lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zn0ULfQNqU27" title="Expected life (in years)"&gt;8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20220301__20230228_pdd" title="Risk free interest rate, minimum"&gt;2.82%&lt;/span&gt; - &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20220301__20230228_pdd" title="Risk free interest rate, maximum"&gt;4.02%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20210301__20220228_pdd" title="Risk free interest rate, minimum"&gt;0.78%&lt;/span&gt; &#x2013; &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20210301__20220228_pdd" title="Risk free interest rate, maximum"&gt;2.0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20220301__20230228_pdd" title="Expected volatility, minimum"&gt;55.02%&lt;/span&gt; - &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20220301__20230228_pdd" title="Expected volatility, maximum"&gt;62.01%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20210301__20220228_pdd" title="Expected volatility, minimum"&gt;50.73%&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20210301__20220228_pdd" title="Expected volatility, maximum"&gt;57.13%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220301__20230228_pdd" title="Expected dividend yield"&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20210301__20220228_pdd" title="Expected dividend yield"&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zKObb5CyTbg8" style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember"
      decimals="INF"
      unitRef="Shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2022-03-012023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-02-28_custom_TwoThousandThirteenStockIncentivePlanMember"
      decimals="INF"
      unitRef="Shares">250759</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">28239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember"
      decimals="INF"
      unitRef="USDPShares">5.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember"
      decimals="INF"
      unitRef="USDPShares">5.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-03-012023-02-28_custom_NonEmployeeDirectorsStockOptionMember"
      decimals="INF"
      unitRef="Shares">16500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-012023-02-28_custom_NonEmployeeDirectorsStockOptionMember"
      decimals="INF"
      unitRef="USDPShares">5.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-03-012023-02-28_custom_EmployeesAndDirectorsMember"
      decimals="INF"
      unitRef="USDPShares">3.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">138085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember"
      decimals="INF"
      unitRef="USDPShares">3.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember"
      decimals="INF"
      unitRef="USDPShares">6.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-03-012022-02-28_custom_NonEmployeeDirectorsStockOptionMember"
      decimals="INF"
      unitRef="Shares">30250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-03-012022-02-28_custom_NonEmployeeDirectorsStockOptionMember"
      decimals="INF"
      unitRef="USDPShares">3.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-03-012022-02-28_custom_EmployeesAndDirectorsMember"
      decimals="INF"
      unitRef="USDPShares">2.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zZkAmVWrdgB6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;&lt;span id="xdx_8B4_z6I1Bec18f2i" style="display: none"&gt;Stock-based compensation - summary of stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Stock Options&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Exercise Price $&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Outstanding&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Exercisable&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;Term - Years&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 35%"&gt;Balance - February 28, 2021&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210301__20220228_zE30H90Femk9" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options outstanding at beginning of period (in shares)"&gt;508,459&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20210301__20220228_z4kWatz5zhx1" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Stock Options exercisable at beginning of period (in shares)"&gt;333,500&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210301__20220228_zJW05n3Vk49d" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)"&gt;2.35&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20210301__20220228_z684LR6idVha" style="font: 11pt Cambria,serif; width: 9%; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)"&gt;2.17&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 9%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200301__20210228_zw79MWxt1hJe" title="Weighted average remaining term outstanding"&gt;6.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Granted&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)"&gt;168,335&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210301__20220228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)"&gt;5.10&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210301__20220228_zLGT7VHWCAL7" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)"&gt;(403,334&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zgqKdd0y3Boi" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)"&gt;(2.12&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20210301__20220228_zKrJjndN7yn7" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)"&gt;(19,750&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20210301__20220228_zvIv8kUPKaW2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)"&gt;(3.27&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Balance - February 28, 2022&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220301__20230228_zJ86AJ2Mo11g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at beginning of period (in shares)"&gt;253,710&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_c20220301__20230228_zXRMycy4g36g" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at beginning of period (in shares)"&gt;61,690&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220301__20230228_z6X2RiH04sG9" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at beginning of period (in dollars per share)"&gt;4.46&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_c20220301__20230228_zx24UyvWYxBi" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at beginning of period (in dollars per share)"&gt;3.53&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210301__20220228_zUAE1Uypk6Ta" title="Weighted average remaining term outstanding"&gt;8.94&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Granted&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in shares)"&gt;44,739&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220301__20230228_pdd" style="font: 11pt Cambria,serif; text-align: right" title="Granted (in dollars per share)"&gt;5.71&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220301__20230228_z5SzFxXaUo7g" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in shares)"&gt;(16,973&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zQtD2LTtdTKc" style="font: 11pt Cambria,serif; text-align: right" title="Exercised (in dollars per share)"&gt;(1.77&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220301__20230228_zFxx7wlizET1" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in shares)"&gt;(30,717&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220301__20230228_zTHt9YCvFr81" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Cancelled (in dollars per share)"&gt;(4.66&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Balance - February 28, 2023&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220301__20230228_zdBTcJX7oaL5" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options outstanding at end of period (in shares)"&gt;250,759&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220301__20230228_zVAaCqMxpmfb" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Stock Options exercisable at end of period (in shares)"&gt;133,609&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220301__20230228_z8TZsHGBm2gf" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average outstanding at end of period (in dollars per share)"&gt;4.84&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220301__20230228_zzj00G6CnJq1" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Weighted Average exercisable at end of period (in dollars per share)"&gt;4.62&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220301__20230228_zJ5ddbmycB56" title="Weighted average remaining term outstanding"&gt;8.52&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-02-28" decimals="INF" unitRef="Shares">508459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-02-28" decimals="INF" unitRef="Shares">333500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-02-28"
      decimals="INF"
      unitRef="USDPShares">2.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-02-28"
      decimals="INF"
      unitRef="USDPShares">2.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-03-012021-02-28">P6Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">168335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="USDPShares">5.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">403334</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="USDPShares">2.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">19750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="USDPShares">3.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2022-02-28" decimals="INF" unitRef="Shares">253710</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2022-02-28" decimals="INF" unitRef="Shares">61690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-02-28"
      decimals="INF"
      unitRef="USDPShares">4.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2022-02-28"
      decimals="INF"
      unitRef="USDPShares">3.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-03-012022-02-28">P8Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">44739</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="USDPShares">5.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">16973</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="USDPShares">1.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">30717</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="USDPShares">4.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2023-02-28" decimals="INF" unitRef="Shares">250759</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2023-02-28" decimals="INF" unitRef="Shares">133609</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28"
      decimals="INF"
      unitRef="USDPShares">4.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28"
      decimals="INF"
      unitRef="USDPShares">4.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-03-01to2023-02-28">P8Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">155077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">256740</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">179283</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">288000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2022-03-01to2023-02-28">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">12898</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zB8iJOzONpQ7" style="width: 100%; border-collapse: collapse; font-size: 11pt" summary="xdx: Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BC_zEb026tMpqa" style="display: none"&gt;Stock-based compensation - weighted-average black-scholes assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 9pt"&gt;&lt;b&gt;Fiscal Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 9pt"&gt;&lt;b&gt;February 28, &lt;br/&gt;
2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 9pt"&gt;&lt;b&gt;February 28, &lt;br/&gt;
2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="width: 61%; font-family: Times New Roman,serif"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Expected life&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 18%; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zPCjUX11Hosf" title="Expected life (in years)"&gt;5&lt;/span&gt; - &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220301__20230228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_ztZnKxWTd8g5" title="Expected life (in years)"&gt;8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16%; font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MinimumMember_zdaG9Stx5At2" title="Expected life (in years)"&gt;5&lt;/span&gt; - &lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210301__20220228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--RangeAxis__srt--MaximumMember_zn0ULfQNqU27" title="Expected life (in years)"&gt;8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20220301__20230228_pdd" title="Risk free interest rate, minimum"&gt;2.82%&lt;/span&gt; - &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20220301__20230228_pdd" title="Risk free interest rate, maximum"&gt;4.02%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20210301__20220228_pdd" title="Risk free interest rate, minimum"&gt;0.78%&lt;/span&gt; &#x2013; &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20210301__20220228_pdd" title="Risk free interest rate, maximum"&gt;2.0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20220301__20230228_pdd" title="Expected volatility, minimum"&gt;55.02%&lt;/span&gt; - &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20220301__20230228_pdd" title="Expected volatility, maximum"&gt;62.01%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c20210301__20220228_pdd" title="Expected volatility, minimum"&gt;50.73%&lt;/span&gt; - &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20210301__20220228_pdd" title="Expected volatility, maximum"&gt;57.13%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220301__20230228_pdd" title="Expected dividend yield"&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman,serif; text-align: center"&gt;&lt;span style="font-family: Cambria,serif; font-size: 11pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20210301__20220228_pdd" title="Expected dividend yield"&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-03-012023-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-03-012022-02-28_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Pure">0.0282</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Pure">0.0402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Pure">0.0078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Pure">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Pure">0.5502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Pure">0.6201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Pure">0.5073</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Pure">0.5713</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_808_eus-gaap--InventoryDisclosureTextBlock_zslgZSQJmrUf" style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;NOTE 5: &lt;span id="xdx_82E_z9qKEG5XDN39"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Inventories consist of the following:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zlanOsxunWb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B0_zVjTzpl5noSi" style="display: none"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230228_zUsT23pXgeTd" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220228_z165FX9yuq7a" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Raw materials and subassemblies&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;1,868,689&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;1,250,589&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Finished goods&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;613,915&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;779,533&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InventoryWorkInProcess_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Work in process&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;760,305&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;343,120&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryGross_iI_pp0p0_z03kbIJjZeO5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;3,242,909&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;2,373,242&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;The Company maintains an allowance for slow moving inventory for raw materials and finished
goods. The recorded allowances at February 28, 2023 and 2022, totaled $332,525 and $327,661, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zlanOsxunWb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B0_zVjTzpl5noSi" style="display: none"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230228_zUsT23pXgeTd" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220228_z165FX9yuq7a" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryRawMaterials_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Raw materials and subassemblies&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;1,868,689&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;1,250,589&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Finished goods&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;613,915&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;779,533&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InventoryWorkInProcess_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Work in process&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;760,305&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;343,120&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryGross_iI_pp0p0_z03kbIJjZeO5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;3,242,909&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;2,373,242&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">1868689</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">1250589</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">613915</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">779533</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">760305</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">343120</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryGross contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">3242909</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">2373242</us-gaap:InventoryGross>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zcmNBFFFI8og" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 6: &lt;span id="xdx_827_zLaRUe54vgw8"&gt;BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Buildings, equipment, furnishings and leasehold improvements
consist of the following:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zR2bDCkmUh47" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8BF_zJVVRvU5kWz3" style="display: none"&gt;Buildings, equipment, furnishings and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%"&gt;Buildings&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals"&gt;2,250,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals"&gt;2,250,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Laboratory equipment&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,647,951&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,421,845&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,807,817&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,729,587&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;789,044&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;715,999&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Tradeshow and demonstration equipment&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,137,346&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,137,346&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,302,545&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,206,918&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Totals&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20230228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;8,934,703&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;8,461,695&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20230228_zp5Sg1Rn3tYd" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation"&gt;(6,309,707&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220228_zKbmWHTVtHsi" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation"&gt;(5,900,511&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net"&gt;2,624,996&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net"&gt;2,561,184&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Depreciation expense for the years ended February 28, 2023 and February
28, 2022 was $&lt;span id="xdx_907_eus-gaap--Depreciation_c20220301__20230228_pp0p0" title="Depreciation Expense"&gt;492,055&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--Depreciation_c20210301__20220228_pp0p0" title="Depreciation Expense"&gt;416,083&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zR2bDCkmUh47" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8BF_zJVVRvU5kWz3" style="display: none"&gt;Buildings, equipment, furnishings and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%"&gt;Buildings&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals"&gt;2,250,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Totals"&gt;2,250,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Laboratory equipment&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,647,951&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LaboratoryEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,421,845&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,807,817&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,729,587&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;789,044&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;715,999&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Tradeshow and demonstration equipment&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,137,346&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeshowAndDemonstrationEquipmentMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,137,346&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,302,545&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20220228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;1,206,918&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Totals&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20230228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;8,934,703&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20220228_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Totals"&gt;8,461,695&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Less: Accumulated depreciation&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20230228_zp5Sg1Rn3tYd" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation"&gt;(6,309,707&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220228_zKbmWHTVtHsi" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Less: Accumulated depreciation"&gt;(5,900,511&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net"&gt;2,624,996&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_c20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Equipment, furnishings and leasehold improvements, net"&gt;2,561,184&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">2250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-02-28_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">2250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_custom_LaboratoryEquipmentMember"
      decimals="0"
      unitRef="USD">1647951</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-02-28_custom_LaboratoryEquipmentMember"
      decimals="0"
      unitRef="USD">1421845</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">1807817</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-02-28_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">1729587</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">789044</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-02-28_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">715999</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_custom_TradeshowAndDemonstrationEquipmentMember"
      decimals="0"
      unitRef="USD">1137346</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-02-28_custom_TradeshowAndDemonstrationEquipmentMember"
      decimals="0"
      unitRef="USD">1137346</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">1302545</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-02-28_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">1206918</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">8934703</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">8461695</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">6309707</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">5900511</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">2624996</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">2561184</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">492055</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">416083</us-gaap:Depreciation>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zNsVHxjSjdwj" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 7: &lt;span id="xdx_82B_z9dLsNPhCuj6"&gt;ACCRUED EXPENSES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Accrued expenses consist of the following:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zNa8OZfAbERi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCRUED EXPENSES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B8_zRQEmE58L03j" style="display: none"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20230228_zXdwIKpIJSFl" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220228_zvrSI9ca9dHf" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maALCzpsS_z8zEMzXZ9VQa" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Accrued compensation&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;352,619&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;449,673&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ProductWarrantyAccrual_iI_pp0p0_maALCzpsS_z3bHoHUOORD9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Estimated warranty costs&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;500,650&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;622,775&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedSalesCommissionCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zBSP0Ci6jcjh" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Accrued commissions&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;157,927&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;195,540&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zT0Y3Rv1Wxzb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;100,921&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;104,850&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zLSIQ7kNBdze" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;315,329&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;431,190&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzpsS_zTGS3ySstipe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 2.5pt"&gt;Total accrued expenses&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;1,427,446&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;1,804,028&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zNa8OZfAbERi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCRUED EXPENSES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B8_zRQEmE58L03j" style="display: none"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20230228_zXdwIKpIJSFl" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220228_zvrSI9ca9dHf" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maALCzpsS_z8zEMzXZ9VQa" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Accrued compensation&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;352,619&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;449,673&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ProductWarrantyAccrual_iI_pp0p0_maALCzpsS_z3bHoHUOORD9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Estimated warranty costs&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;500,650&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;622,775&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedSalesCommissionCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zBSP0Ci6jcjh" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Accrued commissions&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;157,927&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;195,540&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zT0Y3Rv1Wxzb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;100,921&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;104,850&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCzpsS_zLSIQ7kNBdze" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Other accrued expenses&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;315,329&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;431,190&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzpsS_zTGS3ySstipe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 2.5pt"&gt;Total accrued expenses&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;1,427,446&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;1,804,028&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">352619</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">449673</us-gaap:AccruedSalariesCurrent>
    <us-gaap:ProductWarrantyAccrual contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">500650</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">622775</us-gaap:ProductWarrantyAccrual>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">157927</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">195540</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">100921</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">104850</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">315329</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">431190</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">1427446</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">1804028</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_807_eus-gaap--ShortTermDebtTextBlock_z7XRU2X4I887" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 8: &lt;span id="xdx_827_z1iXkNWIb8a5"&gt;REVOLVING LINE OF CREDIT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company has a $&lt;span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20230228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pp0p0" title="Revolving line of credit"&gt;&lt;span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20220228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pp0p0" title="Revolving line of credit"&gt;1,500,000&lt;/span&gt;&lt;/span&gt; revolving line of credit at prime which
was &lt;span id="xdx_90C_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_c20230228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pdd" title="Interest rate"&gt;7.75%&lt;/span&gt; at February 28, 2023 and &lt;span id="xdx_90D_eus-gaap--LineOfCreditFacilityInterestRateAtPeriodEnd_c20220228__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_pdd" title="Interest rate"&gt;3.25%&lt;/span&gt; at February 28, 2022. The revolving credit line is collateralized by the Company&#x2019;s accounts
receivable and inventory. The revolving credit line is payable on demand and must be retired for a 30-day period, once annually. If the
Company fails to perform the 30-day annual pay down or if the bank elects to terminate the credit line, the bank may, at its option, convert
the outstanding balance to a 36-month term note with payments including interest in 36 equal installments.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;As of February 28, 2023, $&lt;span id="xdx_905_ecustom--CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_c20230228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Credit line utilized to collateralize letter of credit issued to customers"&gt;145,000&lt;/span&gt; of the Company&#x2019;s credit
line was being utilized to collateralize Letters of Credit issued to customers that have remitted cash deposits to the Company on
existing orders. The Letters of Credit expire in May and July 2023. As of February 28, 2023, there were no outstanding borrowings
under the line of credit and the unused portion of the credit line was $&lt;span id="xdx_905_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_c20230228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Unused portion of credit line"&gt;1,355,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;As of February 28, 2022, $&lt;span id="xdx_906_ecustom--CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers_c20220228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Credit line utilized to collateralize letter of credit issued to customers"&gt;5,000&lt;/span&gt; of the Company&#x2019;s credit
line was being utilized to collateralize letters of credit issued to customers that have remitted cash deposits to the Company on
existing orders. The letters of credit expire in May 2023. As of February 28, 2022, there were no outstanding borrowings under the
line of credit and the unused portion of the credit line was $&lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_c20220228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_pp0p0" title="Unused portion of credit line"&gt;1,495,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-02-28_us-gaap_RevolvingCreditFacilityMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember"
      decimals="INF"
      unitRef="Pure">0.0775</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="AsOf2022-02-28_us-gaap_RevolvingCreditFacilityMember"
      decimals="INF"
      unitRef="Pure">0.0325</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <sotk:CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers
      contextRef="AsOf2023-02-28_us-gaap_LetterOfCreditMember"
      decimals="0"
      unitRef="USD">145000</sotk:CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="AsOf2023-02-28_us-gaap_LetterOfCreditMember"
      decimals="0"
      unitRef="USD">1355000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <sotk:CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers
      contextRef="AsOf2022-02-28_us-gaap_LetterOfCreditMember"
      decimals="0"
      unitRef="USD">5000</sotk:CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="AsOf2022-02-28_us-gaap_LetterOfCreditMember"
      decimals="0"
      unitRef="USD">1495000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LongTermDebtTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_809_eus-gaap--LongTermDebtTextBlock_zDD9m6AQL9jl" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 9: &lt;span id="xdx_821_zFFE1aQou1Bj"&gt;LONG-TERM DEBT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;In fiscal year 2021, the Company obtained a loan under the Paycheck
Protection Program for $&lt;span id="xdx_90C_eus-gaap--LongTermDebt_c20220228__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_pp0p0" title="Long term debt"&gt;1,001,640&lt;/span&gt;. In April 2021, the Company received notice from the SBA that the loan was forgiven in full and recorded
a gain on forgiveness of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_c20220401__20220430__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zwok1S2DHTl4" title="Gain on forgiveness of debt"&gt;1,005,372&lt;/span&gt;, which is recorded on the consolidated statements of income in fiscal 2022.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-02-28_us-gaap_UnsecuredDebtMember"
      decimals="0"
      unitRef="USD">1001640</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="From2022-04-012022-04-30_us-gaap_UnsecuredDebtMember"
      decimals="0"
      unitRef="USD">1005372</us-gaap:DebtInstrumentDecreaseForgiveness>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zDqKgjVLBI6b" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 10: &lt;span id="xdx_828_zIKMeBpNAhU9"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The annual provision (benefit) for income taxes differs from amounts
computed by applying the maximum U.S. Federal income tax rate of 21% to pre-tax income as follows:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zWIrddinDmXl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Income tax reconciliation (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8BE_zXeRmo71DkQc" style="display: none"&gt;Income taxes - income tax reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20220301__20230228_zOABXeAqaEy3" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210301__20220228_z8RU5Xa11oZj" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 11pt Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maITEBzsB7_zmhc1KC4aPsj" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Expected federal income tax&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;165,882&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;609,883&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_maITEBzsB7_zVutWv5ipXnf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;State tax, net of federal&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;37,204&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;37,894&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationTaxCreditsResearch_iN_pp0p0_di_msITEBzsB7_zBQ8ApzR2AUc" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Research and development tax credits&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(127,329&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(101,573&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pp0p0_maITEBzsB7_zeLnOUwmvdIi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Permanent differences&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;78,252&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(179,320&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pp0p0_maITEBzsB7_zWfCwsGb4vGi" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(5,253&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzsB7_zEqR0e6o5GJ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;154,009&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;361,631&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zHVmRTg9uGjk" style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;Components of the current and deferred tax expense are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zSaiHlmH6prc" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Current and deferred tax expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;&lt;span id="xdx_8BD_z9AhiVHxsgz" style="display: none"&gt;Income taxes - current and deferred tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20220301__20230228_zRxvZwcCjUNb" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210301__20220228_z4D8GLwnpJeg" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;February
    28,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zVF9uE6WnMna" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz4dN_zHY1IR2sngXg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%"&gt;Federal&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;438,263&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;341,882&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz4dN_zVJvEIB7uRF7" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;State&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;83,525&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;38,536&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz4dN_maITEBz5ma_zzwYywLl16Cj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Total current income tax&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;521,788&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;380,418&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzDG5_zAwszYiUk68d" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Federal&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(321,458&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(18,787&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzDG5_zL0kKFl9UZy5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;State&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(46,321&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0835"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzDG5_maITEBz5ma_zQJd3XyNSAOa" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Total deferred income tax&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(367,779&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(18,787&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBz5ma_z1W7r0e6Hve4" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;154,009&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;361,631&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A2_zT17onUWeVdi" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;In assessing the realizability of deferred tax assets, management
considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization
of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences
become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and projections
for future taxable income over periods in which the deferred tax assets are deductible. Management believes it is more likely than not
that the Company will realize the benefits of these deductible differences.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The incorporation of the new tax laws for 2023, requires the Company
to capitalize for income tax purposes research and development expenses incurred during the year and for such expenses to be amortized
over a five year period. As a result, a deferred tax asset &#x201c;Capitalized R&amp;amp;D expenses &#x2013; IRC Section 174&#x201d; has been
recorded.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company does not have any uncertain tax
positions in 2023. There are no interest and penalties related to uncertain tax positions in 2023. As of February 28, 2023, open years
related to the federal and state jurisdictions are 2022, 2021 and 2020.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The deferred tax asset and liability are comprised of the following:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zfnz0YvUahNi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8BD_zSWkGUdJawL2" style="display: none"&gt;Income taxes - deferred tax asset and liability components&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230228_ziGzPWlt4Gi" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220228_zi7igFRzhsd2" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Allowance for inventory&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;76,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;69,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Allowance for accounts receivable&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;3,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--CapitalizedRdExpensesIrcSection174_iI_pp0p0_z5jxT9YPHkEg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Capitalized R&amp;amp;D expenses &#x2013; IRC Section 174&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;441,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0855"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Accrued expenses and other&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;147,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;160,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iIC_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Deferred tax asset &#x2013; Long Term&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;667,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;241,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left"&gt;Deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_zzwMRAS8V7Hf" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Building and leasehold depreciation&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(83,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(169,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zJoJNt2675Ke" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Deferred tax liability &#x2013; Long Term&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;(83,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;(169,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zbW3LTi4DT4d" style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;




</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zWIrddinDmXl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Income tax reconciliation (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8BE_zXeRmo71DkQc" style="display: none"&gt;Income taxes - income tax reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20220301__20230228_zOABXeAqaEy3" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210301__20220228_z8RU5Xa11oZj" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 11pt Times New Roman,serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_pp0p0_maITEBzsB7_zmhc1KC4aPsj" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Expected federal income tax&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;165,882&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;609,883&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pp0p0_maITEBzsB7_zVutWv5ipXnf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;State tax, net of federal&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;37,204&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;37,894&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncomeTaxReconciliationTaxCreditsResearch_iN_pp0p0_di_msITEBzsB7_zBQ8ApzR2AUc" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Research and development tax credits&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(127,329&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(101,573&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_pp0p0_maITEBzsB7_zeLnOUwmvdIi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Permanent differences&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;78,252&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(179,320&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pp0p0_maITEBzsB7_zWfCwsGb4vGi" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0811"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(5,253&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzsB7_zEqR0e6o5GJ5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;154,009&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;361,631&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">165882</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">609883</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">37204</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">37894</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">127329</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">101573</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">78252</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-179320</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-5253</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">154009</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">361631</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zSaiHlmH6prc" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Current and deferred tax expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;&lt;span id="xdx_8BD_z9AhiVHxsgz" style="display: none"&gt;Income taxes - current and deferred tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20220301__20230228_zRxvZwcCjUNb" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210301__20220228_z4D8GLwnpJeg" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;February
    28,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zVF9uE6WnMna" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Current:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_maCFSALz4dN_zHY1IR2sngXg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%"&gt;Federal&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;438,263&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;341,882&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCFSALz4dN_zVJvEIB7uRF7" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;State&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;83,525&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;38,536&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_iT_mtCFSALz4dN_maITEBz5ma_zzwYywLl16Cj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Total current income tax&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;521,788&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;380,418&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDFSALzDG5_zAwszYiUk68d" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Federal&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(321,458&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;(18,787&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDFSALzDG5_zL0kKFl9UZy5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;State&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(46,321&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0835"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_iT_mtDFSALzDG5_maITEBz5ma_zQJd3XyNSAOa" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Total deferred income tax&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(367,779&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(18,787&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBz5ma_z1W7r0e6Hve4" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;154,009&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;361,631&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">438263</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">341882</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">83525</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">38536</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">521788</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">380418</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-321458</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-18787</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-46321</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">-367779</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">-18787</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">154009</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">361631</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zfnz0YvUahNi" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8BD_zSWkGUdJawL2" style="display: none"&gt;Income taxes - deferred tax asset and liability components&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230228_ziGzPWlt4Gi" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220228_zi7igFRzhsd2" style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Allowance for inventory&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;76,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;69,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Allowance for accounts receivable&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;3,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;12,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--CapitalizedRdExpensesIrcSection174_iI_pp0p0_z5jxT9YPHkEg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Capitalized R&amp;amp;D expenses &#x2013; IRC Section 174&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;441,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0855"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Accrued expenses and other&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;147,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;160,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_iIC_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Deferred tax asset &#x2013; Long Term&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;667,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;241,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-decoration: underline; text-align: left"&gt;Deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_zzwMRAS8V7Hf" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Building and leasehold depreciation&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(83,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;(169,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zJoJNt2675Ke" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Deferred tax liability &#x2013; Long Term&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;(83,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;(169,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">76000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">69000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">3000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">12000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <sotk:CapitalizedRdExpensesIrcSection174 contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">441000</sotk:CapitalizedRdExpensesIrcSection174>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">147000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">160000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">667000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">241000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">83000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">169000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2023-02-28" decimals="0" unitRef="USD">83000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2022-02-28" decimals="0" unitRef="USD">169000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_809_eus-gaap--EarningsPerShareTextBlock_zX4D7VcTtw06" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 11: &lt;span id="xdx_82E_zXY8K5WhAwn5"&gt;EARNINGS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The following table sets forth the computation of basic and diluted
earnings per share:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3Hf5T0a7PGg" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;span id="xdx_8B9_zmVIV1SCeWOg" style="display: none"&gt;Earnings per share - the computation of basic and diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220301__20230228_zTSpMW9EH2nb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210301__20220228_zqwCURZvyqKd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProfitLoss_zCzKLzsh0T3e" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left; padding-bottom: 2.5pt"&gt;Numerator for basic and diluted earnings per share&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;635,905&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;2,542,573&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zaSep3GRNYCe" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Denominator for basic earnings per share - weighted average&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;15,735,451&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;15,586,404&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Effects of dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Stock options for employees, directors and outside consultants&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;34,048&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;37,081&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zsXHAIHJXQFi" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt"&gt;Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;15,769,499&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;15,623,485&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Basic Earnings Per Share &#x2013; Weighted Average&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.04&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Diluted Earnings Per Share &#x2013; Weighted Average&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.04&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z8DPqzOm3S5j" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z3Hf5T0a7PGg" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;span id="xdx_8B9_zmVIV1SCeWOg" style="display: none"&gt;Earnings per share - the computation of basic and diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220301__20230228_zTSpMW9EH2nb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210301__20220228_zqwCURZvyqKd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProfitLoss_zCzKLzsh0T3e" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left; padding-bottom: 2.5pt"&gt;Numerator for basic and diluted earnings per share&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;635,905&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; width: 10%; text-align: right"&gt;2,542,573&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zaSep3GRNYCe" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif"&gt;Denominator for basic earnings per share - weighted average&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;15,735,451&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;15,586,404&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Effects of dilutive securities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_i_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Stock options for employees, directors and outside consultants&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;34,048&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right"&gt;37,081&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zsXHAIHJXQFi" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 2.5pt"&gt;Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;15,769,499&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;15,623,485&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Basic Earnings Per Share &#x2013; Weighted Average&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.04&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;Diluted Earnings Per Share &#x2013; Weighted Average&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.04&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">635905</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">2542573</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">15735451</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">15586404</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">34048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">37081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="Shares">15769499</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="Shares">15623485</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-03-01to2023-02-28"
      decimals="INF"
      unitRef="USDPShares">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-03-012022-02-28"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_80B_eus-gaap--ConcentrationRiskDisclosureTextBlock_z5xhXpBYhGqk" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 12: &lt;span id="xdx_828_z8yYal242OP3"&gt;CUSTOMER CONCENTRATIONS AND FOREIGN SALES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;Export sales to customers located outside the United States and Canada
were approximately as follows:&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgJ0hZYW4Mti" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B5_zfi7fc0zqkZ1" style="display: none"&gt;Schedule of customer concentrations and foreign sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Asia Pacific (APAC)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales"&gt;3,260,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales"&gt;5,301,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Europe, Middle East, Asia (EMEA)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;3,448,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;5,255,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Latin America&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;1,546,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;1,097,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;8,254,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;11,653,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;During fiscal 2023 and fiscal 2022, sales to foreign customers accounted
for approximately $&lt;span id="xdx_901_eus-gaap--Revenues_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pp0p0" title="Sales revenue"&gt;8,254,000&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--Revenues_c20210301__20220228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pp0p0" title="Sales revenue"&gt;11,653,000&lt;/span&gt;, or &lt;span id="xdx_90D_ecustom--SalesRevenuePercent_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pdd" title="Sales revenue, percent"&gt;55%&lt;/span&gt; and &lt;span id="xdx_90B_ecustom--SalesRevenuePercent_c20210301__20220228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignCustomersMember_pdd" title="Sales revenue, percent"&gt;68%&lt;/span&gt; respectively, of total revenues.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company had two customers which accounted for &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_c20220301__20230228__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"&gt;14%&lt;/span&gt; of sales during
fiscal 2023. Four customers accounted for &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_c20220301__20230228__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"&gt;44%&lt;/span&gt; of the outstanding accounts receivables at February 28, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company had two customers which accounted for &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20210301__20220228__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"&gt;24%&lt;/span&gt; of sales during
fiscal 2022. Three customers accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20210301__20220228__srt--MajorCustomersAxis__custom--TwoCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_pdd" title="Outstanding accounts receivables, percent"&gt;41%&lt;/span&gt; of the outstanding accounts receivables at February 28, 2022.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2022-03-01to2023-02-28">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgJ0hZYW4Mti" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&lt;span id="xdx_8B5_zfi7fc0zqkZ1" style="display: none"&gt;Schedule of customer concentrations and foreign sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 9pt Cambria,serif; text-align: center"&gt;February 28,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 9pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 72%; text-align: left"&gt;Asia Pacific (APAC)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales"&gt;3,260,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--AsiaPacificMember_pp0p0" style="font: 11pt Cambria,serif; width: 10%; text-align: right" title="Total sales"&gt;5,301,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;Europe, Middle East, Asia (EMEA)&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;3,448,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__us-gaap--MiddleEastMember_pp0p0" style="font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;5,255,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(230,239,255)"&gt;
    &lt;td style="font: 11pt Cambria,serif; text-align: left; padding-bottom: 1pt"&gt;Latin America&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;1,546,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228__srt--StatementGeographicalAxis__srt--LatinAmericaMember_pp0p0" style="border-bottom: Black 1pt solid; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;1,097,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220301__20230228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;8,254,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20210301__20220228_pp0p0" style="border-bottom: Black 2.5pt double; font: 11pt Cambria,serif; text-align: right" title="Total sales"&gt;11,653,000&lt;/td&gt;&lt;td style="font: 11pt Cambria,serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-03-012023-02-28_srt_AsiaPacificMember"
      decimals="0"
      unitRef="USD">3260000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-03-012022-02-28_srt_AsiaPacificMember"
      decimals="0"
      unitRef="USD">5301000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-03-012023-02-28_us-gaap_MiddleEastMember"
      decimals="0"
      unitRef="USD">3448000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-03-012022-02-28_us-gaap_MiddleEastMember"
      decimals="0"
      unitRef="USD">5255000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-03-012023-02-28_srt_LatinAmericaMember"
      decimals="0"
      unitRef="USD">1546000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-03-012022-02-28_srt_LatinAmericaMember"
      decimals="0"
      unitRef="USD">1097000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2022-03-01to2023-02-28"
      decimals="0"
      unitRef="USD">8254000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2021-03-012022-02-28"
      decimals="0"
      unitRef="USD">11653000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember"
      decimals="0"
      unitRef="USD">8254000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-03-012022-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember"
      decimals="0"
      unitRef="USD">11653000</us-gaap:Revenues>
    <sotk:SalesRevenuePercent
      contextRef="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember"
      decimals="INF"
      unitRef="Pure">0.55</sotk:SalesRevenuePercent>
    <sotk:SalesRevenuePercent
      contextRef="From2021-03-012022-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember"
      decimals="INF"
      unitRef="Pure">0.68</sotk:SalesRevenuePercent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-03-012023-02-28_custom_TwoCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-03-012023-02-28_custom_ThreeCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-03-012022-02-28_custom_ThreeCustomersMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-03-012022-02-28_custom_TwoCustomersMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      unitRef="Pure">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-03-01to2023-02-28">&lt;p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zAAFWGYoiLwj" style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;NOTE 13: &lt;span id="xdx_82A_zWxEBBOfOw2c"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;Other than the letters of credit discussed in Notes 3 and 8, the Company did not have any
material commitments or contingencies as of February 28, 2023.&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"&gt;The Company is subject, from time to time, to claims by third parties under various
legal disputes. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on
the Company&#x2019;s liquidity, financial condition, and cash flows. As of February 28, 2023, the Company did not have any pending legal
actions.&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>64
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MTS;N@<F)>HYWFE@3YA+7=3P[\[!B'K8RGV>*)6\@&5I>/PVH1\@)30O0\Z*
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MH2%-WZQ126)\+#S$Q=%NU+UT_QY=MVOXIWK[F''C,GG/_;EBT\'IY_,$7/M
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MQQQ?/L+0!KR?:^W6 CEHOZ7._P502P,$%     @ FT:Y5NB0@<9?!P  'A$
M !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULE5AI;]LX&OZN7T%XFCD
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MC6;792:R?8 ):.VXA3VWB_!-Q/=BZ;%P[K+0#Z,W\**=KI'%BU[3=<.5&%_
MAQF[Y4\(+</.E>+E6MCW_YXOM5&(D_\=TK[%C@]C4^X<ZYJGXG2$Y-!"/8C1
MV<\_!5/_]S>8QSOF\5OH_Y>7WD0ZS//3S?TUBX_9:V+8G:G2K^RFID32+'03
MWW=]WV>!S\+$=V?)@GV!TQ4S&P%O!5&WXT.9PK!(.W:;\])EE45@M9*IT*Q
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MW:4(M%!JZB_K0"_ K1 66E*;"K4<=PZB.O0L9DT]&Y[FT.G<\0V5HT,CN+3
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ML8;;6[7YBET]QXXO5]SX+VS:W.0T@+PQ5HD.3 I$)=L_>^K.80=P%KT"2#I
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M>;L,VQT,KKY7+%K(7$%Y^T;\ Q]_QN;"%^6Z"6X;57_0]O>N']A-<9ON;3*
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MRA-9GI4<1]/YPW)YOUXN5NLGF*WN8/ZP6M^O/BQ6\_O%TS@F3N$7QFD+=]O
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MW#!I&4FG+<3Q"$8(5HFUJ)I%>04AY%SF?N7H5KJRT<L>."J1@!6>0<TGK N
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M<H<8T6Q+-/L.48<H+4F](?X/LHUB[&/; H^:Q'*(CHFA_84))"?3E*6HW9]
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MO<HJ$.&EL;JNW_-M]!^Y0X-MN9V@[38:76,'K<!MM\(WW"VWV^ZXO9X/AQK
M>W5M,Y3K8C@I*-YA>8/K:#W_AN6U_Y->#D\C?4VY H:)@?KGG98#LAQ(I:-%
M7@R!I=!FI!1F:F8X2IM@]A,A]-ZQ!]1_A>@W4$L#!!0    ( )M&N58RA,ID
MZ@(  &4&   9    >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;)U5WV_:,!!^
MYZ^PLC%M4MK\!$('2,#HAC1*16GW,.W!D".)FL29[0#][W=V(*,:Y6$OX.]\
MWW=W/OO2VS'^+&( 2?99FHN^$4M9W%B66,>047'-"LAQ9\-X1B5"'EFBX$!#
M3<I2R[7MMI71)#<&/6V[YX,>*V6:Y'#/B2BSC/*7$:1LUS<<XVA8)%$LE<$:
M] H:P0/(Q^*>([)JE3#)(!<)RPF'3=\8.C<C7_EKAZ<$=N)D350E*\:>%9B&
M?<-6"4$*:ZD4*/YM80QIJH0PC=\'3:,.J8BGZZ/ZK:X=:UE1 6.6_DA"&?>-
MP" A;&B9R@7;?8-#/2VEMV:IT+]D5_FV7(.L2R%9=B!C!EF25_]T?SB'$T)@
MOT%P#P17YUT%TEE^H9(.>ISM"%?>J*86NE3-QN227#7E07+<39 G!XO)T^3N
M<4(6D_'\Z]UT.9W?D8]+NDI!?.I9$B,H/VM]4!M5:NX;:HY+9BR7L2"3/(3P
MM8"%J=7YN<?\1NY%Q5M871,W,(EKN]X%/:^NU]-ZWEOUPA;R$LB&LXR,,5>.
M]P+/7,9DK$\;./DY7 EM_W7N!"I]_[R^>D,WHJ!KZ!OX2 3P+1B##^^<MOWY
M0O9^G;U_2;W.GL.:17FB[_45$12[A;9J;_5""L["$LM2]',E7 QROH3_B-Q8
M[B#=PJL;T<!^\A)?O^[I*6BH!I,F81LBF:2I:KA[@ANW:;E/\H@\O @)F2#O
MB6,ZG:YIVS8)F@C;74<#O]F8YA(B3B6$V&,J3VE(<GSMUVDJ$+@'T)CA0TZN
MAOM$_$-JFYV@58FWFJ1K=IV*U0J:C?ED5ONYIN-7XH[?1.0%SA$UYC+&N^69
M@=?6-K>M/+KM3N6!"2SGR^%W51>&:@7:C*!C.IZGP;D+9)T\?;R[D1YP@JQ9
MF<MJ"M36>H8.J]'QU[T:P#/*HR07)(4-4NWK3LL@O!IJ%9"LT(-DQ20^%+V,
M\3L 7#G@_H8Q>00J0/UE&?P!4$L#!!0    ( )M&N58[1EK=N@,  +D(   9
M    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;)U6:V\J-Q#]SJ\8;4N52+#O
M!Z2 !+E)>U7E@D+:JZKJ![,[@)7=-;5-2/Y]QU[@$BF@]DH)?LS,F3/V,<-@
M)^2S6B-J>*W*6@V=M=:;&\]3^1HKIERQP9HL2R$KIFDI5Y[:2&2%#:I*+_3]
MU*L8KYW1P.[-Y&@@MKKD-<XDJ&U5,?DVP5+LAD[@'#8>^6JMS88W&FS8"N>H
M?]_,)*V\(TK!*ZP5%S5(7 Z=<7 S28R_=?B#XTZ=S,%4LA#BV2P^%T/'-X2P
MQ%P;!$;#"]YB61H@HO'/'M,YIC2!I_,#^KVMG6I9,(6WHOS*"[T>.CT'"ERR
M;:D?Q>Y7W-=C">:B5/83=HUOYCN0;Y46U3Z8&%2\;D;VNC^'DX#>N8!P'Q!:
MWDTBR_(3TVPTD&('TG@3FIG84FTTD>.UN92YEF3E%*='\Z?I[6_=R7A^]PEN
MIP^SNR_S\=/GZ1>X>F*+$M7UP-.4QCA[^1YRTD"&9R"#$!Y$K=<*[NH"B_<
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M>-$]R:91-@LM-K8Y+82F5F>G:_IM@=(XD'TIA#XL3(+CKY71OU!+ P04
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MM7W_4+D"N[^4TNP2=T#WHL[^ E!+ P04    " ";1KE6C)],X44#  #=!@
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MD+(M;0KUQ/</[*#'UW@)+V3[A'WG&]HF)(U4O#P$(X,RK[HW?3O<PTE ]%Z
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M>[$#LID:C:/%VG;J0FCJ>VOF-&A1F@ Z7PJA#XZYH!W=R1]02P,$%     @
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M>&U(>= 23SGJZ>G-S_./M]?D<?;[]0,9/K)%">IT[&F$-@)>WL%<MC#T#9B
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M+,6K2+;34+O1HK$3R$)HG&?L<HT#)$@C@.=+(?1N8PST(^GT;U!+ P04
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MIO/D\<L$%O%3LH"K)5GE5%[W'85Y-=I)FQS#.H?_3@[/AS$OU59"4F8T^Y?
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M$>K>W(86B'J(U(;B.].X*Z[PC,URBW.7"AV ^VO.U<'0"=I)'OT!4$L#!!0
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M/<L@\5)(5K9@5%#F5?.F+VT=M@"V?P#@M #G+6!P ."V %<GVBC3:5U22<.
MLS7ARAO9U$+71J,QF[Q2I_@@.7[-$2?#V>1I,GV<D-DDNKN>WGR_N9N2DTN0
M-"\$F5+.J2KS*?E$'A\NR<G[T\"4&%:!S;@-,6Y". ="V ZY997,!)E4"22[
M!";J[40[&]%CYRCC%<S/B#/\2!S+<7L$1?\.=X[(<;L:NIK//51#6$&U!))R
M5I((4^7X<^(YRHQ$^@2!DY\7<Z'W?_45L.$?]/.K1CX7-8UA9&"G"N K,,(/
M[VS?^M*7_'\BVRG%H"O%X!A[&%&181?53.12]&7:P#T-5Q-F%3I#=VA95F"N
MMI/8][-M?\=O1Y_7Z?..ZOL&4N)IL)3$'))<]DEL&/SMT -O7^&^FW=0GM_)
M\X_+0_M5','F+BCJI06A)5M6O7+]_4KUR=UWZY%K;@T2_&L7>KX*U(&QF_;L
M=KL1?J$GUYO],8[V9A*_TC3WPBWEB[P2I( 4*:VSSRB)-[.V,22K];B:,XFM
MHY<97D_ E0-^3QF3&T,%Z"Z\\"]02P,$%     @ FT:Y5I6RA'NP!   8A4
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M,D#\OB:$OS5D!_6UZN1_4$L#!!0    ( )M&N59$^1R.IP,  .D.   9
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M_P0V)WC$.4Y7H.Z$1(L=.K2;X9V9'FTQC]#W?Q0DNI.0B!]U <[7[]2OK_/
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M7!NH]TO&Y/- +U!VM\$O4$L#!!0    ( )M&N58&!%$^:P8   \K   9
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;,5:76^C.!3]*U9VM9J5V@0,24@W
MC92$CG:TVP]-9G8>1OO@@$.L 9PU3M*N]L>O^2@$XKHD<M67%HCOL>^!:\XQ
M'N\I^Y&L,>;@,0KCY+JSYGQSU>LEWAI'*.G2#8[%+RO*(L3%*0MZR89AY&=!
M4=B#AC'H18C$G<DXN_; )F.ZY2&)\0,#R3:*$'N:X9#NKSMFY_G"9Q*L>7JA
M-QEO4( 7F'_=/#!QUBM1?!+A."$T!@ROKCM3\\JU[#0@:_$7P?ODX!BDJ2PI
M_9&>?/*O.T8Z(AQBCZ<02/S;X3D.PQ1)C..? K13]ID&'AX_HW_,DA?)+%&"
MYS3\1GR^ONXX'>#C%=J&_#/=_XZ+A/HIGD?#)/L+]GG;X:@#O&W":50$BQ%$
M),[_H\>"B(, <_!" "P"8#/ ?B' *@*LM@%V$9!1W<M3R7AP$4>3,:-[P-+6
M BT]R,C,HD7Z)$[O^X(S\2L1<7RR^'(__^-R-EW<N&!^?_MP<[>8?OET?P<^
MN)@C$B;@#C&&TIOS*[@$7Q<N^/#SK^,>%WVG"#VOZ&>6]P-?Z,>$X);&?)V
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MV7&9,I#WEY2*UQ,U?"R&S?W_ 5!+ P04    " ";1KE6;F7.ZXL"  #6!0
M&0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6RM5-%NFS 4_16+35,G985
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MZ<7]]>1^?/493<97%^AZA ;3B^'X*SH9@L2$"G2%.<?:ZU/T =W=#M')V]/
MEFIMC6!'Q3KG^3KN@75&,&L@M_L>N8[K5:0/7I_N[J;;2G$IVRUENP:O=4@V
MK!E=DV2)!ASF1*(1C@@E\AE]OX1X!OQ'E<1:3%UO9R+%$?0M55 "^!JL\-V;
M9MOY6"7X2& [\KU2OF?0O0/R)ZJ/V&)?O)D82XA%I0'>,0TX$MB. :W2@-8K
MWS\MK(B,%56B<R3?(.F/XCIL^H[^!?9Z6\_?XW:H^B55OY;J.)&@#)!(52%4
M\<O3>UOK.@VGT_'_H%<9YKE^-;MVR:Y=RVX"4M';VDMU]5,+]:_;YTA@.ZH[
MI>K.?ZF?SC$-.!+8C@'=TH!N[6LOA)OBR:02_Q/F2#*DCB.JMBG'>@31<G/D
MU86($%D1:(XVX*+*INY^);7\_8+;#_,/5ENO%-:K%7:79$(Q3!DWMXS?U'5@
M%=?>/E?/KR!;$=?J5?"UM\YR?8^ZQ'Q)$J&\7*A,IZ%O'CR_F^0=R5)SO,^8
M5(Z:YDI=YX#K #6_8$R^=/2-H;P@AK\ 4$L#!!0    ( )M&N5;:+ IAB@(
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MV!7ML,+O%I#& )^70NC#Q&S0?PEE_P!02P,$%     @ FT:Y5@-7]V0% P
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M2>+.P;WS*%Z?4_'FMY/1;U!+ P04    " ";1KE6EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( )M&N596)S-H3@0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ FT:Y5OU; '/N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
MFT:Y5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " ";1KE6/0V1EDX(  !*/P  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
MFT:Y5C4@;(P.!@  :Q8  !@              ("!D1   'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( )M&N58$6NEST0(  -@'   8
M          " @=46  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    " ";1KE6!/OK32T%  !=$P  &               @('<&0  >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ FT:Y5HNV1N_T!   _QH
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MDR\  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( )M&N58
M@!T[N 4  %<-   8              " @><X  !X;"]W;W)K<VAE971S+W-H
M965T.2YX;6Q02P$"% ,4    " ";1KE6Z)"!QE\'   >$0  &0
M    @('5/@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M )M&N59O4A"W^@(  %4&   9              " @6M&  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ FT:Y5@E[MGF) P  UP<  !D
M             ("!G$D  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    " ";1KE6UM'3",4"   !!@  &0              @(%<30  >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( )M&N5;,M"1E5@(
M %$%   9              " @5A0  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ FT:Y5HN1L<I: @  (@4  !D              ("!
MY5(  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " ";1KE6
M$4L[.G0&  !K#P  &0              @(%V50  >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( )M&N58KN32G' ,  $L'   9
M      " @2%<  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ FT:Y5BM+K>M) P  1P<  !D              ("!=%\  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " ";1KE6(?<__B<#  #H!@
M&0              @('T8@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( )M&N59:.P$8@ H  &0A   9              " @5)F  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ FT:Y5DC*_CFR
M @  (08  !D              ("!"7$  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    " ";1KE6,H3*9.H"  !E!@  &0
M@('R<P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( )M&
MN58[1EK=N@,  +D(   9              " @1-W  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ FT:Y5MCTV&Z' @  704  !D
M         ("!!'L  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
M    " ";1KE6C)],X44#  #=!@  &0              @('"?0  >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( )M&N59-G\;UL0(  ,8%
M   9              " @3Z!  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M4$L! A0#%     @ FT:Y5@DVS2DP!   G@H  !D              ("!)H0
M 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " ";1KE6I]Z\
MA@(#   :!P  &0              @(&-B   >&PO=V]R:W-H965T<R]S:&5E
M=#(X+GAM;%!+ 0(4 Q0    ( )M&N58E*PEPN0(  -4%   9
M  " @<:+  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
MFT:Y5MVAI&- !   )Q(  !D              ("!MHX  'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    " ";1KE6L\J6+7P#  !!#   &0
M            @($MDP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( )M&N58^<O&T?@0  /08   9              " @>"6  !X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ FT:Y5D%[AYRI @
M_ 8  !D              ("!E9L  'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    " ";1KE6E;*$>[ $  !B%0  &0              @(%U
MG@  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( )M&N59$
M^1R.IP,  .D.   9              " @5RC  !X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ FT:Y5@8$43YK!@  #RL  !D
M     ("!.J<  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
M" ";1KE6HA(T"9("  #1!@  &0              @('<K0  >&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( )M&N59[*P=P<@0  '@6   9
M              " @:6P  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L!
M A0#%     @ FT:Y5FYESNN+ @  U@4  !D              ("!3K4  'AL
M+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " ";1KE6U3R++MH"
M   R"   &0              @($0N   >&PO=V]R:W-H965T<R]S:&5E=#0P
M+GAM;%!+ 0(4 Q0    ( )M&N5:I_0;_\@(  "P*   9              "
M@2&[  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ FT:Y
M5MHL"F&* @  D08  !D              ("!2KX  'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    " ";1KE6B7^:O2X#   5"0  &0
M        @($+P0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0
M   ( )M&N58#5_=D!0,  '()   9              " @7#$  !X;"]W;W)K
M<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ FT:Y5K6X6T,O P  ; H
M !D              ("!K,<  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q0
M2P$"% ,4    " ";1KE63@'TRGH#  #+"@  &0              @($2RP
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( )M&N5;0=,B5
M! ,  )8)   9              " @</.  !X;"]W;W)K<VAE971S+W-H965T
M-#<N>&UL4$L! A0#%     @ FT:Y5@6/GMH"!   5Q4  !D
M ("!_M$  'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " ";
M1KE6YB67"Q\#  !($0  #0              @ $WU@  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( )M&N5:7BKL<P    !,"   +              "  8'9
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( )M&N596)S-H3@0   L@   /
M          "  6K:  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " ";1KE6
MDBR@EK@!  #G'   &@              @ 'EW@  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " ";1KE6C$_JC[H!  #N'   $P
M        @ '5X   6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     .  X #\/
(  # X@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>85</ContextCount>
  <ElementCount>240</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>37</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - BUSINESS DESCRIPTION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/BusinessDescription</Role>
      <ShortName>BUSINESS DESCRIPTION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/RevenueRecognition</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Stock-basedCompensation</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements</Role>
      <ShortName>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/AccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - REVOLVING LINE OF CREDIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/RevolvingLineOfCredit</Role>
      <ShortName>REVOLVING LINE OF CREDIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - LONG-TERM DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Long-termDebt</Role>
      <ShortName>LONG-TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/EarningsPerShare</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/CustomerConcentrationsAndForeignSales</Role>
      <ShortName>CUSTOMER CONCENTRATIONS AND FOREIGN SALES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/RevenueRecognitionTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/RevenueRecognition</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Stock-basedCompensationTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/Stock-basedCompensation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/Inventories</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables</Role>
      <ShortName>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/AccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/AccruedExpenses</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/IncomeTaxes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/EarningsPerShareTables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/EarningsPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables</Role>
      <ShortName>CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sono-tek.com/role/CustomerConcentrationsAndForeignSales</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails</Role>
      <ShortName>REVENUE RECOGNITION - Sales Revenue by Product Line (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - REVENUE RECOGNITION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/RevenueRecognitionDetailsNarrative</Role>
      <ShortName>REVENUE RECOGNITION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/RevenueRecognitionTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Summary of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/Stock-basedCompensationTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/InventoriesDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/InventoriesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails</Role>
      <ShortName>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative</Role>
      <ShortName>BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/AccruedExpensesDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/AccruedExpensesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - REVOLVING LINE OF CREDIT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative</Role>
      <ShortName>REVOLVING LINE OF CREDIT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/RevolvingLineOfCredit</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - LONG-TERM DEBT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/Long-termDebtDetailsNarrative</Role>
      <ShortName>LONG-TERM DEBT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/Long-termDebt</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - INCOME TAXES - Income tax reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails</Role>
      <ShortName>INCOME TAXES - Income tax reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - INCOME TAXES - Current and deferred tax expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails</Role>
      <ShortName>INCOME TAXES - Current and deferred tax expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails</Role>
      <ShortName>INCOME TAXES - Deferred tax asset and liability components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails</Role>
      <ShortName>CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="eps10796_sotk.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative</Role>
      <ShortName>CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentAnnualReport, dei:DocumentTransitionReport -  eps10796_sotk.htm 29, 30</Log>
    <Log type="Warning">[dqc-0033-Document-Period-End-Date-Context] The ending date of 2022-02-28 used for AuditorFirmId must be the same as the Document Period End Date, 2023-02-28. The properties of this AuditorFirmId fact are Context: From2021-03-012022-02-28, Unit: (none), Rule Element Id: 2. eps10796_sotk.htm 5661</Log>
    <Log type="Warning">[dqc-0033-Document-Period-End-Date-Context] The ending date of 2022-02-28 used for AuditorLocation must be the same as the Document Period End Date, 2023-02-28. The properties of this AuditorLocation fact are Context: From2021-03-012022-02-28, Unit: (none), Rule Element Id: 2. eps10796_sotk.htm 5840</Log>
    <Log type="Warning">[dqc-0033-Document-Period-End-Date-Context] The ending date of 2022-02-28 used for AuditorName must be the same as the Document Period End Date, 2023-02-28. The properties of this AuditorName fact are Context: From2021-03-012022-02-28, Unit: (none), Rule Element Id: 2. eps10796_sotk.htm 5661</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="eps10796_sotk.htm">eps10796_sotk.htm</File>
    <File>ex21.htm</File>
    <File>ex23-1.htm</File>
    <File>ex23-2.htm</File>
    <File>ex31-1.htm</File>
    <File>ex31-2.htm</File>
    <File>ex32-1.htm</File>
    <File>ex32-2.htm</File>
    <File>sotk-20230228.xsd</File>
    <File>sotk-20230228_cal.xml</File>
    <File>sotk-20230228_def.xml</File>
    <File>sotk-20230228_lab.xml</File>
    <File>sotk-20230228_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>sotk-logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="432">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>70
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "eps10796_sotk.htm": {
   "axisCustom": 0,
   "axisStandard": 13,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 432,
    "http://xbrl.sec.gov/dei/2023": 41
   },
   "contextCount": 85,
   "dts": {
    "calculationLink": {
     "local": [
      "sotk-20230228_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sotk-20230228_def.xml"
     ]
    },
    "inline": {
     "local": [
      "eps10796_sotk.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sotk-20230228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sotk-20230228_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sotk-20230228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 379,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 11,
    "http://sono-tek.com/20230228": 4,
    "http://xbrl.sec.gov/dei/2023": 6,
    "total": 21
   },
   "keyCustom": 14,
   "keyStandard": 226,
   "memberCustom": 15,
   "memberStandard": 22,
   "nsprefix": "sotk",
   "nsuri": "http://sono-tek.com/20230228",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://sono-tek.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - STOCK-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://sono-tek.com/role/Stock-basedCompensation",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://sono-tek.com/role/Inventories",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements",
     "shortName": "BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - ACCRUED EXPENSES",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://sono-tek.com/role/AccruedExpenses",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - REVOLVING LINE OF CREDIT",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://sono-tek.com/role/RevolvingLineOfCredit",
     "shortName": "REVOLVING LINE OF CREDIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - LONG-TERM DEBT",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://sono-tek.com/role/Long-termDebt",
     "shortName": "LONG-TERM DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://sono-tek.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://sono-tek.com/role/EarningsPerShare",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales",
     "shortName": "CUSTOMER CONCENTRATIONS AND FOREIGN SALES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://sono-tek.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://sono-tek.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://sono-tek.com/role/SignificantAccountingPoliciesTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - REVENUE RECOGNITION (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://sono-tek.com/role/RevenueRecognitionTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://sono-tek.com/role/Stock-basedCompensationTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://sono-tek.com/role/InventoriesTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables",
     "shortName": "BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - ACCRUED EXPENSES (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://sono-tek.com/role/AccruedExpensesTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://sono-tek.com/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - EARNINGS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://sono-tek.com/role/EarningsPerShareTables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables",
     "shortName": "CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Fair values of financial assets of the Company (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:LiabilityForUncertainTaxPositionsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:AdvertisingCostsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - REVENUE RECOGNITION - Sales Revenue by Product Line (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails",
     "shortName": "REVENUE RECOGNITION - Sales Revenue by Product Line (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-012023-02-28_custom_FluxingSystemsMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "sotk:CashDeposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - REVENUE RECOGNITION (Details Narrative)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://sono-tek.com/role/RevenueRecognitionDetailsNarrative",
     "shortName": "REVENUE RECOGNITION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "sotk:CashDeposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2022-02-28",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION - Summary of Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION - Weighted-average Black-Scholes assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative",
     "shortName": "STOCK-BASED COMPENSATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - INVENTORIES (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://sono-tek.com/role/InventoriesDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails",
     "shortName": "BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative",
     "shortName": "BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - ACCRUED EXPENSES (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://sono-tek.com/role/AccruedExpensesDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - REVOLVING LINE OF CREDIT (Details Narrative)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative",
     "shortName": "REVOLVING LINE OF CREDIT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28_us-gaap_RevolvingCreditFacilityMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2022-02-28_us-gaap_UnsecuredDebtMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - LONG-TERM DEBT (Details Narrative)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://sono-tek.com/role/Long-termDebtDetailsNarrative",
     "shortName": "LONG-TERM DEBT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2022-02-28_us-gaap_UnsecuredDebtMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - INCOME TAXES - Income tax reconciliation (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails",
     "shortName": "INCOME TAXES - Income tax reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - INCOME TAXES - Current and deferred tax expense (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails",
     "shortName": "INCOME TAXES - Current and deferred tax expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - INCOME TAXES - Deferred tax asset and liability components (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails",
     "shortName": "INCOME TAXES - Deferred tax asset and liability components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails",
     "shortName": "EARNINGS PER SHARE - The computation of basic and diluted earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails",
     "shortName": "CUSTOMER CONCENTRATIONS AND FOREIGN SALES - Schedule of Customer Concentrations and Foreign Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative",
     "shortName": "CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_custom_ForeignCustomersMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2021-02-28_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "AsOf2021-02-28_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - BUSINESS DESCRIPTION",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://sono-tek.com/role/BusinessDescription",
     "shortName": "BUSINESS DESCRIPTION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://sono-tek.com/role/SignificantAccountingPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - REVENUE RECOGNITION",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://sono-tek.com/role/RevenueRecognition",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "eps10796_sotk.htm",
      "contextRef": "From2022-03-01to2023-02-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 37,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r536",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r536",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r536",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r536",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "auth_ref": [
      "r536",
      "r538",
      "r539",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction.",
        "label": "Document Financial Statement Error Correction [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r536",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://sono-tek.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "sotk_AccountsReceivableReserve": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "AccountsReceivableReserve",
        "negatedLabel": "Accounts receivable reserve"
       }
      }
     },
     "localname": "AccountsReceivableReserve",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Buildings, equipment, furnishings and leasehold improvements, net"
       }
      }
     },
     "localname": "BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_CapitalizedRdExpensesIrcSection174": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized R&amp;D expenses \u2013 IRC Section 174"
       }
      }
     },
     "localname": "CapitalizedRdExpensesIrcSection174",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_CashDeposits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash deposits"
       }
      }
     },
     "localname": "CashDeposits",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognitionDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount borrowed under the credit facility being utilized to collateralize letters of credit issued to customers for cash deposits on existing orders during the period.",
        "label": "Credit line utilized to collateralize letter of credit issued to customers"
       }
      }
     },
     "localname": "CreditLineUtilizedForCollateralizeLettersOfCreditToCustomers",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_CustomerDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "localname": "CustomerDeposits",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_EmployeesAndDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee and Directors",
        "label": "Employee and Directors"
       }
      }
     },
     "localname": "EmployeesAndDirectorsMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_EquipmentAndFurnishingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment and Furnishings",
        "label": "Equipment and Furnishings"
       }
      }
     },
     "localname": "EquipmentAndFurnishingsMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment, Furnishings and Leasehold Improvements"
       }
      }
     },
     "localname": "EquipmentFurnishingsAndLeaseholdImprovementsPolicyTextBlock",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sotk_FluxingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fluxing Systems",
        "label": "Fluxing Systems [Member]"
       }
      }
     },
     "localname": "FluxingSystemsMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_ForeignCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Customers",
        "label": "Foreign Customers"
       }
      }
     },
     "localname": "ForeignCustomersMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_GainFromForgivenessOfPaycheckProtectionProgramLoan": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Paycheck Protection Program Loan Forgiveness"
       }
      }
     },
     "localname": "GainFromForgivenessOfPaycheckProtectionProgramLoan",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_IncreaseDecreaseInCustomerDeposit": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInCustomerDeposit",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerDeposit",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_IntegratedCoatingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Integrated Coating Systems",
        "label": "Integrated Coating Systems [Member]"
       }
      }
     },
     "localname": "IntegratedCoatingSystemsMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Equipment",
        "label": "Laboratory Equipment [Member]"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_MultiAxisCoatingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multi Axis Coating Systems",
        "label": "Multi Axis Coating Systems [Member]"
       }
      }
     },
     "localname": "MultiAxisCoatingSystemsMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_NonEmployeeDirectorsStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Employee Directors",
        "label": "Non-Employee Directors"
       }
      }
     },
     "localname": "NonEmployeeDirectorsStockOptionMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_OemSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OEM Systems",
        "label": "Oem Systems [Member]"
       }
      }
     },
     "localname": "OemSystemsMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_OtherProductLineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Product Line",
        "label": "Other Product Line [Member]"
       }
      }
     },
     "localname": "OtherProductLineMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_PaycheckProtectionProgramLoanForgiveness": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PaycheckProtectionProgramLoanForgiveness",
        "negatedLabel": "Paycheck Protection Program Loan Forgiveness"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoanForgiveness",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sotk_ProceedsFromExerciseOfStockOptionsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued as a result of exercise of stock options.",
        "label": "Proceeds from exercise of stock options (shares)"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfStockOptionsShares",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "sotk_ProductLineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Product Line",
        "label": "Total Product Line"
       }
      }
     },
     "localname": "ProductLineMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_SalesRevenuePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Sales Revenue",
        "label": "Sales revenue, percent"
       }
      }
     },
     "localname": "SalesRevenuePercent",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative",
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sotk_StockIssuedDuringPeriodSharesCashlessExerciseStockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cashless exercise of stock options (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesCashlessExerciseStockOptions",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "sotk_ThreeCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Customers",
        "label": "Three Customers"
       }
      }
     },
     "localname": "ThreeCustomersMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_TradeshowAndDemonstrationEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Show and Demonstration Equipment",
        "label": "Tradeshow And Demonstration Equipment [Member]"
       }
      }
     },
     "localname": "TradeshowAndDemonstrationEquipmentMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_TwoCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Customers",
        "label": "Two Customers"
       }
      }
     },
     "localname": "TwoCustomersMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_TwoThousandThirteenStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the \"2013 Plan\"",
        "label": "the \"2013 Plan\""
       }
      }
     },
     "localname": "TwoThousandThirteenStockIncentivePlanMember",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "sotk_UncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uncertainties"
       }
      }
     },
     "localname": "UncertaintiesPolicyTextBlock",
     "nsuri": "http://sono-tek.com/20230228",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LatinAmericaMember": {
     "auth_ref": [
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latin America [Member]"
       }
      }
     },
     "localname": "LatinAmericaMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r199",
      "r499",
      "r581",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r266",
      "r364",
      "r388",
      "r405",
      "r406",
      "r455",
      "r457",
      "r459",
      "r460",
      "r462",
      "r476",
      "r477",
      "r490",
      "r496",
      "r507",
      "r514",
      "r580",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r266",
      "r364",
      "r388",
      "r405",
      "r406",
      "r455",
      "r457",
      "r459",
      "r460",
      "r462",
      "r476",
      "r477",
      "r490",
      "r496",
      "r507",
      "r514",
      "r580",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r199",
      "r499",
      "r581",
      "r628",
      "r629"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto-Asset [Table]"
       }
      }
     },
     "localname": "PlatformOperatorCryptoAssetTable",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r196",
      "r366",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r479",
      "r497",
      "r513",
      "r548",
      "r575",
      "r576",
      "r581",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r196",
      "r366",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r479",
      "r497",
      "r513",
      "r548",
      "r575",
      "r576",
      "r581",
      "r628"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r259",
      "r266",
      "r296",
      "r297",
      "r298",
      "r363",
      "r364",
      "r388",
      "r405",
      "r406",
      "r455",
      "r457",
      "r459",
      "r460",
      "r462",
      "r476",
      "r477",
      "r490",
      "r496",
      "r507",
      "r514",
      "r517",
      "r573",
      "r580",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r259",
      "r266",
      "r296",
      "r297",
      "r298",
      "r363",
      "r364",
      "r388",
      "r405",
      "r406",
      "r455",
      "r457",
      "r459",
      "r460",
      "r462",
      "r476",
      "r477",
      "r490",
      "r496",
      "r507",
      "r514",
      "r517",
      "r573",
      "r580",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r197",
      "r198",
      "r402",
      "r403",
      "r404",
      "r456",
      "r458",
      "r461",
      "r463",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r480",
      "r498",
      "r517",
      "r581",
      "r628"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r402",
      "r403",
      "r404",
      "r456",
      "r458",
      "r461",
      "r463",
      "r464",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r480",
      "r498",
      "r517",
      "r581",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r14",
      "r512"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable (less allowance of $12,225 and 56,123, respectively)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r64",
      "r108"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://sono-tek.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpensesDetails",
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://sono-tek.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r18",
      "r483"
     ],
     "calculation": {
      "http://sono-tek.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r64",
      "r65",
      "r109"
     ],
     "calculation": {
      "http://sono-tek.com/role/AccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued commissions"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r42",
      "r132",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r68",
      "r512",
      "r631"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r400",
      "r563",
      "r564",
      "r565",
      "r616",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r48",
      "r49",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Stock based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Expenses"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r135",
      "r202",
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance for doubtful accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r107",
      "r134",
      "r154",
      "r183",
      "r190",
      "r194",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r335",
      "r339",
      "r351",
      "r370",
      "r427",
      "r512",
      "r524",
      "r578",
      "r579",
      "r618"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r127",
      "r138",
      "r154",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r335",
      "r339",
      "r351",
      "r512",
      "r578",
      "r579",
      "r618"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r63",
      "r85",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "BUSINESS DESCRIPTION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BusinessDescription"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH AND CASH EQUIVALENTS:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r130",
      "r481"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r23",
      "r82",
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "End of year",
        "periodStartLabel": "Beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r0",
      "r82"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash in excess of the FDIC insured limit"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r21",
      "r60",
      "r372",
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies (Note 13)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r211",
      "r212",
      "r466",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r515",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522",
      "r563",
      "r564",
      "r616",
      "r630",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r67",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, issued shares"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r67",
      "r415",
      "r433",
      "r632",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, outstanding shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r67",
      "r373",
      "r512"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $.01 par value; 25,000,000 shares authorized, 15,742,073 and 15,729,175 issued and outstanding as February 28, 2023, and 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r29",
      "r31",
      "r54",
      "r55",
      "r199",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r29",
      "r31",
      "r54",
      "r55",
      "r199",
      "r394",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r29",
      "r31",
      "r54",
      "r55",
      "r199",
      "r465",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "CUSTOMER CONCENTRATIONS AND FOREIGN SALES"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r29",
      "r31",
      "r54",
      "r55",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Outstanding accounts receivables, percent"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r28",
      "r29",
      "r31",
      "r32",
      "r54",
      "r106",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r29",
      "r31",
      "r54",
      "r55",
      "r199",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r52",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r78",
      "r154",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r351",
      "r578"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Goods Sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal, State and Local, Tax Expense (Benefit)",
        "totalLabel": "Total current income tax"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r549",
      "r562",
      "r615"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r549",
      "r562",
      "r615"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r30",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentDecreaseForgiveness": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.",
        "label": "Gain on forgiveness of debt"
       }
      }
     },
     "localname": "DebtInstrumentDecreaseForgiveness",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [
      "r157",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r358",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r20",
      "r44",
      "r45",
      "r56",
      "r57",
      "r58",
      "r61",
      "r95",
      "r96",
      "r157",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r358",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r562",
      "r614",
      "r615"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "totalLabel": "Total deferred income tax"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r314",
      "r315"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r3",
      "r104",
      "r122",
      "r328",
      "r329",
      "r562"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred tax asset, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r314",
      "r315",
      "r371"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r562",
      "r614",
      "r615"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r51",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Allowance for inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred tax asset \u2013 Long Term"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r51",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Allowance for accounts receivable"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r51",
      "r613"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Accrued expenses and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r50",
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedLabel": "Deferred tax liability \u2013 Long Term"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51",
      "r613"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Building and leasehold depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-DeferredTaxAssetAndLiabilityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r3",
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation Expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r3",
      "r186"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of dilutive securities:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [
      "r257",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r257",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r146",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r172",
      "r174",
      "r175",
      "r176",
      "r177",
      "r181",
      "r348",
      "r349",
      "r367",
      "r380",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Earnings Per Share",
        "verboseLabel": "Basic Earnings Per Share \u2013 Weighted Average"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
      "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r146",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r174",
      "r175",
      "r176",
      "r177",
      "r181",
      "r348",
      "r349",
      "r367",
      "r380",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted Earnings Per Share",
        "verboseLabel": "Diluted Earnings Per Share \u2013 Weighted Average"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
      "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r171",
      "r178",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Compensation expense, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Compensation expense not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r7",
      "r125",
      "r142",
      "r143",
      "r144",
      "r158",
      "r159",
      "r160",
      "r162",
      "r168",
      "r170",
      "r182",
      "r204",
      "r205",
      "r247",
      "r301",
      "r302",
      "r303",
      "r324",
      "r325",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r389",
      "r390",
      "r391",
      "r400",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r53",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Significant accounting policies - fair values of financial assets of the company"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r237",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r350",
      "r360",
      "r361",
      "r362",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r237",
      "r260",
      "r265",
      "r350",
      "r360",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r237",
      "r260",
      "r265",
      "r350",
      "r361",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r237",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r350",
      "r362",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r237",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r360",
      "r361",
      "r362",
      "r492",
      "r493",
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r5",
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current:"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Useful life of intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r133",
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization of patents"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Annual amortization expense this year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Annual amortization expense year five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Annual amortization expense year four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Annual amortization expense year three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Annual amortization expense year two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79",
      "r437"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r6",
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r77",
      "r154",
      "r183",
      "r189",
      "r193",
      "r195",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r351",
      "r489",
      "r578"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r3",
      "r40",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment losses"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r155",
      "r330"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "totalLabel": "Income before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r156",
      "r311",
      "r318",
      "r319",
      "r322",
      "r326",
      "r331",
      "r332",
      "r333",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r112",
      "r123",
      "r169",
      "r170",
      "r187",
      "r316",
      "r327",
      "r381"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense",
        "totalLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
      "http://sono-tek.com/role/IncomeTaxes-CurrentAndDeferredTaxExpenseDetails",
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r141",
      "r312",
      "r313",
      "r319",
      "r320",
      "r321",
      "r323",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r317"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Expected federal income tax"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r611"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Permanent differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r611"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r611"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "State tax, net of federal"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r611"
     ],
     "calculation": {
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxes-IncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r559"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "verboseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) Decrease in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Decrease) Increase in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r38",
      "r39"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r147",
      "r150",
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Total"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory reserve"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r137",
      "r482",
      "r512"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r129",
      "r136",
      "r207",
      "r208",
      "r209",
      "r365",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r555"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Raw materials and subassemblies"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Interest and Dividend Income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets",
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r17",
      "r154",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r336",
      "r339",
      "r340",
      "r351",
      "r413",
      "r488",
      "r524",
      "r578",
      "r618",
      "r619"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r72",
      "r111",
      "r375",
      "r512",
      "r561",
      "r572",
      "r617"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r128",
      "r154",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r336",
      "r339",
      "r340",
      "r351",
      "r512",
      "r578",
      "r618",
      "r619"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsCurrent": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as current.",
        "label": "Uncertain tax positions"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r12",
      "r110",
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Letter of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognitionDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCollateralFeesAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fees associated with providing collateral for the credit facility.",
        "label": "Line of credit collateral amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCollateralFeesAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognitionDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Unused portion of credit line"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Revolving line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r16",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r12",
      "r110",
      "r236",
      "r246",
      "r492",
      "r493",
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "LONG-TERM DEBT"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r20",
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable securities",
        "verboseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets",
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails",
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Net unrealized loss on marketable securities",
        "negatedLabel": "Unrealized loss on marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows",
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MiddleEastMember": {
     "auth_ref": [
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Middle East.",
        "label": "Middle East [Member]"
       }
      }
     },
     "localname": "MiddleEastMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Provided By Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Used In Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income (Expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses [Default Label]",
        "totalLabel": "Total Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r183",
      "r189",
      "r193",
      "r195",
      "r489"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating Income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://sono-tek.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other.",
        "label": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other research and development expense.",
        "label": "Research and development expenses"
       }
      }
     },
     "localname": "OtherResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities, net"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of equipment, furnishings and leasehold improvements"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r1",
      "r10"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows",
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r59",
      "r217",
      "r218",
      "r219"
     ],
     "calculation": {
      "http://sono-tek.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Estimated warranty costs"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r126",
      "r139",
      "r140",
      "r148",
      "r154",
      "r161",
      "r169",
      "r170",
      "r183",
      "r189",
      "r193",
      "r195",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r334",
      "r337",
      "r338",
      "r349",
      "r351",
      "r368",
      "r379",
      "r399",
      "r435",
      "r450",
      "r451",
      "r489",
      "r510",
      "r511",
      "r523",
      "r558",
      "r578"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income",
        "totalLabel": "Net Income",
        "verboseLabel": "Numerator for basic and diluted earnings per share"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows",
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails",
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r90",
      "r117",
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r91",
      "r131",
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Totals"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r4",
      "r369",
      "r378",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Equipment, furnishings and leasehold improvements, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r4",
      "r117",
      "r120",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Land and Buildings"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Buildings, equipment, furnishings and leasehold improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails",
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Estimated useful life",
        "verboseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails",
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r567",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Accounts Receivable, net"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r62",
      "r310",
      "r626"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and product development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Product Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r69",
      "r97",
      "r374",
      "r392",
      "r393",
      "r397",
      "r416",
      "r512"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Accumulated earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r125",
      "r158",
      "r159",
      "r160",
      "r162",
      "r168",
      "r170",
      "r204",
      "r205",
      "r301",
      "r302",
      "r303",
      "r324",
      "r325",
      "r341",
      "r343",
      "r344",
      "r346",
      "r347",
      "r389",
      "r391",
      "r400",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r184",
      "r185",
      "r188",
      "r191",
      "r192",
      "r196",
      "r197",
      "r199",
      "r256",
      "r257",
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Total sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r124",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r436",
      "r478",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r145",
      "r154",
      "r184",
      "r185",
      "r188",
      "r191",
      "r192",
      "r196",
      "r197",
      "r199",
      "r203",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r351",
      "r368",
      "r578"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Net Sales",
        "verboseLabel": "Sales revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative",
      "http://sono-tek.com/role/RevenueRecognition-SalesRevenueByProductLineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCreditDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r199",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Income taxes - current and deferred tax expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Income taxes - deferred tax asset and liability components"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Earnings per share - the computation of basic and diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Income taxes - income tax reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue recognition - sales revenue by product line"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r13",
      "r73",
      "r74",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/BuildingsEquipmentFurnishingsAndLeaseholdImprovementsDetails",
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r8",
      "r9",
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Stock-based compensation - summary of stock options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Stock-based compensation - weighted-average black-scholes assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r28",
      "r29",
      "r31",
      "r32",
      "r54",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedule of customer concentrations and foreign sales"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSalesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Marketing and selling"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r2"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Number of shares available for purchase"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Stock Options exercisable at end of period (in shares)",
        "periodStartLabel": "Stock Options exercisable at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average exercisable at end of period (in dollars per share)",
        "periodStartLabel": "Weighted Average exercisable at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "negatedLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Options cancelled in settlement of shares issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Stock options for employees, directors and outside consultants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Granted (in shares)",
        "verboseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted average grant date fair value, per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Options outstanding",
        "periodEndLabel": "Stock Options outstanding at end of period (in shares)",
        "periodStartLabel": "Stock Options outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Weighted Average outstanding at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "negatedLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Granted (in dollars per share)",
        "verboseLabel": "Options, exercisable price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails",
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r267",
      "r274",
      "r293",
      "r294",
      "r295",
      "r296",
      "r299",
      "r304",
      "r305",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Options, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-Weighted-averageBlack-scholesAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining term outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Options, vesting period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for short-term debt.",
        "label": "REVOLVING LINE OF CREDIT"
       }
      }
     },
     "localname": "ShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/RevolvingLineOfCredit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r85",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Product Warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r7",
      "r22",
      "r125",
      "r142",
      "r143",
      "r144",
      "r158",
      "r159",
      "r160",
      "r162",
      "r168",
      "r170",
      "r182",
      "r204",
      "r205",
      "r247",
      "r301",
      "r302",
      "r303",
      "r324",
      "r325",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r389",
      "r390",
      "r391",
      "r400",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r182",
      "r366",
      "r395",
      "r401",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r452",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails",
      "http://sono-tek.com/role/SignificantAccountingPolicies-FairValuesOfFinancialAssetsOfCompanyDetails",
      "http://sono-tek.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r182",
      "r366",
      "r395",
      "r401",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r452",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://sono-tek.com/role/CustomerConcentrationsAndForeignSales-ScheduleOfCustomerConcentrationsAndForeignSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r66",
      "r67",
      "r97",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Stock-basedCompensation-SummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r22",
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Cashless exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock or Unit Option Plan Expense",
        "verboseLabel": "Stock based compensation expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r67",
      "r70",
      "r71",
      "r87",
      "r417",
      "r433",
      "r453",
      "r454",
      "r512",
      "r524",
      "r561",
      "r572",
      "r617",
      "r632"
     ],
     "calculation": {
      "http://sono-tek.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Balance - February 28, 2023",
        "periodStartLabel": "Balance - February 28, 2022",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets",
      "http://sono-tek.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Disclosure:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/Long-termDebtDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r115",
      "r116",
      "r118",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Management Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r173",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Shares \u2013 Diluted",
        "verboseLabel": "Denominator for diluted earnings per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
      "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r172",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Shares \u2013 Basic",
        "verboseLabel": "Denominator for basic earnings per share - weighted average"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://sono-tek.com/role/ConsolidatedStatementsOfIncome",
      "http://sono-tek.com/role/EarningsPerShare-ComputationOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org//606/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org//260/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org//330/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r525": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r526": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r527": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r528": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r529": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r531": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r532": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r533": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r534": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r535": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r536": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r537": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r538": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r539": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r541": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r542": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r543": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r544": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r545": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org//275/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org//470/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>71
<FILENAME>0001171520-23-000181-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171520-23-000181-xbrl.zip
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MLDS*:GD)7Q'IUI/D0(V&B3J3.HBDH&D55&<A(\W3FA[^9?FB\-^GS00YLQ>
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M'Z9P2_/-,NBIZEPYD%6+;(X'N$ONGPRO5<I+OF"W!;O=?:Y&CM 0CYK?%CK
M=] !]C4FXY$+I_#&@5-X$G#3#<'T6/A;'R:+WCN)>#0+WT/U^SD!EE8(_,9
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M^KO2$_ ZW80-<'5U0"NAHNL"-Z'QQS<K7-L?8!5!V:6-@8P8)QK5QXE$FQ'
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M<4:^;-.LMM\WX4I2&)&R%4H3=-NF1H]6Y4'(R/F=&@SC7%<(I4="C\ [,+8
M?A6M&J,6Y@AS),4S2B<$80_^=HQ>>J36VE2-F1>H$E16N9:?9KH$D2\;.0/X
MF<!J/+R NH]K^N:&"$@EC1A?O1UZ:<H-<(_H,\E#$*#N\J4J=CJ&FF<LCE3C
MOMF( L1\P4_/.YID_4RJ &D< JKP@K?V@D%/(:X'B?;5[IC8-]I2Z4ZQCUP^
MJF[^ECJ@F F<D+KM^;)O94=R T(7FNX$?F[\K%)4^4NA!)_#/'KQ8'CYY5M9
M@ZK#UHH,!!O6<3GOXG#0>_S\P;@;'$!!9NTN7$.P8%3@3%D?CK;F[@S1T&/+
M\I3/57'_3"EJHD:H#VXP%E<]($SBBCLL"+SMMGQ?*!@(00#D+$A6YU[:\?Z$
MX7"AUAEO!KXK<684^TN=YL7U[]O.)Y^3>5EQE65U2Y;!9!Q-X9DI4, V'[6B
MO _,HJ;:Z#U0SI;A&> *F\8KMST>Q=)V"VREAG(#O%',[H)GFA&C0(;]!$ZS
M<4S'6/GR$2KP<%F;"CGD0/JTQ\ 5:735!\N/(=)6$G^'6V'']T)RY6\94X0S
M!?8-.9;B3L4M!N8N<A#,H!4&Z:W?*32<>>TV]E!R,8$H![$;I"I6[JHXJZFE
M9,.)M.SY88%0L( M\;D]@+&^$QJHJBHLLS;XN"ZS=JGH69"E)JV\<BIFE1A9
M2P-':_B _H"$?J@++:4(MN\E>.U(I/8 .U'B0<:+:U= LYOY0*FK&X(?&6BR
M\91.?M<B$"LQ\-HCH/S_"GN56#2MSC/Q&E3*(3=?N@LRC#UY+NBT.X1K+4+G
MG<E2)]= 4KOD,-DT\;)X:M5HA2SQCR"@@Q4;[DM&SU(>AQN963T&J5G6E-"B
MN6M31J.]KGM5VLE96CH8^,K,F._#!.<C=4+=87D_LTH0X_/0B-'754-N<Z^/
MKN3TPBR^(>98JSJ5BJ+0;<N3T%GXTBJ-K*M1-*?:2.U=64-P489D36C2W1![
MK[Q\I0/2\J(AY>8U*IOB'XW%_"[U;<-/+6N0E_ZG2 J 2K_HDI>&U,*Z"4R_
ME1QD<!"X>,Y3>0NF$Y4..WP%%\K+*<']OT&/\Y#PORML;LH7D"ZE>@4[^264
MP_#/ 8@3CL@LWI(?71$9_HI_(MEAJR;^B@CMI'LQOU"W0:JAQS!V& ;?_5!*
MX4R3F-$HWDXP#LZ)248X!V8IT I46O%@6-D\HAC4Q!G6)1%\ X%C4K -^HIN
ME1P,BTH@O)%E6I(W!C#-E8AARD8<O"KV>3$M7=WY>#9<-' 2I.#&I"J 4"?3
M%-#U^;,VV<>Y7NHKT\%U8=$@T2.K'YUCA1A;9T(0:DD68'8:1^4CRQ/>4H^B
M ?7/<A5OA/?YGE/9V?I]>\(DP.&;3@+LO]4D@+JSJ7Y/.!FSD([:*,Z7'.-V
MI/A_#@'%';&Y1N&B,$Z#:JR31E6Q\L5G.V/XH$VW]5ALCM4ZFT<;>D7"XQ*Q
MC\!\FL[>(?DS,,VM[]T%6*&E.9.(/I#\L^ O7U5'2>NIYEJGC:[9*C!%;> \
MK,^K2';HFWQ"S,$Q^@X%R\!3T%_@KM6V'_0S;EQ.:.U!^X,.(UYT".]2D/3D
M.=8[7 PJY",_@S2G7$J=\TK)=4J^2*5%54YD@W4OFF$Y4A% IQ?P(1C&8*2P
MX)H#P[XJ6*;>_4+2J_2MG%0SX*G$E8<<8=S8W<6N=Q4B9C2#=@R']E^\G#*L
M1SPE%,(P>:\SXKC7OA=_F[Q<NP[*/!Z;,#FM)AYQ*B@L%HEZB9,F[V'/W5)?
MAR;;\L/X7I*"EG,61%S=-_R<LOX5SLEG]J_[R8"4G/7"Y=8"2KFI=]%R)%X_
MZ(0/1> (+FVG<6(U@:R,OB5H:>'W0.NPH\P?8H*:7G+DJRAYO0Z#=:+K_$J@
MM 2UENK7.^PS,;+08XZ,2U%>6!@Z$^),T[U.Y,YBD-CV9DV54VI,DYC.0D=]
MRM'DCH6U;-&CP0>I0A'<A6WG?_C]&*&RW&B/YU3RRO)S$R>GRA8#]-I[OH?(
M#MU!R)6Y/)0[LCEEP[!@'5SI'E:..6B;.WP-<L<@"D@P06^-EM?^'L8W<CA;
M&YKO N2Q"OZ+Q )RNQP-.V$=J1B)OL1S":L$_-R2)I',!%@*C2&Y^ J&@:69
M)&<-5[#EX]HDZ$?/5P7PA_ YZ)8.=O&.^,3"5;[L3B6(S0TU8^[^4;=/+#?I
M^,.67P6^<]='\A3\AUCRK?JN>3TVEAFDP[LWOU_SV][:MKA;C*]AX0['Q/)8
MK""W.ENX+(;H@^3^K_8WFCO:YQ:,"QQN-N<C387+3BA)HZ1E$I,,MV/1GI(9
M+Y]"USZ]R>!%@4F;JJBH]0K,Z#T,L[N-J+M_5 >VG<^RB#9G83<.P4 QL$[>
MG-C/TQT?16MB!<1L8NNG<7\]_;1^:XQ?CX'-4@QD?R&PXA\=0QDV.R$&5K93
M\8=66[DZ]>*.%- IW4>T_S\'09^[@VGWF1#6=RH0> F:L!=<BID8,J(H1@8)
M!9FN\;9:@\Z-;XI.6BC7_\16^\E:OA,3V^&Y:-441O!.#=^)14[YQ,]:L$]2
M7*LQ%<Y%+N[DHGN385R+>'JH\DPU*YIB1^[\4-CWE$)2R/@6.)"JJ_L64:%"
M$]O>P7@W!M@@BHM23P-OO1(3K82F%Y#;+6>7,UB>3HYQ8 35HVN8A!FU0;8*
MKY_LEO523+04<B"BTZN35LC(V:/KD[8X6"<</916DE!C.!5><@V!+A9?K\!$
MEK]C[86.C[>I@=5$A"X@%U-%?KB6Z"3#2ADW+W2U'7?S=33&_JP%.LFP4 __
M5(%.*Q"01UJ18.)'D/5:JI/PRC#*AX!P2(@45+.-V)-<V44A'\84+""ZKQ5W
M>AYNC8N[%MXDPT*Z)_!YOWU/O"#RU]MZ"ITS_4&*^WU[%7B0CMYT1=#!6ZT(
MNJ8\.'SR+YWNS!7G"/28JCW9W%!ID^%LR=AP^W2Y.\J[J-)@>@C1+PIUG<YN
M(+I62783IHD-#>.S'=O.)>5LF0+OYSA1B33,#96D+H;(:=1;)/M$Z!V/U0^7
MY3F'P/!&-N=N,T>)]4;5]G<?8WT5%^>;I.GH-BO*$<?W*U>!4 !989K-4CE+
M,MI":J+X.N?/-S?XFRB]&%%17<ZD/D5S5SC->LI[W4X01H->B_O0*7-IP8EP
MRR375(&=[TA7#@LR!Z@/]U@D),$,J('2'R554>P_BCP?JF[<G*C4RD!-L+B2
MW'J);S=0.GK5BTR-TNZ)H:2NT1R7>S-HU"-&2._@+V/KJL?@JK;)H8HW?]MI
M*E6TP:I9FC;8CS(0=DW$2&4=$K#HJFJA(3%; U,X98K]I*NZ,^C=#+SG&,V7
M-"QW6!::F$VQ'1%'#X% X)#YEULJ56S^J.V@")MP94E> D*NT&;O?6Y_I399
M^#T\9V5-$IY8TJ:-UA41Z +PEQ"=+U\W(D7E_*T4N87P6#68KYQ'?\A]O/+1
MKD!A)"F$ .KU,]9&15%LP2'F@>A+81UR)@U[*V![YQ >#/*SZ<U;77MW-0!K
M4:FVMJH:Q=DH=$/QZ B4<^6HMKNY\?X??Z_M?K3_1K_X0#"ZA-:OF@1D)9VA
MA53%^U)9AJ CB31Z<?E(OGNYK5K]$?T!<3BWL 2+BN;HJV0M/,Y@XO9#-)$.
M69V@$V!-*'IP6)=!+?2Y]S@CQZ@*?CW$@^K@]]E =</8X^I=U7BSN?&NNK?C
MP'4H% XK$66(_!6ZCJ7CT4"PB[(7$P-ZFQ&JI+R7[45,,22DM3*UGPQER*VG
M0MW\H!(UWLT-@A-GY/"$':SOV=PP1Y9!8,+W"K *3BR*HRWYIZB\&+1;/Z07
MX0>\+F)GJ\BW<>/03M'FT6E\_?5[+^5YTX&XN:&/'^Y+$\FTI+382[_['66;
M#7(5/\MUC.\889ER:'<5#KUZY<QD^5OJDVP@5W808Z/FD=0$26B4W3,E32'#
M>/?@M+Q5*);81V:1@2CH-[LF#/?-J/$Q6!^5/*DACD//H1$\:EYS[),CCV;2
M=,&9H+H_.J5M;(N54Q +]YH\LBC6' 2(RD;B8N1-!/@UL)TYMU^!/ML@ ]0(
M2FXD02P[7@_;JPSHG+&]*WRT\5M&R"X=$AXA/A2EE\/P,S(D)YDKL 50)7I0
M^&&ME.!2M1^>TT!TZMM8VY QRX!O/90/J9A18='[ 4<Q$B\\MR86[L.0CKLP
MK(1J]>]]]0KIH!X:_%1:L(H[9U*\U2^-\\95_:N#N*O.Y_KQ]<55<\4@5O\0
MA#6[Z92H[G)76:9,]/*<ASI_!98B-7Y.S@TJ@ &7,%UU?/ F\J3!*@)E450%
M$6@W50++@8+>3(\)6,R%&3N#'J&@FXH>?(6-6+UL1>Y51T&AS1@OF<4E)SAQ
M%R%%5 >M:9I3#4$EA=7#7"XNZ@TR->/_,H *+K;A;%/0S40$R]YBLW'LLOE5
MX"FE$"L(ZVM/,?!S52_\66HH4Y I&I*:> [\2-5>&PX0X_WP 9A3&*88L>:#
M936<PU6W1H7WY0M?&;VA3XX*P6!=#,-CLU!U<<+0AD28<MHD7IY;VYA=%0_(
M)9$%25OW$Y5OIPF[G,%I>\LYC<.WFM.8Z%:A/7:?8YKJ"D"TM51'IOH\U2[Q
M?VB*'$.\-!QIT7L9"9,S=CX4_EGLEMU88MCF-ZI!PK#O^#_\]H#V=PX47'"U
M^BI[H1%[N('W!SA*AI5']>%QK B_SK@>!.1'!E()ZMA^AX$W8(.B\ V4T%*_
MG1M+X;4?K1?$$36B);[/7. H41TFR%%T&+.BU@[YKCOZ]O?D.U[IK6Z48@0K
M>'<:]Y8\RQRL49<#[X5#DJTP875$0G3: 2&SMT*XC,*Q,\10IJESY/,YQ#)%
MFJ!%3SP,'>Y,'XA[-GSD<Y]0RTX(C*.LLZGMJ*BT"/:G_;H<C #?RSG*0U28
MU.3+R4?R'JE'J.7S/AER%<V)2G00J:1/2RA&]%FGN49<@RGZN/LG.:NQ?->O
M"!=!N?G'!B3TVW9SV_G"^=\0/32TQ*!&-E8*Q\W057M?&FK_4J]?E@;5/R@:
M\"G(:YA-A8Q0_M)A2FISU"[6;K.IIH1?SE]EK_T/H@_H,V(/9=')9:*<4!E3
M'&6'D*@I1F9:H<_#Q3%PJWHEB[P)*$YXF3"FB.-M '<L=6ABWA*9#YQ/A$W[
M7G3A<[WY25;_@\M)1 6?J-SU%ARKG#WK\75/OY:#<\S\9>6L[-6U!P\?1KI@
M[M)&HX(OUP<W<X'AT00BP3X:6T?TZ'%GVWA)X'T%;4'PM=ERC-LPZE$NV%[B
MY24 =9S7.?CGK",5&FS593@B$-,G92=/_+2=!'UM8IJ6LI<@%:E *#]6 N#X
M'MH2Q[9NF&5K&G\%5./22S(YNDYA0*?P)_[GH:L<@]*OTN@&?<6IDSPX)U[F
MZ<@LC644Y(!( 0&41 F-,Z*PUM6*W&@S9&I!,#KK,U]JF2K8.)-YR Y5H#A0
MCHAO6?&D6'.RN8&:,)*-4;ZXL@;_-!)+HI#'2HDF[X4,4+GE&/ACWQ;+@?XS
MZ-P8?3#-#'9W)5]"4R-Q T,]WG3).E(E H4UQ>UPAU<6K)Q9VK(E6F%S3^*W
MQ>Z,DGH7N44]JZHD8#8Z"]G[EIS3Q%0]&6$%$7+KB>2I63X$1ZNCZ G-%D77
M-+HA1D7^VT?!=Z&ZMI849R$\.9H^"N)Y/PH?)10>50(G\!?Z^I0?H:!=BE$D
M?AWK]L*!;U-<42XHOE<92:$1$:)7G>ULMQ,P55S'H49D#=15!>$.#"'!  M:
M&N8,]'U=EZ'H6PN!)HS\!W3%D[&P:0GSMTU7<#J&!X<]]@K(P )(I\*12.U-
M%+/B/H"W=^)!*T-<$[&2.-P?;8&6C5NP^> MZ!]@EUZ<2#R620(YM@3&MVU!
M#$RDA 1.EGCW<O>U@$ML7B++ 2A4.JI2E98?!OZ=+P!/U&9BJ(0H0QLD[4$/
M3PKJ3M.I<4*TUGW@C]B8;8P_#HRI4,XI'S$V; +-AK".U%0M0A5U(K5U\=#(
M@^?U'" 7]@U/DT,.(<J1"<FE!32U@/P,VISEDJR69.7O/7F!"-(JO,P7<)JR
MJ!4V^J>15'!P#,>U9:,%)G D+03?YET<AW=\NL(!X">XM8JA[VVG6?HDBRF3
MR'-22?+0(U'8/;BGW9F".A.W1OHQ(DZ$US ;A8YBV3!'O!NE8$M*X_A-:'&9
MXY%X9X?#!D+^2%90<X?*:G]21!@GB@C#M0("8O3%0HM2$0@:5O[1V:9M)_=9
M&F9=@5!5,[)XO\D.L&K")I=ZY:%R9:K1B8EI?G/#%!X8<&\BT!Q$^J  .X,6
MA.]G%#$2OY.8?S TJ:H;E+@QU^SBC@.[&L:!%/$,84%SF:TT.QE*=DE8XW&B
M1Z<1&ERY=9=61""F+-=52!2$SIX_P8@R.XG)4A"FG\;:@8M&Q,\F'/MN'B*Z
M+!A@,+;K$O3$8PG9.E25CA_Z&AS!D*%X_'6!!L/HF(&G(4]!Q1(&7,XQ(K7E
M='T_%^BE6Y?<AD<DN!3KR"C+9E4^V^_+H_:(@VP'S#2N(A+0Q(G'>.4(7C1@
M[$-=3&M1RVM2Y]S9*G#T%HP2WE%#A0)D(%4H.MGQZ'X7:D$P8%*1/_5IA]AT
M33-XKWS#"::CMY!@PNK+&SB[HLY6.P[CY!>T$IFO7(XS0I)I>=%WBK&#C9;0
M!P8.4C1$F"(V+I9J9PDUN01#6YI_*V/1#GVZ":/!3&^+^5>RC!U\8OZ^!/9?
MW.%R,Y:G=)@^E/R(!P/*-*K5[LF"?@X79\SK_R!42Q-OH(XH7>+.?%94SJ37
MFR]+@6+0RMUI9?VMU;?R",5GCGJB.L[U0ZCT5/3/U0TK,RD0'2,&WFVN\&<C
M9/W1D7_]O4;_-P83S<9 *V*DY8=7':V1.=2TG)D<-I+C#,&C3;##>&D[VU5R
MK+DE=/2?1W:B-HF*J;0SMG)8RS<YF\?/N=WU#]\9RM/!U1Z=*RX0%+_!%->A
MZYED73CR8A<[6# VH*,!K)>BM>:WL97. Z\CD+841B['[+/W(*4U%-4F)[$7
M1_X#TZYU*22#..3&98Y\GUDM9+02Z97J$ZQWU]:8JFUAS +4&"<)8PLR51(X
M:@D%U=G+33-YE6:\@[UEW.;R0=- RD8]9,*M2_O3+7BA%=FT(2_ MFZQ(J]W
M_.)V?*D(G\T"G Z=@KTAA\B0\E!,S9>/<&>QAN(F_""=U*#OBWU +B*_HV]8
M_4'2%WI?VD\J6:!W% 5MAQ_KV?<;MD/6Q=VJ.-86"F]Y=O%:X2MXJLK9BK>W
M.R_4KU?<C>#@LC'34\'@H1^0N<'F$VRX&G$ %\I5["QH.DBD1 ]NRE*M<>/A
ME^6*GU!<U>](#0:;6?,]JD=:FX+79@I>_O#GXY$C4N5:39ZJ]8M<[PN6IQFJ
M8CAO"XV+I2>A=;Z":4!*;_PM+-9]=JN"4XPQC#X)86KID!6Z\795Z8(WQ%-5
M?W']WV:1C,=C[AI"]IY0'\?F1HLZ2ZC1@FG.?=-?D4NE% J9[/1WR]<I#%<5
M.%DK*/Z80FZEJ&V4=WCLV_3"RI^&XT#V R8+J=#."CK__3=,>E9:N-]%O_J_
M+@N\\]%^_\<DR,US1\J9IF7E]+IQYE0^Y;I4E@OW!V;S[?RJT;SX^J_&B=.\
MKG_^[!Q?G)TUSJ^;SI9S'A-.1'[<"P$"FKO>5M=J.Y/:5I=;:T\:S>.KT\OK
MTXMSY^*S<WEU<=FXNCYM-.>MK?2?"OI_$[B*E<4DB<%CB>\CX7=!V%ERZKWD
M.WC-;4\*@<Z",,.\"0K_WW'RG2OWS!?@YH#?('R'E \;*@7\H5J[]G;<G9T=
M)\6.=A\S-MQXALDJ+C.XI^0+)5Q@#_G<7L-_3TU-1P=)56*"AJ<4X@!3)DS*
MR,WDJ=]K$<DC[,-08%FQ"-Y,)<L-G&9*M2F(&\*YU0'""/WE.[6#X3$GSL'N
M3RI12G-64+S6X8J/D[H(CBQ;HR'? /F;5&&XNL%AS#_U?3(E"B)$\07=8T;N
M-NBK%Q=7BAL+B)_62EE*4A*TM4.-?>"9H ,X5PZ8^>MC/:<WE5J9WFCA(V*3
MSSFW1 '<A#ZQ@/,?4 06<<=MD'0X?NM3_A'3S#?@YD:*"751DIGYR*FMCYR9
MCIS:<A\Y7QM?ZE_QI#EN-$Y.S[\TJ:JW4OE(;M)J>DF[:Y6=265WEUMEST[/
M&TZS_KEQ_6_GY+1Y_/6B^0V\?4MQ,Z>N@43FK<(T!*6P)O?Z2&E"]2V7)E1W
M7G%I DMONEUV6;^Z=DY/9P5ZF+OAW%L;SID,Y]Z2&\[ZU>^-:^?SQ95SU?AR
MVKR^JI]?2UMDDR(D<.]L_,^WT^M_N_")K_5K"I]<'/_^V\77D\:5<U:_OFY<
M-9WZ^8ESVFQ^@U]=?KLZ_JW>!/,+%U;^+K9P?;LZ7<2]]=DN Q=%/#XIB PI
M(8PW'L&H//?2CO<G/)Y#I&=44++L-QVZ)Y]Y<,LY=)WJ3K6F LOW^%]'!Y2I
M@PN+*DHLP5SEXMG\7;OB[E6.X(X9^7![ICIZN[)1'G+,#VD2TNARR\D .&5P
M\ 1<'$P9QB'<*WM63AHP0H846FYO;OQ!7%T^IT*E(M;W$NS?2 V2*L-\^JI.
M(U?FW-7%F@8>1'*O\^P0F/N1LK\^4F8Z4O:7^T@!O[MQ]:_&R<H:^CFK^\%:
MW6=2]X/E5O>S^GG]2P,32=IMPAOHMV830_;H%L$'OOZ[>4KNT.?3\_KY\6G]
M*_A6YR>GU^HSL&F^?;VFCV" OXY_>"Y7J?3R^MRH=Y_C!/LTM[[&\7>!!Y!^
MNWE?B>;D!G08@2?/IFZ:_,LIZ5W%@YRO\D8<]Q F[JIS7OI0\)0WU$Z"(^0B
M@ "^BH+*TGC#?L!]$F"_$_\F*70M<D.F-.AW1=PABYO:Y^63&@XYL7I(C*^K
M(]NZ9RBX\^TBQQQ%8\?+/(WM8I%4(^@E#>F!WA-$MSX_?W-#-UBIUE:-%3I@
MG&)LK_U+@"2%+I*K3QBB<D U6*T"8X6% &#:,NVE,["NU&L#SFRNRY,1I0H=
MGDJHJEF&FW=!&AYX?C?:.6.@<4_*_C5+AI)1KN?)8C\SM)<NH4YAVP[UW&;>
M#]>6?@G/HI6<LLDT\\DA!6L_@LCQH^%DPN8A2MVDB-_P@"@J 6$!$*:GM&@K
M<#EPBENB3+J-3XAV'$P ^3V,"#'H5::JW3L#4XS/*17^H(;HR5>L$#YJ3H)I
MS-I'+518MH]RQZY&@C)!UQRW'^Y:<+9E2FG?9^X$;E3R54.NZX"&QPQ*=.M[
M87;;1BVE\F'6RD'$38)<,IVHWEZJ8S2U- PE9LLWC0W?AZ;E)37O];&%G7H6
M#7Q$=HN%E-3@=W\+6HMX_+%1%JQ8!JFEW0<&206I&*0R2C<AX5N^@(= 6J4Q
M"V\LT@-K,78:(D_3C%YHQS5+K=;)T7FM!.Y'(2HL9@7;HO0,:0C::VDZ0X6I
MSMW,>]A"=',2$+;6P0GL@4)B#)2Z]Q^L1C82K UP=A\GWT&^N,3JN2)F[!OL
MZKG9N5BQ2G9QDT'48APN#>KHR7NLS5/H[[25]F-Q'6D<NE=26I4Q'DVH9S9L
M)F'=6F_Q4DOL]CORA7=6&RFA )@N6D(!\]J,T(!(1M1(*6@%'X>*</'?#>SL
M2^(H:*<_GP7M)/;-+VCL9S[!XTBO#&(*(-@ BD)O=$TZ 7_HQ/>1 #!T!PD9
M1=G-FQN\G747K6U?/A;Q-%4M?X>U@JKUP.#9>JH>)RQ)0\-IX[-"-FIBM@@,
M-. F9!2 !QY %__&#0V6)15UH/X@CQ"NU,AR+-M\DJ@-HE8=F\X15<"N3X[Y
M-#2F&TTI*V&;\3#D6(UN/F+)'2@OMI\I3E(WIV:88(]H#X".9(SR5Q"@.8!#
MGR'P)Y7Q1T0Y0'O:,S.@O^N6[(^*.4#^#)L7T1D3#O2 #]B^A4T;^JIDD#G?
M/UJ28N(3J0N5ZHB>:!I%ED+"ZF) :CQ$;QZ4!GY$OPH+$Q&[@MHS AM+,>AQ
MTRK:/IP];)4$X2' ;$7Q7W\I+"B<0!PQ9&&,E?)Q(@"G_@^K*UDC)RJJ! 3#
M:]\2258<#HP[<1O<W/H*E@3KU!E8[*/40N8XO8R;QRWG$?L>M$M3.@$490L,
MJNVEA$-$E!=89L^24U!6S^\FDT=,WCRA<T:Q!9E)YU"?(#8(F#SO>1H7]:G#
M?DKNK?:F<V^55YQ[>]+E\S?8J"&29,]\V7RV()49,K-F,4D+!N[5+62.#:%S
M:?4H>>LT+1[S[>2P)QGZW4R/137!E+YAR1L^SL$OX:.@J!*@]W*J5ZH_T:FX
MN?&N<K!=T3Q!8*3?5?;,+^"JQ+C]N1L?_'<8^@2@R=XGM5%*&Q/13_0S]H<8
M*>*!"MQ2C;OO(R@_N1X&.@0NE;=!7X(4E&2C/\"\.OKP59Z2G*#*]\T>^@+3
MJ. Y$(2,V9LBS?(#8PS(O0U]KT-N'3X TUH^(E,P5A/WJQBT>()A1-^(7FO+
M@!$A'^E%F?\&6>O_H_K_)8G9/^LB! W9CS+CR#N!FGKW=K8/?V*P(V&.@-_4
M?D+OTWRINE[KY5OK"WV5@17%F,%HD[>_^Q,M]KO]0Z[@M=?[767[2!O!_+)K
M$TC!+4770^"P.BJEWD(86MK\P@M:A I!D1LJ9^>/,5"/'KI&!!I6L$G6W^;L
M'KO>+[? G_CZB/7-G_U6,L CH2H5!@X&B3R\%L)=RP+]PVL3'B+O#K?W]-+8
M:T:<;:,?3.2![_:V:^8LLY8 _[B_\].V0VT#?$O5?X/540_FB J\4#$8YT\X
M=8K1 UQ]4/$!I:Z]M/SVD20'%EPF R((E8.)X,>[B=?S<Q?'W"FF[JZ*.E2-
M">$8(D=?B%,"M,)PJ@*"1$ XCKU0W#NZB4<<:7*H8L1&G>AT:5/T>O>^/L0%
MJUU$I8(!<'Z_/@T^'MU$SL$'LOX6\:J)H)!YJ6SO:B5&,&-1ULT-O0UH7=Y5
M=K8/RCZHM7H[GP-\F?^;;\-M_EXQ_;U_X@O>F03M8-&^^/%-XO5!HYT39@7(
M'I8TQ<A<193_\G/PH'DB'C^ZY>@=D0#11#MJ9MN;&Y\>5+1/98#:&->R8F!#
M<4BB>) S[LZ7OAW9]!I\ ;>]2178K4 ^]?=@3L%7O*4^H:1&_$>P.-JB4#K"
MSH8L>0'8==SQF/2*Y@?^PIT]\5]@"^<#YC];/[LJGHD\B"::Z;#M=NU>*@EL
MLOQ\N";=,/E4"M8<,\B8,BM$IBG=N.3B$QIQS[G1VY"N7ZRPOB+O$,=)&N':
M&I&# 1LQ2TRIRR0>W&#E'<JL-=#LG%2.B>ER;J,3AC>)GWZ+"/>2Z@OXX\=>
MY'4\UVF<->K.^\8@ 0?-=<Z"3@<,>P/98XEAIXO>R0?7J5_6CYWW]33PG$MP
M[V%'?N#*QZ^XBYPZK!5\T'EODA)G_H^@'7\@P"[+176+?8E[/YE@+OA"-YC&
MH5V7I92HZXZ=P/*O/+.I1(8XC;H@P>]!%/$VU4IPLR;V:5#H6.@W;%7?W*#<
M+"83T9:H;DK!Y+-T :%6>=G_Z?41]_3X%@3JP@& M1BPVZZ]X!Y__SN80U.D
MP E(;@:%[ZHN4]?YUJRK?+\] B:G0M>@WU<>?S..XJUK_WN.2H2L*WE_!NZ4
M4W_43JKS1!V_%T<$@*$3"25BH/L.IIW$>,,PC-P$FB;6P11T1EOL$6)2F.,L
M?@0+YON,0"<98$Y-D@9FOH<C+] X8GJ&$?'D6. <:J>#M0#<\*BR@F2YK+-)
M-<[BD2R,D!BG9!<ZX6Q+&O?Q)A#PHDI:A8L/M#!)Q,;+PKR8PD]?_CV@,,II
M@7 [YU*']_K0S^A7?L?5'Q*Q$LDR?0CNCC[AI'3T*6N.ZL2_(46PS]H(EF[H
MO'7%(*=X1MV 6@TBR5*J>A I8\JEYZ@81!:W(R$7241.ROVW^Z9S,-57G(-Y
M2O_3E8&&N=#5#[/[Y;/7-BH<V::GTL0<9KPDG?]E"'#UJ=' 8L$J_\(%C:+Q
MR&9HQV'H]5-8=O53(7#X2$TPJX-5%CSB!LX#@SMTQSD:%DYQ)^5T*U>:"Z/$
M)?SOO^W_;<2V_A1Z[>_X!+69Q[^Z3,\^LT_U;PQT--#ZS7<VUH.>,/'J4Y_U
M4J_51<9+J$75OTWVZ%(MD8 *OZ%ZZ"Y,2];37GZ;P=R%<Y;%:FR=^0L3;[.K
MHU8+ED1U+0F4Q+NU&% ,/[V4B2D#L\0K5+6VXU9K1VYU;^]#27O8H_GIW=V?
M\C/%! W7GI"+7#[?,0^L_C1B?2;.F)<.:(3^C<V\%QZ48'W5WWZM[+D[>X>8
M.9[^D:5#&Z?6*RVH [=2JZT%]:B@WE?=G8.].0KJP[+(Z(DK-E)0E>H( _I4
M$<UD/_]@2.DIA#6<R2ZU\,=Q2E4%7^*XDSI-.!PFG_7D!]Y4A]PDLQFUWO-Y
M@^C @;N[LS_=7BD1R3R4];5+^M#=J^ZL)?T,DGY?<2N5W86(>HJC8&HI+X,>
MC)!G;8IS8CI)OIS'_?CA4=W>,X6O')%^NACD85-O,_H>40>'_G0[;<BCFMOS
M]=FQOU>=;9O1VQ>ARZ]0W(?N?F5*_W\M[J>+^_W1?F5!TI[A%)E T,NB#B/.
MDLH,9\EC$IWK_:,@A;$RGU2$)1*9K$BW^+GU:%9C-"OFWSBS;LYG/0.FN$O,
M<!!0&]/ZS'U.><]RWYA2WD^0ZB+>6"J))W]_/>'_&D9S6]:ZQ5QCI6FL>R?^
M)Q%D@]=$#2_ZRE7LR,,. .GAH@K.=_JV4&RW=,H:.7-M-=RW67B!6]+(F?](
ME0IX-S>"'H)X,$*5E(7?E+TR51V GE0_JA+67O"#)R&=6OQ7_EJQ_0_;J:27
MBP''?&*82;PH>^#"<63;\P241CAJE[N.M5C'3L@]) *IZ2W" +^KNA4.+7)5
M*76+;6Y0$2QU8DLKG/3WW<>F;OE%T$RXY.]25IORFC-6^BVJ?B\_K<.20L(Q
MR>E'\^N'<\FO5W:?DF O>7?9'*[O_?#.=\[@B[?IH^5_3YC0-$*>J<AI[DLX
MPT"?5,HTX=N?3>]*R^8F5"N[_7+!^H0H\4%[D1-_Y VE=2M.W%W(<-<+OE[P
MN<W[216B$PKDT0K1I\CB=9G5^0O]D4K29=]]DPGD";OS.H;OK-SV7+"FC*NT
M?;.:DJTU98I*Y#<DAG&5R L]RF;+&^R,+F$\+"WT^QP.?A"# +<+CPC3CGGL
M9)61HQ\P7?7HZ.<4IZ>J;-W*P=&8M.^T YO  LXLK<>?LXBQC1#@J%3)(@:Y
MPGJV?S2NN&"M98^(;W>M91.)Z7!<9\5J"^F)HQDAJ8.192FSC&N1]? EXQH>
MS"EX)S>$8N$<"P[5E"?W4]=N]@4K/YW'%O;./(Z1]F-&"SDWLUBFNM/;PED7
M9]F4XG!<&>I:*=Z@4KS?G_+DF[Q*<]DG/L5!]M)E^1,-Z0R)@+;J/X+T59QA
M^^[!X;CNQ#=IKG;WWKB].G*/*NM#K%@)^(1@PJO2BO<UMU(]>*,'66UD=_*S
MG63SN()=-,Y6^KRJNI7=]9VK>.=X0@#J55FFJEL[G#*"N=:*5Z\5X/:_U=.J
MLO/BI]5,]Z[2C.0%XH)//JU% 0O,L(CS>8,L<LT]K(T#RYA,)'.T04_$&)CN
MB8L=;_GI,BJ(L=B1OT6=KKI'^U/:[+5./T6G*T\(R:YU^DDZ?;@_90G'LLAY
M&498;B6.IO!NGC#69[ZEC^B!O+ZXKG]]^CSGVI [T5Z: 01CPAO-8^B,DXKE
M20W0$[;73(>),<U#%S[J*;I@GVL*;U31'T/77"OZ6M%?@Z(_BHXZBZ)/'+N9
M1;<7MA.?]N#'P53G(-&9T0P6T:C.I"UQU[$R] 4N<21U105&$MI:]2?#Z-L9
M^$0;C*RK/G%GC:!"=X4K-B RXCPS;($0MN7CA_H#HCXCWL]^Z$4(%6!3%VL^
M=.2!BC<WAC^S:S[#W$_(X:1[[Y%C>) P\:L?Y9\MG*W;3J%,7OKWTULB?\WS
MY6YN'%1^RK,AQ\P(!I_LQ'W"+4#F-N2I(C+VD)$:TG[B/3A=>1-,(^O&2<\E
M?C1\O_._547EKIY(C)8M'_G80P)H$!B%S8V\7/NP(OBW=I"T!T$&OK>7=.@I
MB8< #5XTZ'K$*8>TM%H/</!(;%G=^4B10_JY\E$#.[2\%/DS#=A$Z\&!FP4B
M7&QNO)-;&Q(UJF%X2:8$8[Z4JM<1E?$=LER!+'"-\/,I_'?[NW?#<T6EBA,F
M:Z./UYN73H_4U4-U%0XTY)D+X?&=!X58T472IF4!BE"0"4*TND9,>-(=>XV8
M,%?$A#4ZPKI9?MTLOU[PM[K@:W2$-3K",NV^-3K"<VK*&AUAC8XP@436Z BO
M%AWA;[\V0K^-O-Y!._WY+&@GL6]^,7DH<$5:B??<O9TU,,(,+>NU)]1_K% [
M]MP4#1-Q4]:;KQ4MUTLU*A&Q5K1"QL;=KTZ9"7L23^"SBVB^T AP6,X+&^$E
M>G+^]NN9W\%'3SJ'I:HKK[D'.^N^P&(UVEOO%MUU:[69^]O76O'*M.+]_K3=
M":^G^V;4VJ](]\WPD.HAW)PC+PON?*<1^<G-PTJN3,W=V1_'>OHV+=6H7K&W
M8JEJ[OZTR&1O0"N><&][55KQ?K_Z5D%[1C8'/=_Y-0^L@T;/QY*E&^?J'UZO
M__&$JN>F:B)=JF6I[<[<S?SJC-0;MU%'E?6Y5<P,O'&5>+]W,#,2QHH>6_LO
M#]$S?]"#TZ@S2#/XU,01P]??45MU=W>GO,:MN\2G>KKJ0ULC'SR73H/1WINQ
M$6JMTY/H]%JEGT^E:]-BBRZ+I)=AA.4RK4T##;_&/G@UG;)K[(-U2_C;4/0U
M]L%:T=^"HJ^Q#];8!W/%/I"&_>%<O>M8Q>$,(B!5:/CD[WZ6:B@$ZH*O'/SD
M.M7:3YL;^-'*WD^(>M"')\ CPX=MYROWP\<)H@%0\[L7AOCNU-</'""<P""Q
MV]L5"@.C /@_^C Y/VK#.SM^Z#WP_\(KX+>I:K1G'(;-C6$@!AQ:+[XCL :!
M"R@#6! T!D17L$$5MIWK6X114,$U&;=SDX")0Q& GZW&X D  $^%9[&Y00_F
MAO^.XV7.NXJ[QU$I%W_>.:2?&8@ )L\?O_=2@G/H,W2#/5"<#RY?XO=@JCBM
M=[O[UC-\>83ZNM>%91:$!@104,@,UC,U8@!HV?_9VG(^(XS +\ZE=P.VJNG_
M.4#I@\KO?73^A?, Y7.VMM1V[P1W(TP?1CF/#MW*[IY;.3C\X%3-!9$U=2N+
M^ZS)^C?JN_OXNZ%-AP;';(3AIHW\@W=*GKM#C[!FJ>;WT;E^Z,/4ZHG7"MH?
MG7.OY[,,SF.<;;5F?^MG]37\D]FH__4S2*-,,+!IOF^U_&Z<P$/[)%A[I/LE
M(ZWD;I_6<^UAX/AX+9Z(SO#%CV\2KP];;840&HY&>1H3]!T=S7+MGZV/MN35
MLX,Q/&$^D\MS+F ,8YX^+9[&# .=/&*QQ&I7VJ\_H5JI?GU^P_BF_7DHU7K:
MRVQD'FW6?XHL7M<6F[_0'VG67S+U6[ DQC6COR%)C&NV?D-B&-=LO5!3-%MY
M1HF++7[N;CD5_;?MYK9#=8;PO<CK>&.":>4/GK#];O0#INM0'/V<HQ$DX>[A
MSKA6V&D']FC,<37%M.?N'HXK3EF+226'JZ]7FYXXFA&RJHYB<III7(O,]):,
MJZ2I* T\Y])K!]V@[;RO7]:/1T6MAQ[WU$6;?:5*^T>J8[N*%C".I9K_GEO;
M&5=S^MKGCXF<W9D%L)JZ_[XVDHMCFEF_G%=7TC8R2.*^[SIG0:<3^D[#2S/7
M(5OUOG'6J*_F.M7<W=UQU2.O?8_NH6:\X?F_KX#W/JY_Z%7;J&G\IQ?I9YM@
M'"/NQE\1X=ZI]^!+[2GNG(NJ/9UA3>?S!GV]V-L=!S\PF4CFH9"O7]([1U,:
MEK6DGR3IW=UQD'=++.=E&&&Y1$<64\]GK"_GUCZAKGKRI\RG"F^B;35#%=Z$
MYNNQNNI)Q;((O7V-\GZLO'<M[[G*^]$JTUGD/?%]8-8*ZA=5B&FK3.<@T:6L
M,CW-%2RZCM?O)_&/H.=E?OC@[.XA<0+5?#(GTKV?4/GDMR;5-E)6+/ BIPW/
MBWO$U71]&Z2;&T34U4/.I Y^'IFY<K61556LF>=<DG)7^_$>O[0?IP'7JB*W
ME-?.N*Q5E8G"-[[$\&.$G%/P6/@L5<NFQ $61/!3IIB7;A+?CQR?RFCA >TL
M3IB$JW/G4>EJXJ>^E[1O5>'KMH.!;/CUG1\-_'Q=;>VH,#,0HCU $,  GKFY
MP1.$CQ[?!I&G:V%E_/3+K18]U9!?42$L7#)3514;]^'37*&+SD5!7F?^CZ =
MPVC#-':YC'20)" 0$%J*I<(WFQOPT1,L\TN<6P_9J3H^T7EM7?O?%8L6O@TD
MCL6\48H5QS#H?WI]6&9\23,>9+?.[_ );P1SFJK\[0] AC"C]&DL5S.INRJ9
M_"_,AJOOT0[H(%\<R? 7!SPS/PF#"&[Q%RQ9F$F#YDW5E?CE7Y>SR#(_,Y3(
M5AK\Y5-5CI&<3*#,$I>ZOO2<KM<+PH=?1M7V//G%C]=*M<KN4N/'4UZA,#Q&
M]9""PA3'#UK#)9T\['Q=)^K 4DGTY9<R7^WW^B:ZEO!B)OJD\L.5F=V,RSA_
MFU926+LV9NLU6L$U6F[?055J+\G"O6$KNXS:P27E2Z(;2_#BU5FVZGK95F[9
MWJW7;.76[*>E6;.%Y_GLUH.GC?]QL7);\I4*9V+X3F)\3L>_\\.XC^'2L?+6
M-=63C7)<[-^J8E[LA-]-,J.CB891FB=X^LBJ;D4E_!\?X:2"FD#FZ^6;R_)5
MW(/:SGKY5G7Y=BMO9.]-\*B7,7]8M+D0X<^WDG.&*9Y1RA#S2'C:IGX8PL^E
MDRY=I4>3Y\^Z7C6W<C#:WDT^@66;56W_X-7-ZGWE:,RDGO[<#V.N%:L@EOUR
MDS-?B2S\MC#':\^DT_R"%1)>**41O2 *TBRAHHK%7-"FJ-!ZPEUUT<^?NZ>Y
MO_>XI[D06:\7<$X+6-U?+^#J+J#J9'\5J[=,#YWW.HV_4LQCYHMI$QM1/[K8
M0_TZSN!('RYVFTJ&4XQTZBU?W:X6ZZ)?*E0QG_'-6=WWW:/]QZ,8"UJQM2(L
MDR(<5&MK15@K0G5W>C]SN=5@V1X[[S#T=![+TV9?TFXR9;^(N"]_W]DYV#E>
M2/,)E^CGTI.7DIX\,>G)893C.;SZL9PHS#[-4JL_Y9TD#[#EXIU.XVUN=.,D
M!_DM?1VYQA:/T,_Q38D?>M@8PD^GR$JD/XL]%(D]+GL\V)$#\POY6P2A3@_%
MGAQX7 3>W,#?W,"F#_MK<=>)0$MT9P<.%W^!#_%_!"DY@:K-99X"7I2VY./K
M38ZO+T1%2B/YLG*F!>B=A%U)+W2\W"FJ13\)X'T!PMYK!'KU$%SW=MSK!6F*
M>._<=^-S)Y7Y$,+,]SVX='AA^ #KVDW]#!N,C*9EB0<+SZ#S"3;VI+?QO7K<
MLJ_N"7<[Y?JH[J4)J8/0^+G&M'?[[/N0G(WLTLT-SVH\NP^R6^?=T<&N_BAN
M#U@*LS@/L-M<>RU@P[RK[1'R$[>HC5\E)TB=L@7=W @BH6R((W@/=W^U?)SC
M#056I3\,>^M 'OC1T.E@B#5H#;(X25WA5("96.]E7@+/N85#R$\<? Q,"HP(
M/B>(MFYC)&F09CK?Z[VN5:\='9JE)&UG.HL2=2]J075G[U$ML$PQJD'EJ&;4
MX)%MMKFA7XP+YDEGG*)YN GC%KPG#+ID4."WQQ?_.CW9JASA!V'-V]34M^2K
MI5@(3%Z@GLL++,0,CW[=\!G-,3LRQ3J CBL.Q_3P$5TX>=,L;G^7#DS4'5A,
MVKP%>ZR_,LH>*R.0LL%(^C%M4J4>K+ M#T_W5J8?OMP+G^\2?E14]I(<'+*?
M1&[3'A^5A:U9.6#/:ER#\"0K5&1?,:8Y[M/GO'LOZ6!'\"W84.HJ!J,Z8-J6
M4INP[5S8WZ2M+2_K.-AN#%]+?)\^BQVY].O(P69CW.9@U7N+W-./4,#LOVD*
MF-U710$SUB*;<.YI!!MC,7;X AR,6+\HH!?E_&"WNK//U$:)L[_[DTMF>/^P
MEM_;FQNT-XLFP#T\/!I_/JN];+6U.\@V%7?^\??#:N7@8YISU6Z2.$WQWM,-
MLFTKX,W3+#D4]$S@'7L_%098J?PTQDC4P3+@6%"I<8'ITI6Q%^9:0M,N@K&/
M!V@;P7" K>K'X#(2!,+N?A%3H#"<(="!ZI(?(*RGI[CG$8@!C\"3X"[H@)>W
M2)W-O;"C7BBZ:QU2E5K%. Z[Q1N<J&S)S6*\Q@Z?8,'8\:2VBL-WPC!N>XH"
M#/Q[O%/@T8(7>V$_^]9TKO'I@X20+,";SE2HH8T)JFX 3_")SJWC$X0&SJ$5
M1&H.66&$:F?ID:+SDL(&@MW?Q^!$E-G# *4-@_8#CMW ;/@_VC[LO;:7WN(C
M\:H"'E(8_#D(.JX3@I.>!.GW)XP==EKFJ#9)6)5#5ZX,.(N>]Y\8'O&@ $MN
MXQ /(SZT^;H%ISY"?;1BPK30<[A!+WY%-A!IRK7W0R7N%K)M_D#U:Z-SH)4S
M@U<J-XON1GN[I7$.M4,V-WB+U/:KDVP2VW*7O'&D8S?!88#J:ME@.1%68;4G
MQBXYA\-&6U&)+,]?*_ M0\<^7'C@\#YB&%K<70=[ZN2O[9?;T>+%W-W;K4VK
M(Y$9R[!NV)?O?)1-JP$J!7W;BTI5?-A(7EY>.E]CCSR'&[A\1FCBK%UBC9R&
MO/P*-JEVG1*:D1VST$HV7P5;R+T564YC7%*Q%CKN C/H^+V@G8O+WQ@,*8]#
M,BY8,M]I^3<8+D!.3OPC!8*IU9MN^7C<M 9I0#H!_SZC"#ZH(WD48'$R'P6(
MD3YX0OS@JV/.1LU"HE7SS'8XZ(!V=F@J&#'"XY\.6SPCP25(XW8@$4,O0M A
MU^F&_@_YK',?)]]!4^'"<PO_!"_4CVX9W*H=^EZDH]KP8P:'*0X2_CA(T&$-
M@U[ ]U>.=-W?^A%'XD"_04PNQS!TX J?U:8C'QW?.-HRL\2[-XRFZ[6#$,]F
M>E3DXX?AK6K:>EXJCX'?:\&1'G? "\"#FTI0419$*$O!071$!K"T]IHE_LT@
M%'PL A [.79NP.OP49.7/;KVQVT0^HIQE_PB"29J>;$<K(7 3S_ @Q_$XM%9
MAY=PB3J;-!-^QNN H%*#H);76_Q4-XA0F9!VUT] ?7JH,G2_P8\6MY+>0?Y=
M'-ZAYMS[]")07U37TH'<!R$\'79$))$SPQFL!BC#T]JCA@A*[,&^ B7CR#B^
M"K0D!3&2LQB!@WAJYD\!70RM8R09-@^Y!_CMQ._!^VF+@'P3W'+L4K?C0=BA
MMP<)O=EKL=K"0/QN5Y$E(T ;7?-R8^.3)*-$FV\O@L9L@Y_1\463PAN<=FUK
MD,&FR7C7T?73==H/+10$^<0/_"5U4LFY>S<(,2QJQJ<_C;&+]BVN!CUER\LR
MK_T=_PGG[@#YA>^"9 "W4!@&S#V->_>@9"Z>W7&&.844!H+X<(AVEZ5Z7@-*
ML&P[?] :PP&B=D#K5[.$;C[\">K!.4YCZQ1Y,Q[V,5TJ.#/)JANJ3 E:PL@/
M4:Z8X83?>YC0Z&$T%38"F+UDT#<;O1W&O%_$^1>#8Y%.&Y?%&I1E.O!W=-59
M;B.ACR]$[_/"-#9@@W<>*/@ 4\)(ZYVJU .S;3M,MNV!G G-D?/'L [6]E,+
MKTV"+64=256.M)VW<+I)W"N5)JJ+;=5[,1PX,2T[Z"OM.Q@1[$GOOI#B1G6-
M(U+!06I<K!PXHFLR9A2EC1A'4FF!TBW>9&H8G=R\Y+%Y3G*9K!8V6IJVAYDU
M.)# U("I?:"(-+RES5$E-728VR!"H=*:I+=Q@B$A^CWA(LJ^($YTNJN.F[F<
MM,; R_U(-%GE/QR]I++.2Z[$H!.WWIUO_"D$BPS!%J'0&3#32?&0%V!)# >0
M]N*\=3#$F%YM3?G+PF!O"[SM]0,L?.7$8I"QHR/8G';ZD#(Z[:#/<1<2<.YS
MZ _9#S$+%/D<.\R\[SGS+W[DB*FA[G4'^*B7RQ,<O.D\P=Y;R!/ CJ,Z C@F
MR8%A*ZQN 5X*YW5*'O^MKYW#;L[) RN=O^CPI9S\*_UA]=5(^8M@LGC#:MQ:
ME^."W3"^=R4F"%Z+.]K]S'D M/%MK^P'N#T9NLA>LD7/"&-0+$R\F6.,\L7^
MC0HN6N# +KNC?*/ 84<#<%'P$"67EDH3/,0'%O>8-JI=7T770UVF(9'.0:0-
M%EIS<&3 O6M12#<%D] *\;KE=P(\(9;<4G_!2(<$B<$WQ*76LX,5 )^+6AU0
M4.JP= MJ0V>GY0&0Y4<LX9RS[\3#UVA\#BXLY5&WG>8MN>=\08(GLH5-45=2
M\ +(H_3PS$<5P!.%''XW=^N':X ,S#XUO.A!:3 'A^U%)Z<X=2AG3'M(0RH/
MHN]1? _W#)PB3TN?Y'IZ?&\H3@]][Z?O#CWY)=>>::),7]5D!?F;S^LKGUPL
MJS]EOB&GW#5F_A'</^"*27M#ID/!Z<I'%9VEK,J]?$:Y*-J]V]QX5ZOMF;Q4
MQ:U4.,SJF2R(HY(@[(*_J^RX!X?549\J*:HHOI[*6E2Q(FX)I:EJAXP(MUL1
M65Q # .1*H,_FJ#_6U8JHP'"\=EP\ 9D4Y=<J?$HO;E)_!NLZJ$ILI6''W *
M=W#_B'30!2M("2W<2G!A<2!%$%2LKN6%'MV_;GV?4X-ZYV\[G_&R-$CZL8B)
M',8X! /!ELL+'\#ZL97+J+DKP+ATUT\$>A_6$Q>INO/Q&,:X33]7/I9GTNCE
M0TKCZHAB04\Q1MGY93[@[E.!JELO*%;"\R]<\/_HA0N#7Q_'0K$B-.[#@+.M
MQ/GY5X=A*N<YL5<HH>I:0B@AM"DBE%,Y5>8LF)?CVQ(#L7=82KM]/,KT3\X@
MLVRT[I6=<J[RFEN;EFAUA7C=YR>G7?=P6L[H-RFG]Q5W]W!*)L^Q0UMJ-M>S
M,B]P\HF_=@;,0W?G:&<U.3!73-)[[N'^C*R(:TE/).FJ6ZU6%R[IY6,BQ?OG
MTZ?\"ID:*W#2[2Z*J7'-C#DL[QWW8&=&1N6UO">7]T%M1D+VB82]E,R9U[E
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MWU1VX/'%R!J#]H==8>D8A%X2YD'HJ71ZJ]F&78LFSSKRTP&FUU+)D,+=!HS
M78QD89R'TUM/N,)#Y@>@G5O\&VSYKD_\'VQ;B? 0!>1+$5R)7/E"I(X;"T2>
M.CT+ Y?WX"B)708E3A3JX&/@M#.?C3/R5/%[L;@J4[-3^=_<*TW?,[T2#BJL
ML4*G!>XK'E,D(= ^YFSDM-/"8QLA-#Q\1<L/F$9(6Q]YB:)8,&[XB^0VL3U7
M# KX1E <98O4^6-[='03*HQRV_DMOH>'):ZBRB/:J)+ABD.E7EB^ZC:I W^"
M"A--1MTB1V)N,.-[>C("N0B#MEH#& B/-*^-D,?GV%ZT9VL_49,'R*/%7;26
M6:V_;"-[$TM-Y>:&VIBY?6R?1NIJFM,>GG^NZ#)?*?=Z#/,57_V=*R.31=$+
MC&@8/[0O;_SFL:WEUZA@=JR:3OI4!3'RD1RV[Z@%^SO[F(3BS]!^.H8G)\2M
M1Q]2;=>"']]&/TR'?8R=#E2D)<*T';F]Z:WL!QF+'@K9D7X@ 1G*Z.'&AF?!
M(=\+4B+9C#O$SP12O O:3!-I<M/$FZ(B./1>V<RI##)*@X[$R,@H\B#IL*/1
MB2U79HM^&?*&E 0-OL/_(;NLJUVJH8&93I'7HON&S!6+[NT0;!)',;IE^9#[
MBH3;ZW;8TIZ(JGY0+(L/8- TE:,)BFYN='SX@G*\\9/6?4FN:%Y'SF4TE^1.
MC'DK/</VYXL$,8;W)G?/@JUEHJ+Y,/+V_%6G&.&SGSI9L(P4+^C\]]\00.K
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M;5MRXW)=HN\EA8M8<YN2\>3*14M]8%W[ ]B#;=4(CO U^!VT4#IB+C5PJ44
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M+E&Z#:1GE@^BK_$-Q@3:=&.PH[Q895,2H\$"R6*,!@U@RD6[UGEHWJO/81@
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MPAX;=?SY2<GQ9T+1I0>A8T>VF9%1NYF,:\<\QETK*9<:]CQ8^^U2V,I7G-C
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MB1GM(% ,X&/ I2JV-= -,-=E#IM1UT&TTH;HMU13<1I]AOI_4UGZ88W>S;
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MT636&@$QHPR#-' !H/X#6%'Z"@E(0#AT3ST".V/0AB-I 4$<'_44HV</4?3
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ML&7I)$X>B\Q^93%XY$$!*G;'3Y'7I0%6W %\$/F5 )PK4/CB(/\1Q#+^P0-
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M)T%5MU0J\]EL>MW*#TQZ=YATT-?;T#4]3&V.KA"Z5,P4OOYH6]F^]7GK^;C
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M837KQ ]6Y-\V*Z-LMO49&@DU<[J2260T(HEFTF)?-P0XBPE'J$6,!Z5'KN%
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M^"7\6FGR,\:9>\C6"E0X;/\U;S]^_8'7U95CV>KH*44TI5$\_4 ?6Z"//2.
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M^!T;\)%:$%WBN* =5S,@CFH^: Z,)$5&VX$:R7U0_B60(*X3VK'P)\UPQP<
MV-0QC +O+R7Y 1@Y'"7=-EU_I4)=V)35J<]!*QP69#VB">X\B*$A"@Y(G1YL
MSJ&/)P[]*,RA'X#"0 %3S.@-G@/HH3:-!SK?D6$0VK0)X<:AI05;@RT/47(I
M8^9T<;1*O0NG@+GJ%0U43J;7#E&-F7C2UJ:??<2H%X\@CH^"]Q'-J:>#UQV
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ML!>1^L_A4(7]L=S07JNVO4#?2+#8$+G(E7!\B P4FEC!V>A(D".''#ED,4'
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M/6 W_QS68+DXG8AY)>IBUC@] ;JN(>3>Y65W1;IU:[+,DZE$BF:37C%8)N'
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M!-),,2[8FN"'G& 0\@ZNJR!\]X]+QNE8)+:5I*:C$MBC,"$X(DB?8E5L]K4
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MBPPI ;,!#W!+,Q4CNZ?*R3T02$0@C.%Z1B(QOQ,PO*+3X%X(;V RHOF2#0C
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MZN*.0^7^#7W0OOV*."A5ZA3,OP@8JIM@6"B9\"A"D)ZY_ E#=<I1/V#HDEL
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MD$L*+N<KDL*<%KF0D"<0Y#QOA?1W\'*!8T2KXW>4B^RD85NM7R#)A;9=4R*
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M8XZ-XQ/C]&0CBLDM-(+YS)#D0<WFD/_QZ>E'6),>61!?]AE?],@,!QZ8\$>
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MIH?FA_K0=#OV9]0?C'YMYBES%0CJ$R%Z1#B<+I6L"(*R#KW3/ZB "9(/CXF
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M);9'DW715%8@ZBW4NMZW)O%B ?!SZ@H;)OX;HCIP]FBS7JI^HS/3/()>"SQ
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M782P 6NUS"A"96CA2J+:*502ZSNFNUS>8D=_O_'K@UO.LO";.6E3X39_#*2
M5P4:7G *^86*H36T;%3(3B.G?766-QF3*.'Z)679(EZ(^)XITOC,S5%6)(#'
MY6RCT\,E>))R=K/(]7OC.)N#QSWKU)CW\($N(CZAZW'JR>7;D_FRUQ\-]YIQ
M(//DH"^C-"#SJ] /F7>+!4S$HO"N@L+&"X*'^7"VSE6=%)@N*54:FK$A=<:V
MFBXI&7;N.JXMLA6$@C2)[+?&\WP-DKN4ZV+N,)I#/(8$LKCUY&G0!QB@9.1*
M5W9Y7>,%HT@"3VP;L4=-'HWE$XFTDHOQZ?>+9SH;>[&;4"^\,:Z48Z1E)8U;
M:>O6S;.5MF^Q#G1?"J?XP>TMAK?IFZ@IS)SD\_HKKZEG3')P28[.Q+6,.2Y3
M%=?60%7AB9X#,UDF@.50&>(TVSC?45A<4IO/4(GC2(*^&4-=300LC4@*CG /
M05XH*2K>O#M1R-8<]_DDZO8S5B4#4WV0^\JIT9.E7A _^>'MY)FP&5=XH%14
MM.E;STKZC>28JYZ,.-QUJ-;<8G:'I8- I,AG<:7&K[N69;D"?.X\5#'[+^D0
M]MGP*\%]81T=+N)2S)>CYVX[*^;]$"Y4V+U=[/H7PSE<")C'U%^J9BK;HV[L
MZ,2L+2Q\_<ET!O-A\]C\J6(VJW(XC_+TQ'#N<B#S=TT:G_Q+-AF"3?NJQ/6I
MIFB6'3>P6=Q5'R7Q'AW:\ J-Z,ZOV*F=O+N3+WDP'!;B5S#Z]+KNU$+9<SEU
M"[,!%X2O-YT8N#6)%PN G[//R@B]D+GDN]Q\P?17R]998LJD?2OM8,,+V3C%
MOT'_=DY-WQ9X@!C<PHL T'+$G=-*I$U(O%!@0BYCKX )VQU:RQXGRQY9[LY5
ME[J=LTG:V8MMCK6I=H:W<!F5^5)D!)Z3<+]'@+W<8.>\:KEGV[KO24AI(#PB
ME"]2[-V%,:[CZI2)>S.C(GD8?W5C"5EZ26.KF 'QJU4)"(GH;,9K7>4TRJ7Z
MA;+08[$9 ["0W@"HIS<]=S^*)5OPV'!-W#7I6LCA:Y&1WG_-FF9HJE5[<1^@
M9[CY1JLLWR.WBJ8TJ[7."TB==",.40_JEDO%5L+;-9BW:S!OUV ,N 9CW%V-
M;71&S VE[\ TG<6DY!T88782;8'CR?J1<P;FO1$WVTO,.O_SAFN0!9NZ$?2F
M$"].)39U+7UJB]2MS:=3+ZNJ/L#1YVDMHG?LD[L>AI"%=6!(Z&B-8#K7U>"/
M+8G@=:IJ4XP[/-_6WM0O%Q.=BKM$\*:X^S"N&=-*E^*N5I@?**#-L-SUS<^Y
M0@QORKL?Z[@[KM>LOHW.O$(,;^J['^MXZJOMXF(M]'?]!]^#H<>H;UAK-[M^
M4]:=.,;344VW-#GA0FKQ7KE7KOEOJ!N3L_0MUN<MUN<MUL>X6)_5 :0D'VNF
MU.L[PRLDTSAGB&IPA1G!-87,+.:WN5$QN['<R$/ 7<72Z.73Z2.:SE%,0.A-
MYSZ.( P32\D)6= ^-5\8-N$-G!(M:(H<$<=\[$"#<1/56P#I+@&DYOHJC0_]
M>PL@U;]4'KX6F;QLOP60UA= JNFY<",B2)M,OC! X0I(U\?0I?6(B@!99:6Z
MUQ]>KR3+,8'K[:Q8I"LX[*KY&I+X$0)^C<8S/30L/AGI/*'MG#/B+9:[EECN
M:D]EWV*Y366GD?;@7R.6^^U)@[<G#?+A!.9Z2'BKS"!F5*7K%&G'T1QA_T\H
M2%E=>5?7IZ::58T'#(A9Q%,[O1Z57:+4[:=['R>%1Q#[2*9M573Q2K6L.M88
MYZ3?F7%I4IUA')$(A)X?WB['50US&J^K5ZIMU;/H\,X:)'1^HP4CXJ1#ZQM&
MI([ ('YG;YJGS*1FML^-G% 4DKI*M-5>YMFRGR!V?0)'V'?WB0^M#L1?4%>K
M9AYW*W)P-F'*@!^0,()#;WUK$;%/*>G,)[;%E#%D$J?+2@>%$09N%(.@KHNH
ME6-\I2/ (-YR#QJ,G>3WF2&27W9!!->AYTT9'U(@KU35FV8@]PSF4/5Y8V/@
MT 'LA\1W:]9<;I=O.EJ253QM_&B6-I95I;^*'HB%^$E[\,PR-WPQ]@$*'Y:V
M J.?3%$$@LW?=Q")!BCZ T9INNH_H;>9U%DA$*?.[E^?BC7(-I[&?GYU&KNT
M#7H(;^1<%^QLFL7QIL-5\(_K>#<W4E9B-% R9]"/8@S7UFU]QEQ!9Z]/+VMC
M$E?Y-+TPX="A%5*-]J'XP8&/VS>,G<$/>S =CAU[TL1K"A>Q'S"CF*R?"N_%
M./3)G'UKAUX?4DG,4> YBWN,'I:^/R%%G[8INKAR^EUG\&WRLV7_\\H975+Z
M?K9Z5^.!,_G.OEOM0=?JV^V)_7W8[UK.Y6@\_&&S8A/=+R=P'U3/*7J)!^7[
MYMR&YF)4ONPL:\&8N\SJHN3>55;CEOE7D7ED7#S+[Y(I538@8%515J@\<<8%
M&/!)I9U*+]2J5-9TL;F$-!3EF.>(23>[ZA:DD7&V30C;T,M5*^-+=J,J6T[7
M;>H28PI)X%<]A7(NS?3!#<*L]/,:K/#*#+>\KIMK._!<3@=WWM.V@%T"E^XW
M('[>)%$V* 25&H^]WGN(R(CAAD=HDUGAQE F,T$E77?2=I>9C!CN"6?%L]P4
M P^2.7IDM]W@ H4D6D;%JDUZJM4;?[UXOSFP%%G<DR-MPROQPC _%X7?\Y\2
MCY=L=/'K-/\X\MZC2T8,?Z]MWCY,$CTKKG=]JNFR]<X.$Q5Z>.+39HNW73=>
MQ %@*2WA/8:NG^:)O ]@PN;0:R\0COP_ES<.>#3RQ5Q5#X>G$-52?CC^EP$4
MJ(.HUN&)6$X-=]NAYX!FGX,/2=;8S[6<@#3RG#@=J3B&2<QJ2,1'5^]/MLEL
M=SKC*[MKV;^SO+C-G%^-X0,*'JC,F((.9QT,/3]2$M/[TX+'W(?]'U0>5M\9
MV-:P9W7&=M>9FI/<=Y/('G"3'.&YD5FP[1)7T[2!+  E.7425#'FF$E)1-L[
M21DKC#]2RF(7GR 5E=5V8"1G/9*"-\X@R8*4'1P4E]9SY"-@KT@.YA[I["\*
MDP]M]A*7H8<R:XLBBUGF?!%6TW1D(QPDJ!Q\XR:Y/HPBEF-B"5CN><Z7UG6J
M4T(L7-CF'>(4K:1IRID+A#%Z9,H%[NEOHN=R)AZO%5U9"*LR\81T&><@*Z)@
M\Y6X=K2,Q[1#09!LB48.7;HBLJJ>3#DG0TM #-P5>T_J3\@"MSLH8)XX#-B'
MY?Q"5MBGJ!.3""WH)\YIT3Y-'H1$*R%2P=>E?_!V8HQ9?,U^DS.OE8,0]JYT
M<:U6/;[,/@IOZ1>\Z,(;1>?7V;;SJS\<?&M-[?&EU;4O#')Y,9(<=G@;*X9=
M<ROH&7E9.!('5V%A8UQ;$E%L#2H!X<:[L]B 6HTG>4AT<6EM+BT1XY$"</-V
M>ELP95X47GD]+BTAD\7R,->M58U(3'9M[2TV0]U;5R&!+EWR/896YC4I**S)
ME249&D@%MI$3VS0E2CQV5J4:S]>\T]*?0VR<,R-+3Q>ZF!WWTUW>+;5T0RB*
MUI)6/0P9J9&A,&2:O55+?X13\ 1):_TSNXD>LDW;YL.^Q;N>\_QMV\[PTK:F
M[=_M"?MGTJ85@2<+9UIM(I1AD[AT]YG$KLX@_=FCW].H#"&%[R44I@U;(/0L
M+VTZH1<N&V^:T WRVH1 1G'?!S?++3A:W*-0=N'X_0<)R=U-,@'K)*$^6'5C
MN>M^FJ#>!IAE>2,CB).K[BU&9APE:C:<70#BN\FS)4$<06^[L) 1N=>J[?9X
MD(07C>RQ-?G>'MOTXW0.$XK3+BTTLVY8ITN56'9KP;1?BVX[+,)Z;H(U*R=:
M!R7O+R[CM5DP%IV6H'\;3D! 5>;ECJ=2>2'+<M?O.U>3*56>L=49#CKV8#I.
MGO=>!FCUAF/;^3:P)NU^HE@K((R%*RA6%DO"U!2-E<#1?:-]0L4.%5TI164U
MW5A?(9'=2]\J9XSOA,_V[=OFA93J\9A(GL180_T&T2T&]W/?!0'_02-!<7WW
MQ8NYC51 -[.=D,E@J7>;Z+A[<48.OWCS+QK)>8M4@#?D'6E($$;Z1*H2ED$O
M);6)#T; ]6>^*WK3)U>L:?^'DNXC,5[C'!^7ON<%T 9$?LMWJV3C,3ME^"_"
MS)VE&ETN^M0L#=O43J5$B-0^7T['>U9E%)^#F,=V?1>GQ_ !AC'L44)7F;Y_
M\Z/Y:@-!-\=!S"ZFL.TP_8_MC(51AV4;N_ZL*:><J@6\*TT*3L8F?55E-J>2
MP_I<2C7U7:HQY_@9-HQ]<J>P_Q35T13.O8U(LA_EE3=F7RH7RW8DMY #QI_L
MY^!?/%_ T)TO +Z37%N1UM2VBY7(1") #@<,,A?SD%> I1<JI#4UW7-1%8),
M=L6,,"E4H#[A&;E5KE? A@85)+9,:K<-H'135UA<UQT9U2&%U$@P;O)LNRZ*
MPXB"=:'_P!8&F7AX-70=;.\H(B$9W#&D+42[8,:0AQX**QVL/2*/131'2BK1
M;\)*QA@@DB@W!<J--COV%-2!&1N["[,>$X-S0RGUA:QOSP@SU147-L5N$*>C
MXV,W;XHK<EPQ"F5V@Z2BMNNVZI(J00A7;-6^NBOQYU^"?R&\5BK^V7M1.</-
M PYJ[LS4)-L'8 &'LPP\T6&OH'CSI^X"IB(5Q TM]0U)P,AE?6\I-;J&3Q^1
MVOJ=+ZCC-%>NVD@*N?+#7!YKZ6^A(G,+BC:^82_-7AYHKN[J/K85[,57):X_
M&F+G]-4.6I> %4Y/J]#H3;_9B%H,Q1E36=&"DN9S5@3<.,]@CJP4+;B%@J<9
M1;7,%Y J$0J[,EXP0?J=_8\]#D^__#]02P,$%     @ FT:Y5G^WIRAY2P
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M3;$G\0C=Q]8J60"JJ>/6,QA5S /B:IBU:R+CHB'/$AHC]93$\@ !7L163<O
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M;C+]<(,6HQF L=DX6:W"O R0C ,:.TR<.H[]SKJN+EW-L#+L$G4'\[J,'5
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MN#W48FON&2BW6=(W=B;]BF4O*=<>RC#O]BGW&JWX6K'!I4 :)^X.W@)Y:,J
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MYLR^PS[,IQJV?P.,<("J9YA+&YE3VYE;I9]<6/< C=!HHJWU *RCJGJMK@V
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MCC \9%Q**^$]L7 ZMP TT*VMCJNB >=$"^\SG,[7!;@C<A=>5&%+I9)X[S?
M\2T;4)6TZ#1T'2=1**9:ELMFU)ZU=:/*9,+[5;"H MXC#W5)4<B.SLV,1);K
M$V=@43\Y9[/M>!-[/)Z9+8%XEF0Q39"Z>$]$U&4,C@@Z>679=*8AS/<EVIA^
M7L"*4.7PKW\@@OGV1?L'(:U0;\Q=DML$W36)7#LW<QQ=+/D OUC2^<M1>__U
M>M&DX=6.YP6/G+QA0/M!?!\M8Z\<\JIV:^HU<\'75.K@A3[UYA;;S)RF- '
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MM &E]]PQ>A"N@MI2OP!W04G<JJ,R#1VIK@Y5CW.'Z#6@'C*\+EHSX) U,5/
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MXL<DEZ2XVKA^+AK7;/!I,+D;L/_VILS,\":W3(+]L[:<G,]NM-Z'.*JM"]P
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M5Q7'=T_*=*F,?I4,[9QZ#+WXR?57\UW(+4UZV%%=%,V[($>K?*HAD_34);<
MW)$?D15-7QFP(B#,JDIHFTA=P&'2MP3]3>Q%+C<R#>05=3"=QUK @V1O"?<I
MV4"@+A=#"W+615<D85N \CUH;NLFAU50&"T.51M<J;0M00Q%MSZP[_"GO]9
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MO^Z[&DK:DB[P!?K*WYUS_=CU5],M2;// .Y\GM+FQ>VH3@<0?:#.;"V31&/
M5E:\O.T1$ M3.#O:MNDSIZI^>=L@+5Q,83'G93F!3& KE[>1J8-2HRNL<Y]!
MI-V5SRRR@PA8_<O; >DA4UL%3'AT>B]JM5].5Q5@K5S>-JL.2B]"+4Z<,32;
MP7[K^.21XL7/&6?WM;26RO;5UR+RM>0\+-TP)-SILK\-O^/OZ@4^43Q!\]WW
M"J]+/^]IL?A'$@>,M_],QSY\Y]4!T] 6X(#H=%ED&.!K 5:_.+>*%BPO8DH_
M2'=X$DL]?U?5N3R?BQH!](UZJ8M<ONQWV;3#SU?IPW%*$\\+'BW?YD%3_2"^
MCY:QQ_X6Q-(CK#:^=7F.G/80;^OBF[5UH^1ZEC,[9'P<47M.[.2EY!^_JZ \
MN>\%J'A!3ANH2!=MV<FA:],FG#5ZN7Z9$S T3P^DZ:VK2U^N Z5*:G1*!&O
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M/GN?<[[SW_^[WWWNGCQ)9M;,K%FSVJPU[TOL)8[0M^@$>[@"@*$A( X  !U
M!]D-4((U"/@!(#P -;D. #Z0?3_J@9"#W\90@#^RI%^ '_R&0^3(=0[P^P"B
M1JY3>7K[ M<\ *IO<Q^#WX^ 9.-S !#;]?U?TP7IC! T=D>BD 'N2%]!+3-%
M*5E!*P\?%V10 " G(ZL(E5&$RBH*@A5Y%:B"' !0/H3\I/,AQ7?\M#P/*7^L
M]0#8*300RF]C:7[=$T3\YYX@<K_NB0+R'0<$2O$#-UW$-WS'O^$G_Q-[B;,
M$WD'CEJ&8'L.8"&W )??R/T#P&6 B8Z.CIZ.B9Z>B8V1@9&-DY6)B95S+SL[
M)SO[7C8F<OGV]^<%PLS(R,S"O(N%91<'"PL+!^F'A6-G"MN_@X#X'&"C UB
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MLA\NDK[\<KWE@8!+D1CZH_S+ ?]&^64]*1*Z'^P1U-[)Q@5)?(.#J3_:7S
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M"&02L@39H*"D8*+@H."C$*60IE"AT*0PH#"GL*=PH_"C"*&X3!%)D4"13E%
M44%13_&6HHOB$\4T!8X2H&2DY*+<3RE)J4*I16E$:4OI2NE/&4X907F/,IVR
MB!)+V4390?F)<H9RG8J&BIU*D$J22HWJ.)4%%9S*CRJ<ZA;5?:H<J@JJ!JH.
MJA&J!:IM:F9J7NK#U%!J?6IK:C?J(.JKU/>HLZC+J5]1=U%_I5ZEH:'AHA&C
M4:8Y3F-#XTD32G.+)IFFF.8Y31O-* V.EI:6F_8PK3JM$:T3+8KV*FTB;0%M
M'6T[[5?:-3I&.@$Z.3I=.ELZ'[J+=/?H\NAJZ=KIQNDVZ7?1'Z"'TAO1N]"?
MHX^BSZ3'TK?2?Z7?9&!C$&-09S!G\&2XP)# 4,3PBN$CPS(C(Z,0HRJC":,'
MXV^,"8R/&5\SCC"N,^UF$F?28CK-A&:*9,IF>L[4Q[3,S,PLRGR4V989Q1S)
MG,O\DGF(>8V%G46*19_%A07#DL12P=+.,L=*SWJ 59/5@36$]1YK&6LKZ\PN
M^EVBN[1V.>T*WY6TZ^FNGETX-G8V638C-F^V6VQY;&_8)G;3[A;=K;/;9??E
MW1F[7^X>9:=D%V;78H>S7V+/9'_%_I6#AD.,0Y_#D^,F1R''>XX%SMV<"IR6
MG,&<29PUG)^X*+E$N?2YO+BBN$JYNKDV]O#MT=R#V'-C3]&>]CWXO?OV'MV+
MV!NQMWAOU]X-;D%N'>ZSW-'<E=R#/%0\XCPF/$$\*3RO>&;V<>Q3VP??%[&O
M=%\_+P6O.*\I;RAO!F\++XZ/GT^/SY<OD>\EWPP_%_]1?D_^./Y:_DD!=@$-
M 0^!.($Z@2E!3D%-02_!!,$&P87]O/N/[T?O3]O_?O^FD)B0A=!%H6*A06$&
M815A5^$XX1?""R("(H8BYT7R1?H/T!]0.>!^(/Y TP&\J)BHE>@UT4K1";&]
M8OIB(6+Y8A\/,A^$'?0[F'ZP\Q#-(95#9P\E'_H@3B&N*.XNGB3>>ICBL-)A
MC\/)A]LDJ"54)7PDTB5Z))DD-24#)?,E1Z2XI$Y*792JE)J3%I&VE8Z6;I+>
MEE&4\9+)E!F0W2U[0O:B+%9V24Y<#BZ7)-<ISRRO*X^1KY)?5#BL@%!(4>A5
M9%<T5+RF^$*1H*2LY*]4I#2I+*)\1OF!<H\*AXJQRBV5UZK4JL=4,:K/5->A
M2E 4M!0ZKR:I=E8M3VWBB-@1Q)',(Z/J0NI.ZFGJGS0$-<YH/-3X!-L/<X*E
MPSX?%3[J<C3KZ+CF(4U/S0+-N6,RQ_R/E1_#:T&UPK2>:U-JZVE':+_7V:UC
MH7-?9TA72-=--U]W04]1+U3O^7'JXP;'HX_WZ//IP_5S]1=.*)\(.]%@P&1@
M9G#?X/-)\9/^)[&&%(8G#&,-/YXZ<,KG5*418*1O%&LT:"QF[&=<;4)C8FR2
M9#)F*FMZWK3)C-W,T2S/;-7\F'F4^8#%00NTQ0M+5LO3EKF6>"MMJQBK3];2
MUF'6;VUX;#QLJFQI;2UMLVQQ=CIV=^V^GE8\??5TM[V8?;#]&P<>!R^'&D=6
M1R?'LC/49ZS.Y)W9<C)R2G?".>L[/W!>@&O!X^'3+D==XEPF$>J(&,2XJ[IK
MC.N$F[I;K-ND.\S]GON,AY;'?8]%S^.>J9[XLT9GL\\2O:R\BKWIO,]X/_79
M[7/6IP')CPQ&MOD>]KWJ^\D/ZG?7;\'?P#\K !)@'U"%X@"#J1;T0?05]$B@
M1F!2X%J095!9,%NP3W#+.?%S-\Z-A^B&/ JE"H6'OCB___R%\R-AFF%IX9!P
MY_ 7&&',9<S7W_1^R[G <.'LA7<792[&7%RY9'4)>YGO\F^71Z_H7<F_RG+5
M_VK/-;5KJ=>IKGM<?W]#_D;BC>T(EXCFFS(W[]W<N@6_U7Q;]G;";6*D:^3[
M**6HE#LT=WSN=$?#HG-BV&)"8D9C#6,KX@3C(N)6[CK>?7-/X5YJ/$,\.OY3
MPLF$JD21Q#N)6_?=[W<E'4LJ?L#[X,8#?+)+<GO*T92B5+[4FZD;#ST>]J;I
MI56DBZ;?RZ#)",P8R[3,;'JD\B@WBR?K9A8AVR?[4XYI3D.N<FYN'F]>5#Y%
M/CI_LN!TP8="[<*J(LFBM&*NXIN/@<?HQU,E9TJZ2PU*7Y2IE!4].?#D03E[
M>40%I.)<Q4*E>^6G*INJMJ<GGK[ JF'+JZ6JLY_M?Y94PUD35<M0>[F66!=2
MAWON^WRFWJU^](7CBX&7UB\[&TP:WK\R>/6Z4;?Q99-F4]UK]=?/WD#?/&U6
M::Y\J_2VHD6QI?R=XKOR]TKO*UJ56ZL^J'[ MAUIJVV'M==W:'<T=NIWONTZ
MU=76;='=VW.ZYU.O2^]$GU??8G]@_^; ;Q^I/T8,[AJ\-\0[E#Y\:+CXD]*G
MFA'MD9;/9I\'1N&CTU\"OFQ]O3S&/'9O7& \=T)NXMFD[N2'*;NIK].^TYLS
M5V?99A_,'9Q[,G]TOF7!>N'KHO\B<>G6,O=R]HK"R@N<,6YHU7MU$Q^QQKV6
MLZZRWK1AM3&^&;1%NY5 .$3 ;AML?R1Z$XF_O(]V%/C^/AKDGQ2*;W^_*Y2_
M+S^'@@?V/_3^&V7G?;0'M#R4$+9?WT?[0FR @&$M0$-!^>O[JG0TU%3TE P4
M$( 1!--0_GP;#6Q14U'24M!!Z '2^V@4$$HJ""4EB20*&GHT2!\5&_5NFOVT
M[$( G2R'IIPP)[W),2XG$?D]IGX7]CI'']!**UD05?!GX*YO4Q0;,5.ZN!B3
MKFT>H*.KK <_:&%IQ5/ZHOWSDLLE5.QE1$;9RX[10RJNRVAQ5>AQ_1-@L.;F
M[N$9&!1\+N3*U6O7;T3$W;T7GY!X/_-15G9.;MZ3\HK*JJ?8AE>-3:_?-'=V
M=??T]O5_^3HV/C$YM8);Q:^M;["12":]OT9-145%0T/M#9+,1K5_-[4L#2#$
MKFE"*^?$X4=W[()P-*=IFC.7/'V)2'V;EO_"GI&+"@=BS/;"M1?32T45N<V5
M=%S$& (NQ>JB2/1:(-"6RI>OD E>/L03E_F$]"+;W9TWV0[J6;FJ_'B9[>>[
M=,>MW8.O)^14O>Z=6%/5M_$X=R,Q]^F;OLEU<>@)6\^0B/MYV.;^J8W?O_(V
M/#J,Q3O@YVIZ:C:+T?/ATX.A?P/^!OP-^+\.@"%^^&',G1)7#01N9.2\_GIV
MHB1AXS@B)[_HM86FCIX!%5MB5DIZWJ.[;&R<R8D) $2D-Q3O,%6V;8!18;WH
MN(<K3W+^8[5;@,NDJ9.H0!'>S7[N68'9,4^VATF\\G%+^;39"(3@+AO:KBJ\
M%5V3NFGJ62+PXDFMY.Q&_Y34D^FA5ZU/Y$[%=7'/U64KQ$R<VRWJ>4MWHH2F
M+:GX4PR,G]#5(!&\8K)<MU!<^(J_>&[\F'=(U& I$>#J#ZT]_#+@;5C%F$9Q
MQ[: 8WB3W8*1?O$&XV89$9CGWR"] )F,(P)]RG7PPC7UT.V+VS-$8+.IMIH(
M?' +PZP:SO=.#[$Z$(&'==6P[<7Y(B*PPCWL2(@-787B+_7434C/M1*!9Z'3
M=02:H!XBX#)$B*SYA)O_TQ6*@__+*W1E$(&#P^/X&DRB\IN"J&/C&ZGN,\WB
M4K4?-S\@?*O"WFE9MG^2ZWW@:<9=VG=_8J7J==FN_4_;)5XT",#S%$)T0OJ(
MP##V;#$HC>DA0@\67X>>NQ#^>9VYO8;VM\*/895]2<)P$Q.33BLZ9:GY@7TA
M%170D'-YYU$<?1O-CH>KLN\*6R#-#IFL*.'M@ >0;JRC1-V(:>JNC?#L_958
M.\9J->$ 8W4=Y2'SV5NZ;NZM%I2='=.7),OQ<F4OVO4H#U_YNK=R!3^7;*T_
MVL6%M]H2+QMS(,1@XPLW\(6KEE"_(^:X)P&!EJR23*;<,:HF9UI/7-2QTA7X
MK1F676.5327HEO=NN.[]\/K]^?M//7/#;? ^#;M/=3 8QO>K?;YX3] E:$$W
MMOLUBCGD:%V;U3"V]O+*A"KLW<#Z0P*L#[]N1 0R;@9C<$9UZ%GZR7:\"Q&
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MI_-\=)A]/YT(YYS$M0"=M?RX[O'6HFS^A?R$V<V6V-X)>S_/BG68QS^WFNF
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MOJ3%/ONS#?^^V7+?E):9W5913FZP?7(3\J;Z^:7[NN84%^7WI+6GQF!G[#@
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M4_P;"? $T8*-2SR$3MP'S]]F_^,G'Z-"U]%%B-@]5>+.WA#_LCL4A)Y^RQ:
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MG6@XADF#'ZB1 +?AV[;!V21 :)WNGQ&H7U[ 0R(,3KQYI'L\%XK.;XM4IY
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MSJ/!R."UVW_=7HLP)Q)@B@N?10)TA&Z""0=30#(:B$(OOFPB 1:/*0&AY\M
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MA523GX(F$XH1;<I "<-YUFN#9'+Y7]>8_;OK^]N2O%<] P9++2Z^^S<OG?_
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M*RO?!!4KJ6?>E7!,AZERA+]RK+@U.<JWV-:CN^Z ]2^88(ECTA9EDZ>(HBN
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M$9V@EMX3N2TQZ$+6>NY093+=$\4B_2?Y.HV%AK7-VQUT\OX"CBL72GLYKCP
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M52BRL>128-"D-0Y(06FBMQ*=2#3VEL1\O#&MN8D'[?>R3@875RY[_IQ;U9#
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M/MCP60J%=5B,P"*Z%P/8.R<6B%C:L:'FCY7!H:4!/-J]</=V[X8A'='SG3?
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M.WNG9D^_QBP%CX)]^M71K,\![)LA?\L# ?JAF"NVI3@@F X>N*S7LZ,9% %
M;3?^(:DDY_U)4OF7[U^0M7H!?6"^AGV>14R>8V$;<HG]+OY-GP>5SARTT++>
MHT!WT, 9+(X_/RMP'/5LJ1T0DEFUJ&+R;\_2-5N8F-B8JBLZ:^^&5PH:;M)3
M-S8GFFJK9L18NX2;628\3G"^H+LQE%O<%E<_0:!YK$"7>,[/8B_02UJ\16O<
M'U_^:J*WA]AO;D:W8+VT6@@Z0=-,S'^:5/EJ*ZP,NHXOB*JA)&DZ,F4P8Q+>
M1C9?$U??C*K03L]7#)@,U,WDFKU3,1^/!HWXQM*;=5@QQ6.2<1S0=QQ]D2)
M.-&I+PC'98PE92/Z)2 L4'J$OE\%BE4YLX"0B.IAVX28-D+JW;Q%-/DE%\C\
M#9-Y<=5RYR_E>57K5C><I]TZMOP6_W?MT*N1Y5 @5.V_2=.=[NI$3[C\)3F^
MQ/_(_("ZY4_C4<VF=5_I9S?<"'U)$46D5_8_\C[.F*_@YP_JZ^(^R:%I\2)7
ME234&YR-ZJKHL[ 'S.  ?B6SM<X/BH3!X%]6)W6_+9I$I<*E%E($<E?0M,,>
M >QMZ#YGU6"7Q*W6>8Y':]WWZ/*,97P")>%WZ8? C1HX($<@8J53"L$7SU:A
M?KL]-X66%(6X%NGI[2$2VS5&$1Q+BY S,'$T4#44TSMPQ@1>%+6U'+S)I%EZ
MBKN+#"<]0:;!5A1IDRM%%KY^8W,AW0_7:X7VEWF JT)$^_J2\\/*>B],[ZK,
MS5>XT91@OB+)(K5&0=)C/@(>]-Z[,U;V]KV-(V'-8W2XJ+C+F%87]/P]!P.L
MC9R]?*O2?4/F0U- P_3>04KW'".B7Y@TV;XSPH?-SQ.2CT(."Y4S[,@E=A&:
M5PP^"X104FW;)%,5-6*9,O'C"/VB1"B);,L3EZ@KDN\\*-:4HGOD@>Q3&8T2
M)2#O=SBV3'FEHP-(+I,FB&=#&DQV6&N>4'(Y*R\WS<T_=W1(6%ANX<S&=^ [
ME1*>+P_N@87_4E0D2X4V<XD:C?D;2NFFV?-S<VS,C/@>"$0%%*J8U':1MAXF
M&N0&=G)Y8V@4'^\>^"S5KH9$9S0E*]C&&O"!-MTJD3IQ#!C^OQ=#S630XC-\
M" <A,)1OFT-EZ0IKL;J:9T-NH7->6,N> *_W<]-VAB8SHHC2Y!FB^/5?SIO2
M\5N!\!YT',D!B>CD?2)S_>,OQ$U;C+7[KLQ&Y#,+8'$$1T (I\[45\>\'2KW
M%F%8ZES;DADOFU(HR-<7V/?P;L>M3')+_#0KD+G^%9+URI$7W_7;3L_YIJL%
M:#EH!)-8GK)7O4'3KM[?)"&L;63ZG7:,RX-N29C*HR[I1P\VBE7IWAU<0Q=2
MAX[%[=HE 7?]SF+?]_Q285[3X64'K3&I-O;#%7I$@6>,4FY0[Q7Z>YW:G#1_
M?/;'#WF+5]^XX%AM?:6A >-L0$\:YA>?HA+\B@B<_K_2?^@'\ /XAX!WITK0
M8R^X%4G<O!U9O2;4H4"?F3$&LP4V6Z]CPP&-^LTB6=,'&5GM.?D+,?<G"7[>
MA=COE&\.H6;_,6OX ?Q/ $?.VQ]NX ?P+^T&_JR*^[_:^/Z/ HZ<GA]NX ?P
MPPW\_P8<_UI3TA_ #^ ? [9HHXYKUVF?%^L:[QU;G*:OJOOD]C>N5 ,Y]&UF
M[+H2 6W%M&4)H(66.ACD5G0M#,V $(+GV9,,=4I3X4TR]U@8]!0'],R+ R+L
MYX"*I A^L\MS=[A=3UM'V+,<4"9R#&(0NK*7 5M)P\@/MC!A#*]BO0H.R)V<
M$LQP()XD<EM$_K6R03^ [P"<@7\#4$L! A0#%     @ FT:Y5MW,"C\ZFP$
M:[P- !$              ( !     &5P<S$P-SDV7W-O=&LN:'1M4$L! A0#
M%     @ FT:Y5E!' 'X% @  9P<   @              ( !:9L! &5X,C$N
M:'1M4$L! A0#%     @ FT:Y5D"2MY1, @  '0@   H              ( !
ME)T! &5X,C,M,2YH=&U02P$"% ,4    " ";1KE6:6+Y6KH"  #W"   "@
M            @ $(H $ 97@R,RTR+FAT;5!+ 0(4 Q0    ( )M&N5:]&BZ>
MPP<  -DD   *              "  >JB 0!E>#,Q+3$N:'1M4$L! A0#%
M  @ FT:Y5L.*KZ*M!P   R0   H              ( !U:H! &5X,S$M,BYH
M=&U02P$"% ,4    " ";1KE6XYL'>0,$  "W#   "@              @ &J
ML@$ 97@S,BTQ+FAT;5!+ 0(4 Q0    ( )M&N5;O6N;_!P0  ,H,   *
M          "  =6V 0!E>#,R+3(N:'1M4$L! A0#%     @ FT:Y5KQ7WZ-X
M#    G(  !$              ( !!+L! '-O=&LM,C R,S R,C@N>'-D4$L!
M A0#%     @ FT:Y5@"E0.5X$0  N,X  !4              ( !J\<! '-O
M=&LM,C R,S R,CA?8V%L+GAM;%!+ 0(4 Q0    ( )M&N5:1-[32U!H  )%Z
M 0 5              "  5;9 0!S;W1K+3(P,C,P,C(X7V1E9BYX;6Q02P$"
M% ,4    " ";1KE6?[>G*'E+  !_/@0 %0              @ %=] $ <V]T
M:RTR,#(S,#(R.%]L86(N>&UL4$L! A0#%     @ FT:Y5I*HX7'\-   L%@#
M !4              ( !"4 " '-O=&LM,C R,S R,CA?<')E+GAM;%!+ 0(4
M Q0    ( )M&N59ZVIW'!24! /!] 0 -              "  3AU @!S;W1K
?+6QO9V\N:G!G4$L%!@     .  X 2P,  &B: P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
